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Abstract
Abstract
Chiral aldehydes are versatile intermediates in natural product synthesis. This thesis 
describes a new three-step strategy that combines oxazolidin-2-one chiral auxiliaries 
and substrate directable reactions in a novel manner for the asymmetric synthesis of 
chiral cyclopropyl aldehydes (Scheme 1). This protocol utilises the stereoselective 
aldol reaction to reversibly generate a stereogenic /?-hydroxyl centre (Step 1). This 
new ‘temporary’ hydroxyl group then carries out a substrate-directable 
cyclopropanation reaction to afford a cyclopropane aldol (Step 2). Cleavage via an 
anionic retro-aldol reaction regenerates the chiral auxiliary and an enantiopure 
cyclopropane carboxaldehyde (Figure 1) in excellent de and high yield (Step 3).
In contrast, simple Evans’ auxiliaries failed to cleave under the same anionic retro- 
aldol conditions. The phenylalanine derived syw-aldol underwent a novel 
rearrangement reaction to afford a chiral l,3-oxazinane2,4 dione when treated with a 
catalytic amount of diethyl zinc (Scheme 2). Alternatively, treatment of alanine 
derived syn-aldol with potassium terf-butoxide resulted in a novel elimination 
reaction to afford the a,p-unsaturated amide natural product, Semiplenamide C 
(Scheme 3).
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Synthesised Aldehydes >95% d.e.
Step 1: 9BBN-0Tf, !Pr2NEt, CH2C12, -78-0°C; 76-87% Yield, >95% d.e. 
Step 2: EtjZn, CH2I2, CH2C12, -10-0°C; 89-99% Yield, >95% d.e.
Step 3: LHMDS, Toluene, 5°C; 51-75% Yield; >95% d.e.
Scheme 1 Figure 1

















The principle of this temporary stereocentre methodology was then further explored 
through the asymmetric synthesis of the cyclopropane containing natural product, 
Grenadamide (Scheme 4). Cleavage of the oxazolidin-2-one fragment of the a-chloro 
cyclopropyl syn-aldol with phenylethylamine and subsequent treatment of the amide 
product with samarium(II) iodide, initiated a P-elimination reaction to afford an a,P- 
unsaturated amide which was reduced to Grenadamide.
‘C7H15 Phenylethylamine




Finally, electrophilic cleavage of the cyclopropane motif of these syn-aldol substrates 
was explored via treatment of these compounds with mercury(II) trifluoroacetate for 
the synthesis of chiral lactones and pyrans.
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1 Introduction
Chapter 1.1 Asymmetric synthesis
1.1.1 Chiral drugs
The field of asymmetric synthesis is vital to the development of new pharmaceuticals. 
In 2002, chiral drugs represented a $159 billion market, with approximately 30% of 
all drugs currently being sold as single enantiomers.1 Chirality arises in a molecule 
whose three-dimensional structure has a non-superimposible mirror image. The two 
mirror images of the same molecule have identical physical and chemical properties 
in achiral environments; however, they can exhibit distinctly different properties 
when interacting with chiral environments, such as receptors or enzymes within the 
body. Therefore, the two enantiomers of a drug can have dramatically different 
effects. For example, the widely used anti-inflammatory drug ibuprofen (Figure
1.1-1), which is produced by the chemical industry on a huge scale every year, is sold 
as a racemic mixture of the two enantiomers, despite most of its pharmacological 
activity being attributed to its (5)-enantiomer.2
Me Me
(/J)-Ibuprofen (S)-Ibuprofen
Figure 1.1-1 -  The two enantiomers of Ibuprofen
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An efficient asymmetric synthesis of the (S')-enantiomer would allow for a more 
effective drug with lower doses, whilst also creating an opportunity to extend patent 
protection. Therefore, the field of asymmetric synthesis continuously strives to 
develop new methodologies and reactions for the development of structurally 
challenging chiral molecules.
1.1.2 Different strategies for asymmetric synthesis
The aim of asymmetric synthesis is to construct chiral molecules in the most efficient 
and effective manner possible. This is a challenging task, since enantiomers display 
identical physical properties, other than their ability to interact with plane polarised 
light. The simplest way to prepare an enantiopure compound is to use a chiral 
building block available from nature via the chiral pool. These naturally occurring 
chiral molecules are often cheap and readily available from commercial sources and 
may be derivatised in a variety of ways for the synthesis of more complicated drug­
like compounds. For example, Abraham and co-workers3 have exploited L-tyrosine 
methyl ester for amide bond formation from acid 1, followed by preparative HPLC 
separation of the resulting diastereomeric mixture (2 and 3) for their synthesis of the 







Reagents and conditions: (i) PyBOP, NMM, C //2C/2, RT; (ii) Preparative HPLC separation.
Scheme 1.1-1 -  Chiral pool synthesis from enantiopure a-amino acids
15
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Unfortunately, the variety of enantiopure starting materials that nature can provide is 
limited, as is the number of transformations that can be applied to functionalising 
these molecules. In order to synthesise compounds that nature does not provide easy 
access to it is necessary to devise alternative strategies for their asymmetric synthesis. 
A simple approach involves carrying out standard synthetic reactions to generate a 
target compound as a racemic mixture that can then be separated by kinetic 
resolution. For example, Liu and co-workers4 have employed a chiral salen derived 
cobalt species 4 to catalyse stereoselective ring-opening of one enantiomer of racemic 








Reagents and conditions: ( i)4  (1 mol%), H2 O.
Scheme 1.1-2 -  Kinetic resolution of racemic epoxides
The chiral catalyst reacts faster with one of the epoxide enantiomers of the racemic 
mixture by creating diastereomeric transition states that are different in energy, which 
results in differing rates of enantiomer hydrolysis affording an enantiopure diol and 
epoxide, which can then be easily separated by standard chromatographic methods. 
The main disadvantage of classical kinetic resolutions is that the maximum yield of 
the desired enantiomer can only be 50%. Therefore, current research in this area has 
been directed towards developing dynamic kinetic resolution protocols, whereby the 
starting material is continually racemised in-situ, so that >50% yields of chiral 
products can be achieved. Kim and co-workers5 have demonstrated this dynamic 
kinetic resolution strategy for racemic a-chloro esters using diacetone-£)-glucose as a
16
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chiral auxiliary in their synthesis of chiral a-amino acids. The a-chiral centre of 
esters 6 and 7 are continuously epimerised under the reaction conditions, whilst the 
secondary amine then selectively reacts with only one of the diastereomers, to afford 





Reagents and conditions: (i) 1,2,3,4-Tetrahydro-isoquinoline, diisopropylethylamine, tetrabutylammonium iodide, 
CH2 Cl2.
Scheme 1.1-3 -  Dynamic kinetic resolution of a-chloro esters
Enzymes are nature’s own chiral catalysts and have been exploited for asymmetric 
synthesis through a variety of transformations, due to the high levels of selectivity
7observed. For example, Williams and co-workers have used a lipase enzyme 
catalyst in the dynamic kinetic resolution of racemic alcohols. The transfer 
hydrogenation rhodium catalyst acted to continuously racemise alcohol 9, so that 
under lipase catalysed conditions only one enantiomer of the alcohol is esterified 
(Scheme 1.1-4).
17
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<^ H (i) QAc




Reagents and conditions: (i) Pseudomonas fluorescens lipase, Rli2(OAc)4, o-phenanthroline, vinyl
acetate/cyclohexane (2 :1 ).
Scheme 1.1-4 -  Enzymatic dynamic kinetic resolution
A potentially more efficient process is to use a chiral catalyst to prepare a chiral 
molecule containing new chiral centres. This approach again relies on the principle of 
diastereomeric transition states, whereby the two faces of a prochiral centre within the 
substrate become diastereotopic due to coordination to the chiral catalyst. For 
example, Jacobsen and co-workers8 have developed a chiral chromium(III) Schiff 
base complex 10, for their asymmetric Diels-Alder synthesis of quinone derivative 








Reagents and conditions: (i) 10 (5 mol%), toluene, 5A MS; (ii) DBU, air.
Scheme 1.1-5 -Asymmetric catalysis
Finally, the most commonly employed method for asymmetric synthesis is the use of 
a chiral auxiliary fragment for asymmetric induction.9 In this approach, an
18
Temporary stereocentres for the asymmetric synthesis of chiral aldehydes
Introduction -  Chapter 1.1
enantiopure substrate is attached to a prochiral molecule, which then controls a 
diastereoselective transformation before cleavage of the auxiliary for subsequent 
recycling. Badia and co-workers10 have used this concept in the asymmetric synthesis 
of aldol substrates using (S^-pseudoephedrine as a chiral auxiliary. The /V-acylated 
chiral auxiliary 12 underwent a zirconium mediated aldol reaction to afford aldol 13 
in 90% yield, 88% de and >99% ee. It was proposed that coordination of the chiral 
auxiliary fragment to the zirconium catalyst was the driving force in controlling the 
stereoselectivity of this reaction. The chiral P-hydroxy carboxylic acid 14 was then 
cleaved from the chiral auxiliary fragment under acidic hydrolysis conditions in 91% 
yield (Scheme 1.1-6).
Q H  O  
Ph'^V ^'O Hi
14
9 I 9H 9 I  91% Yield
\ A NA^Ph _£U . PhA ^ A NA^ph a ,
I I  i l l
1 O H  5 1 O H
12 13
90% Yield I
94/6 synlanti H  O H
>99% ee
Reagents and conditions: (i) LDA, THF, then ZrCp2 Cl2, then PhCHO; (ii) 4M H2SO/dioxane reflux.
Scheme 1.1-6 -  Chiral auxiliaries in the asymmetric aldol reaction
This project seeks to exploit chiral auxiliaries in a novel manner for the asymmetric 
synthesis of chiral aldehydes and as a consequence, a brief overview of the methods 
currently employed for their preparation are now discussed.
19
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Chapter 1.2 Strategies for the asymmetric 
synthesis of chiral aldehydes
1.2.1 Introduction
The increasing demand for the synthesis of complex natural products and chiral drug 
like molecules has driven many research groups to investigate new strategies for the 
synthesis of versatile chiral building blocks that can be subjected to a variety of 
transformations. Chiral aldehydes are important compounds in this respect, due to the 
range of versatile reactions that the aldehyde functionality can undergo. Simple one- 
step transformations can convert this functional group to a variety of substrates in 
high yield, thereby providing a simple approach to introducing remote chirality into 








h 2n  r
n h 2o h .h c i





Figure 1.2-1 -  Range o f one-step transformations o f the aldehyde functionality
20
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Chiral aldehydes may be synthesised from chiral amides and esters via hydride 
reduction; however, the efficiency of this reaction is often compromised by the 
difficulty in controlling the reactivity of the resultant aldehyde equivalent to avoid 
over reduction to the parent alcohol. For example, Paterson and co-workers12 have 
utilised this reaction in their synthesis of Scytophycin C (Scheme 1.2-1). The key 
chiral aldehyde intermediate 17 was synthesised in three steps from commercially 
available chiral ester 15 via formation of Weinreb amide 16. Coordination of the 
oxygen atom of the Weinreb amide motif to the counterion of the DIBAL-H reducing 
reagent afforded chelated intermediate 16a, which limits over reduction to the 
primary alcohol in this case.
17
TIPSO Y  ff  P(OMe)2
OMe O O
Reagents and conditions: (i) BnOC(CCl3)=NH, TfOH (cat.), Et20 ; (ii) MeNHOMe.HCl, 'PrMgCl, THF; (Hi) 
DIBAL-H, THF; (iv) (E)-butene, KO'Bu, "BuLi, then, (+)-Ipc2BOMe, BF3 .OEt2, thenNaOH, 30% H 2O2.
Scheme 1.2-1 -  Reductive synthesis of chiral aldehydes
21
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Chiral aldehydes can also be synthesised through the oxidation of primary alcohols. 
Miyashita and Hayakawa13 utilised this reaction in their synthesis of a chiral fragment 
directed towards the asymmetric synthesis of Swinholide (Scheme 1.2-2). Therefore, 
Sharpless epoxidation14 reaction of primary alcohol 18 followed by subsequent Swem 
oxidation afforded chiral aldehyde 19, with no epimerisation of the potentially labile 
a-stereocentre. The mechanism of the Swem oxidation reaction prevents any over 





OMe O ^ N
Reagents and conditions: (i) Ti(<yPr)4, D-(-)-DET, 'BuOOH, CH2 CI2; (ii) (COOfe, DMSO, CH2 CI2, then Et3N; 
(iii) Na[PhSeB(OEt)3], AcOH, EtOH; (iv) (E t0)2P(0)CH 2 C 0 2Et, NaH, THF.
Scheme 1.2-2 -  Oxidative synthesis o f chiral aldehydes
These two strategies rely on manipulation of the oxidation state of the parent chiral 
substrate molecule, which clearly increases the number of steps in the synthetic 
protocol and risks epimerisation of any newly formed stereocentres. Therefore, this 
review will now focus on methodologies for the direct asymmetric synthesis of chiral 
aldehydes that do not rely on oxidative/reductive steps to generate the aldehyde 
functionality.
22
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1.2.2 Asymmetric hydroformylation
Hydroformylation is an atom efficient one-carbon homologation reaction for 
converting an alkene functionality into an aldehyde. The key challenge in this 
reaction is the formation of the new carbon-carbon bond with both high regio- and 
enantioselectivity (Scheme 1.2-3).16
Scheme 1.2-3 -  Potential products arising from the hydroformylation o f mono-substituted 
alkenes
Takaya and co-workers17 have developed a protocol for the asymmetric 
hydroformylation of olefins catalysed by a chiral phosphinephosphite-rhodium(I) 
complex derived from ligand 20. The reaction was shown to be effective for the 
hydroformylation of various acyclic and cyclic 1,2-disubstituted olefins (Scheme
1.2-4) with up to 97% enantioselectivity and 90% regioselectivity. Unfortunately, the 
reaction requires high pressures of hydrogen and carbon monoxide gas to obtain these 







Reagents and conditions: (i) Rh(acac)(CO ) 2 (cat.), 20, H /C O  (1/1, 100 atm), benzene. Note; absolute 
configuration o f products not determined.
Scheme 1.2-4 -  Rhodium(I) catalysed asymmetric hydroformylation of 1,2-disubstituted 
olefins
23
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This protocol was further expanded for the asymmetric hydroformylation of 
conjugated dienes once again using the chiral phosphinephosphite rhodium(I)
1 ftcomplex catalyst derived from ligand 20 (Scheme 1.2-5). The reaction proved to be 
highly selective for the terminal alkene functionality of diene 21, affording chiral p-y- 






Reagents and conditions: (i) Rh(acac)(CO ) 2  (cat.), 20, H fC O  (1/1, 100 atm), benzene. Note, absolute 
configuration o f  products not determined.
Scheme 1.2-5 -  Asymmetric hydroformylations of conjugated dienes
Due to limitations with this phosphite ligand strategy, Breit and co-workers19 
developed a substrate-bound catalyst directing group strategy for the asymmetric 
hydroformylation of prochiral bis-alkenyl carbinols. The desymmetrisation of these 
compounds is achieved through the formation of an o-diphenylphosphanyl ferrocene 
adduct 24, via coordination of the hydroxyl oxygen atom of bis-alkenyl carbinol 23. 
This catalytic species then directs the hydroformylation reaction to one of the alkene 
functional groups with excellent enantio- and diastereoselectivity (Scheme 1.2-6). 
Cleavage of the ferrocenyl directing group was achieved through saponification; 
however, this did require prior protection of the aldehyde functionality as an 
acetonide group.
24
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OH /C D G  /C D G
® V 00 ?
lBu lBu tn., lnn 1
H
Bu Bu Bu Bu O
23 24
75% Yield 82% Yield
>99% ee >95% de
>99% ee
CDG = ' Fe " PPh2
Reagents and conditions: (i) 'BuU, o-DPPFA, BOP; (ii) Rh(CO)2(acac) (cat.), P(OPh)i, H /C O  (40 bar, 1/1). 
Scheme 1.2-6 -  Hydroformylation desymmetrisation
1.2.3 Chiral auxiliaries in the synthesis of chiral aldehydes
The aldehyde functionality has the potential to reversibly react with a variety of chiral 
molecules to afford intermediates containing prochiral fragments that may be 
transformed in a diastereoselective manner, before subsequent regeneration of the 
aldehyde functionality. For example, Yamamoto and co-workers20 have used 
enantiopure tartaric acid to transform a,(3-unsaturated aldehyde 25 into enantiopure 
acetal 26. This substrate was then employed in a Simmons-Smith cyclopropanation 
reaction to afford cyclopropane acetal 27 in reasonable yield and high diastereomeric 
excess, which was then subsequently hydrolysed back to the cyclopropane 
carboxaldehyde 28 in excellent de (Scheme 1.2-7).
25
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P h ^ > y H
O
28







Reagents and conditions: (i) (R,R) Diisopropyl tartrate; (ii) Et^ Ln, CHjh, CH2CI2 ; (iii) p-TSA, H2 O.
Scheme 1.2-7 -  Tartaric acid directed cyclopropanation
This type of aldehyde derivatisation strategy was subsequently employed by Alexakis
01and co-workers for converting dialdehydes into a-aminoaldehydes. Glyoxal 29 was 
desymmetrised by formation of monohydrazone 30, before its subsequent reaction 
with chiral diamine 31 to afford chiral imine 32. The chiral imidazolidine fragment of 
32 was then used to control the facial selectivity of nucleophilic attack by methyl 
lithium at the imine functionality, before subsequent hydrolysis to reveal the a- 

















NHBoc P l T ^ }  HN—NMe2
73% Yield 72% Yield
ph' Y
p t A ]NH\
31
95% de
Reagents and conditions: (i) H2N-NMe2, (ii) 31, (iii) MeLLLiBr, Et2 0 ; (iv) H2, raney nickel; (v) (Boc^O; (vi) 
HCl(aq.y
Scheme 1.2-8 -  Synthesis of chiral a-aminoaldehydes
26
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Enders and co-workers developed this prochiral aldehyde derivatisation strategy 
further to generate chiral hydrazones that can act as excellent nucleophiles. Chiral 
hydrazone 34 was deprotonated with LDA, before subsequent alkylation with benzyl 
bromide. The resultant chiral hydrazone 34 was then hydrolysed to reveal the chiral 
aldehyde 35 in high ee (Scheme 1.2-9).
r ”V O ''C H 20Me 0
S / ' C H j O M e  (i) i f ”  (ii)
w ^  ; H
H /h J  Hr
Ph
34 35
92% Yield 78% Yield
82% ee
Reagents and conditions: (i) LDA, THF, -78°C to 0°C, then BnBr, -95°C; (ii) CH31, 60°C, then HCl(aq ). 
Scheme 1.2-9 -  Nucleophilic chiral aldehyde derivatives
1.2.4 Sulphur compounds as aldehyde equivalents
Chiral sulphur compounds can act as masked chiral aldehyde equivalents for a series 
of asymmetric reactions. This allows access to umpolung reactivity patterns for the 
aldehyde carbonyl, resulting in access to an acyl anion equivalent. Scolastico and co­
workers24 reacted the anion of chiral sulfoxide 35 with benzaldehyde to afford 
sulfoxide adduct 36, which was subsequently O-methyl protected due to the 
instability of the hydroxyl intermediate to afford 37. Reduction of the sulfoxide 
moiety of 37 followed by hydrolysis of the resulting dithioacetal under optimised 
conditions afforded chiral a-methoxyaldehyde 38 (Scheme 1.2-10).
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Reagents and conditions: (i) nBuLi, THF; (ii) BU4NOH, Me2S0 4 , H2 0 , CH2 CI2 ; (Hi) Nal, I2, PPh3; (iv) I2, 
NaHCOi, H2 0 , dioxane.
Scheme 1.2-10 -  Sulfoxide acyl anion equivalent
Trost and co-workers25 further developed this strategy by derivatising a,P- 
unsaturated aldehydes as chiral a-acetoxysulfones. Chiral sulfone 39 was 
dihydroxylated with osmium tetroxide under standard conditions to afford dihydroxy 
sulfone 40 with excellent diastereocontrol. Attempts to hydrolyse this compound to 
its corresponding dihydroxy aldehyde proved unsuccessful; however, following 
acetonide protection of 40 to afford chiral sulfone 41, this compound could be 
employed as a masked aldehyde equivalent via alkylation reaction with phenyl 
magnesium bromide (Scheme 1.2-11).
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Reagents and conditions: (i) OSO4 (cat.), NMO, CH2 CI2; (ii) acetone, H+, molecular sieves; (iii) excess PhMgBr, 
Et2 0.
Scheme 1.2-11 -  Chiral sulfones as acyl anion equivalents
1.2.5 Conjugate additions to a,(3-unsaturated aldehydes
Methodology for the 1,4 addition of nucleophiles to a,p-unsaturated aldehydes 
presents a significant chemoselective challenge, due to the high reactivity of the 
aldehyde functionality towards competing 1,2-addition pathways. However, Maruoka 
and co-workers have achieved a 32:1 chemoselective chiral 1,4-addition of silyl 
nitronates to a,p-unsaturated aldehydes using a chiral quaternary ammonium 
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Reagents and conditions: (i) 42, (cat.), toluene; (ii) HCl.
Scheme 1.2-12 -  Chiral 1,4-addition ofsilyl nitronates to aldehydes
The Michael addition/elimination reaction of ylides to electron deficient olefins is an 
important reaction for the synthesis of functionalised cyclopropanes. Although this 
protocol has been successful for the cyclopropanation of oc,p-unsaturated esters27 and 
amides,28 the inherent reactivity of the aldehyde functionality makes a comparable 
reaction on these substrates challenging, due to potential carbonyl epoxidation. Tang 
and co-workers29 solved this problem by carrying out tellurium ylide mediated 
cyclopropanation reactions of a,P-unsaturated imines (Scheme 1.2-13). For example, 
unsaturated imine 43 was reacted with the sodium anion of chiral tellurium ylide 44 
to afford chiral cyclopropane imine that was treated with damp silica gel, which 
resulted in imine hydrolysis to afford chiral 1,2,3-substituted carboxaldehyde 45 with 
high enantio- and diastereoselectivity.
Ph CHO











Reagents and conditions: (i) NaHMDS, HMPA, THF, -78°C; (ii) S i02.
Scheme 1.2-13 -  Stereoselective cyclopropanation with tellurium ylides
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1.2.6 Catalytic asymmetric isomerisation
The catalytic enantioselective isomerisation of allylic amines has been proven to be a 
highly successful strategy for the synthesis of chiral aldehydes. Otsuka and co­
workers first described this reaction in 197830 and this protocol has since been 
developed for the highly enantioselective synthesis of menthol,31 which has now been 
applied on an industrial scale (Scheme 1.2-14), It has been proposed that the 
reaction proceeds either through either a 1,2-hydride shift mechanism or through the 
formation of a TC-allyl intermediate. Allylic amine 46 was treated with chiral 
rhodium(I) catalyst 47 to generate chiral enamine 48, which is subsequently 









Reagents and conditions: (i) [Rh((-)-BINAP)(NBD)]Cl0 4  47 (cat), THF, 100°C; (ii) H2S0 4(aq y 
Scheme 1.2-14 -  Rhodium catalysed enantioselective isomerisation of allylic amines
Fu and co-workers sought to adapt this reaction to a comparable enantioselective 
isomerisation of allylic alcohol substrates (Scheme 1.2-15). Using chiral ferrocene 
derived ligand 51 to afford chiral rhodium complex 52, they catalysed the highly 
enantioselective isomerisation of allylic alcohol 53 chiral aldehyde 54 in high yield.
31
Temporary stereocentres for the asymmetric synthesis of chiral aldehydes







M e- " ^ " ' " • M ee -
Me
51
Reagents and conditions: (i) [Rh(cod)(51)]BF452 (cat.), THF, 10(fC.
Scheme 1.2-15 -  Enantioselective catalytic isomerisation o f allylic aldehydes
1.2.7 Kinetic resolution
Strategies for the kinetic resolution of racemic compounds are an important method 
for the synthesis of chiral compounds.34 The asymmetric alkylation of aldehydes with 
diethyl zinc and catalytic amounts of chiral amino alcohols has proved to be a highly 
selective method for the synthesis chiral secondary alcohols.35 Oguni and co-workers 
have exploited this reaction for the kinetic resolution of racemic aldehydes. 
Racemic aldehyde 55 was reacted with diethyl zinc using chiral amino alcohol 









Reagents and conditions: (i) Et2Zn, 56 (cat.), toluene.
Scheme 1.2-16 -  Kinetic resolution of racemic aldehydes
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1.2.8 Organocatalysis 1: Conjugate addition and cycloaddition 
reactions
The largest area of current research into the synthesis of chiral aldehydes has been in 
the study of organocatalytic protocols. This strategy is particularly attractive because 
it eliminates the need to use expensive and potentially toxic metal catalysts and the 
inherent problems that can arise with their removal, particularly upon scale-up.37 
Ha and co-workers have demonstrated organocatalytic Diels-Alder reaction of a,P- 
unsaturated aldehyde 25 with chiral 1,2-diamino- 1,2-diphenylethane catalyst 58 
(Scheme 1.2-17).38 It was proposed that the reaction proceeded through hydrogen 
bonded iminium ion intermediate 59, which serves to control the enantioselectivity of 
the reaction.
59
Reagents and conditions: (i) 58 (cat.), HBr, Dioxane-H20  (95:5).
Scheme 1.2-17 -  Organocatalytic Diels-Alder reaction
Macmillan and co-workers have previously noted that the reversible formation of 
iminium ions from a, p-un saturated aldehydes lowers the energy of the olefin LUMO. 
Using this concept, they were able to demonstrate the conjugate addition of NJSI-
25 endo exo
98% Yield
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dimethyl-aniline 60 to a,(3-unsaturated aldehyde 61 using a chiral imidazolidone 
catalyst 62, to afford chiral benzylic aldehyde 63 with high enantioselectivity and 
yield (Scheme 1.2-18).39
The Michael addition reaction of enolates to a,P-unsaturated carbonyl compounds is 
an extremely important reaction in organic synthesis. Jorgensen and co-workers have 
applied an organocatalytic strategy to this reaction for their synthesis of chiral 5- 
ketoaldehyde 6 8 . It was proposed that chiral amine 65 reacts in situ to activate 
aldehyde 64 as its nucleophilic enamine 6 6 , which then undergoes conjugate addition 






Reagents and conditions: (i) 62 (cat.), CH2 CI2.






Reagents and conditions: (i) 65 (cat.), THF.
Scheme 1.2-19 -  Organocatalytic Michael addition
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Asymmetric hydrogenation protocols often requires expensive metal catalysts that are 
highly substrate specific to be effective. Preliminary work by List et al has recently 
demonstrated an asymmetric conjugate reduction reaction of a,p-unsaturated 
aldehyde 69 using chiral amine 70 as an organocatalyst.41 It was proposed that 
Hantzch ester 71 acts as a transfer hydrogenation agent to reduce the alkene 








Reagents and conditions: 70 (cat.), 71 (1 equiv.), dioxane.
Scheme 1.2-20 -  Organocatalytic transfer reduction hydrogenation
1.2.9 Organocatalysis 2: a-substitution
Heteroatom substituted chiral aldehydes are attractive building block for the synthesis 
of biologically active molecules, due to the versatility of synthetic methods that 
employ these compounds as substrates.42 In this respect, Jorgensen and co-workers 
have developed an organocatalytic a-chlorination reaction of aldehydes.43 Prochiral 
aldehyde 73 was treated with A-chlorosuccinimide 74 in the presence of chiral amine 
catalyst 75, to afford cc-chloroaldehyde 76 in high yield and enantioselectivity 
(Scheme 1.2-21).
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N—Cl (1)
\ 76
S ’H/n I Conversion
94% ee
Reagents and conditions: (i) 75 (cat.), DCE, RT.
Scheme 1.2-21 -  a-Chlorination ofprochiral aldehydes
Jorgensen and co-workers subsequently expanded this protocol for the asymmetric a-
sulfenylation of prochiral aldehydes.44 Prochiral aldehyde 77 was reacted with
sulfenylating reagent 78 and catalysed by chiral amine 79, to afford a-sulfenyl chiral
aldehyde 80 in 90% yield and 98% ee (Scheme 1.2-22).
o
77
Reagents and conditions: (i) 79 (cat.), toluene.






1.2.10 Organocatalysis 3: Aldol reactions
Aldol reactions are some of the most widely used reactions in organic synthesis, since 
this carbon-carbon bond forming reaction can generate up to two new chiral centres. 
The cross-aldol reaction between two aldehydes presents particular difficulty, since 
under standard basic or acidic enolate equivalent forming conditions, the reaction 
invariably results in a mixture of homocoupled aldol substrates due to the inherent 
reactivity of the aldehyde functionality to nucleophilic addition. Tanaka and co­
workers have developed an organocatalytic solution to this problem 45 Using a chiral
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proline derived catalyst 81, they were able to demonstrate a cross-aldol reaction 
between an aliphatic aldehyde 82 and an electron deficient aryl aldehyde 83 to afford 
aldol adduct 84 with high levels of stereocontrol, particularly considering that this 
reaction results in the formation of a chiral quaternary carbon centre (Scheme 
1.2-23). It was proposed that the origin of stereoselectivity in this reaction was due to 
the hydrogen bonded transition state 85, which delivers the electron deficient 





R A r ^ H  
85
Reagents and conditions: (i) 81 (cat.), CF3 CO2H (cat.), DMSO.
Scheme 1.2-23 -  Organocatalytic cross-aldol reaction
Similarly, Macmillan and co-workers have utilised a proline aldol strategy for their 
elegant asymmetric synthesis of various carbohydrate derivatives.46 The protocol 
requires asymmetric dimerisation of two a-oxyaldehydes 86, to afford aldol product 
87, which does not react further despite containing a comparable a-oxyaldehyde 
functionality (Scheme 1.2-24).
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Reagents and conditions: (i) L-proline (cat.).
Scheme 1.2-24 -Aldehyde dimerisation
1.2.11 Conclusion
This brief review serves to illustrate the variety of methods for the asymmetric 
synthesis of chiral aldehydes; however, it is reasonable to conclude that the 
development of methodology for the asymmetric synthesis of this class of compound 
remains a significant challenge.
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2 Results and Discussion
Chapter 2.1 A novel strategy for using temporary 
stereocentres in asymmetric synthesis
2.1.1 Introduction
This Chapter establishes the key principles of a new three-step strategy for the 
asymmetric synthesis of chiral aldehydes that employs the concept of temporary 
stereocentres for stereocontrol. It describes how a conventional chiral auxiliary 
approach, normally employed for the asymmetric synthesis of enantiopure a-alkyl-p- 
hydroxy acids, can be modified to establish a three-step asymmetric aldol/substrate 
directed transformation/relro-aldol strategy for the stereoselective synthesis of chiral 
aldehydes. Previous work carried out within the SDB group towards the development 
of this new three-step strategy is first described. This details how methodology for 
highly diastereoselective syrc-aldol reactions of racemic TV-acylated oxazolidin-2-ones 
was established and describes the discovery of a novel rearrangement/elimination 
reaction of alkoxides of these types of syn-aldol substrates. My research into the 
application of this methodology to convert chiral syw-aldol substrates into their 
corresponding chiral l,3-oxazinane-2,4-diones, as well as the synthesis of the (E)- 
amide functionality of the natural product Semiplenamide C, is then discussed. 
Finally, the use of a chiral SuperQuat oxazolidin-2-one auxiliary for asymmetric syn- 
aldol reactions is described, with the resultant aldols being shown to undergo the 
desired retro-aldol reactions under basic conditions.
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2.1.2 A conventional chiral auxiliary approach for the asymmetric 
synthesis of chiral P-hydroxy acids
The versatility of the aldehyde functionality, both in terms of its reactivity and the 
range of transformations it undergoes, has made this class of substrate a highly 
desirable building block for organic synthesis. A wide range of simple one step 
conversions of chiral aldehydes to a variety of other functional groups are known,11 
which contributes greatly to their widespread popularity as substrates for the 
asymmetric synthesis of natural products and important biologically active 
molecules.47
As described in the introduction of this thesis, there are currently relatively few 
methods for the direct synthesis of chiral aldehydes that do not rely on oxidative13 or 
reductive12 protocols, with the inherent problems these redox approaches bring in 
terms of selectivity and reactivity. The aim of this project was to develop a novel 
three-step strategy to synthesise chiral aldehydes. This process would exploit the 
well-established stereodirecting control of chiral auxiliaries48 to mediate a reversible 
aldol reaction, thus generating a temporary stereocentre that would be used to direct a 
diastereoselective reaction49 on a prochiral fragment within the aldol substrate.
In the development of this protocol we chose to use chiral oxazolidin-2-ones, also 
known as Evans’ auxiliaries, since this class of chiral auxiliary had been shown 
previously to afford excellent stereocontrol for a wide range of transformations. For 
example, a conventional three-step procedure that has been widely employed to carry 
out stereoselective aldol reactions for the asymmetric synthesis of chiral a-alkyl-(3- 
hydroxy carboxylic acids is described in Scheme 2.1-1. 5 0
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Scheme 2.1-1 -  Conventional three-step procedure for the synthesis of chiral P~hydroxy 
carboxylic acids
In step 1, a prochiral acid derivative (S) is attached to the chiral auxiliary (CA) to 
generate a new chiral substrate (CA-S). In step 2, the chiral oxazolidin-2-one 
fragment is used to control the facial selectivity of a diastereoselective aldol reaction, 
generating two new chiral centres (CA-P). Finally, in step 3 the substrate is cleaved, 
releasing the chiral auxiliary (CA) for recycling and the target chiral a-alkyl-P- 
hydroxy carboxylic acid (P). Overall, the three-step protocol converts a prochiral acid 
(S) into a chiral acid (P), containing two new stereocentres in high de. This general 
strategy, using oxazolidin-2-one derived chiral auxiliaries, has been shown to be 
effective for a wide range of transformations; including alkylations,51 conjugate 
additions52 and Diels-Alder reactions.53
2.1.3 A new three-step procedure for the synthesis of chiral 
aldehydes
It was proposed that a new strategy could be developed using chiral oxazolidin-2- 
ones for the direct asymmetric synthesis of chiral aldehydes, using the novel 
stereoselective cyclopropanation strategy described in Scheme 2.1-2.
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In step 1, the A-acylated oxazolidin-2-one chiral auxiliary (CA) would react via an 
asymmetric aldol reaction with a prochiral aldehyde (S), under the stereocontrol of 
the chiral oxazolidin-2-one fragment to generate a new chiral substrate (CA-S). This 
new chiral substrate (CA-S) would contain a stereodefined hydroxyl functionality, the 
temporary stereogenic centre, which would then be used in step 2 to direct a 
diastereoselective transformation on the prochiral alkene fragment, to generate a 
second chiral substrate (CA-P). Finally in step 3, the substrate (CA-P) would be 
cleaved via a retro-aldol reaction, which destroys the temporary stereogenic hydroxyl 
functionality, thus generating a new chiral aldehyde (P). Overall, this three-step 
procedure would convert the prochiral a,P-unsaturated aldehyde (S) into chiral 
cyclopropane carboxaldehyde (P). 
o o














Scheme 2.1-2 -  New three-step procedure for the asymmetric synthesis of chiral aldehydes
There was clear literature precedent that the new three-step strategy described in 
Scheme 2.1-2 might prove successful for the asymmetric synthesis of chiral 
aldehydes. Firstly, A-acyl-oxazolidin-2-one mediated asymmetric aldol reactions 
have been used previously in a large number of transformations to afford either syn- 
or anti-aldols with high diastereoselectivity. For example, Staunton and co-workers 
used a phenylalanine derived oxazolidin-2-one chiral auxiliary 88 for a syw-aldol 
reaction to synthesise a polypropionate sub-unit in their total synthesis of 
Erythromycin (Scheme 2.1-3) . 5 4
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Reagents and conditions: (i) Dibutyl boron triflate, Et3N, MeCHO, CH2 CI2 ; (ii) AlMe3, MeONHMe.HCl, THF; 
(iii) TBDMS-OTf imidazole, DMAP, THF; (iv) DIBAL-H; CH2 Cl2; (v) N-propionyl-oxazolidin-2-one ent-8 8 , 
dibutyl boron triflate, Et3N, CH2Cl2; (vi) H2 0 2, LiOH, THF/H2 0 ; (vii) HCl, THF/H2 0.
Scheme 2.1-3 -A n  asymmetric syn-aldol reaction used for the synthesis o f Erythromycin
Additionally, for the case of substrate directable transformations, Evans and co­
workers had shown that the hydroxyl functionality of .syn-aldol product 89 could be 
used to carry out a directed hydrogenation reaction on its alkene group, affording 90 
containing a new stereogenic centre with high diastereocontrol (Scheme 2.1-4) . 55
O o  OH o  o  OH
I T  Me^ *  o ^ W ^ e
\ — L  Me 11 V -A *  Me Me
Plf Me Pif Me
89 90
86% de
Reagents and conditions: (i) H2 (640 psi), [Rh(NBD)DIPHOS-4)]BF4 .
Scheme 2.1-4 -  Directed hydrogenation reaction o f a syn-aldol substrate
Finally, while the retro-aldol reaction has often been observed as an unwanted side 
reaction in total synthesis,56 or has been used for the degradation of natural
cn
products, Funk and Yang have previously employed this reaction for asymmetric 
synthesis. They were able to exploit this reaction in a one-pot conjugate addition 
protocol for the asymmetric synthesis of P-aryl-ketone 92, where the chiral auxiliary
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fragment of aldol 91 was removed in the final step via a retro-aldol reaction (Scheme
2.1-5). 58










Reagents and conditions: (i) Oxalic acid, CH2 CI^H2 0 ; (ii) Ph2 CuCNLi2; (iii) MeOH 
Scheme 2.1-5 -  The retro-aldol reaction o f menthol derived /3-hydroxy ketones
Whilst there were no previous examples of retro-aldol reactions having been reported 
for Af-acyl-oxazolidin-2-one syn-aldols, Bartroli and co-workers had described an 
unwanted retro-ketol reaction for related substrates in their synthesis of antifungal 
agents.59 In an attempt to form an epoxide, they found that treatment of ketol 93 with 
LiHMDS and NaHMDS in THF at -20°C and -40°C respectively, initiated a clean 
retro-ketol reaction to afford a-chloroketone 94 and Af-acyl-oxazolidin-2-one 8 8  
(Scheme 2.1-6).
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93 94 88
Reagents and condition; (i) LiHMDS, THF, -78°C to -2(fC; (ii) NaHMDS, THF, -78°C to -4(fC.
Scheme 2.1-6 -  Metal alkoxide mediated retro-ketol reaction
In order for our proposed three-step aldol/directed transformation/refro-aldol protocol 
to become a useful addition to synthetic methodology, each of the three reactions 
employed would have to be high yielding and show high levels of stereocontrol. If 
successful, the variety of substrate directable transformations described in the 
literature would then allow for a wide range of chemical diversity to be introduced 
into the chiral aldehyde substrates using this methodology. This synthetic flexibility 
would outweigh any disadvantage associated with using a chiral auxiliary strategy for 
asymmetric synthesis, since this chiral auxiliary approach would ensure high levels of 
stereocontrol for a wide range of substrates, whilst enabling diastereomeric 
intermediates to be purified to homogeneity via simple recrystallisation or 
chromatography.
2.1.4 The asymmetric aldol reaction
Previous work within the SDB group had been directed towards establishing efficient 
protocols for the aldol reaction of Af-acyl-oxazolidin-2-ones, and the retro-aldol 
reaction of p-hydroxy Af-acyl-oxazolidin-2-ones. A racemic series of aldol products 
was prepared using Caddick’s modification of Evans’ ^yn-aldol chemistry,60 via 
reaction of boron enolates of A-acylated oxazolidin-2-one derivatives with a variety 
of aldehydes.61 These types of boron mediated aldol reactions are known to be syn- 
selective due to minimisation of 1,3-diaxial interactions in the aldol transition state,
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as explained by consideration of the Zimmerman-Traxler transition state models 



















Scheme 2.1-7 -  Zimmerman-Traxler transition state model for the selectivity of aldol 
reactions
The (E) and (Z) selectivity of enolate formation is vital for the stereoselectivity of 
these aldol reactions. When (£)-enolate 95 reacts with an aldehyde, two possible 
isomers of the six-membered transition state may occur. TSi places the large R-group 
in an equatorial position, thus minimising 1,3-diaxial interactions in the transition 
state. TS2 places the large R-group in an axial position, maximising 1,3-diaxial 
interactions and as a consequence, affords a higher energy transition state when 
compared to TSi. Therefore, (£)-enolates generally lead to awri-selectivity in the 
aldol reaction affording anti-91. For (Z)-enolate 96, the opposite selectivity occurs; 
for TS3 , the bulky R-group is placed in an axial position, maximising 1,3-diaxial
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interactions and leading to a high-energy transition state. In TS4 , the bulky R-group is 
placed in the equatorial position, which affords a lower energy transition state and 
sy72-selectivity in the aldol reaction to afford syTi-aldol 98. Boron Lewis’ acid 
mediated enolate formation is known to afford (Z)-enolates with high levels of 
selectivity, and therefore sy/i-selectivity is normally observed in boron mediated aldol 
reactions.
It has been proposed that the closed transition state model described in Scheme 2.1-8 
controls the enantioselectivity of aldol reaction by coordination of the Lewis acid to 
the aldehyde to afford intermediate 99, in which the chiral oxazolidin-2-one 
fragment rotates to minimise dipole-dipole interactions, and therefore directs the 




Scheme 2.1-8 -  Proposed mechanism to explain the Re face attack in the oxazolidin-2-one 
aldol reaction
For achiral oxazolidin-2-ones, it was shown that using 9BBN-triflate and 
diisopropylethylamine as base, resulted in the formation of syw-aldol substrates in 
good yield and high de (Scheme 2.1-9). In a typical example, treatment of N- 
propionyl-oxazolidin-2-one 101 with 9BBN-triflate and diisopropylethylamine in 
dichloromethane at 0°C afforded a (Z)-enolate, which was reacted with benzaldehyde 
at -78°C before warming to 0°C, to afford (rac)-syn-a\do\ 102 in an acceptable 69% 
yield and >95% de. The relative sy/i-stereochemistry of 102 was confirmed by 
comparison with the previously published data for this compound, and was evident 
from the small coupling constant of the a-proton in the ^-N M R  spectrum (J2,3 = 
3Hz), since the ^-N M R  spectrum of the corresponding awfr'-diastereomer showed a 
larger coupling constant for its a-proton (J2.3 = 8.5Hz).64
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(Rac)
101 102
72% Yield 69% Yield
>95% de
Reagents and conditions: (i) nBuLi, CH3 CH2 C 0 2CI. THF, -7S°C, 2 hours; (ii) 9BBN-OTJ, ‘P rflE t, 0°C, CH2 Cl2, 1 
hour, PhCHO, -78?C, 1 hour, then hold temperature at CPC, 1 hour.
Scheme 2.1-9 -  Racemic syn-aldol reaction of achiral N-propionyl oxazolidin-2-ones
2.1.5 An unexpected elimination reaction of racemic aldols
From the precedent of Bartoli and co-workers,59 it was predicted that treatment of 
racemic .syn-aldol product 102 with an appropriate base would initiate an anionic 
retro-aldol reaction, releasing benzaldehyde and the acylated oxazolidin-2-one chiral 
auxiliary 101 (Scheme 2.1-10).
(Rac)
102 101
Reagents and conditions: KHMDS, THF, -78?C, 2 hours.
Scheme 2.1-10 -  Proposed anionic retro-aldol reaction
However, when this reaction was carried out no evidence of any retro-aldol products 
were observed in the crude ^-N M R  spectrum; since it was found that the potassium 
alkoxide of 102 had instead reacted as a nucleophile, undergoing intramolecular 
attack at the carbonyl of the oxazolidin-2-one, followed by subsequent elimination of 
carbon dioxide from oxazinane-2,4-dione intermediate 104 to afford (£)-a,(3- 
unsaturated amide 106 in high de (Scheme 2.1-11) . 65
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Reagents and conditions: (i) KHMDS, THF, -78°C, 2 hours.
Scheme 2.1-11 -  Proposed mechanism for the intramolecular cyclisation/Elcb type 
elimination of aldol products
It was proposed that the potassium alkoxide 103 attacks the oxazolidin-2-one 
carbonyl in a unique intramolecular cyclisation reaction to form six-membered 
alkoxide intermediate 104. Proton equilibration then affords potassium enolate 105, 
which undergoes an E lcb type elimination, releasing carbon dioxide, and generating 
the (£)-a,P-unsaturated amide 106 in 91% yield and >95% de. The (£)-selectivity of 
this reaction was rationalised by the simple conformational model shown in Scheme
2.1-12.
(£)-110 (Z)- 111
Scheme 2.1-12 -  Conformational model for the stereoselectivity of the E lcb elimination
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There are two possible transition states that lead to either the (E) or (Z) elimination 
products. Transition state 107 requires overlap of the equatorial carbanion with the 
a*-orbital of the C-O bond, thus allowing elimination of carbon dioxide to occur. 
This may only result from a chair conformer in which the methyl group occupies an 
axial position and the phenyl group occupies an equatorial position, resulting in the 
(£)-a,P-unsaturated amide 110. Alternatively, the chair conformer transition state 
109, which would lead to (Z)-oc,P-unsaturated amide 111, would require both the 
methyl and phenyl groups to adopt axial positions for the same orbital overlap to 
occur, which is clearly higher in energy when compared to transition state 107. This 
new methodology proved useful for the stereoselective synthesis of a wide range of 
(£)-a,p-unsaturated acids and (£)-a,P-unsaturated oxazolines (Figure 2.1-1) . 6 5
Figure 2.1-1 -  Representative examples o f a,/3-unsaturated acid synthesis
2.1.6 l,4-Oxazinane-2,4-dione synthesis from racemic aldols
The mechanism of this elimination reaction was further confirmed through the 
synthesis of the l,3-oxazinane-2,4-dione intermediate 108. Softer deprotonation of 
syn-aldol substrate 102 using diethyl zinc as base, exclusively formed racemic 1,3- 
oxazinane-2,4-dione 1 1 2  (Scheme 2.1-13), without further elimination to the a,P- 
unsaturated amide. Subsequent treatment of racemic l,3-oxazinane-2,4-dione 112 
with KHMDS in THF at -78°C, afforded (£)-a,p-unsaturated amide 111, thus 
demonstrating the intermediacy of 108 in this type of elimination reaction.61
o
50
Temporary stereocentres for the asymmetric synthesis of chiral aldehydes












Reagents and conditions: (i) EtiZn (10 mol%), CH2 CI2, RT, 2 hours; (ii) KHMDS, THF, -78°C, 2 hours.
Scheme 2.1-13 -  Synthesis o f racemic 1,3-oxazinane-2,4-dione intermediate
My initial goal was to explore whether chiral Af-acyl-oxazolidin-2-ones Yyrc-aldols 
would undergo this type of rearrangement reaction to afford either chiral 1,3- 
oxazinane-2,4-diones or their corresponding (£)-amides, since this pathway had the 
potential to completely derail our novel three-step strategy for the synthesis of chiral 
aldehydes described in Scheme 2.1-2.
2.1.7 Development of methodology for the asymmetric synthesis of 
chiral l,3-oxazinane-2,4-diones
Benzo-l,3-oxazinane-2,4-diones demonstrate a variety of biological properties66 and
fnhave therefore been the target for development of a number of synthetic protocols. 
Methodology for the synthesis of other types of l,3-oxazinane-2,4-dione derivatives 
is less well developed, and as a consequence their biological properties are relatively 
poorly understood. Therefore, it was proposed that application of our aldol/diethyl 
zinc cyclisation protocol to chiral aldol substrates would be a useful addition to the 
synthesis of this class of heterocycles. The first work I carried out on this project was
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to develop a chiral variant of the sy«-aldol intramolecular cyclisation reaction to 
afford chiral oxazinane-2,4-diones (Scheme 2.1-14).
(5)-phenylalaninol was cyclised with diethyl carbonate as a carbonyl source under
/TO
basic conditions, as adapted from Evans’ standard procedure, to afford CS)-4-benzyl- 
oxazolidine-2-one 113 in 73% yield. Acylation of the AMithium anion of 113 in THF 
with propionyl chloride at -78°C afforded A^-propionyl-(iS')-4-benzyl-oxazolidin-2-one 
8 8  in 75% yield. Repeating this A-acylation reaction, but allowing the reaction to 
warm from -78°C to 0°C over two hours, improved the yield of 8 8  to 89%. The (Z)- 
boron enolate of 8 8  was then generated using 9BBN-triflate as a Lewis’ acid and 
diisopropylethylamine as base in dichloromethane at 0°C. The reaction was cooled to 
-78°C, isobutyraldehyde added, and the reaction stirred for one hour before being 
warmed to 0°C and stirred for a further hour. This gave the desired oc-methyl P- 
isopropyl .syn-aldol 114 (J2 3  = 2.6 Hz) in 85% yield and >95% de.69 
Subsequent treatment of syn-aldol 114 with 10 mol% of diethyl zinc caused the 
desired rearrangement reaction, to afford (5S,6R)-3-((S)-l-hydroxy-3-phenylpropan- 
2-yl)-6-isopropyl-5-methyl-l,3-oxazinane-2,4-dione 115 in 91% yield and >95% de. 
The structure of 115 was confirmed by examination of its !H-NMR spectrum, which 
displayed the characteristic change in chemical shift of the a-proton of syn-aldol 114 
from 83.96 ppm to 82.51 ppm for the C5 proton of 115, which arises due to the loss 
of anisotropic deshielding effects of the benzyl group.70 As expected, further 
elimination of 115 to its corresponding cc,P-unsaturated amide was not observed 
under these conditions.71
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Reagents and conditions: (i) Diethyl carbonate, KCfBu, THF, 70°C, 4 hours; (ii) nBuLi, propionyl chloride, THF, - 
78°C to 0°C, 2 hours; (iii) 9BBN-OT/, ‘Pr2NEt, CH2 CI2, 0°C, 1 hour, then isobutyraldehyde, -78°C 1 hour then 0°C 
1 hour; (iv) 10 mol% diethyl zinc, CH2 CI2, RT, 2 hours.
Scheme 2.1-14 -  Synthesis o f chiral l,3-oxazinane-2,4-dione
Examination of the crude ’H-NMR spectrum of this rearrangement reaction revealed 
that approximately 10% of the sytt-aldol 114 starting material remained. Increased 
reaction times had no effect on this level of conversion, indicating that this 
rearrangement reaction was likely to be reversible, giving a mixture of 114 and 115 
products under thermodynamic control. The use of stoichiometric amounts of diethyl 
zinc not only failed to improve the conversion ratio, but remarkably prevented the 
desired rearrangement reaction from occurring.72 Conversely, reduction in the amount 
of diethyl zinc to less than 10 mol% resulted in greatly increased reaction times (>6 
hours).73 In order to explain these results, it was proposed that this rearrangement 
reaction might be proceeding via a b/s-alkoxide zinc intermediate 117 (Scheme
2.1-15), which activates the zinc alkoxide to nucleophilic attack at the oxazolidin-2- 
one carbonyl in an intramolecular fashion to afford intermediate 118. Ligand 
exchange of the l,3-oxazinane-2,4-dione fragment of 118 for another molecule of 
.syra-aldol 114 could then occur to regenerate the reactive bis-aldol zinc intermediate 
130, which would then react further. At low concentrations of diethyl zinc (10 mol%), 
formation of the reactive aldol zinc dimer 117 would be favoured, which would result 
in the formation of oxazinane-2,4-dione 115. Alternatively, when stoichiometric
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amounts of diethyl zinc were employed as base, then formation of the stable 
monomeric zinc alkoxide species 116 would occur that does not undergo the 







Scheme 2.1-15 -  Proposed mechanism for zinc mediated rearrangement of syn-aldols
This methodology was subsequently employed by other members of the SDB group 
for the synthesis of a range of l,3-oxazinane-2,4-diones in high yield and 
diastereoselectivity, representative examples of which are described in Figure
2.1-2.75
54
Temporary stereocentres for the asymmetric synthesis of chiral aldehydes


















Figure 2.1-2 -  Representative examples of chiral 1,3-oxazinane-2,4-diones using our 
rearrangement methodology
Having established conditions for the rearrangement of syn-alkoxides of chiral syn- 
aldols to their corresponding oxazinane-2,4-diones, I next decided to determine 
whether potassium alkoxides of chiral syrc-aldols would eliminate further to afford 
their corresponding a,P-unsaturated amides. In this regard, it was decided to explore 
this type elimination reaction using an aldol substrate that could be used for the 
asymmetric synthesis of Semiplenamide C 119, since this natural product represented 
an attractive target for this methodology.
2.1.8 Elimination reactions of sjw-aldols for the total synthesis of 
Semiplenamide C
Semiplenamides are long chain fatty a,p-unsaturated amides, which have recently 
been isolated by Gerwick and co-workers from the marine cyanobacterium Lyngbya 
Semiplena. These compounds have been shown to exhibit a range of biological
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activity, including cytotoxicity towards a model brine shrimp system, and affinity for 




Semiplenamide A; R = H, Rj = H, R2 = (3£)-H-Cj7H33 
Semiplenamide B; R = Ac, Ri = R2 = (3£)-n-Ci7H33 
Semiplenamide C; R = H, Rj = Me, R2 = n-C13H27 
Semiplenamide D; R = Ac, Ri = Me, R2 = «-CI7H35 
Semiplenamide E; R = Ac, R! = Me, R2 = n-C15H31
Figure 2.1-3 -  Semiplenamides A-E: natural products containing 0,/3-unsaturated amide 
fragments
In light of this biological activity and since these compounds had not been prepared 
previously, we were interested in synthesising Semiplenamide C 119 using our 
aldol/P-elimination methodology, which required the use of (S)-alaninol as a 
commercially available chiral starting material (Scheme 2.1-16).
(5)-Alaninol was cyclised with diethyl carbonate under basic conditions78 to afford 
(S)-4-methyl-oxazolidin-2-one 120 in 77% yield. Acylation of the A-lithium anion of
120 with propionyl chloride in THF at -78°C afforded (S)-4-methyl-3-
propionyloxazolidin-2-one 121 in 11% yield. Tetradecanal 122, which was required 
for the subsequent syn-aldol reaction, was prepared via Swem oxidation of 
commercially available tetradecanol under standard conditions in 73% yield. The 
boron mediated ^yn-aldol reaction of A-propionyl-oxazolidin-2-one 121 and 
tetradecanal 122 under standard conditions (Scheme 2.1-14), afforded a-methyl P- 
tridecyl syn-aldol 123 in 78% yield and >95% de. The sy/i-stereochemistry of syn- 
aldol 123 was assigned from precedent discussed previously and confirmed by the 
small coupling constant of the a-proton (J2,3 = 2.6 Hz). The high level of 
diastereoselectivity in this aldol reaction was surprising, as intuitively the decreased 
steric requirement of the stereodirecting methyl group of the oxazolidin-2-one 
fragment of 121, when compared with A-propionyl-(S)-4-benzyl-oxazolidin-2-one 88, 
might have been expected to lower the diastereoselectivity of the aldol reaction. To
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the best of my knowledge this is the first example of an asymmetric aldol reaction 
using (S)-iV-propionyl-4-methyl-oxazolidin-2-one 121 as a chiral auxiliary.79













Reagents and conditions: (i) Diethyl carbonate, KCfBu, THF, 7(fC, 4 hours; (ii) "BuLi, propionyl chloride, THF, - 
78°C to 0°C, 2 hours; (iii) 9BBN-OTf 'P^NEt, CH2 CI2, (fC , 1 hour, then tetradecanal 122, -78°Cfor 1 hour, then 
warm to 0°C fo r  1 hour.
Scheme 2.1*16 -  Synthesis o f (S)-alaninol derived syn-aldol
With the desired syn-aldol substrate 123 in hand, it was then necessary to establish 
conditions to affect the intramolecular cyclisation/elimination reaction. There was 
some concern that the increased steric hindrance within the aldol substrate caused by 
the presence of the (5,)-4-methyl group of the oxazolidin-2-one fragment might 
protect the endocyclic carbonyl from intramolecular nucleophilic attack, thus shutting 
down the desired elimination pathway (Table 2.1-1).
Treatment of syn-aldol 123 with KHMDS under our previously established conditions 
developed for the racemic aldol series (Scheme 2.1-11, Entry 1), resulted in a 
complex mixture of products being formed, which included from inspection of the 
crude !H-NMR spectrum the desired Semiplenamide C 119.80 It was proposed that 
this mixture of products had arisen from incomplete elimination of l,3-oxazinane-2,4- 
dione intermediate 124, which was revealed in the ^ -N M R  spectrum by the presence 
of a characteristic resonance for its a-proton at 52.83 ppm.81 I therefore undertook a 
screen of bases and conditions that would result in clean elimination of sy«-aldol 123 
to afford Semiplenamide C 119 in good yield (Table 2.1-1).
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It was found that changing the counter-ion of the base used for deprotonation of aldol 
123 from potassium to sodium (Entry 3 and 5) or lithium (Entry 4), failed to 
improve the conversion of the elimination reaction. It was proposed that this was 
likely to be due to the increased stability of chelated lithium and sodium alkoxides 
when compared to their potassium counterpart. Changing the base to potassium tert- 
butoxide did improve the conversion of syn-aldol 123 to Semiplenamide C 119 at 
-78°C (Entry 6), although at room temperature the formation of a third product, (S)- 
4-methyl-oxazolidin-2-one 120 was also observed (Entry 7). The origin of the parent 
oxazolidin-2-one 120 in this reaction remains undetermined; however, it is not 
believed to arise from a retro-aldo\ reaction, since none of the corresponding non­
volatile aldehyde 122 was observed in the crude ^ -N M R  spectrum.82
Me o
ho^ n^ o








Entry Base Solvent Temp. (°C) Conv. ratio 123:124:119 de (%)a
1 KHMDS THF -78 43:29:28 NDb
2 KHMDS THF 0 >5:36:47 83
3 NaHMDS THF -78 64:26:18 88
4 LiHMDS THF -78 71:18:11 NDb
5 NaH THF -78 63:12:25 75
6 KOlBu THF -78 12:>5:83 >95
7 KCfBu THF RT >5:>5:90c 83
8 K&Bu THF -78 to RT >5:>5:88c >95
(a) Ratios determined from examination o f the 300 MHz 1H-NMR spectrum o f  the crude reaction products; (b) de 
not determined due to low levels o f conversion; (c) lH-NMR analysis also revealed the presence o f  (S)-4-methyl- 
oxazolidin-2 -one 1 2 0 .
Table 2.1-1 -  Optimisation of the intramolecular cyclisationJ'elimination reaction o f syn- 
aldol 135 to afford Semiplenamide C 119
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The (3-elimination reaction using potassium tert-butoxide was then optimised to 
suppress the formation of oxazolidin-2-one 120, by carrying out the reaction at -78°C 
and allowing it to slowly warm to room temperature overnight. This gave 
Semiplenamide C 119 in 74% isolated yield and >95% de with <10% of any other 
competing side products. The (£)-amide 119 afforded spectroscopic data that exactly 
matched the previously published data for this natural product and gave a specific 
rotation of [ cc] d 25 = -8 ( [ a ] D Ut' = -5), thus confirming the absolute configuration of this
natural product 83
Q 9  ° H Me O
- N
Me H
- ! ! ! —  H a ^ N Ci3h27
Me Me
123 Semiplenamide C 119
74% Yield 
>95% de
Reagents and conditions: (i) KCfBu, THF, -78 to RT overnight.
Scheme 2.1-17 -  Optimised intramolecular elimination reaction for the synthesis of 
Semiplenamide C
We had therefore completed the total synthesis of Semiplenamide C in four steps 
from commercially available (S)-alaninol in 36% overall yield.84 Application of this 
methodology to the asymmetric synthesis of the remaining Semiplenamide series of 
natural products is currently underway within the SDB group.
2.1.9 Blocking the intramolecular cyclisation/elimination reactions 
using the SuperQuat auxiliary
It had been demonstrated that zinc alkoxides and potassium alkoxides of chiral syn- 
aldol substrates could undergo useful cyclisation and elimination reactions to afford 
oxazinane-2,4-diones and (£)-cc,|3-unsaturated amides respectively. However, the 
existence of these two competing reaction pathways would prevent the original 
objective of a new three-step aldol/directed reaction/refro-aldol strategy for the
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synthesis of chiral aldehydes (Scheme 2.1-2) from being realised. It was evident that 
the elimination and cyclisation reactions of syrc-aldols were due to intramolecular 
nucleophilic attack of the P-hydroxy alkoxide on the oxazolidin-2-one carbonyl 
fragment. Therefore, it was proposed that if these unwanted competing reactions 
could be suppressed, it might result in the desired retro-aldol reaction occurring.
It has long been known that the endocyclic carbonyls of oxazolidin-2-ones are 
susceptible to nucleophilic attack. For example, Davies and co-workers have shown 
that sterically hindered 0S)-7V-pivaloyl-4-benzyl-oxazolidin-2-one 125 underwent 
competing endocyclic cleavage when treated with lithium hydroxide (Scheme
Reagents and conditions: (i) LiOH, THF/H2 0 , RT, 2 hours.
Scheme 2.1-18 -  Endocyclic cleavage of N-pivaloyl- oxazolidin-2-ones
In this instance, the increased steric hindrance of the tertiary butyl group of 125 
blocks nucleophilic attack at the exocyclic carbonyl, and as a consequence, 
competing nucleophilic ring opening of the endocyclic oxazolidin-2-one carbonyl 
occurs. To address this problem, Davies and co-workers developed a new class of 
chiral auxiliary, (iS)-4-benzyl-5,5-dimethyloxazolidin-2-one 126, which were termed
Q/r
as SuperQuat auxiliaries (Scheme 2.1-19). They found that the gera-dimethyl group 
of the oxazolidin-2-one ring of the SuperQuat fragment blocks nucleophilic attack at 
the endocyclic carbonyl, even when the exocyclic carbonyl is sterically hindered, thus 
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Reagents and conditions: (i) nBuLi, pivaloyl chloride, THF; (ii) LiOH, THF/H2 0.
Scheme 2.1-19 -  Exclusive exocyclic cleavage o f N-acyl-oxazolidin-2-ones derived 
from SuperQuat auxiliaries
These SuperQuat auxiliaries have been shown to demonstrate the same excellent 
levels of stereocontrol in syn-aldol reactions as previously seen for Evans’ 
auxiliaries.87 Therefore, it was proposed that these SuperQuat auxiliaries might prove 
useful for our new three-step chiral aldehyde strategy, since it was reasoned that the 
gem-dimethyl substituents of the SuperQuat fragment should also be successful in 
blocking intramolecular nucleophilic attack at the oxazolidin-2-one carbonyl, thus
oo
enabling the desired retro-aldol reaction to occur in good yield (Scheme 2.1-20).
Ph.







Scheme 2.1-20 -  Proposed retro-aldol reaction of SuperQuat derived syn-aldols
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2.1.10 Synthesis of the SuperQuat auxiliary
The (5)-4-benzyl-oxazolidin-2-one ‘SuperQuat’ chiral auxiliary 126 was synthesised
QQ
via the standard literature procedure (Scheme 2.1-21). Commercially available (S)- 
phenylalanine was esterified via formation of its acid chloride with thionyl chloride, 
which was then trapped in situ with methanol, to afford (S)-phenylalanine methyl 
ester 127 in quantitative yield without further purification. A-Boc protection of ester 
127 via treatment with Boc-anhydride and solid sodium hydrogen carbonate afforded 
128, once again in quantitative yield without further purification. Reaction of N-Boc 
ester 128 with excess methyl magnesium iodide afforded tertiary alcohol 129 in 77% 
yield without further purification. Cyclisation of 129 with potassium terf-butoxide, 
using the N-Boc protecting group as a sacrificial carbonyl equivalent, gave (S)-4- 
benzyl SuperQuat oxazolidin-2-one 126 in 55% overall yield from (^-phenylalanine.
.NHBoc
.NHBoc
Reagents and conditions: (i) SOCI2, MeOH, 12 hours; (ii) Boc-anhydride, NaHCOs, EtOH, 48 hours; (iii) Mg, 
CH3I, THF, 48 hours; (iv) KCfBu, THF, 2 hours.
Scheme 2.1-21 -  Synthesis of the SuperQuat chiral oxazolidin-2-one
2.1.11 Aldol reactions of SuperQuat auxiliaries
It was then necessary to demonstrate that SuperQuat chiral auxiliaries would give 
comparable results to standard Evans’ auxiliaries for syn-aldol reactions. As a model
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system, we carried out the syw-aldol reaction of (S)-4-benzyl N-propionyl-oxazolidin- 
2-one SuperQuat chiral auxiliary 130 with isobutyraldehyde (Scheme 2.1-22). (S)-4- 
Benzy 1 -TV-propiony 1 SuperQuat oxazolidin-2-one 130 was generated via acylation of 
the AMithium anion of 126 with propionyl chloride in 89% yield. The boron aldol 
reaction of 130 with isobutyraldehyde gave a-methyl-P-isopropyl syrc-aldol 131 in 
82% yield and >95% de as determined by examination of the crude ]H-NMR 
spectrum. The stereochemistry was assigned from literature precedent, and confirmed 
by the small a-proton coupling constant of 12,3 = 3.0 Hz.
Reagents and conditions: (i) nBuLi, propionyl chloride, THF, -78?C to 0°C, 2 hours; (ii) 9B BN -01f 'Pr2NEt, 
CH2 Cl2, 0°C, 1 hour, isobutyraldehyde, -78?C 1 hour then 0?C 1 hour.
Scheme 2.1-22 -  syn-Aldol reaction o f SuperQuat auxiliary
2.1.12Attempted refro-aldol reactions of SuperQuat aldols
Having demonstrated that the SuperQuat auxiliary afforded syn-aldol results 
comparable to the standard Evans’ auxiliary, it was then necessary to examine 
whether the increased steric hindrance of the SuperQuat auxiliary fragment would 
suppress the intramolecular rearrangement/p-elimination pathway. a-Methyl-P- 
isopropyl syn-aldol 131 was therefore treated with 10mol% diethyl zinc under our 
standard cyclisation conditions.
Analysis of the crude !H-NMR spectrum revealed that treatment of a-methyl-p- 
isopropyl syra-aldol 131 with 10 mol% diethyl zinc at room temperature had resulted 
in the formation of less than 10% of its corresponding l,3-oxazinane-2,4-dione 
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one fragment of 131 had significantly reduced the rate of the diethyl zinc mediated 
rearrangement reaction.
Alternatively, treatment of syrc-aldol 131 with KHMDS at -78°C in THF resulted in 
no reaction occuring, affording only recovered starting material. Repeating the
4-benzyl SuperQuat oxazolidin-2-one 126 with no other compounds being observed, 
including the initially expected A-propionyl-oxazolidin-2-one 130. It was proposed 
that formation of the parent oxazolidin-2-one 126 was arising due to ^yn-aldol 131 
undergoing a retro-aldol reaction, followed by decomposition of the resultant 
potassium enolate 132 via a refro-ketene type pathway to generate oxazolidin-2-one 
126. Isobutyraldehyde and methyl ketene 133 would not be expected to be observed 
in the crude ^-N M R  due to their inherent volatility (Scheme 2.1-23).90 No 
corresponding elimination or cyclisation products were observed under either the 
diethyl zinc or KHMDS conditions, indicating that the gem-dimethyl substituents of 
the SuperQuat auxiliary were functioning as intended.
Reagents and conditions: (i) KHMDS, THF, RT, 2 hours.
Scheme 2.1-23 -  Proposed retro-aldol/retro-ketene decomposition pathway of the potassium 
enolate of N-propionyl-oxazolidin-2-one
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2.1.13Optimisation of the retro-aldol reaction
Having demonstrated that SuperQuat oxazolidin-2-one derived syrc-aldol 131 
underwent retro-aldol reactions without any competing rearrangement pathways 
under basic conditions, it was then necessary to demonstrate that the aldehyde could 
be isolated in from the retro-aldol reaction high yield. a-Methyl-p-nonyl syn-aldol 
134 was therefore synthesised via reaction of the boron enolate of N-propionyl 
SuperQuat oxazolidin-2-one 130 with decanal under our standard conditions to afford 
.syrc-aldol 134 in 55% yield and >95% de. (Scheme 2.1-24).
55% Yield 
>95%de
Reagents and conditions: (i) 9BBN-07'f, ‘Pr2NEt, CH2 Cl2, 0°C, 1 hour, decanal, -78°C, 1 hour then (PC, 1 hour. 
Scheme 2.1-24 -  syn-Aldol reaction of decanal
It was reasoned that the retro-aldol reaction of syw-aldol 134 would result in 
formation of the N-acyl-oxazolidin-2-one fragment and the relatively non-volatile 
decanal, thus enabling it to be observed in the ]H-NMR spectra of the crude reaction 
product. Treatment of syn-aldol 134 with KHMDS at -78°C in THF gave no reaction 
once again affording only starting material 134 and consequently, a range of bases 
and conditions were screened to optimise this retro-aldol reaction (Table 2.1-2).
The majority of these screening reactions (Entries 1-8,12), gave very poor yields of 
the desired decanal 135; however, the use of LiHMDS as a base at 0°C to 10°C did 
give acceptable yields of decanal 135. From these results, it was apparent that the 
amount of decanal formed in the retro-aldol reaction was directly proportional to the 
amount of A^-propionyl-oxazolidin-2-one 130 present in the crude *H-NMR spectra. 
Conversely, any formation of SuperQuat oxazolidin-2-one 126 appeared to result in a 
matched loss in yield of decanal product 135. This observation was difficult to justify,
130 134
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since no other products were observed in the crude ^-N M R  spectra of these 
reactions, and despite repeated attempts, no alternative products could be isolated 













Entry Basea Temp.(°C)b Solvent
Product Ratioc 
130:126:135
1 KHMDS -78 THF NRd
2 KHMDS -40 THF NRd
3 KHMDS 0 THF 10:82:8
4 KHMDS RT THF <5:95:<5
5 NaH 0 THF <5:95:<5
6 KO'Bu 0 THF <5:95:<5
7 KCfBu/HCfBu 0 THF <5:95:<5
8 LiHMDS -40 THF NRe
9 LiHMDS 0 THF 30:45:25
10 LiHMDS 0 Toluene 33:35:32f
11 LiHMDS 10 Toluene 31:37:32
12 LiHMDS RT Toluene 8:85:7
(a) 1.1 equivalents o f base; (b) All reactions were carried out over a period o f  2 hours; (c) Product ratio 
determined by examination o f the crude !H-NMR spectra; (d) Reaction displayed clean spectra o f  126; (e) 1H- 
NMR indicated a mixture o f aldol diastereomers; (f) Reaction fa iled  to go to completion.
Table 2.1-2 -  Optimisation o f the retro-aldol reaction of/3-alkyl syn-aldol
Consideration of these results revealed that employing the more aggregating lithium 
counter-ion (compare Entry 3 with Entry 9) and the more aggregating toluene 
solvent, (compare Entry 9 with Entry 10), had resulted in an improved yield of 
aldehyde isolated from these retro-aldol reactions. It was also clear that temperature 
played a key role in the success of this retro-aldol reaction (Scheme 2.1-25). 
Treatment of .syw-aldol 134 with LiHMDS at -78°C resulted in no retro-aldol reaction 
occurring; however, as the temperature was increased to -40°C, the reaction resulted 
in a crude ^-N M R  spectrum that was extremely complicated, which was tentatively 
justified as the refroaldol reaction becoming reversible (Scheme 2.1-25), resulting in 
a mixture of the aldol diastereomers derived from syrc-aldol 134. This was indicated
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by the appearance of two new resonances in the ^-N M R  spectrum of the crude
reaction mixture at 54.56 ppm and 54.60 ppm, which were assigned as the C4 protons 
of the oxazolidin-2-one fragment of each diastereomer. This diastereomeric mixture 
presumably forms due to the well-known poor stereocontrol of lithium enolates in
of 134 was then carried out at 0°C, which gave an increased conversion to the desired 
retro-aldol products at this temperature. It is likely that a reversible retro-aldol 
reaction also occurs at 0°C; however, the equilibrium at this temperature clearly lies 
towards the retro-aldol cleavage products.
Reagents and conditions: (i) LHMDS, toluene, 0°C, 2 hours.
Scheme 2.1-25 -  Proposed mechanism for the reversible retro-aldol reaction o f syn-aldol 
134 with LiHMDS in toluene
The retro-aldol reaction was therefore optimised at 10°C, where it became the major 
reaction pathway affording A-propionyl-oxazolidin-2-one 130 and decanal in 59% 
and 52% yield respectively (Scheme 2.1-26). Above this temperature, it was found 
that SuperQuat oxazolidin-2-one 126 became the major product, and under these 
conditions very low yields of decanal 135 were observed (Entry 12).
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Reagents and conditions: (i) LiHMDS, toluene, l(fC , 2 hours.
Scheme 2.1-26 -  Optimised retro-aldol reaction for j.3-alkyl syn-aldol 134
2.1.14 Conclusions
It has been demonstrated that chiral oxazolidin-2-one derived syn-aldols can undergo 
novel intramolecular cyclisation and elimination reactions with excellent levels of 
diastereocontrol, and applied this methodology to the synthesis of chiral oxazinane- 
2,4-diones and the first total synthesis of Semiplenamide C. These unwanted reaction 
pathways were suppressed using .syn-aldols derived from SuperQuat chiral auxiliaries, 
due to the presence of a gem-dimethyl substituent that prevents intramolecular 
nucleophilic attack of the alkoxide species at the oxazolidin-2-one carbonyl. As a 
consequence, conditions were established enabling lithium alkoxides of this type of 
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Chapter 2.2 A novel protocol for the asymmetric 
synthesis of cyclopropane carboxaldehydes
2.2.1 Introduction
In this chapter the asymmetric synthesis of a range of unsaturated syn-aldols derived 
from N-propionyl-oxazolidin-2-ones, which are then used as substrates for 
stereoselective hydroxyl directed cyclopropanation reaction, will be described. The 
optimised retro-aldol reaction of cyclopropane syn-aldols is then discussed, which 
completes the novel three-step strategy for the asymmetric synthesis of chiral 
aldehydes (Scheme 2.2-1).
o o
* J U  Step






















Scheme 2.2-1 -  Novel three-step strategy for the asymmetric synthesis of chiral aldehydes
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2.2.2 Optimisation of the asymmetric syw-aldol reaction of (E)-a,(3- 
unsaturated aldehydes
Having developed conditions that enable aldol and retro-aldol reactions to be carried 
out in acceptable yields, our three-step synthesis of chiral aldehydes required access 
to a series of (3-vinyl syn-aldol products that could be used for hydroxyl directed 
cyclopropanation reactions. For reasons discussed in the previous chapter, the boron 
enolate of (S)-4-benzyl-iV-propionyl-5,5-dimethyl-oxazolidin-2-one 130 was chosen 
as a chiral auxiliary for the syn-aldol reaction with (£)-dec-2-enal.92 Unfortunately, 
under our previously optimised reaction conditions for aliphatic aldehydes, (E)-a- 
methyl-P-vinyl syn-aldol 137b could only be isolated in a disappointing 38% yield 
with the remaining mass balance comprising starting material (Scheme 2.2-2).
38% Yield 
>95%de
Reagents and conditions: (i) 9BBN -01f 'P^NEt, CH2 CI2, 0°C, 1 hour, (E)-dec-2-enal, -78°C, 1 hour then 0°C 1
Scheme 2.2-2 -  Boron mediated syn-aldol reaction of a,/3-unsaturated aldehydes
It was proposed that the decreased yield of syn-aldol product 137b was a result in this 
instance of the lower reactivity of {E)~dec-2-enal 136b when compared to 
isobutyraldehyde, arising from conjugation of the aldehyde functionality with the 
alkene. In an attempt to increase the yield of the reaction, the stoichiometry of the 
syn-aldol reaction was altered. Using two equivalents of 9BBN-triflate increased the 
yield of syn-aldol 137b to 75%, but lowered the diastereoselectivity to 81% de. This 
observation was not totally unexpected, since Heathcock and Walker had previously 
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the boron enolate had the potential to change the diastereoselectivity of the aldol 
reaction from syn- to anti-selective (Scheme 2.2-3).93
o o 9H
Q 9 '  © .AlEt2hY'X ^  yX
Ph
PH
Reagents and conditions: (i) Dibutyl boron triflate, 'P^NEt, CH2 CI2, 0°C, 1 hour, then aldehyde/Et2AlCl, -78°C, 5  
hours.
Scheme 2.2-3 -  Heathcock’s Lewis acid mediated anti-aldol reaction
In this case, it was proposed that coordination of the Lewis acid to the aldehyde 
creates an acyclic transition state (Figure 2.2-1), which in contrast to the 
Zimmerman-Traxler transition state shown previously (Scheme 2.1-7), affords the 




Figure 2.2-1 -  Acyclic transition state of Lewis acid mediated anti-aldol reaction
It was believed that the second unreacted equivalent of 9BBN-triflate in our reaction 
might be acting as a Lewis acid in this manner by coordinating to the aldehyde, thus 
reducing the overall diastereoselectivity of the reaction. Increasing the amount of 
base, diisopropylethylamine, used in this aldol reaction had little effect on the 
conversion, whilst increasing the stoichiometry of the aldehyde to two equivalents 
decreased the diastereoselectivity to 90%, whilst only increasing the conversion to 
65%. Therefore, it was clearly necessary to maintain the stoichiometry of the aldol
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reaction at a ratio of at one equivalent of aldehyde to one equivalent of 9BBN-triflate 
and diisopropylethylamine in order to achieve high diastereoselectivity.
The reaction time and temperature were then investigated. The (Z)-boron enolate of 
130 was generated at 0°C for one hour before the reaction was cooled to -78°C and 
(£)-dec-2-enal 136b added. The reaction was then allowed to slowly warm to room 
temperature overnight. This afforded .syrc-aldol 137b in an acceptable 77% yield and 
>95% de. Therefore, it would appear that the decrease in concentration of aldehyde as 
the syw-aldol reaction proceeds is matched by the increase in reaction temperature, 
which serves to maintain the reactivity and diastereoselectivity of the reaction under 
these conditions.
2.2.3 Synthesis of a series of a-methyl (2£)-P-vinyl syw-aldols
Using these optimised syn-aldol conditions, it proved possible to synthesise a series 
of chiral unsaturated aldol substrates in 76% to 87% yield and in >95% de in all cases 
(Table 2.2-1). Therefore, A range of commercially available a,(3-unsaturated 
aldehydes containing aryl (electron withdrawing and donating), heteroaryl and alkyl 
substituents all afforded syrc-aldol products in good yield and excellent de. The syn- 
configuration of these aldol products were confirmed from their small J2,3 coupling 
constants between 4.0 Hz and 5.0 Hz.
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Entry Aldehyde Ri Ri de (%)a Aldol Yield (%)
1 136a Ph H >95 137a 80
2 136b Me(CH2)6- H >95 137b 81
3 136c p-MeOPh- H >95 137c 77
4 136d o-N02Ph- H >95 137d 87
5 136e 2-Furyl- H >95 137e 85
6 136g Me H >95 137g 76
7 136h Me Me >95 137h 76
Reagents and conditions: 9BBN-OJf 'Pr2NEt, CH2 CI2, 0°C, 1 hour, 0,/3-unsaturated aldehyde, -78?C to RT, 
overnight;
(a) Determined by examination o f the crude ‘H-NMR spectra.
Table 2.2-1 -  syn-Aldol reactions of (E)-0,/3-unsaturated aldehydes
2.2.4 Synthesis of an a-methyl (Z)-P-vinyl syw-aldol
In order to complete the series of unsaturated aldol substrates, it was necessary to 
synthesise a (Z)-unsaturated syn-aldol. (Z)-a,(3-unsaturated aldehydes are known to be 
unstable under mildly acidic conditions and this was confirmed by attempted 
Lindlar’s hydrogenation of oct-2-ynal 136h, which generated an inseparable mixture 
of (E) and (Z) isomers (Scheme 2.2-4),94 It is likely that the (Z)-isomer is initially 
formed in this reaction in this hydrogenation reaction, but that it rapidly isomerised to 
its thermodynamically more stable (£)-isomer in the presence of adventitious acid.
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Reagents and conditions: (i) Lindlar’s catalyst, H2 ( l  atm), MeOH.
Scheme 2.2-4 -  Isomerisation of (Z)-a,/3-unsaturated aldehydes under acidic conditions
An alternative strategy to this class of ^yn-aldol was therefore devised involving the 
aldol reaction of the boron enolate of Af-propionyl SuperQuat oxazolidin-2-one 130 
with oct-2-ynal 136f, which under our previously described optimised conditions, 











Reagents and conditions: (i) 9BBN-OTf 'P^NEt, CH2 CI2, CPC, 1 hour, oct-2-ynal, -78°C to RT overnight. 
Scheme 2.2-5 -  Asymmetric syn-aldol reaction of oct-2-ynal
P-alkynyl ^yn-aldol 138 was then hydrogenated with Lindlar’s catalyst under one 
atmosphere of hydrogen for one hour in methanol,96 to afford exclusively the (Z)-
07diastereomer of .syn-aldol 137f in quantitative yield (Scheme 2.2-6). The cis- 
stereochemistry of the alkene fragment was clearly evident from the coupling 
constant of 11Hz between the alkene protons.
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Reagents and conditions: 10 mol% Lindlar’s Catalyst, 1 atm H2, MeOH, 2 hours.
Scheme 2.2-6 -  Lindlar’s hydrogenation o f a-methyl jfalkynyl syn-aldol
2.2.5 Directed cyclopropanation reaction of P-vinyl-syn-aldols
With a variety of (3-vinyl .syw-aldol substrates in hand, it was then necessary to carry 
out a stereoselective substrate directable transformation on these compounds and 
therefore complete step 2 of our new three-step synthesis of chiral aldehydes. A 
review of the literature revealed that the hydroxyl directed cyclopropanation reaction 
of allylic alcohols had been shown previously to proceed with excellent 
diastereoselective control.98 Under modified Furukawa’s conditions, Charette and co­
workers cyclopropanated a variety of chiral allylic alcohols with >100:1 
diastereoselectivity and in excellent yield (Table 2.2-2).99
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Reagents and conditions: (i) Et2Zn, CH2I2, CH2 CI2, -10 to 0°C, 2 hours 
Table 2.2-2 -  Directed cyclopropanation of allylic alcohols
Five equivalents of diethyl zinc and diiodomethane were required to ensure complete 
consumption of the olefin substrate in these reactions. The results demonstrate that 
excellent levels of diastereocontrol could be achieved for a wide range of allylic 
alcohols, containing various substituents at their 3-position.100 A proposed pseudo- 
pericyclic mechanism for this hydroxyl directed cyclopropanation reaction is shown 
in Figure 2.2-2.101 Deprotonation of the allylic alcohol functionality forms an 
alkoxide species containing two zinc atoms, which then serves as the 
cyclopropanating reagent. This reagent acts as a carbenoid equivalent that delivers a 
methylene unit to one face of the olefin. It is known that the hydroxyl group plays a 
vital role in the diastereoselectivity of the reaction, since in its absence, a simple 
olefin is cyclopropanated at a rate approximately 1000 times slower than for an allylic 
alcohol.101
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cu2\
I—Zn
Figure 2.2-2 -  Proposed mechanism for the cyclopropanation o f allylic alcohols
The nature and stoichiometry of the reagents used to generate the cyclopropanating 
species is also important in determining the diastereoselectivity of the reaction. 
Originally, the Simmons-Smith cyclopropanation reaction was carried out with 
activated metallic zinc to generate the methylene carbenoid equivalent.102 These 
conditions have largely been superseded by the use of Furukawa’s reagent, due to the 
greater consistency of results achieved.103 Diethyl zinc and diiodomethane react via 
halogen-metal exchange to afford an iodomethyl zinc iodide species in-situ, whose 
precise structure is dependent on the stoichiometry of the reagents. Three reactive 
species have been proposed for the reagents generated under these conditions; 
IZnCHfel, Zn(CH2l)2 and EtZnCHhl. A structure of the proposed reactive 
cyclopropanating species IZnCCFhl), which was co-crystallised with benzo-18-crown- 
6-ether, has been elucidated via X-ray crystallographic studies (Figure 2.2-3).104
Hydrogens omittedfor clarity; Red =  Oxygen, Grey = Carbon, Purple = Iodine, Turquoise =  Zinc. 
Figure 2.2-3 -  X-ray crystal structure o f IZnCH2I*benzo-l8-crown-6-ether
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Whichever reactive species is responsible for the stereoselective cyclopropanation,105 
it is inevitably minimisation of allylic strain in the transition state that determines the 
diastereoselectivity of the reaction. Coordination of the carbenoid cyclopropanating 
species to the stereodirecting hydroxyl group is then responsible for establishing 
which of the diastereotopic faces of the olefin is cyclopropanated.















Zn* = I . n ^ n"CH2I
OH R2 OH R2
R i^ < |
Scheme 2.2-7 -  Minimisation of allylic strain in the cyclopropanation of allylic alcohols
Upon reaction of the allylic alcohol with the cyclopropanating reagent, the methylene 
carbenoid can be delivered to either of the two diastereotopic faces of the olefin. 
Transition state 140 arising from trans-allylic alcohol 139 places the sterically 
hindered Ri group adjacent to the proximal olefinic hydrogen atom resulting in A1,2- 
strain; whilst positioning the sterically hindered distal alkenyl hydrogen close to the 
Ci hydrogen atom, resulting in A1,3-strain. This reactive conformation will lead to the 
formation of the syrc-cyclopropyl alcohol 141. Rotating the C1-C2 bond affords 
conformer 142 that allows the hydroxyl group to direct cyclopropanation to the 
opposite diastereotopic face of the olefin. However, whilst this conformer positions
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the Ci hydrogen atom and the olefinic hydrogen atom close together, resulting in 
1 0minimisation of A ’ -strain, it also places the sterically hindered Ri group close to the
1 ^distal alkenyl proton, maximising A ’ -strain. Therefore, transition state 142, leading 
to the anfr’-cyclopropyl alcohol 143, is higher in energy than transition state 140 and 
as a consequence, ^ -selectiv ity  is observed. This stereodirecting effect is even more 
apparent for cis-allylic alcohol 144, since the energy difference between transition 
states 145 and 146 is increased by the R2 group pointing towards the Ri group, thus 
increasing A1,3-strain even further.
It was decided to apply this type of highly diastereoselective hydroxyl directed 
cyclopropanation reaction to our prochiral unsaturated oxazolidin-2-one sy«-aldol 
substrates. Therefore, the previously prepared syn-aldols 137a to 137h were treated 
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1 137a H Ph 147a 1 >95 95
2 137b H n-CgHn 147b 1 >95 89
3 137c H p-PhOMe 147c 1 >95 90
4 137d H o-PhN02 147d 1 >95 90
5 137e H 2-Furyl 147e 2 >95 92
6 137f n-CsHn H 147f 2 >95 96
7 137g H Me 147g 4 >95 95
8 137h Me Me 147h 2 >95 92
Reagents and conditions: (i) Et2Zn, CH2I2, CH2 CI2, -10 to 0°C
(a) Determined from examination o f the crude 300 MHz }H-NMR spectra
Table 2.2-3 -  Cyclopropanation o f a-methyl f.3-vinyl oxazolidin-2-one syn-aldols
Under these conditions, it was demonstrated that the hydroxyl directed 
cyclopropanation reaction proceeded with excellent diastereoselectivity, regardless of 
the type of alkene substituents present in the aldol substrate. Examination of the crude
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300 MHz !H-NMR spectra of each cyclopropanation reaction revealed no evidence of 
any ^^/-cyclopropane diastereomer and as a consequence, the stereocontrol was 
assigned as >95% de in favour of the syn-diastereomer. The yields obtained of 
cyclopropane aldols 147a-147h obtained in these cyclopropanation reactions were 
excellent in all cases, with the crude products found to be near analytical purity after 
work-up, requiring only simple chromatography to remove residual diiodomethane. 
a-M ethyl nitrophenyl cyclopropyl .syrc-aldol 137d (Entry 7) required increased 
reaction times to ensure complete consumption of the starting aldol 137d. This is 
likely to be a result of the electron deficient nature of its olefin substituent, caused by 
the presence of the electron withdrawing ortho-nitrophenyl functionality. No 
evidence of any products arising from a competing cyclisation pathway to their 
corresponding l,3-oxazinane-2,4-diones (Scheme 2.1-14), or subsequent E lcb 
elimination to their corresponding a,P-unsaturated amides (Scheme 2.1-11) was 
observed in any of these reactions, thus demonstrating the effectiveness of the 
SuperQuat auxiliary in blocking these competing reaction pathways.
The cyclopropane rings of these aldol substrates were easily identified in their ’H- 
NMR spectra due to the high field chemical shifts observed for their cyclopropyl 
protons, which has been attributed to the sigmatropic aromaticity of the cyclopropane 
ring. The Walsh model106 describes cyclopropane bonding as being constructed from
2 2
three sp hybridised orbitals, for which the basis set is shown in Figure 2.2-4. The sp 
hybrid orbitals are pointed towards the centre of the ring, resulting in diminished 




Figure 2.2-4 -  Walsh’s basis set fo r  the bonding in cyclopropane
Energy
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The high field chemical shift of the cyclopropane protons can be explained through 
this model by considering sigmatropic aromaticity. Occupation of ij/i results in a 
three-centre two-electron bond.107 This sigmatropic resonance complies with the 
4n+2 rule for aromaticity around the three-membered ring, which creates a ring 
current that shields the cyclopropyl protons from the applied magnetic field. In the 
absence of electron withdrawing groups, the cyclopropane protons arc 
characteristically observed in the 0 to 1 ppm region of their 'H-NMR spectra.
The all syw-stereochemistry of cyclopropane sy«-aldols 147a-147h were assigned 
from literature precedent for this class of cyclopropanation reaction (Scheme 2.2-7), 
and was confirmed for the crystalline nitrophenyl-a-methyl-p-cyclopropyl s>w-aldol 
147d by X-ray crystallographic studies (Figure 2.2-5).
Me
Selected hydrogens omitted for clarity; Red = Oxygen, Grey = Carbon, Purple = Nitrogen, White = Hydrogen. 
Figure 2.2-5 -X -ray crystal structure o f nitrophenyl-a-methyl-(fey clopropyl syn-aldol 14 7 d
This crystal structure clearly revealed the all syH-stereochemistry of the TV-acyl 
fragment caused by delivery of the methylene carbenoid to the alkene functionality of 
137d by its hydroxyl group.
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2.2.6 Retro-aldol reaction of p-cyclopropyl-syw-aldols to afford non­
volatile cyclopropane carboxaldehydes
To compete our new three-step synthesis of chiral aldehydes, it was necessary to 
carry out retro-aldol reactions on our cyclopropyl syn-aldol substrates. Therefore, (3- 
cyclopropyl-syrc-aldols 147a-147h were subjected to the retro-aldol conditions we 
had established previously for syn-aldol 134 involving treatment with LiHMDS in 
toluene (see Scheme 2.1-25).
108The results of the retro-aldol reactions carried out are described in Table 2.2-4. It 
became apparent that the success of these retro-aldol reactions was highly dependent 
on the temperature at which the reaction was performed. It was found that the retro- 
aldol reaction of each cyclopropyl aldol substrate had to be optimised to maximise the 
conversion to the required aldehyde. For example, the retro-aldol reaction of syn- 
aldol 147a (Entry 1) when carried out at -20°C, unreacted starting material was 
recovered as the major product, with less than 10% of any retro-aldol products being 
observed; when the temperature was increased to 20°C, the major product recovered 
was oxazolidin-2-one 126, again with less than 10% of any retro-aldol reaction 
products being observed. Only at the optimised temperature of 0°C could 
cyclopropane carboxaldehyde 148a be isolated in an acceptable 75% yield. Following 
the course of this retro-aldol reaction via thin layer chromatography, in an attempt to 
identify when the cyclopropane ^yn-aldol had been consumed proved unsuccessful. 
This was because the aliquot taken for analysis warmed to room temperature when it 
was removed from the reaction mixture, and as a consequence the analysis did not 
reflect the mixture of products obtained upon quenching these retro-aldol reactions.
82
Temporary stereocentres for the asymmetric synthesis of chiral aldehydes







Temp. de  
(°C) (% /









O  7 1 - C 5 H 1 1
148f
- 10*>95147f
Reagents and conditions: (i) LHMDS, toluene, 2 hours.
(a) Determined by examination o f the crude 300 MHz lH-NMR spectra; (b) Run in CHCI3 and were comparable 
with known literature values (see reference 108); (c) Run in CH2 Cl2; (d) Run in CHCI3, specific rotation was 
comparable with structurally related (IS,2R)-2-hexylcyclopropanecarbaldehyde (see reference 108).
Table 2.2-4 -  Retro-aldol reaction of cyclopropyl syn-aldols
Analysis of the crude !H-NMR spectra of successful retro-aldol reactions once again 
displayed a clear proportionality between the amount of cyclopropane 
carboxaldehyde isolated and the amount of A-acylated oxazolidin-2-one 130 formed. 
Similarly, formation of any oxazolidin-2-one 126, presumably via a retro-ketene
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decomposition pathway, was always associated with a proportional loss in the amount 
of desired cyclopropane carboxaldehyde (Appendix 4.1). No other products were 
observed in the crude 300 MHz !H-NMR spectra of any retro-aldol reactions, and 
despite repeated attempts, I was unable to isolate any by-products from these 
reactions that might be responsible for consuming the aldehyde fragment.
Since epimerisation of the (3-stereocentre of cyclopropane carboxaldehydes 148a- 
148f was unlikely, each of the cyclopropane carboxaldehydes were assumed to be 
single enantiomers as determined from their diastereomeric excesses that were found 
to be >95% de via examination of their crude ^-N M R  spectra. No epimerisation at 
the a-centre of any of the cyclopropane carboxaldehydes was observed, including for 
cw-cyclopropane carboxaldehyde 148f that had been shown previously to readily 
epimerise to its more thermodynamically stable trans-diastereomer under basic 
conditions.109
Therefore, a series of six cyclopropane carboxaldehydes had been prepared in 
acceptable to good yields (55% to 75%), and in >95% de in all cases. The absolute 
configurations of cyclopropane carboxaldehydes 148a and 148b were confirmed as 
(*S,5), via comparison of the signs of their specific rotations with literature values 
previously reported for these chiral aldehydes.108
2.2.7 The retro-aldol reaction of volatile aldehydes
Attempts to carry out the retro-aldol reaction with LiHMDS in toluene on 
cyclopropyl aldols 147g and 147h, failed to afford the desired short chain 
cyclopropane carboxaldehydes 148g and 148h. It was proposed that this failure was 
probably due to the volatility of these aldehydes that had resulted in their loss during 
work-up of the reaction due to the need to remove solvent in vacuo. To solve this 
isolation problem, an alternative protocol was devised in which cyclopropyl syn- 
aldols 147g and 147h were dissolved in deuterated toluene and LiHMDS (as a 2 mol
-J Q
dm' solution in toluene-d ) was added in one portion, followed by stirring for 2 hours 
at 10°C. The reactions were then quenched with 5 drops of distilled water, dried over
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3A molecular sieves and filtered. The crude reaction mixtures were then distilled 
under atmospheric pressure (at 120°C for 148g, and 130°C for 148h) to afford 
cyclopropane carboxaldehydes 148g and 148h isolated as solutions in toluene-d8, 
with overall yields of 65% and 51% respectively (Scheme 2.2-8).110
147g 130 148g 126
73% Yield 51% Yield 18% Yield
>95% de 
[ot]D25 (toluene-d8) = +54°
147h 130 148h 126
70% Yield 61% Yield 19% Yield
>95% ee 
[a]D25 (toluene-d8) = +63°
Reagents and conditions: (i) LiHMDS, toluene-d8, lCfC, 2 hours
Scheme 2.2-8 -  Retro-aldol reaction for the formation of volatile cyclopropane 
carboxaldehydes
The yields of cyclopropane carboxaldehydes 148g and 148h were calculated by the 
addition of a known amount of 2,5-dimethylfuran as an internal standard to each 
distillate. This enabled the concentrations of the cyclopropane carboxaldehyde 
solutions to be determined accurately by comparing the intensity of their respective 
integrals in their ^-N M R  spectra. The diastereomeric excess of methyl cyclopropane 
carboxaldehyde 148g was determined as greater than 95% by examination of its 300 
MHz ^-N M R  spectrum. However, dimethyl cyclopropane carboxaldehyde 148h 
contained only a single stereogenic centre at its a-position; therefore, its 
stereochemical purity could not be determined from analysis of its !H-NMR 
spectrum. Mangeney and co-workers have described that the enantiomeric excess of 
chiral aldehydes can be determined using their chiral diamine derivatising agent that 
affords imidazolidine diastereomers ideally suited for *H-NMR spectroscopic
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analysis.111 Barrett and co-workers have previously described the use of this 
imidazolidine derivatisation approach for determining the enantiomeric excess of 
methyl cyclopropane 148h with both enantiomers of chiral diamine 149 being used to 
prepare diastereomers 150 and 151.112 They demonstrated that the two imidazolidine 
diastereomers 150 and 151 exhibited significantly different !H-NMR spectra that 
enable their individual resonances to be clearly distinguished (Figure 2.2-6).
Ph. / h  Ph% Ph
\  r ~ \ /
H'
Figure 2.2-6 -  Diastereomeric imidazolidines of chiral cyclopropanes
N. .N
Q
Therefore, a solution of dimethyl cyclopropane carboxaldehyde 148h in toluene-d , 
was reacted with enantiopure (1S,2S)-N1 ^ -d im ethy l-1,2-diphenylethane-1,2-diamine 
149 (Scheme 2.2-9) to afford chiral imidazolidine 152. Examination of the crude 300 
MHz ^-N M R  spectrum of this derivatisation reaction revealed a single set of 
resonances for the peaks corresponding to the imidazolidine fragment of a single 
diastereomer, and as a consequence the enantiomeric excess of my sample of 
dimethyl cyclopropane carboxaldehyde 148h was assumed to be >95% ee.
148h 149 152
Single diastereomer observed 
in 'H-NMR spectrum
Reagents and conditions: (i)4A  MS, EtiO, 2  hours.
Scheme 2.2-9 -  Derivatisation of dimethyl cyclopropane carboxaldehyde
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2.2.8 Conclusion
Methodology has been developed for the asymmetric synthesis of a series of N- 
propionyl oxazolidin-2-one derived unsaturated aldol substrates 137a to 137h in high 
de and yield. These substrates were cyclopropanated using modified Furukawa’s 
conditions to afford cyclopropyl syn-aldols 147a to 147h with excellent de in near 
quantitative yield. The retro-2\do\ reaction of these cyclopropyl syrc-aldols was then 
optimised to afford a range of cyclopropane carboxaldehydes with no epimerisation 
or racemisation of any stereocentres being observed. The original aim of this project 
had therefore been completed employing temporary stereocentres for asymmetric 
synthesis in a novel three-step synthesis of chiral cyclopropane carboxaldehydes in 
38% to 55% overall yield from the starting chiral auxiliary, and >95% ee in all cases 
(Scheme 2.2-10).113
+ X J L  ®























89% to 99% yield 
>95% de
CA-P
Reagents and conditions: (i) 9BBN-OTf 'Pr2NEt, CH2 CI2, 0°C, 1 hour, a,J3-unsaturated aldehyde, -78°C to RT 
overnight, (ii) Et2Zn, CH2I2, CH2 CI2, - l ( fC  to 0°C, 1 to 4 hours; (Hi) LHMDS, toluene, 0 to 10°C, 2 hours.
Scheme 2.2-10 -  Novel three-step protocol for the asymmetric synthesis o f chiral aldehydes
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Chapter 2.3 Further developments of the retro- 
aldol reaction and the total synthesis of 
Cascarillic acid
2.3.1 Introduction
This chapter describes further attempts to improve the retro-aldol reaction by 
exploring three alternative synthetic protocols to carry out this critical reaction. 
Application of optimised retro-2ddo\ conditions for the three-step aldol/directed 
cyclopropanation/refro-aldol strategy to a novel total asymmetric synthesis of the 
cyclopropane containing natural product Cascarillic acid is then described.
2.3.2 Proposals for the loss of aldehyde yield
In the previous chapter it was described how competing formation of oxazolidin-2- 
one 126 as an unwanted side product in the anionic retro-d\do\ reaction of 
cyclopropyl yy/i-aldols lead to a loss in yield of our desired chiral aldehydes. It was 
difficult to identify reasons for the loss in yield of aldehyde product in these types of 
retro-aldol reactions, which proved extremely capricious, with different yields of 
cyclopropane carboxaldehydes being obtained for different types of cyclopropyl aldol 
substrate under the same conditions. For example, simply changing the temperature 
of the reaction from 10°C to room temperature in the anionic retro-aldol reaction of 
yyw-aldol 147d, resulted in the yield of cyclopropane carboxaldehyde 148d being 
reduced from a reasonable 55% yield to almost zero, with the crude ^-N M R  spectra 
indicating no compounds other than the oxazolidin-2-one auxiliary 126 being present 
(Scheme 2.3-1).
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Reagents and conditions:(i) LiHMDS, toluene, RT, 2 hours.
Scheme 2.3-1 -  Loss of aldehyde in the anionic retro-aldol reaction
It was therefore proposed that two mechanisms might be operating, whereby the 
aldehyde fragment could be lost in this reaction. In the first proposed mechanism 
(Scheme 2.3-2), the retro-aldol reaction would proceed as desired to afford a 
cyclopropane carboxaldehyde and lithium enolate 153. This enolate intermediate 
would then undergo retro-ketene cleavage as previously described (Scheme 2.1-23), 
to afford methyl ketene 154 that could potentially react with the aldehyde in a [2 + 2] 
cycloaddition reaction, to afford an unstable beta-lactone intermediate 155. This 
compound could then oligomerise, or be hydrolysed during workup, to afford 
products that were insoluble in organic solvents. This would therefore leave 
oxazolidin-2-one 126 as the only observable by-product in the crude ^-N M R  
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Reagents and conditions: (i) LiHMDS, toluene, RT, 2 hours.
Scheme 2.3-2 -  Proposed retro-ketene mechanism for the loss o f aldehyde in an anionic 
retro-aldol reaction
There is literature precedent for this type of pericyclic reaction since Miyano and co­
workers have reported a similar asymmetric [2 + 2] cycloaddition reaction of ketene 










O .S -N H  HN-SO,
Reagents and conditions: Me^Al, 159, (10 mol%), Toluene, -78°C.
Scheme 2.3-3 -  Chiral /3-lactone synthesis from aldehydes and ketenes
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The second mechanism proposed (Scheme 2.3-4) would involve lithium alkoxide 160 
undergoing competing nucleophilic attack at the exocyclic carbonyl of the aldol 
substrate, with the anion of oxazolidin-2-one 126 departing as a leaving group. P- 
Lactone intermediate 161 would then be hydrolysed or oligomerise in a similar 
manner to afford products that were insoluble in organic solvents, once again leaving 
oxazolidin-2-one 126 as the only visible by-product in the !H-NMR spectrum.
Reagents and conditions: (i) LiHMDS, toluene, RT, 2 hours.
Scheme 2.3-4 -  Proposed anionic cyclisation mechanism for the loss o f aldehyde yield in the 
anionic retro-aldol reaction
Once again there is literature precedent for this reaction pathway since Schick and co­
workers proposed a similar cyclisation mechanism in their one pot aldol/P-lactone 
synthesis, in which a lithium alkoxide intermediate 162 was proposed to cyclise to 
lactone 163 in situ (Scheme 2.3-5).115
126
|  Aqueous workup
o
Further reactions or hydrolysis 
to give organic insoluble 
product
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Reagents and conditions: (i) LDA, THF, -78°C.
Scheme 2.3-5 -  One pot aldol/(3-lactone formation
Whilst I was unable to identify the causes for the decreased yield in aldehyde 
formation with any certainty, the optimal conditions established for these retro-aldol 
reactions were consistent with both these mechanisms. Changing the solvent used for 
the retro-aldol reaction from THF to the more aggregating toluene and using lithium 
as an alkoxide counter-ion instead of potassium was proposed to have stabilised the 
metal enolate intermediate 153 (or the cyclic metal intermediate 160), thus limiting 
the rate of either of these unwanted decomposition pathways and subsequent loss in 
aldehyde products.
2.3.3 Alternative chiral auxiliaries
Despite completing our three-step step synthesis of chiral aldehydes, we remained 
frustrated by the precocious nature of the retro-aldol reaction that had to be optimised 
for good yields of individual cyclopropane carboxaldehydes to be achieved. Analysis 
of each retro-aldol reaction had to be carried out by examination by *H-NMR 
spectroscopy of the crude reaction mixture following work-up, since monitoring of 
the reaction by thin-layer chromatography did not accurately reflect the actual 
products observed in the crude ^-N M R  spectrum.
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In an attempt to improve the yield of the retro-aldol reaction, we decided to screen a 
range of oxazolidin-2-one chiral auxiliaries that contained different N-acetyl 
substituents. It was proposed that these chiral auxiliaries would afford syn-aldol 
substrates with electron withdrawing groups at their cc-positions, which might serve 
to promote the retro-aldol reaction to afford the desired cyclopropane 
carboxaldehydes in higher yields.116 Therefore, the lithium anion of oxazolidin-2-one 
126 was reacted with five commercially available acid chlorides or bromides to afford 
N-acyl-oxazolidin-2-ones 164 to 167 in 72% to 89% yield, using the previously 
described procedure (Scheme 2.3-6).
o n o
R
_  Me, Ph, p-PhOMe 
1 ~  Cl. Br
72% to 89% Yield
Reagents and conditions: (i) "BuLi, RCH2 COCI or RCH2 COBr, THF, -78 to 0°C.
Scheme 2.3-6 -  Synthesis o f various N-acylated oxazolidin-2-one auxiliaries using 




Two further N-acylated oxazolidin-2-ones 168 and 169 were synthesised via an 
alternative procedure, where their corresponding commercially available acids were 
converted in-situ to their acid chlorides using oxalyl chloride and triethylamine in the 
presence of a catalytic amount of DMF. The resultant acid chlorides were then 







R = SMe, C F j
PH
48% and 52% Yield 
respectively
Reagents and conditions: (i) Oxalyl chloride, RCH2CO2H, 5 mol% DMF, THF, 0°C, 1 hour, then nBuLi, 
oxazolidin-2-one, THF, -78 to 0°C, THF, 2 hours.
Scheme 2.3-7 -  Synthesis of N-acylated oxazolidin-2-ones from commercially available acids
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The boron enolates of these new chiral auxiliaries were then reacted with para- 
methoxycinnamaldehyde under our standard syrc-aldol conditions (9BBN-OTf, 
‘P^NEt) to afford syw-aldols 164 to 169 in moderate to good de (59 to >95% de). The 
results of these aldol reactions are summarised in Table 2.3-1.
p-PhOMe
Entry R Auxiliary Aldol Conv.a dea
1 Me 130 137c 90 >95
2 Ph 164 164a 78 90
3 p-PhOMe 165 165a 70 73
4 Cl 166 166a 81 81
5 Br 167 167a 65 63
6 SMe 168 168a 63 59
7 c f3 169 169a 0 /
Reagents and conditions: (i) 9BBN-OJf ‘Pr2NEt, CH2 CI2, 0°C, 1 hour, (E)-para-methoxycinnamaldehyde, -78 to 
RT, overnight; (a) de determined by examination o f  the crude 300 MHz 1H-NMR spectrum.
Table 2.3-1 -  Asymmetric syn-aldol reaction o f various N-acylated oxazolidin-2-one 
auxiliaries
It was immediately apparent that the levels of stereocontrol observed in these aldol 
reactions were inferior to the very high levels (>95% de) originally obtained in the 
.syw-aldol reaction of N-propionyl-oxazolidin-2-one 130 (Entry 1). The syrc-aldol 
reaction of a-phenylacetyl-oxazolidin-2-one 164 (Entry 2) afforded syn-aldol 164a 
in an acceptable 90% de, but the compound proved unstable to purification by silica- 
gel chromatography. The oc-para-methoxyphenylacetyl-oxazolidin-2-one derived 
aldol 165a (Entry 3) was stable to chromatography; however, the diastereomeric 
excess of 73% was low and the major diastereomeric aldol products could not be 
separated. a-Halo oxazolidin-2-ones 166 and 167 (Entries 4 and 5) displayed a 
similar drop in diastereoselective control (63-81% de); whilst, a-thio oxazolidin-2- 
one 168 (Entry 6) displayed the lowest selectivity of 59% de. Interestingly, a-
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trifluoromethylacetyl-oxazolidin-2-one 169 (Entry 7) gave no syn-aldol product at all 
resulting in only unreacted a-trifluoromethylacetyl-oxazolidin-2-one 169 being 
recovered at the end of the reaction. Therefore, due to the relatively poor 
diastereocontrol observed for these chiral auxiliaries in the asymmetric syn-aldol 
reaction, these aldol products were not carried further through our three-step protocol.
2.3.4 Pyrolysis of syw-aldol substrates: High temperature thermal 
retro-aldol reactions
Disappointed by our attempts to change the a-substituent of the chiral auxiliary as a 
strategy to promote the retro-aldol reaction, it was decided to examine alternative 
methodologies to develop an improved retro-aldol reaction using Af-propionyl- 
oxazolidin-2-one chiral auxiliary 130. Intuitively, the retro-aldol reaction may be 
achieved by simple hydrogen transfer from the P-hydroxyl substituent to the 
exocyclic carbonyl of the sy«-aldol substrate 170 in a pseudo-pericyclic process to 
afford an enol 171 and an aldehyde (Scheme 2.3-8).
Scheme 2.3-8 -  Proposed thermal retro-aldol reaction
This type of pericyclic rearrangement reaction has been shown to occur for P- 
hydroxyesters at 170°C by Houminer and co-workers (Table 2.3-2). 118 They 
demonstrated that increasing the steric demand of the a- and P-substituents of the 
aldol substrate dramatically increased the rate of decomposition and therefore 
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bonded transition state, such that the driving force for this thermal retro-aldol 
reaction was as a result of the release of steric strain from a chair-like transition state.
o
. ,o v ?  —R2 R3 R3
Reagents and conditions: (i) 170°C, diglyme.




Entry Ri r 2 r 3 r 4 Exper. k.A (rel.)
1 Me H H H 1
2 Me Me Me H 20
3 Et H ’Pr Me 96
4 Me Me Me Me 2100
It was proposed that these thermal conditions for the retro-aldol reaction might be 
applicable to our a-methyl cyclopropyl sy«-aldol substrates. Therefore, neat a-methyl 
cyclopropyl syw-aldol 147a was heated in a Kugelrohr under reduced pressure (400 
mb) in the absence of solvent. At 220°C, phenyl cyclopropane carboxaldehyde 148a 
was observed to distil from the reaction bulb to give spectroscopically pure material. 
Upon completion of this distillation, the residual product that remained in the reaction 
bulb was found to be spectroscopically pure iV-propionyl-oxazolidin-2-one 130, with 
no decomposition to the parent oxazolidin-2-one 126 being observed. It was therefore 
concluded that coordination of the (3-hydroxy functionality to the exocyclic carbonyl 
of the aldol fragment had initiated the desired pseudo-ptncycXic reaction, resulting in 
clean retro-Mo\ cleavage of syrc-aldol 147a (Scheme 2.3-9).119
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Reagents and conditions: (i) 220°C.
Scheme 2.3-9 -  Pyrolysis o f a-methyl phenyl cyclopropyl syn-aldol 147a
Unfortunately, it was found that this type of thermal retro-aldol reaction was limited 
to the synthesis of cyclopropane carboxaldehydes that did not contain y-protons prone 
to elimination, since heating ds-cyclopropyl ^y«-aldol 147f to 220°C resulted in the 
formation of two aldehyde products that were inseparable by chromatography. 
Examination of the ]H-NMR spectrum (see Appendix 4.2) of the crude reaction 
product revealed the expected cyclopropane carboxaldehyde 148f (CHO doublet at 
89.35 ppm), and a second aldehyde peak at 89.72 ppm that appeared as a triplet. 
Since this crude ^-N M R  spectrum also revealed a 2H multiplet at 85.31 ppm, 
characteristic of a non-conjugated alkene group, it was tentatively concluded that 
cyclopropane carboxaldehyde 148f had undergone a further pseudo-ptncycMc 
elimination reaction of the cyclopropane ring to afford acyclic aldehyde 173 (Scheme
2.3-10).
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Scheme 2.3-10 -  Proposed mechanism for the pseudo-pericyclic decomposition o f cis- 
cyclopropane carboxaldehyde 148f
Due to the orientation of the c/s-cyclopropane ring in aldehyde 148f, the C3-C4 bond 
can easily rotate to adopt a conformer that positions the allylic carbon-hydrogen bond 
close to the aldehyde carbonyl, thus affording a six-membered transition state. This 
hydrogen atom is then transferred to the aldehyde carbonyl, resulting in cleavage of 
the cyclopropane ring to afford enol intermediate 172, which then simply 
tautomerises to afford &fs-homoallylic aldehyde 173.120
Despite repeated attempts, I was unable to devise distillation conditions that would 
remove cyclopropane carboxaldehyde 148f from the Kugelrohr bulb quickly enough 
to prevent this second rearrangement reaction from occurring. Similar elimination 
products were observed in the thermal retro-aldol reaction that afforded dimethyl 
cyclopropane carboxaldehyde 148h.
Finally, it should be noted that attempts to carry out this thermal retro-aldol reaction 
on saturated acyclic aldol 134 that does not contain a cyclopropane ring proved 
unsuccessful, even at temperatures above 250°C. This indicated that the presence of 
the cyclopropane motif within the syn-aldol was essential for successful pyrolysis of 
these compounds, presumably due to the added release of steric strain in the trasition 
state that results from the presence of the cyclopropane ring (Scheme 2.3-11).
Ph Ph
143a147
Scheme 2.3-11 -  Failed pyrolysis o f non-cyclopropyl syn-aldol 134
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2.3.5 Pyrolysis of syw-aldol substrates: Surface catalysed thermal 
retro-aldol reactions
It was proposed that the high temperatures required for the thermal retro-aldol 
reaction of relatively simple aldol substrates were unlikely to be applicable to more 
structurally complex substrates containing sensitive functionality. Furthermore, it was 
anticipated that if the temperature at which the pyrolysis reaction occurred could be 
reduced, then competing cyclopropane ring cleavage might be avoided. It had been 
previously observed that the attempted purification of a-phenyl syn-aldol product 
164a via silica-gel chromatography had resulted in partial retro-aldol decomposition 
(Scheme 2.3-12) and as a consequence, we wondered whether we this observation 
could be exploited to lower the temperature of the thermal retro-aldol reaction.
164
Scheme 2.3-12 -  Partial retro-aldol decomposition ofsyn-aldol 164a over silica-gel
Firstly, it was found that refluxing oc-methyl cyclopropyl syra-aldol 147a in toluene 
for twelve hours resulted in no retro-aldol reaction, with only starting material being 
recovered in quantitative yield. Addition of 10 mol% silica (or activated carbon) to 
the reaction mixture in refluxing toluene, resulted in complete retro-aldol cleavage 
after 6 hours to afford cyclopropane carboxaldehyde 148a in 81% yield and >95% de. 
Retro-aldol cleavage of a-methyl cfs-cyclopropyl syn-aldol 147f was also complete 
after eight hours under these conditions, with no evidence of any products arising 
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heterogeneous solid capable of adsorbing the aldol substrate onto its surface had 








83% Yield 81% Yield
>95% de






d V i + i
PH
130 148f
85% Yield 71% Yield
>95% de
Reagents and conditions:(i) 10 mol% silica or activated carbon, toluene, l l ( fC , 6  hours. 
Scheme 2.3-13 -  Surface catalysed pyrolysis o f a-methyl cyclopropyl syn-aldols
It was proposed that the mechanism of this surface catalysed retro-aldol reaction was 
likely to be due to a ‘templation’ effect that promotes an intramolecular hydrogen 
bond within the cyclopropyl aldol substrate by adsorption to the surface. Examination 
of the solid state X-ray crystal structure of a-methyl o-nitrophenyl cyclopropyl syn- 
aldol 147d revealed that the hydrogen atom of its hydroxyl functionality is directed 
away from the exocyclic carbonyl, to form an intermolecular hydrogen bond in the 
solid state, such that a herring bone motif is formed throughout the crystal (Figure
2.3-1).
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Selected hydrogens omitted for clarity; Red = Oxygen, Grey = Carbon, Purple = Nitrogen, White = Hydrogen.
Exocyclic carbonyl -  Hydroxyl oxygen: Hydrogen Bond length = 2.774(3) A; Exocyclic carbonyl -  Hydroxyl 
hydrogen: Hydrogen Bond length = 2.286 A;0-H-0 angle = 117.86(16)°.
Figure 2.3-1 -  X-ray crystal structure o f syn-aldol 147d  displaying an intermolecular 
hydrogen bond
This intermolecular conformational ground state clearly suggests an intrinsic energy 
barrier to the formation of an intramolecular six-membered transition state 
conformation that is required for the thermal retro-aldol reaction. To reveal whether 
this intermolecular hydrogen bond was also prevalent in solution state, we carried out 
infrared spectroscopic analysis of a-methyl o-nitrophenyl cyclopropyl syw-aldol 147d 
dissolved in chloroform at various concentrations (Scheme 2.3-14).
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Scheme 2.3-14 -  Infra-red spectroscopic analysis o f different concentrations cyclopropyl 
syn-aldol in chloroform
It was found that the oxazolidin-2-one carbonyl stretch appeared at 1774 cm'1 and 
remained constant throughout the change in concentration, indicating that it is not 
involved in any hydrogen bonding interaction. At high concentrations (0.75 mol dm'3) 
the exocyclic carbonyl displays a single v(C=0) stretch at 1686 cm'1, with the 
hydroxyl group displaying a broad intermolecular hydrogen bond absorption at 3536 
cm'1. Halving the concentration to 0.31 mol dm'3 resulted in the exocyclic carbonyl 
and hydroxyl absorptions decreasing in intensity with respect to that o f the 
oxazolidin-2-one carbonyl. When the concentration was halved again to 0.15 mol 
dm'3, the sharp absorption at 3154 cm'1 increased in intensity, whilst the exocyclic 
carbonyl had resolved itself into two absorptions at 1686 and 1677 cm'1 (Figure
2.3-2).
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Endocyclic carbonyl Exocyclic carbonyl
Figure 2.3-2 -  Expanded carbonyl region o f IR-spectrum displaying splitting of the exocyclic 
carbonyl absorptions
Finally, at low concentrations (0.04 mol dm'3) the new absorption at 3154 cm '1 
became increasingly strong, the broad absorption at 3536 cm-1 had essentially 
disappeared, whilst the exocyclic carbonyl region had split cleanly into two distinct 
absorptions at 1686 cm'1 and 1677 cm '1.
This infrared analysis was interpreted to infer that at high concentrations, the
cyclopropyl aldol exists almost exclusively as a hydrogen bond dimer, therefore 
displaying only a single set of absorptions. As the solution becomes increasingly 
dilute, the molecule becomes less likely to form this dimer and intramolecular 
hydrogen bonding begins to occur, which results in an increase in intensity of the 
sharp absorption band for intramolecular hydrogen bonding at 3154 cm*1, and
splitting of the exocyclic carbonyl absorption into two peaks at 1686 cm'1 and 1677
, - 1  121 cm .
With reference to the thermal retro-aldol reaction previously described, it is proposed 
that adsorption of the aldol substrate onto a surface shifts the position of equilibrium 
from the hydrogen-bonded dimer to the monomeric species, which in turn is 
responsible for the retro-aldol reaction.
This proposed mechanism is likely to be an oversimplification of the reaction 
pathway occurring in the thermal retro-aldol reaction; however, it is clear that an 
‘activated’ surface is certainly required for the retro-aldol reaction of these types of 
aldol substrate to occur at lower temperatures. Interestingly, attempts to carry out the
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thermal retro-aldol reaction under stringently dry conditions, or by adding 
triethylamine to the reaction mixture prevented the retro-aldol reaction from 
occurring.
In conclusion, although this thermal retro-aldol reaction provides a useful addition to 
our list of fragmentation conditions, it also proved to be quite inconsistent, sometimes 
failing to produce the same results under identical conditions, and it therefore requires 
further optimisation if it is to prove to be synthetically versatile alternative.
2.3.6 Samarium(II) iodide, a unique reagent for the retro-aldol 
reaction
Recent work by Nevalainen and Simpura demonstrated that treatment of P-hydroxy 
ketones with trimethyl aluminium derivative in the presence of benzaldehyde resulted 
in a trans-dl&o\ reaction occurring to afford a new aldol product 174 and acetone 
(Scheme 2.3-15).122
O OH O rix O OH OX Xwe + X I I  * X
H Ph Me M e M e
174
Reagents and conditions: (i) BINOL-AlMe (5 mol%), CH2 CI2, 48 hours.
Scheme 2.3-15 -  Lewis acid mediated aldol transfer reaction
Attempts to repeat this reaction using our cyclopropyl aldol substrates with trimethyl
1 7^aluminium and lanthanum triiodide in the absence of any sacrificial aldehyde, 
failed to initiate a retro-aldol reaction, affording only unreacted starting aldol. 
However, during concurrent studies into the synthesis of Grenadamide (discussed in 
Chapter 2.4.5), we observed that attempts to carry out a samarium(H) iodide 
mediated elimination reaction of a-chloro-P-hydroxy syw-aldol 195b, resulted in an 
unexpected retro-aldol reaction (Scheme 2.3-16). Therefore, it was found that
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treatment of syrc-aldol 195b with two equivalents of samarium(II) iodide produced the 
desired elimination product 198 in only 60% yield, with Af-chloroacetyl-oxazolidin-2- 
one ent-166 and cyclopropane carboxaldehyde ent- 150c being observed as competing 
side products.
Reagents and conditions: (i) Sml2 (2 eq.), THF, RT, 2 hours
Scheme 2.3-16 -  Retro-aldol reaction in the synthesis of Grenadamide
Since this retro-aldol reaction had occurred in the presence of competition from the 
(3-elimination reaction, it was proposed that treatment of an a-methyl cyclopropyl 
syn-aldol substrate that was not susceptible to (3-elimination should result in a clean 
retro-aldol cleavage.
Therefore, it was established that treatment of a-methyl cyclopropyl syn-aldol 147a 
with two equivalents of samarium(II) iodide at room temperature resulted in a clean 
retro-aldol reaction to afford the desired cyclopropane carboxaldehyde 148a in 78% 
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Reagents and condition; (i) Sml2 (2.5 eq.), THF, RT, 2 hours.
Scheme 2.3-17 -  Samarium(ll) iodide mediated retro-aldol reaction of a-methyl cyclopropyl
syn-aldol 147a
The mechanism of this novel retro-aldol reaction was not easily explained. Collin and 
co-workers have previously used samarium(H) iodide as an Oppenauer oxidation 
catalyst and implied the formation of a samarium(III) alkoxide species derived from 
aldol substrates, but this reaction also required the presence of nickel(II) bromide as a 
catalyst to proceed (Scheme 2.3-18).124
Reagents and conditions: (i) Sml2 (2 eq.), NiBr2, THF, 30 minutes.
Scheme 2.3-18 -  Samarium alkoxide formation from aldol substrates
No co-catalyst was required for our samarium(II) iodide mediated retro-aldol 
reaction, but it was evident that the reaction did require two equivalents of reagent to 
proceed to completion. Samarium(II) iodide is known to be a strong single electron 
donor, and during the reaction a gradual colour change was observed from the deep 
blue of a samarium(II) species, to the characteristic yellow colour of a samarium(III) 
species. Therefore, it was tentatively proposed that the following mechanism is 
operating for the samarium(II) mediated retro-aldol reaction of our aldol substrates 
(Scheme 2.3-19).
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Reagents and conditions: (i) Sml2 (2.5 equ.), THF, RT, 2 hours.
Scheme 2.3-19 -  Proposed mechanism for the samarium(II) mediated retro-aldol reaction
Oxidation of samarium(II) to samarium(HI) releases an electron, which reduces the 
exocyclic carbonyl of syn-aldol 147a, to afford samarium(III) radical enolate 
intermediate 175. Oxidation of a second equivalent of samarium(II) to samarium(III) 
releases a second electron that abstracts the P-hydroxyl proton, thus initiating a 
radical mediated retro-aldol reaction,125 to afford phenyl cyclopropane 
carboxaldehyde 148a and samarium(III) enolate 176, which is subsequently 
protonated to afford 7V-propionyl oxazolidin-2-one 130. It is proposed that the radical 
recombination step for the elimination of 175 provides the driving force for the 
homolytic cleavage of its O-H bond, which is normally considered to be an 
unfavourable process.
In contrast, saturated syrc-aldol 134 displayed no retro-aldol cleavage when reacted 
with two equivalents of samarium(II) iodide under identical conditions (Scheme
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2.3-20), indicating once again that release of steric strain plays a pivotal role as the 
driving force in retro-aldol reaction of these types of syn-aldol substrates.
o  o o h  o o




Reagents and conditions: (i) Sml2, THF, RT, 2 hours.
Scheme 2.3-20 -  Failed samarium(II) mediated retro-aldol reaction of saturated aldol 134
2.3.7 Applying our three-step synthesis of cyclopropane 
carboxaldehydes: a previous total synthesis of Cascarillic acid
In the previous chapter it was described how a novel three-step aldol/directed 
cyclopropanation/re/ro-aldol strategy was used for the asymmetric synthesis of 
cyclopropane carboxaldehydes in high yield. Following a review of the literature, it 
was decided to apply this methodology to the asymmetric synthesis of the 
cyclopropane containing natural product Cascarillic acid 177 (Figure 2.3-3). It was 




Figure 2.3-3 -  Cascarillic acid 177
Cascarillic acid 177 is a major component of cascarilla essential oil that has been 
used for many years in the treatment of colds and bronchitis. It has an interesting 
structure that contains a frans-cyclopropane ring in its fatty acid chain, which is in 
contrast to the majority of naturally occurring cyclopropane fatty acids that are cis in 
orientation.127 Baird and co-workers recently confirmed the absolute stereochemistry
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of this compound to be 2-((lS,2/?)-2-hexylcyclopropyl)acetic acid 177 through its 

































Reagents and conditions: (i) Trifluoroethyl butyrate, lipase, (ii) PCC, CH2 CI2, (iii) B rP +Phj(CH2)4Me, BuLi, THF 
—40°C, (iv) LiAlH4, THF, (v) N2H4, H2 0 , N aI04, CH3 COOH, CuS04, (vi) PCC, CH2 Cl2, (vii) NaOMe, MeOH, 
(viii) LiAlH4, THF, (ix) 1,2-bis-diphenylphosphinoethane, CH2 CI2, (x) NaCN, DMSO, (xi) NaOH, H2 O, EtOH.
Scheme 2.3-21 -  Baird’s total synthesis o f Cascarillic acid
Baird’s synthesis of Cascarillic acid 177 comprised eleven linear steps, including 
enzymatic desymmetrisation of meso-cis-1,2-dihydroxymethylcyclopropane 178, 
epimerisation of cis-( 1 S,2/?)-2-hexylcyclopropanecarbaldehyde 179 to its more 
thermodynamically stable ?ra«s-(l/?,27?)-2-hexylcyclopropanecarbaldehyde 
diastereomer 180c, and a one-carbon homologation of bromide 181 to afford 
carboxylic acid 177 using sodium cyanide. We believed that this was an overly long 
and complicated synthesis for such a simple natural product that contained only two
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stereocentres and therefore devised an alternative total synthesis of Cascarillic acid 























V A ,  Me 
Ph
ent-143a
Scheme 2.3-22 -  Retro-synthetic analysis of Cascarillic acid
In this new retro-synthetic analysis of Cascarillic acid, there are two key 
transformations. Firstly, the one carbon homologation of 180c to 177 would be 
achieved using dithiane anion/Peterson elimination methodology first established by
190Corey et al, thus eliminating the need to use toxic cyanide chemistry. Secondly, we 
would use our new three-step synthesis of cyclopropane carboxaldehydes to generate 
the key aldehyde intermediate 180c with defined absolute and relative 
stereochemistry. This reaction sequence would therefore generate Cascarillic acid in 
only five steps from chiral auxiliary ent-130, thus allowing easy access to structural 
analogues of this natural product by simply varying the a,P-unsaturated aldehyde 
substrate used in the initial syw-aldol reaction.
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2.3.8 Asymmetric synthesis of the key cyclopropane carboxaldehyde 
intermediate
The iV-propionyl oxazolidin-2-one auxiliary ent-130 was prepared from unnatural 
(7?)-phenylalanine according to the procedure described earlier in this thesis. It was 
necessary to use the (#)-enantiomer of the SuperQuat oxazolidin-2-one to generate 
the correct absolute stereochemistry of the key cyclopropane carboxaldehyde 
intermediate 180c (Scheme 2.3-23).
o



















Reagents and conditions: (i) SOCI2, MeOH, 12 hours; (ii) Boc-anhydride, N aH C03, EtOH, 48 hours; (iii) Mg, 
CH3I, THF, 48 hours; (iv) KCfBu, THF, 2 hours; (v) "BuLi, propionyl chloride, THF, -78 to CPC, 2 hours.
Scheme 2.3-23 -  Synthesis of(R)-4-benzyl-5,5-dimethyl-3-propionyloxazolidin-2-one
The (/?)-N-propionyl oxazolidin-2-one auxiliary ent-130 was then reacted with (£)- 
non-2-enal under our standard syn-aldol conditions (9BBN-OTf, ‘P^NEt), to afford 
unsaturated aldol intermediate 180a in >95% de as determined by examination of the 
crude 300 MHz !H-NMR spectrum, and in 82% yield after purification by silica gel 
chromatography (Scheme 2.3-24). The sy/i-stereochemistry was assigned as shown 
from literature precedent and confirmed by the small coupling constant of the a- 
proton of J2 3  = 4.0 Hz.
I l l
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Reagents and conditions: (i) 9B BN -01f lPr2NEt, CH2 CI2, 0°C, 1 hour, (E)-non-2-enal, -78°C to RT overnight. 
Scheme 2.3-24 -  Asymmetric syn-aldol reaction ofnon-2-enal
(3-vinyl syn-aldol intermediate 180a was then cyclopropanated under our standard 
Charette conditions to give cyclopropyl aldol intermediate 180b in >95% de from 
examination of the crude 300 MHz ^-N M R  spectrum and in 93% yield following 
purification by silica gel chromatography (Scheme 2.3-25).




93 % Yield 
>95% de
Reagents and conditions: (i) Et{Zn, CH2I2, CH2 CI2, -10 to CPC, 2 hours.
Scheme 2.3-25 -  Directed cyclopropanation o f syn-aldol 180a
Cyclopropyl syw-aldol 180b was then treated with LiHMDS in toluene; however,
despite repeated attempts to optimise this retro-aldol reaction (Scheme 2.3-26), we
were only able to achieve a 55% yield of the key (\R,2R)-2-
1 ™hexylcyclopropanecarbaldehyde 180c.
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° ? ?H ° ?\
Me ) j r \  Me H> k N ^ „ - C 6H13
Ptl
180b ent-130 180c
58 % Yield 55% Yield
Reagents and conditions: (i) LHMDS, toluene, 10°C, 2 hours.
Scheme 2.3-26 -  Retro-aldol reaction o f cyclopropyl syn-aldol 180b
Consequently, our novel samarium(II) iodide mediated retro-Mo\ reaction
methodology was applied to the synthesis of key cyclopropane carboxaldehyde 
intermediate 180c. a-methyl cyclopropyl syrc-aldol 180b was treated with two 
equivalents of samarium(II) iodide in THF, to afford the desired cyclopropane 
carboxaldehyde 180c in an improved 78% yield (Scheme 2.3-27). 
o  o  o h  o o
+ X -
Me y \  Me
Ph Ph
180b ent-130 180c
78% Yield 78% Yield
>95% de >95% de
Reagents and conditions: (i) Sml2(2 eq.), THF, RT, 2 hours.
Scheme 2.3-27 -  Samarium(II) iodide mediated retro-aldol reaction in the synthesis of 
Cascarillic acid
Despite this improvement in yield, samarium(II) iodide proved to be a difficult 
reagent to work with, since it has a large molecular weight, with a maximum solution 
concentration in THF of around 0.1 mol dm'3. The high dilution required in these 
reactions combined with the air and moisture sensitive nature of this reagent, results 
in even minimal scale-up becoming problematic.
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2.3.9 An alternative synthesis of key cyclopropane carboxaldehyde
At this stage of the project, observations on a number of aldol substrates under 
different retro-aldo\ conditions had revealed that even small changes in the steric 
demand of the aldol substrate had a dramatic effect on the yield and rate of the retro- 
aldol reaction. For example, replacing the a-methyl group of the aldol substrate with 
a more sterically hindered phenyl group in syw-aldol 164a (Table 2.3-1), dramatically 
increased the rate of the retro-aldol reaction, although it is likely that electronic 
stabilisation of the enolate may also play an important role in this case.
164
Scheme 2.3-28 -  Unwanted retro-aldol reaction of a-phenyl syn-aldol over silica gel
Unfortunately, the propensity of this substrate to undergo a facile retro-aldol reaction 
also meant that this syn-aldol was unstable to silica gel chromatography. In contrast, 
saturated syn-aldol 134, which does not contain the increased steric demand of the 
cyclopropyl group, failed to undergo a retro-aldol reaction under our thermal and 
samarium(II) iodide conditions. It was concluded that the retro-aldol reaction might 
be improved by simply increasing the steric demand of the chiral auxiliary fragment 
at its a-position.
Therefore, iV-isopropyl oxazolidin-2-one 181 was prepared as a new chiral auxiliary 
via reaction of the lithium anion of oxazolidin-2-one ent-126 with isovaleryl chloride 
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Reagents and conditions: (i) nBuLi, isovaleryl chloride, THF, -78 to 0°C. 
Scheme 2.3-29 -  Synthesis o f a-isopropyl oxazolidin-2-one 181
This boron enolate of a-isopropyl oxazolidin-2-one 181 was then reacted with (E)- 
non-2-enal under our standard .syrc-aldol conditions (9BBN-OTf, ‘P^NEt), to afford 
a-isopropyl .syw-aldol 182a in >95% de and 82% yield. This syw-aldol 182a was then 
cyclopropanated using Charette’s modified Furukawa conditions to afford the a- 
isopropyl cyclopropyl syw-aldol 182b in >95% de and isolated in 94% yield. 
Therefore, it was demonstrated that substitution of an a-methyl group for a more 
sterically demanding a-isopropyl group had failed to alter the stereoselectivity of 














Reagents and conditions: (i) 9BBN -01f lPr2NEt, CH2 CI2, (PC, then -7 8  to RT, (E)-non-2-enal; (ii) Et2Zn, CH2I2, 
CH2 Cl2, -10 to (PC, 2 hours.
Scheme 2.3-30 -  Synthesis of a-isopropyl cyclopropyl syn-aldol 182b
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The anionic retro-aldol reaction of a-isopropyl cyclopropyl syrc-aldol 182b was then 
compared with the corresponding retro-aldol reactions of a-methy 1 -p-alky 1 -.syn-aldol 
134 and a-methyl cyclopropyl syrc-aldol 180b, under conditions that had previously 








O o OH O o











Reagents and conditions: (i) KHMDS, THF.
Scheme 2.3-31 -  Comparison o f sterics in the retro-aldol reaction
Treatment of a-methyl-p-alkyl-syrc-aldol 134 with KHMDS in THF at -78°C resulted 
in essentially no retro-aldol reaction occurring as determined from examination of the 
crude 300 MHz !H-NMR spectrum. a-Methyl cyclopropyl syrc-aldol 180b under 
these conditions was cleaved to give approximately 5% conversion to the desired 
cyclopropane carboxaldehyde product 180c; whilst a-isopropyl cyclopropyl syw-aldol 
182b was cleaved to afford 17% conversion to the desired retro-aldol products. 
Raising the temperature to -40°C, it was found that a-methyl-p-alkyl-^yn-aldol 134 
still gave less than 5% conversion to its retro-aldol products, a-methyl cyclopropyl 
syn-aldol 180b proceeded in 16% conversion, whilst a-isopropyl cyclopropyl syn- 
aldol 182b resulted in 72% conversion under these conditions. Finally, increasing the 
reaction time to three hours, the retro-aldol reaction of a-isopropyl cyclopropyl syn-
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aldol 182b at -40°C resulted in complete conversion to the desired (lR,2R)-2- 
hexylcyclopropanecarbaldehyde 180c in 85% yield with less than 5% competing 
formation of oxazolidin-2-one ent-126 being observed (Scheme 2.3-32).
o o oo A
O F I + I Or NH
Ph' J
ent-181 180c enf-126
87% Yield 85% Yield <5 % yield
>95% de
Reagents and conditions:(i) KHMDS, THF, -40°C, 3 hours.




2.3.10 An efficient synthesis of Cascarillic acid
With the desired cyclopropane carboxaldehyde 180c in hand, it was necessary to
carry out an oxidative one-carbon homologation to afford Cascarillic acid 177. Using
methodology first established by Corey et a/,131 treatment of (lR,2R)-2-
hexylcyclopropanecarbaldehyde 180c with the lithium anion of (l,3-dithian-2-
yl)trimethylsilane resulted in nucleophilic addition of the dithiane to the aldehyde
functionality, followed by subsequent Peterson elimination, to afford 2-(((lR,2R)-2-
hexylcyclopropyl)methylene)-1,3-dithiane 183 in >95% de and 93% yield. This
reaction was successful in establishing the correct oxidation state of the homologated
carbon atom, and no evidence of any epimerisation of the cyclopropane ring was
observed. Treatment of ketene thioacetal 183 under acidic hydrolysis conditions
failed to hydrolyse the compound to the desired carboxylic acid 177, instead
affording thioester 183a in good yield as determined by ^-N M R  spectroscopy.
However, sequential treatment of ketene thioacetal 183 under acid and base catalysed 
1hydrolysis conditions gave Cascarillic acid 177 in >95% de and 78% yield, whose
1 Oftspectroscopic data matching that previously published for this compound. The 
negative sign obtained for the specific rotation of my sample of Cascarillic acid 111
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([%Id25 = -11), compared well with the reported value ([a]DUt' = -10.9), thus















Reagents and conditions: (i) nBuLi, (l,3-dithian-2-yl)trimethylsilane, THF, 0°C, 1 hour, then (lR,2R)-2- 
hexylcyclopropanecarbaldehyde 180c, -30°C, 2 hours; (ii) p-TSA, THF/H2 0 , 6  hours, then KOH, Acetone/H2 0 , 2 
hours.
Scheme 2.3-33 -  One carbon homologation of cyclopropane carboxaldehyde 180c to afford 
Cascarillic acid 177
2.3.11 Conclusion
Optimisation studies on the retro-aldol reaction of Af-acyl-oxazolidin-2-one syn- 
aldols resulted in anionic, thermal and samarium(II) iodide mediated conditions being 
developed that afford chiral cyclopropane carboxaldehyde products in acceptable 
yields. These optimisation studies enabled an efficient asymmetric synthesis of the 
cyclopropane natural product Cascarillic acid 171 to be carried out in only five steps 
as a single enantiomer in 41% overall yield.
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Chapter 2.4 An alternative elimination strategy 
for using temporary stereocentres in asymmetric 
synthesis
2.4.1 Introduction
In this chapter, an alternative strategy for using temporary stereocentres to relay 
stereochemical information will be described. In this regard, conditions for the 
diastereoselective synthesis of a-chloro-(3-hydroxy cyclopropyl syrc-aldols have been 
established, and their subsequent samarium(II) iodide mediated elimination reaction 
described. This new methodology has been applied to the total synthesis of another 
cyclopropane containing natural product, Grenadamide. Further attempts towards 
exploiting this new methodology for the asymmetric synthesis of structurally 
challenging oligomeric cyclopropane motifs will then be described, based on an 
iterative aldol/directed cyclopropanation/samarium(II) elimination strategy for 
stereocontrol.
2.4.2 A new temporary stereocentre strategy for asymmetric synthesis
The previous strategy employed for the three-step synthesis of chiral aldehydes, 
involved a final cleavage step of the aldol bond via a retro-aldol reaction, which 
destroyed the directing temporary stereocentre to afford chiral cyclopropane 
carboxaldehydes (Scheme 2.4-1).
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PH PH
Reagents and conditions: (i) LiHMDS, toluene, 5°C, 2 hours.
Scheme 2.4-1 -  Retro-aldol cleavage to remove the temporary stereocentre
To expand our methodology for using temporary stereocentres to generate remote 
chirality, we chose to investigate alternative cleavage strategies for their removal. It 
was proposed that this could be achieved by cleaving the carbon-oxygen bond of the 
aldol substrate, thus affording access to a new class of chiral cyclopropane products 
(Scheme 2.4-2).
Scheme 2.4-2 -  Proposed new strategy for the removal o f temporary centres for synthesis of 
remote chirality
A review of the literature revealed that Haigh and co-workers had demonstrated that 
reduction of the (3-hydroxyl functionality of Af-acyl-oxazolidin-2-one .syrc-aldol 184 
could be carried out using silyl hydride methodology (Scheme 2.4-3).134




Reagents and conditions: (i) Et3SiH, CF3 C 0 2H, 4 days.
Scheme 2.4-3 -  Silyl hydride reduction of /3-hydroxy syn-aldols
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Alternatively, Wee and co-workers had carried out a radical reduction on syrc-aldol
185, via formation of its phenyl thiocarbonate 186 and reduction with BusSnH, to
afford chiral A-acyl-oxazolidin-2-one 187 in 75% yield, with no evidence of any
1competing rearrangement products (Scheme 2.4-4).
Reagents and conditions: (i) Ph.OC(=S)Cl, DMAP, CH2 CI2; (ii) Bu3SnH, AIBN, toluene.
Scheme 2.4-4 -  Radical -cleavage of thiocarbamates
These two transformations required either formation of a reactive carbocation like 
intermediate at the P-position of aldol 184 (Scheme 2.4-3) or a radical intermediate at 
the P-position of aldol 185 (Scheme 2.4-4). Application of these methodologies to 
our new strategy for the synthesis of chiral cyclopropanes was unlikely to be 
successful since both would result in formation of reactive intermediates allylic to the 
cyclopropane ring, which would result in unwanted cleavage of the cyclopropane
136,137ring. ’
Therefore, removal of the hydroxyl group of a syw-aldol product that was allylic to a 
cyclopropane ring appeared to be a non-trivial transformation, since the methodology 
to replace hydroxyl groups with hydrogen atoms in this manner generally required 
either the use of strong acids to generate carbocations, or relied upon free radical 
chemistry. However, a review of the literature for alternative strategies to effect this 
transformation revealed recent work by Concellon and co-workers who had described 
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Entry Amide R de (%) Yield
1 188 Ph >98 90
2 189 c 7h 15 >98 89
3 190 MeCH(Ph) >98 82
Reagents and conditions: (i) Sml2, THF, RT, 30 minutes.
Table 2.4-1 -  Samarium(Il) iodide elimination of a-chloro-ffhydroxyamides
This P-elimination reaction was shown to proceed with excellent (E)- 
diastereoselectivity and in high yields, which had been applied to a variety of a- 
chloro-P-hydroxyamides.139 Furthermore, it was proposed that this methodology was 
less likely to result in formation of an intermediate containing a reactive species 
allylic to the cyclopropane ring during cleavage of the hydroxyl functionality. 
Therefore, a retro-synthetic strategy was proposed that relied on a key samarium(II) 
iodide mediated elimination reaction of an a-chloro cyclopropyl syw-aldol, which 
would result in the simultaneously removal of two stereocentres. (Scheme 2.4-5).140







;  ' r ,  elimination= R N
Ph
Scheme 2.4-5 -  Proposed elimination strategy for the synthesis o f chiral cyclopropanes
A review of the literature revealed that this approach appeared ideally suited to the 
asymmetric synthesis of another cyclopropane containing natural product,
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Grenadamide, the structure and previous synthesis of which is described in the 
following section.
2.4.3 The previous total synthesis of Grenadamide
Grenadamide 191, Debromogrenadadiene 192 and Grenadadiene 193 (Figure 2.4-1) 
are natural products isolated from the marine cyanobacterium Lyngbya majuscula by 
Sitachitta and Gerwick in 1998.141 These structurally unique cyclopropyl fatty acid 
metabolites demonstrated cannabinoid receptor activity and cytotoxicity towards 
cancer cells.
Figure 2.4-1 -  Grenadamide, Debromogrenadadiene and Grenadadiene
Baird and co-workers subsequently confirmed the absolute stereochemistry of the 
cyclopropane fragment of Grenadamide 191 as (R,R) via total synthesis of the wrong




enantiomer of this natural product.142 Their approach required fifteen linear steps, 
using an enzymatic desymmetrisation reaction to introduce chirality,143 and an
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(X V ) C7H15
Reagents and conditions: (i) LiAlH4, THF; (ii) PrOCl, DMAP, THF; (iii) PPL, H2 0/ethylene glycol, pH  6.5; (iv) 
PCC, CH2 Cl2; ( v )  B rP +Ph3(CH2)5Me, BuLi, THF -78°C; (vi) K2 C 0 3, MeOH (vii) N2H4, 'PrOH, NaI04, 
CH3 COOH, CuS04, (viii) PCC, CH2 Cl2; (ix) NaOMe, MeOH; (x) Ph3PCHCOOEt, toluene; (xi) K 0 2 CN=N C0 2K, 
AcOH, MeOH; (xii) KOH, EtOH, water; (xiii) SOCl2; (xiv) PhCH2 CH2NH2.
Scheme 2.4-6 -  Baird’s synthesis o f the wrong enantiomer o f Grenadamide
We considered that this approach was once again an overly complicated synthesis for 
such a simple natural product that contained only two stereocentres. We therefore 
decided to apply the new temporary stereocentre strategy previously outlined in this 
chapter to the asymmetric total synthesis of Grenadamide 191.
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2.4.4 Model studies on the asymmetric syn-aldol and 
cyclopropanation reactions of a-chloro oxazolidin-2-one 
auxiliaries
As had been previously observed in our studies on the three-step synthesis of 
cyclopropane carboxaldehydes, the nature of the a-substituent of the A-acyl- 
oxazolidin-2-one had the potential to adversely affect the diastereoselectivity of the 
subsequent syn-aldol reaction. In this respect, the effect of having an a-chloro 
substituent on the subsequent cyclopropanation reaction was also unknown. We 
therefore undertook a model study to establish reagents and conditions for both these 
protocols. a-Chloro oxazolidin-2-one auxiliary 166 was synthesised by the previously 
described method using chloroacetyl chloride as an acylating reagent in 81% yield. 
This compound was then reacted under our standard aldol conditions (9BBN-OTf, 
‘P^NEt) with (£)-cinnamaldehyde, to afford the a-chloro-p-vinyl-syw-aldol 194a in 
only 80% de as determined by examination of the crude 300 MHz ^-N M R  spectrum. 
Disappointed by this result, the Lewis’ acid source was changed to dibutyl boron 
triflate, which under the same conditions gave the desired a-chloro P-vinyl sy«-aldol 
194a in 92% de, which was purified to >95% de by recrystallisation in 83% yield 
(Scheme 2.4-7).
Reagents and conditions: Dibutyl boron triflate, ‘Pr2NEt, CH2 CI2, CPC, 1 hour, (E)-cinnamaldehyde, -78 to RT, 
overnight.
The a-chloro-p-vinyl-syn-aldol 194a was then cyclopropanated under our standard 
conditions to give the desired a-chloro cyclopropyl syn-aldol 194b in >95% de and
166 194a
Scheme 2.4-7 -  Asymmetric syn-aldol reaction of a-chloro oxazolidin-2-one auxiliary
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94% yield. Therefore, it had been demonstrated that the a-chloro substituent was 
stable to our cyclopropanation conditions, and had exhibited no detrimental effect on 








Reagents and conditions: (i) Et2Zn, CH2I2, CH2 Cl2, -20 to CPC, 2 hours.
Scheme 2.4-8 -  Cyclopropanation of a-chloro-/3-vinyl syn-aldol
2.4.5 An efficient asymmetric total synthesis of Grenadamide
We therefore sought to apply this new methodology to the total synthesis of 
Grenadamide 191 using the retro-synthetic analysis described in Scheme 2.4-9. A 
key reaction in this retro-synthetic analysis would involve the direct aminolysis of the 
oxazolidin-2-one fragment of a-chloro syn-aldol 195b with phenylethylamine,144 in 
which the oxazolidin-2-one carbonyl would be protected from endocyclic cleavage by 
the presence of their 5,5-dimethyl substituents of the oxazolidin-2-one ring. A second 
important reaction would be the samarium(II) iodide mediated elimination of the a- 
chloro and P-hydroxyl substituents, as well the development of conditions to 
hydrogenate the alkene functionality of 197, in the presence of a cyclopropane ring.145
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P,K^ ' N > V ^ X t VC7H|!=^ > P K ^ N - '^ ^ ^ < 4 'C 7H,5
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I 195b C l
Ph
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Scheme 2.4-9 -  Retro-synthetic analysis of Grenadamide
The unnatural (7?)-enantiomer of oxazolidin-2-one auxiliary ent-126 was N-acylated 
with chloroacetyl chloride under our standard conditions to give a-chloro oxazolidin- 
2-one ent-166 in 88% yield. This chiral auxiliary was then subjected to our modified 
syn-aldol conditions (Bu2BOTf, ‘P^NEt) with (E)-dec-2-enal to afford the desired a- 
chloro-P-vinyl-syn-aldol 195a in 92% de, which was purified to >95% de in 74% 
yield following silica gel chromatography. The a-chloro-P-vinyl syn-aldol 195a was 
then cyclopropanated under our standard conditions to afford the desired a-chloro 
cyclopropyl syrc-aldol 195b in >95% de and 98% yield (Scheme 2.4-10).
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9 0 9
q  n h  a)
ClS'!
PH Ph
8 8 % Yield
ent-126 ent-166
(ii)
O o OH o  o OH
Cl v  Cl
98% Yield ' / 74% Yield
P h  > 9 5 % de P h  92% de
195b 195a
Reagents and conditions: (i) "BuLi, chloroacetyl chloride THF, -78 to CfC, 2 hours; (ii) dibutyl boron triflate, 
'Pr2NEt, CH2 Cl2, 0°C, 1 hour, (E)-dec-2-enal, -78 to RT, overnight; (iii) Et2Zn, CH2I2, CH2 Cl2, -10 to 0°C, 2 
hours.
Scheme 2.4-10 -  Synthesis o f a-chloro cyclopropyl syn-aldol 195b
It was then necessary to simultaneously eliminate the a-chloro and (3-hydroxy 
substituents of cyclopropyl .syn-aldol 195b to ideally afford an (£)-alkene fragment in 
high de. Treatment of a-chloro cyclopropyl syn-aldol 195b with three equivalents of 
samarium(II) iodide gave the desired a,(3-unsaturated cyclopropane 198 in only 60% 
yield, as determined from examination of the crude 300 MHz ^-N M R  spectrum, 
with the remaining mass balance being comprised of products from a retro-aldol 
reaction (Scheme 2.4-11).
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Reagents and conditions: (i) Sml2 (3 eq.) THF, RT, 1 hour.
Scheme 2.4-11 -  Samarium mediated elimination of a-chloro syn-aldol
Two competing reaction pathways were therefore proposed to be occurring through a 
common intermediate arising from radical reduction of the exocyclic carbonyl of a- 
chloro cyclopropyl .syw-aldol 195b (Scheme 2.4-12). Samarium(II) is oxidised to 
samarium(III) with the release of an electron that reacts with .syn-aldol 195b to afford 
a common radical anion intermediate 199,146 This radical enolate intermediate 199 
can then be reduced father, to afford anionic intermediate 200 (red arrow), which then 
proceeds via the expected elimination pathway. Firstly, the a-chloro substituent is 
eliminated from intermediate 200, to afford samarium(III) enolate 201, which then 
undergoes samarium(III) mediated E lcb type elimination of the p-hydroxyl group, to 
afford the desired a,P-unsaturated oxazolidin-2-one 198.147 Alternatively, the second 
equivalent of samarium(II) can abstract a proton from common radical intermediate
i ^ r
199 (blue arrow), which then initiates a radical retro-aldol reaction to afford ent- 
cyclopropane carboxaldehyde ent- 150c and samarium(III) enolate 203, which would 
tautomerise during work-up, to afford a-chloro oxazolidin-2-one auxiliary ent-166. It 
was proposed that the formation of radical intermediate 200 is the driving force for 
this retro-aldol reaction, since this type proton abstraction mechanism is unlikely to 
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Scheme 2.4-12 -  Proposed mechanism for the radical elimination and retro-aldol reactions 
of cyclopropyl aldol 195b
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As described earlier in this thesis, retro-aldol reactions under samarium(II) iodide 
mediated conditions have not been reported previously; however, it was noted that all 
Concellon’s previous reports on elimination reactions had been carried out on simple 
a-chloro P-hydroxy amides, esters and ketone substrates. It was proposed therefore 
that the presence of the oxazolidin-2-one fragment of these types of syw-aldol 
substrates must have been acting to promote this unique retro-aldol reaction pathway. 
We therefore chose to remove the oxazolidin-2-one auxiliary fragment of ^yn-aldol 
195b to afford secondary amide intermediate 196, which it was then hoped would 
undergo a clean P-elimination reaction. Davies and co-workers had previously shown 
that iV-acyl derived 3,3-dimethyl-pyrrolidin-2-one chiral auxiliaries underwent clean 
aminolysis reactions with primary amines.144 Therefore, a-chloro cyclopropyl syn- 
aldol 195b was dissolved in neat phenylethylamine and stirred overnight, which 
resulted in cleavage of the oxazolidin-2-one auxiliary ent-126 to afford the desired a- 
chloro cyclopropyl amide 196 as the only product in 89% yield after silica gel 
chromatography (Scheme 2.4-13).
Reagents and conditions: (i) phenylethylamine (neat), overnight.
Scheme 2.4-13 -  Aminolysis of a-chloro cyclopropyl aldol 195b
Importantly, no competing side products arising from nucleophilic displacement of 
the a-chloro group by the amine or competing nucleophilic attack at the endocyclic 
carbonyl were observed in this reaction. This new a-chloro P-hydroxy cyclopropyl 
amide 196 was then treated with samarium(II) iodide in THF to afford the desired 
a,p-unsaturated cyclopropyl amide 197 in 85% yield and >95% de, with no 
competing products arising from the retro-aldol reaction being observed in this case 
(Scheme 2.4-14).
P h  195b 196
89% Yield
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Reagents and conditions: Sml2 (3 eq.), THF, RT, 30 minutes.
Scheme 2.4-14 -  Samarium(II) iodide mediated elimination o f cyclopropyl amide 196
In order to explain the change in reactivity between Ar-acyl-oxazolidin-2-one derived 
sjw-aldol 195b and secondary amide 196, it was proposed that coordination of the 
samarium(III) species to the p-hydroxyl functionality is essential for an efficient p- 
elimination reaction to occur. Competing coordination of samarium(III) to the 
oxazolidin-2-one carbonyl of intermediate 203, decreases the rate of this elimination 
reaction, and as a consequence, the rate of the competing retro-aldol reaction pathway 
becomes significant. In samarium(III) amide complex 204, this type of interaction 
cannot occur, so only products arising from the P-elimination pathway are observed 
(Schem e 2.4-15).
Reagents and conditions: Sml2 (3 eq.), THF, RT, 1 hour.
Scheme 2.4-15 -  Proposed change in reaction pathway in samarium(II) mediated 
elimination and retro-aldol reactions
Ph
en/-166 e n t-U lb
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The alkene fragment of a,P-unsaturated amide 197 was then reduced via treatment 
with sodium borohydride and cobalt(II) chloride in methanol/THF,148 to afford (R,R)~ 
Grenadamide 191 in 88% yield and >95% de.149 The spectroscopic data of this 
sample of (R,R)-Grenadamide 191 matched that previously published for this natural 
product; whilst the specific rotation of [ cc] d 25 = -11 ( M d 111 = -11)150 confirmed we 
had synthesised the correct enantiomer of this natural product. We had therefore 
completed the asymmetric synthesis of Grenadamide in six steps and 42% overall 




[ “ I d 25 =  - 1 1 °
Reagents and conditions: (i) NaBH4  (4eq.), C0 CI2 (20 mol%), DMF, RT, 2 hours.
Scheme 2.4-16 -  Conjugate reduction of a,/3-unsaturated amide to Grenadamide 191
2.4.6 Temporary stereocentre methodology for the asymmetric 
synthesis of oligomeric cyclopropanes
In the previous section the application of our new temporary stereocentre strategy to 
the asymmetric synthesis of the cyclopropane containing natural product 
Grenadamide was discussed. We wished to expand this methodology to more 
complicated natural product targets by exploiting the excellent diastereoselectivity of 
the samarium(II) iodide elimination reaction for the synthesis of oligocyclopropane 
motifs.
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2.4.7 Oligomeric cyclopropanes
The natural products FR-900848 205 and U-106305 206 (Figure 2.4-2) were first 
isolated by Yoshida and co-workers in 1990 from the fermentation broth of 
Streptoverticilium fervens and have demonstrated reasonable antifungal activity 
against filamentous fungi.152 However, full structural elucidation was not achieved 
until Barrett and co-workers confirmed the configuration of their cyclopropane rings







Figure 2.4-2 -  Oligocyclopropyl containing natural products
Additionally, this oligocyclopropane structural motif is also of structural interest, 
since it displays helical chirality due to the cyclopropane ring of each vicinal trans- 
syrc-cyclopropanes adopting a conformation that minimises eclipsing interactions with 
the adjacent cyclopropane ring. This type of secondary structure represents a rare 
example of helical architecture that does not rely on hydrogen bonding and as a 
consequence, these types of oligomeric cyclopropanes have potential applications as 
chiral ligands or chiral membrane mimics (Figure 2.4-3).154
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Hydrogens omittedfor clarity; Grey = Carbon, Red = Oxygen.
Figure 2.4-3 -  X-ray crystal structure displaying helical chirality o f trans-syn- 
quincyclopropane
Barrett demonstrated that the key to the synthesis of these types of natural products 
was stereoselective formation of the challenging core oligocyclopropyl functionality, 
which was carried out using an iterative strategy.155 Each successive enantioselective 
cyclopropanation reaction was achieved using methodology developed by Charette 
and co-workers,156 employing chiral boron tartramide additives 207 and e«/-207 to
form a diastereomeric complex for the enantioselective cyclopropanation of allylic 
alcohols (Scheme 2.4-17).157
Reagents and conditions: (i) Et2Zn, CH2I2, 207, CH2Cl2; (ii) Et2Zn, CH2I2, ent-207, CH2Cl2.
Scheme 2.4-17 -  Boron-tartramide mediated enantioselective cyclopropanation o f allylic 
alcohols
>12:1 diastereoselectivity >12:1 diastereoselectivity
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Barrett and co-worker used this chiral boron tartramide methodology to carry out 
enantioselective cyclopropanation reactions of the two allylic alcohol functionalities 
of mucandiol 208 in high yield and stereoselectivity. Subsequent oxidation and 
homologation of the resulting aldehyde functionality using Wadsworth-Emmons 
olefination chemistry afforded vinyl-cyclopropane 209. This was then reduced to diol 
210 before a second iteration of the enantioselective chiral boron tartramide 










Reagents and conditions: (i) (4S,5S)-207, Et2Zn, CH^h, CH2 CI2, 0 to 25°C; (ii) PCC, NaOAc, silica, CH2Cl2  0 to 
25°C; (iii) Ph3P =C H C 0 2Et, CH2 Cl2, (iv) DIBAL-H, CH2 Cl2, -78TC.
Scheme 2.4-18 -  Barrett's synthesis of quartcyclopropane
An alternative strategy for the synthesis of a key triscyclopropane diol 212 is 
described in Scheme 2.4-19. rnms-Butene-l,4-diol was cyclopropanated using 
Charette’s chiral boron tartramide methodology to afford chiral cyclopropyl diol 213 
in 83% yield and 89% ee, which was again homologated using Wadsworth-Emmons 
chemistry on the corresponding dialdehyde derivative of 213 to afford &/s-vinyl 
cyclopropane diol 214. This compound then underwent subsequent enantioselective 
cyclopropanation, to afford triscyclopropane diol 212, which was then elaborated to 
the natural product via a series of iterative protocols.
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Reagents and conditions: (i) (4S,5S)-207, 4k  molecular sieves, Zn(CH2I)-DME, CH2 CI2, -40 to 25°C, Dess-Martin 
periodinane, pyridine, CH2 CI2, then PPh3; (iii) Ph3P= CH C02Et, CH2 Cl2, (iv) DIBAL-H, CH2 CI2, -78°C.
Scheme 2.4-19 -  Barrett’s synthesis of triscyclopropane diol 212
Although this approach proved successful for the synthesis of these structurally 
challenging natural products, they rely upon the Wadsworth-Emmons olefination 
reaction for each homologation step, whose (£)-/(Z)-selectivities were no greater than 
8:1 in a number of cases. Therefore, as an alternative we wished to apply our highly 
stereoselective cyclopropanation/samarium(II) p-elimination methodology described 
earlier in the chapter for the synthesis of these types of oligomeric cyclopropanes.
2.4.8 A new synthesis of oligomeric cyclopropanes
An alternative refro-synthetic strategy employing a combination of asymmetric 
aldol/directed cyclopropanation/p-elimination methodology for asymmetric synthesis 
of key intermediate &/s-vinyl-cyclopropane 215 was proposed as described in Scheme
2.4-20.
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Scheme 2.4-20 -  Retro-synthetic analysis of biscyclopropanes
The key intermediate targeted was &/s-vinyl-cyclopropane 215, which would then 
undergo further iterations to extend the chain length of the oligomeric cyclopropane. 
This would be achieved by removing the chiral auxiliary (Xc) fragment, via treatment 
with DIBAL-H using the reductive protocol first established by Davies and co­
workers,158 to afford dialdehyde 215. The 5,5-dimethyl motif of the oxazolidin-2-one 
ring of 218 had been shown to protect the endocyclic carbonyl from hydride attack in 
this transformation, ensuring no endocyclic cleavage products were formed. The 
SuperQuat oxazolidin-2-one fragment acted as an aldehyde equivalent in this 
reaction, due to the stability of the tetrahedral intermediate 220 arising from chelation 
of the aluminium counter-ion to the oxazolidin-2-one carbonyl, thus preventing any 
over-reduction to the corresponding alcohol (Scheme 2.4-21).
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Reagents and condition; (i) DIBAL-H, CH2 CI2, -78°C, then NH4 Cl.
Scheme 2.4-21 -  Reduction of N-acylated SuperQuat auxiliaries to chiral aldehydes
It was proposed that the a,(3-unsaturated olefin functionality of 218 could be 
generated via treatment of 218 with samarium(II) iodide in high de; whilst 
disconnection of 217 using a combination of our previously described directed 
cyclopropanation and syn-aldol reactions, reveals mucanaldehyde 216 as the key 
starting material.
Therefore, mucanaldehyde 216 was synthesised via a previously published procedure 
via reaction of glyoxal with the commercially available stabilised Wittig reagent, 
diphenyl phosphanylidene acetaldehyde (Scheme 2,4-22).159 Attempts to synthesis 
this compound via an oxepin strategy previously described by Davies and co-workers 
was unsuccessful.160
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Reagents and conditions: CHOCH=PPh3 (1.95 eq.), DMF, 70°C, 4 hours.
Scheme 2.4-22 -  Synthesis of mucanaldehyde
The desired mucanaldehyde 216 was isolated in >95% de and 62% yield following 
silica gel chromatography, but was found to slowly decompose on standing. 
Stabilised Wittig reagents are known to be (£)-selective, with the high 
diastereoselectivity of this reaction also being due to equilibration of any (Z)- 
diastereomeric olefin to its thermodynamically more stable (E)-isomer under the 
reaction conditions. We then attempted to react this dialdehyde in a syrc-aldol reaction 
with the boron enolate of a-chloro oxazolidin-2-one auxiliary 166 (Scheme 2.4-23).
Scheme 2.4-23 —Attempted syn-aldol reaction of mucanaldehyde
Reaction of dialdehyde 216 under our standard syw-aldol conditions (9BBN-OTf, 
‘PrNEt; Scheme 2.2-2), afforded none of the desired bis-aldol 217, resulting in a- 
chloro oxazolidin-2-one 166 as the only product recovered. No unreacted dialdehyde 
216 was observed on examination of the crude 300 MHz ^-N M R  spectrum, and no 
other by-products could be isolated from possible further reactions or from 
decomposition of this compound. We therefore screened a number of alternative 
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dibutyl boron triflate or titanium tetrachloride as Lewis acid sources, as well as 
lithium enolate formation using LDA as a base; however, in each case only unreacted 
a-chloro oxazolidin-2-one auxiliary 166 was recovered, with no evidence of any 
aldol product having been formed. It is likely that the high reactivity of 
mucanaldehyde 216 meant that it was incompatible with the strong Lewis acid 
conditions used in these reactions,161 and as a consequence our attention turned to an 









O OH Cl O QH
OH O
nA = x
Scheme 2.4-24 -  Retro-synthetic analysis of trimeric cyclopropane
The key difference in our proposed synthesis of triscyclopropane dialdehyde 221, 
would be the synthesis of the double aldol motif of intermediate 224, which would be 
achieved from coupling two molecules of a-chloro syn-aldol 223 using an 
intermolecular Grubb’s metathesis reaction. a-Chloro syn-aldol 223 would be 
prepared from the syn-aldol reaction of a-chloro oxazolidin-2-one auxiliary 166 with 
acrolein 222. Cyclopropyl bis-aldol 225 would be synthesised following the 
previously described directed cyclopropanation protocol using aldol 224 as a 
substrate. The target intermediate, Z?/s-vinyl cyclopropane 227, would then be
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synthesised via the samarium(II) iodide mediated ^-elimination reaction of 225, and 
subsequent DEBAL-H mediated cleavage of the oxazolidin-2-one fragment. 
Cyclopropane dialdehyde 227 could then undergo further iterations for the synthesis 
of odd-numbered oligomeric cyclopropanes.
Therefore, a-chloroacetyl oxazolidin-2-one 166 was reacted under our standard syn- 
aldol conditions (dibutyl boron triflate, ‘P^NEt) with acrolein, to afford a-chloro syn- 
aldol 223 (Scheme 2.4-25). a-Chloro syrc-aldol 223 was obtained in good yield, but 
with decreased diastereoselectivity when this syn-aldol reaction was allowed to warm 
to room temperature overnight in the usual manner. Under these conditions, the 
desired a-chloro-(3-vinyl syw-aldol 223 was generated in 88% de and 82% yield, and 
in >95% de after purification by silica gel chromatography. Alternatively, the desired 
sy«-aldol could be synthesised with a diastereomeric excess of >95% de, but with 
decreased yield, by maintaining the reaction temperature at -78°C for one hour before 
warming the reaction to 0°C, which resulted in syn-aldol 223 being isolated in a 
decreased 63% yield. The remaining mass balance from this second low temperature 





Reagents and conditions: (i) Dibutyl boron triflate, 'Pr2NEt, CH2 CI2, 0°C, 1 hour, acrolein, -78 to RT; (ii) Dibutyl 
boron triflate, 'Pr2NEt, CH2 CI2, 0°C, 1 hour, acrolein, -78°C, 1 hour then (PC 1 hour.
Scheme 2.4-25 -  syn-Aldol reaction of acrolein
With the desired syn-aldol 223 in hand, an intermolecular metathesis reaction was 
then attempted (Scheme 2.4-26). First generation Grubb’s catalyst showed no 
reactivity with this compound, despite increased reaction times, resulting in only 
starting syn-aldol 223 starting material being recovered. Changing to second
1 ftf)generation Grubb’s catalyst afforded the desired (£)-unsaturated &fs-aldol 224 in 
>95% de and in essentially quantitative yield. The (^-configuration of 224 was
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1assumed from literature precedent, and since no resonances corresponding to a (Z)- 
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1 st Generation Grubb's catalyst 2nd Generation Grubb’s catalyst
•sndReagents and conditions: (i) 2 generation Grubb’s (5 mol%), CHjClj, reflux, 2 hours.
Scheme 2.4-26 -  Intermolecular metathesis reaction of a-chloro unsaturated syn-aldol
This unsaturated bis-aldol 224 was then treated under our standard cyclopropanation 
conditions (Et2Zn, CH2I2, see Section 2.2.5); however, the yield of cyclopropane 
aldol 225 was found to be disappointingly low (<5%). Increasing the reaction time 
and temperature of this directed cyclopropanation reaction was successful in 








Xc = SuperQuat 81% de
Reagents and conditions: (i) Et2Zn (5 eq.), CH2I2 (5 eq.), C //2C/2, -40 to RT overnight.
Scheme 2.4-27 -  Directed cyclopropanation o f bis-aldol 224
Analysis of the ]H-NMR spectrum of the crude reaction product revealed that this 
hydroxyl directed cyclopropanation reaction had proceeded to afford the desired
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cyclopropyl bis-aldol 225 in a non-optimised 81% de, which was purified by silica 
gel chromatography to afford the desired compound in >95% de and 71% yield. 
NOE-NMR experiments on the two diastereomers of cyclopropane aldol 225 proved 
inconclusive in assigning their configurations, presumably due to the conformational 
mobility of both diastereomers. Attempts to grow crystals of the major diastereomer 
for X-ray crystallographic studies were also unsuccessful. Therefore, the all syn- 
stereochemistry of major diastereomer 225 was assigned from literature precedent for 
this type of directed cyclopropanation reaction.113
Due to the C2 symmetry of the compound, both hydroxyl groups should direct the 
zinc to the same diastereotopic face of the olefin; however, they clearly cannot carry 
out this reaction simultaneously. Therefore, it was proposed that the reduction in rate 
and selectivity in the cyclopropanation reaction of bis-aldol substrate 224, when 
compared to the cyclopropanation reaction of mono-aldol substrates, was possibly 
due to steric hindrance arising from the presence of a non-participating zinc alkoxide 
fragment in the cyclopropanation reaction (Scheme 2.4-28).
Cl 224 o h  o
^ZnCHoI ^ZnCH2I
X,-c









Scheme 2.4-28 -  Proposed mechanism for the reduction in facial selectivity o f the directed 
cyclopropanation ofbis-aldol 224
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Reaction of &w-aldol 224 with the cyclopropanating reagent has the potential to 
generate bis-zinc alkoxide intermediate 228. This conformation results in a 
minimisation of A1,3-strain with the a-chloro substituent, and should result in 
cyclopropanation of the olefin to afford the desired all syrc-cyclopropyl aldol 225. 
However, this conformation also results in two sterically hindered zinc alkoxides 
fragments being positioned in close proximity, which may generate A1,4-strain that 
could be minimised by rotation around the C3’-C4’ bond to afford an alternative 
conformational intermediate 229. These two cyclopropanating species would then 
direct the cyclopropanation reaction to opposite diastereotopic faces of the olefin, 
with the C3-zinc-alkoxide fragment affording the syn-cyclopropane and the C3’-zinc- 
alkoxde fragment affording the anri-cyclopropane. From the diastereoselectivity of 
the reaction, it would appear that the major reactive conformer is syrc-intermediate 
228, but that the relatively small differences in energy between the two conformers 
results in small amounts of the a/tf/-conformer 230, which leads to the observed loss 
in diastereocontrol under these reaction conditions.
Cyclopropyl bis-d\do\ 225 was then treated with ten equivalents of samarium(II) 
iodide under our previously described conditions (Scheme 2.4-29). This tandem 
elimination reaction afforded the expected fo's-alkene cyclopropyl substrate 226 in a 
disappointing 37% yield, though excellent (£)-diastereoselectivity (>95% de) for both 
P-elimination reactions was observed. The desired cyclopropyl diene 226 was 
purified simply via recrystallisation of the crude reaction product, but the by-product 
231 of this ^-elim ination reaction proved difficult to isolate, despite repeated 
attempts at chromatographic purification. The structure of 6 /s-alkene cyclopropane 
226 was assigned from consideration of its *H-NMR spectrum, due to the presence of 
a low field chemical shift at 57.35 ppm for the a-protons of the conjugated alkene, 
which arises from the strong anisotropic deshielding effect of the benzyl group on the 
oxazolidin-2-one fragment. The rraws-stereochemistry was assigned from literature 
precedent, and confirmed by the large alkene coupling constant of J2 3  = 15 Hz. The 
molecular weight of the molecule was confirmed by the high-resolution mass 
spectrum, whilst the C2-symmetry of 226 was evident from the 13C-NMR spectrum 
that displayed only fifteen resonances.
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Reagents and conditions: Sml2 (10 eq.), THF, 2 hours.
Scheme 2.4-29 -  Double elimination reaction of cyclopropyl bis-aldol
During our synthesis of Grenadamide 191 (Section 2.4.5), it had been observed that 
replacing the oxazolidin-2-one auxiliary fragment for an amide functionality had 
greatly improved the yield of the resultant (3-elimination reaction. We therefore 
treated fo's-aldol 225 with trimethylaluminium and A^O-dimethylhydroxylamine, 








Reagents and conditions: (i) Me^Al, MeNHOMe, THF, (fC, 1 hour.
Scheme 2.4-30 -  Formation o f Weinreb bis-aldol amide
OH O
55% Yield
Unfortunately, treatment of 232 with samarium(II) iodide under the same conditions, 
failed to improve the yield of the |3-elimination reaction, once again affording 
significant amounts of an unwanted by-product that was structurally related to 231 as 
indicated by examination of the crude ^-N M R  spectrum.165
Examination of the impure !H-NMR spectrum of the by-product 231 (Scheme
2.4-29) from the 6/s-elimination reaction (Appendix 4.3) revealed no evidence of a 
cyclopropane ring, as indicated by the loss of the diagnostic high-field resonances 
corresponding to the cyclopropane protons. Resonances corresponding to a new non­
conjugated double bond were evident, as established by a 2H multiplet at 85.73 ppm 
and 85.49 ppm respectively. We therefore tentatively proposed fo's-alkene oxazolidin-
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2-one substrate 231 as the major by-product in the (3-elimination reaction of bis-aldol 
225 (Scheme 2.4-31). The deshielding effect of the alkene functionality was seen to 
have shifted the a-proton downfield from 85.82 ppm to 56.93 ppm. A new doublet at 
83.78 ppm was assigned to the central methylene unit, deshielded by two alkene 
functionalities. Resonances corresponding to the oxazolidin-2-one fragment were still 
present, as observed for the characteristic peaks at 84.17 ppm, 82.91 ppm and 52.24 
ppm respectively. Finally, the presence of only fifteen resonances in the 13C-NMR 
demonstrated that the molecule retained its C2 symmetry, whilst the low-resolution 
mass spectrum revealed a molecular ion at 581 Da ([M+Na]+) that confirmed the 
structure of 231.
c i  o h  o
Xc = SuperQuat
225 231
Reagents and conditions: (i) Sml2 (10 eq.), THF, RT, 2 hours.
Scheme 2.4-31 -  Formation o f by-product 231 from bis-elimination reaction
In order to explain the formation of bis-alkene 231 it was proposed that the 
cyclopropane bis-aldol 225 undergoes a radical reduction of one of its exocyclic 
carbonyl groups to afford samarium(III) radical anion 233, which is further reduced 
with a second equivalent of samarium(II) to afford anion 234. Elimination of chloride 
is then followed by subsequent E lcb elimination of the (3-hydroxyl group in the usual 
manner, to afford unsaturated intermediate 236. This process is then repeated for the 
elimination of the second a-chloro-(3-hydroxy motif of 236, to afford the desired 
divinyl cyclopropane 226. Due to the presence of excess of samarium(H) iodide used 
in this reaction however, divinyl cyclopropane 226 may then undergo further 
reduction of its exocyclic carbonyl, to afford radical anion intermediate 237, which it 
is proposed then initiates a further elimination reaction of the cyclopropane ring to 
afford radical enolate 238,166 which can then be reduced to afford &zs-enolate
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intermediate 239. This product is then subsequently protonated during the work-up of 
this reaction to afford diene 231 as a competing by-product.167
OH
o h  o
225






Reagents and conditions: (i) Sml2(10 eq.), THF, RT, 1 hour.
Scheme 2.4-32 -  Proposed mechanism for elimination of cyclopropane motif
Evidence for this mechanism was provided by treatment of divinyl cyclopropane 226 
with samarium(II) iodide in THF for one hour, which resulted in formation of by­
product 231 as determined by examination of the crude !H-NMR spectrum of the 
crude reaction product, thus demonstrating the intermediacy of divinyl cyclopropane 
226 in the formation of by-product 231 (Scheme 2.4-33).
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Reagents and conditions: (i) Sml2 (3 eq.), THF, RT, 1 hour.
Scheme 2.4-33 -  Radical reduction o f divinyl cyclopropane 226
Divinyl cyclopropane 226 was then treated with DIBAL-H in dichloromethane at 
-78°C for 2 hours, before quenching the reaction at this temperature with aqueous 
saturated ammonium chloride solution and subsequently warming to room 
temperature over four hours. Examination of the crude ^-N M R  revealed the 
presence of an aldehyde doublet at 59.39 ppm, an alkene multiplet at 56.21 ppm and a 
vinyl-cyclopropane multiplet at 51.98 ppm, which were assigned as cyclopropane bis- 
a,P-unsaturated dialdehyde 240. Due to the small scale of this reaction (10 mg of 
divinyl cyclopropane 226), this dialdehyde 240 was not isolated but further reduced 
with sodium borohydride to afford cyclopropane bis-allylic alcohol 241, whose
spectroscopic data matched that previously described in the literature. (Scheme
1682,4-34). The stereochemistry of the cyclopropane fragment of 241 was confirmed 
as (R,R) by comparison of the specific rotation of this compound with known 
literature values ([cx ]d 25 = -105, [a]oUt' = -131).169’170
Xc = SuperQuat 240
Reagents and conditions: (i) DIBAL-H, CH2 CI2, -78°C, then NH4 Cl(aqj; (ii) NaBH4, THF, RT.
Scheme 2.4-34 -  Selective reduction o f divinyl cyclopropane 226
Methodology has therefore been developed to access the key intermediate, bis-a,P- 
unsaturated dialdehyde 240, which it is proposed in the future will be used as a 
substrate for further iterations of our aldol/directed cyclopropanation/samarium(II)
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elimination/DIBAL-H reduction strategy for the synthesis of odd numbered 
oligocyclopropanes.
2.4.9 Conclusion
It has been demonstrated that an alternative approach for using temporary 
stereocentres to relay chiral information can be applied to the asymmetric synthesis of 
Grenadamide. Key steps in this asymmetric synthesis include a highly 
diastereoselective syw-aldol and directed cyclopropanation reactions of a-chloroacetyl 
oxazolidin-2-one derived substrates, and the ability to carry out direct aminolysis on 
Af-chloroacetyl-oxazolidin-2-one derived syw-aldols. Cleavage of the temporary 
stereocentre in this synthesis was achieved using highly diastereoselective 
samarium(II) iodide P-elimination methodology. To exploit the high 
diastereoselectivity of this reaction, a new strategy was proposed towards the 
synthesis of oligomeric cyclopropanes. Conditions were established for the 
asymmetric aldol reaction of N-chloroacetyl-oxazolidin-2-one 166 with acrolein, and 
the resultant sy/i-aldol was used in an intermolecular metathesis reaction. Conditions 
for cyclopropanation of the resulting bis-d\do\ 224 were described; whilst the 
subsequent samarium(H) p-elimination reaction was found to be only partially 
successful. Work is continuing within the SDB group towards further optimisation of 
this new methodology.
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Chapter 2.5 Preliminary investigations into the 
asymmetric synthesis of chiral lactones as 
synthons for polypropionates
2.5.1 Introduction
This chapter describes attempts to exploit the excellent stereocontrol observed in the 
directed cyclopropanations of SuperQuat syn-aldols for electrophilic cleavage
9-4-reactions of the cyclopropane ring using Hg species for the asymmetric synthesis of 
polypropionate motifs in high de. An alternative strategy for the synthesis of highly 
functionalised gamma-lactones is also described that are easily accessed via directed 
epoxidation reactions on ft-vinyl syn-aldol substrates.
2.5.2 A cyclopropanation approach towards the asymmetric 
synthesis of polypropionate sub-units
Polypropionate sub-units are key structural motifs found in a vast array of natural 
products that demonstrate a wide range of biological activity and as a consequence, 
they have been synthetic targets for many research groups.171 Whilst most synthetic 
strategies rely on iterative aldol strategies to introduce contiguous stereocentres, 
recent work by Cossy and co-workers has demonstrated that oxymercuration of chiral 
cyclopropanes offers an alternative for constructing these structurally challenging 
motifs (Scheme 2.5-1).172
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Reagents and conditions: (i) Hg(OCOCF3)2, CH2 CI2, then NaCl(aq ); (ii) reductive demercuration.
Scheme 2.5-1 -  Oxymercuration of cyclopropyl alcohols
This reaction involves the stereoselective electrophilic ring opening of the 
cyclopropane ring through coordination with mercury(II) species, with the 
cyclopropane ring then being attacked by the trifluoroacetate anion to afford 
organomercury intermediate 242. This reaction normally proceeds with essentially 
complete inversion at the cyclopropyl stereocentre and occurs in a highly 
regioselective manner via cleavage of the most electron rich carbon-carbon 
cyclopropyl bond. However, it is also likely that coordination of the mercury species 
to the allylic alcohol functionality plays a pivotal role in the regioselectivity of this 
reaction. Reductive demercuration of the organomercury intermediate 242 may then 
be carried out to afford the polypropionate sub-unit 243.
The cyclopropane ring can also be cleaved by nucleophiles other than the 
trifluoroacetate counter-ion. For example, Barrett and co-workers have shown that the 
cyclopropane ring of 244 can be opened in the presence of methanol with excellent 
regioselectivity and complete inversion in configuration (Scheme 2.5-2).173
244
Reagents and conditions: (i) Hg(OCOCF3)2, MeOH, RT, then NaCl, H2 0 ; (ii) LiAlH4, THF, 0°C.
Scheme 2.5-2 -  Intermolecular electrophilic ring opening of cyclopropanes
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The excellent stereocontrol observed for cyclopropanation of syn-aldols described 
previously in this thesis provided an excellent route to stereodefined cyclopropyl 
alcohols and as a consequence, it was decided to employ them as substrates for this 
mercury(H) mediated ring opening methodology.
2.5.3 The oxymercuration of cyclopropyl syn-aldols
Oxymercuration of a-methyl cyclopropyl syrc-aldol 155b via treatment with 
mercury(II) trifluoroacetate in dichloromethane at room temperature, followed by 
reductive demercurative workup with lithium aluminium hydride did not afford any 
organic-soluble ring opened products. Despite repeated attempts, only oxazolidin-2- 
one auxiliary 126 could be isolated from the reaction mixture (Scheme 2.5-3).
Reagents and conditions: (i) H g(0 2 CCF3), CH2 CI2, RT, overnight, then NaCl(aq ^  (ii) LiAlH4, THF, (fC , 1 hour. 
Scheme 2.5-3 -  Oxymercuration/reductive demercuration o f a-methyl cyclopropyl syn-aldol
Due to the difficulties in isolating the products of this reaction, oxymercuration of a- 
methyl cyclopropyl syn-aldol 147b was therefore carried out in deuterated chloroform 
under the same conditions, such that any organomercury intermediates could be 
identified by !H-NMR spectroscopy (Appendix 4.4). Analysis of the ^-N M R  
spectrum of this reaction revealed that following hydrolysis the oxazolidin-2-one 
fragment had been cleaved from the compound, as indicated by the diagnostic peaks 
at 83.96 ppm, 82.84 ppm and 82.67 ppm respectively. A new peak at 86.34 ppm was 
characteristic of a conjugated alkene resonance, whilst the low field chemical shift of 
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electron withdrawing functionality. Therefore, the product of this oxymercuration 
reaction was tentatively assigned as the a,P-unsaturated lactone 245 (Scheme 2.5-4).
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Reagents and conditions: (i) H g(0 2CCF3), CDCl3, RT, overnight, then NaCl(aq ).
Scheme 2.5-4 -  Synthesis of organomercurial derived cc,(3-unsaturated lactone
The exocyclic carbonyl of syw-aldol 147b acts as an intramolecular nucleophile to 
ring open the cyclopropane at its C-5 position, thus affording cyclic cationic 
intermediate 246. The trifluoroacetate anion then deprotonates this cationic 
intermediate 246 at its a-position to initiate an E lcb-type elimination to afford 
intermediate 247, which is subsequently hydrolysed to afford a,p-unsaturated lactone 
245. Further !H-NMR spectroscopic studies of this oxymercuration reaction of a-
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methyl cyclopropyl syrc-aldol 147g revealed that cleavage of the cyclopropane ring is 
extremely rapid (Scheme 2.5-5). Therefore, within five minutes of adding 
mercury(II) trifluoroacetate to the reaction mixture in deuterated chloroform at room 
temperature, no starting syn-aldol 147g remained. E lcb elimination of the resulting 
intermediate 248 then occurs slowly over the following twenty hours, as indicated by 
the increasing intensity of the resonances at 52.31 ppm and 52.09 ppm that 
















Reagents and conditions: (i) Hg(C>2CCF3), CDCl3, RT, overnight.
Scheme 2.5-5 -  ]H-NMR spectroscopy study o f oxymercuration reaction o f a-methyl 
cyclopropyl syn-aldol 147g
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Kobayashi and co-workers have previously demonstrated that the oxazolidin-2-one 
fragment of aldol substrates could react as a nucleophile in an intramolecular fashion 
in their iodolactonisation of related (3-vinyl syn-aldols substrates during their 




Reagents and conditions: (i) I2, NaH C03, acetonitrile/H20, RT. 
Scheme 2.5-6 -  Iodolactonisation o f unsaturated aldols
To avoid this potential elimination reaction and due to the difficulties encountered in 
isolating the products of these reactions, it was decided to reductively cleave off the 
oxazolidin-2-one auxiliary fragment prior to carrying out the oxymercuration 
reaction. a-Methyl cyclopropyl syn-aldol 147g was treated with lithium aluminium 
hydride to afford cyclopropyl diol 249 in an essentially quantitative 97% yield 
(Scheme 2.5-7).175 No competing side products arising from endocyclic cleavage of 
the oxazolidin-2-one carbonyl were observed in this reaction.








Reagents and conditions: (i) LiAlH4, THF, 0°C, 2 hours.
Scheme 2.5-7 -  Reductive cleavage of oxazolidin-2-one auxiliary
Cyclopropyl diol 249 was then treated under our standard oxymercuration conditions 
(Hg(02CCF3)2, CH2C12), which resulted in intramolecular nucleophilic cleavage of 
the cyclopropane ring by the primary alcohol functionality of 249 to afford 
organomercury intermediate 250, which was not characterised further due to its
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potential toxicity. Organomercurial intermediate 250 was then subjected to radical 
demercuration via treatment with tributyltin hydride and catalytic AIBN, to afford 
(2Jft,3S',4R,5/?)-tetrahydro-2,3,5-trimethyl-2H-pyran-4-ol 251 in 91% yield. The 
structure of pyran 251 was confirmed by examination of its COSY spectrum and its 
stereochemistry assigned from literature precedent for this type of cyclopropane ring 
opening reaction (Scheme 2.5-8).176,177













Reagents and conditions: (i) Hg(OCOCF3)2, CH2Cl2, RT, 2 hours, then NaCl, H?0, 2 hours; (ii) Bu3SnH (4 eq.), 
AIBN, THF, RT, 4 hours, then NaF, H20 .
Scheme 2.5-8 -  Intramolecular cyclisation o f cyclopropyl diol
Therefore, the potential of this new methodology for the asymmetric synthesis of 
chiral lactones and polypropionate sub-units has been demonstrated and work to 
develop this methodology for natural product synthesis is currently underway with 
the SDB group.
2.5.4 The directed epoxidation of aldol substrates and the synthesis 
of gaiwma-lactones
Having demonstrated the utility of the directed cyclopropanation of chiral syw-aldols 
derived from iV-acyl-oxazolidin-2-ones, a preliminary investigation was then carried 
out into an alternative directed reaction on our (3-vinyl syrc-aldol substrates. The most 
widely exploited substrate directable transformation reported to date has been the 
hydroxyl directed epoxidation of chiral allylic alcohols. For example, Evans and co­
workers exploited this reaction for the synthesis of macrolide antibiotics with
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excellent levels of diastereocontrol, despite the presence of many surrounding 
stereocentres that had the potential to influence the outcome of this reaction (Scheme
2.5-9).178
Ph
o <r^< OH OH OTIPS 
Me




Me Me Me Me Me
>95% de
Reagents and conditions: (i) VO(acac)2, 'BuOOH, benzene, RT.
Scheme 2.5-9 -  Hydroxyl directed epoxidation for the synthesis ofmacrolide antibiotics
In the three step-catalytic cycle described in Scheme 2.5-10,179 the allylic alcohol 252 
first coordinates to the vanadium complex to afford intermediate 253 with 
displacement of an alkoxide ligand. Peroxide then binds to the metal centre with 
displacement of a second alkoxide ligand to afford intermediate 254. An oxygen atom 
of 255 is then delivered to the olefin, regenerating the active site on the metal centre, 
which completes the catalytic cycle. The diastereoselectivity of these types of allylic 
epoxidation reaction arises from minimisation of A1,3-strain in the transition state, as 
previously discussed in this thesis for the directed cyclopropanation reaction (Scheme 
2.2-7).
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Scheme 2.5-10 -  Proposed mechanism for the vanadium catalysed epoxidation o f allylic 
alcohols
2.5.5 Epoxidation of 1,1-disubstituted unsaturated syn-aldol
1,1-Disubstituted unsaturated .syrc-aldol 256 was synthesised via aldol reaction 
between the boron enolate of (5')-A^-propionyl-4-benzyl-oxazolidin-2-one 130 and 2- 
ethylacrolein to afford ^yn-aldol 256 in 81% yield and >95% de (Scheme 2.5-11).
0  Q







Reagents and conditions: 9BBN-OT/, 'Pr2NEt, CH2 CI2, 0°C, 1 hour, 2-ethylacrolein, -78°C to RT, overnight. 
Scheme 2.5-11 -  Synthesis ofsyn-aldol containing a 1,1- disubstituted alkene functionality
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1,1-Disubstituted unsaturated .syn-aldol 256 was then treated with 10 mol% 
VO(acac)2 and one equivalent of tert-butyl hydrogen peroxide in benzene at room 







Reagents and conditions: (i) 10 mol% VO(acac)2, tert-butyl hydrogen peroxide, benzene, RT then water 
Scheme 2.5-12 -  Directed epoxidation of syn-aldol substrate 256
Examination of the crude !H-NMR spectrum of this reaction revealed that treatment 
of 256 under these epoxidation conditions had failed to produce any of the desired 
epoxy aldol 257. Instead, this ^-N M R  spectrum revealed the presence of only clean 
oxazolidin-2-one 126, with no products derived from the syn-aldol chain. However, 
subsequent saturation of the aqueous layer generated during work-up with sodium 








Reagents and conditions: (i) 10 moI% VO(acac)2, tert-butyl hydrogen peroxide, benzene, RT 
Scheme 2.5-13 -  Lactone formation from /3-vinyl syn-aldol 256
The proposed mechanism for the formation of hydroxyl gamma-lactone 258 is shown 
in Scheme 2.5-14. The hydroxyl directed epoxidation occurs on the olefin to afford 
epoxy .syn-aldol 257, whose absolute configuration was assigned from literature 
precedent.178 As observed for the cyclopropane ring-opening reactions described 
earlier in this chapter, the exocyclic carbonyl then acts as a nucleophile to ring-open
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the epoxide in an intramolecular manner with inversion of configuration to afford 
iminium intermediate 259. Treatment of this intermediate with water hydrolyses the 
resultant iminium species, cleaving the oxazolidin-2-one fragment and releasing the 













Reagents and conditions: (i) 10 mol% VOfacacfo, tert-butyl hydrogen peroxide, benzene, RT.
Scheme 2.5-14 -  Proposed mechanism for the intramolecular cyclisation of epoxy aldol
This intramolecular cyclisation pathway appeared the most likely mechanism; 
however, it was also possible that direct hydrolysis of the epoxide by water might 
have resulted in lactone formation occurring. In this case, water would attack the less 
sterically hindered end of the epoxide to afford diol 257, which would then cyclise on 
the exocyclic carbonyl, with the oxazolidin-2-one fragment being cleaved as a leaving 
group (Scheme 2.5-15).
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Reagents and conditions: (i) 10 mol% VO(acac)2, tert-butyl hydrogen peroxide, benzene, RT. 
Scheme 2.5-15 -  Alternative mechanism for formation of gamma-lactone 260
This alternative mechanism would result in the opposite configuration at the 
quaternary centre of the gamma-lactone 260 to that arising from the intramolecular 
mechanism shown in Scheme 2.5-14. Therefore, in order to confirm which reaction 
mechanism was operating, the stereochemistry of the lactone’s quaternary 
stereocentre needed to be confirmed. It is notoriously difficult to determine the 
configuration of stereocentres within gamma-1 actones from analysis of coupling 
constants and as a consequence, an X-ray crystal structure of 258 was obtained 
(Figure 2.5-1). This established the (S) absolute configuration of the tertiary centre of 
lactone 258, which confirmed a ring-opening mechanism involving inversion by Sn2 
intramolecular nucleophilic attack by the exocyclic carbonyl of intermediate 259.
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Colour code: grey, C =  Grey, O =  Red, H  =  White; selected hydrogens omitted fo r clarity.
Figure 2.5-1 -X -R ay crystal structure o f gamma-lactone 258
In contrast, epoxidation of the allylic alcohol functionality of a-methyl syn-aldol 
156a under the same conditions revealed that this epoxy aldol 261 had greatly 
increased stability to lactonisation (Scheme 2.5-16). The stereochemistry of this 
epoxide was assumed from literature precedent and by minimisation of Au -strain in 
the transition state. This resulted in assignment of the all syw-stereochemistry of 
epoxy-aldol 261 in a non-optimised 78% de, which was purified to >95% de and in 







Reagents and conditions: (i) 10 mol% VO(acac)2, tert-butyl hydrogen peroxide, benzene, RT then water saturated 
with NaCl and extracted with EtOAc
Scheme 2.5-16 -  Formation o f stable epoxy-aldol
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This epoxidation methodology is currently being applied within the SDB group to the 
asymmetric synthesis of the mycotoxin (-)-Vertinolide 262 as a further example of
I Q 1
our temporary stereocentre methodology in synthesis (Scheme 2.5-17).
262
Scheme 2.5-17 -  Proposed synthesis of (-)-Vertinolide
2.5.6 Conclusion
It has been demonstrated that cyclopropane syn-aldols derived from N-acyl- 
oxazolidin-2-ones undergo a highly diastereoselective and regioselective electrophilic 
ring-opening reaction that may be used in the synthesis of pyrans. Directed 
epoxidation reactions on these types of 5y«-aldol products have also been carried out 
in high yield and de that resulted in a novel ring-opening/cyclisation reaction for the 
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3 Experimental
General procedures
Infrared spectra (4000 cm to 0 c m 1) were recorded from thin films or as potassium 
bromide discs on a Perkin Elmer (1600) FT spectrometer with internal calibration. 
Only selected peaks are quoted in v cm'1.
All capillary melting points were measured using Buchi 535 melting point apparatus. 
The readings were taken from a mercury in glass thermometer and are reported 
uncorrected as the meniscus point, rounded to the nearest 1°C with a heating ramp of 
0.5°C.
Proton magnetic resonance spectra were recorded at 300.22 MHz on Bruker Avance 
300 spectrometer. The following abbreviations are used: s, singlet; d, doublet; t, 
triplet; q, quartet; dd, doublet of doublets; ddt, doublet of doublet of triplets; qd, 
quartet of doublets; ddd, doublet of doublet of doublets; m, multiplet. Chemical shifts 
(5H) are quoted in parts per million and are referenced to the residual solvent peak. 
The multiplicities and general assignments of spectroscopic data are denoted as: 
singlet (s), doublet (d), triplet (t), quartet (q), doublet of doublets (dd), doublet of 
doublet of doublets (ddd), doublet of doublet of triplets (ddt), quartet of doublets (qd), 
multiplet (m), apparent (app.), obscured (obs.), broad and aromatic (Ph). Coupling 
constants (J) are quoted to the nearest 0.5 Hz.
Carbon magnetic resonance spectra were recorded at 75.5 MHz on a Bruker Avance 
300 spectrometer. Chemical shifts (5C) are quoted in parts per million and are 
referenced to the residual solvent peak. Coupling constants (J) are quoted to the 
nearest 0.5 Hz and are denoted as above.
Mass spectra were recorded at the EPSRC National Mass Spectrometry Service 
Centre, Swansea. Electron impact (El) and chemical ionisation (Cl) analyses were
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performed in the positive ionisation mode. For low-resolution measurements, 
ammonia was used as a Cl reagent gas on a Micromass Quattro II triple quadropole 
instrument. For high resolution measurements, heptacosa (perfluorotributylamine) 
was used as the El and Cl reference compound, and were performed on the Finnigan 
MAT900 high resolution double focusing mass spectrometer with tandem ion tap or 
on a MAT95 high resolution double focusing mass spectrometer. Both low and high- 
resolution fast atom bombardment (FAB) analyses were performed, in positive or 
negative ionisation mode, on either a Finnigan MAT900 or a MAT95, using 3- 
nitrobenzyl alcohol (NOBA) as the matrix liquid.
Single crystal X-ray diffraction data was collected on a Nonius Kappa CCD machine. 
Structure determination and refinement were achieved using SHELX suite of 
programmes; drawings were produced using ORTEX or MERCURY.
Analytical thin layer chromatography was carried out using commercially available 
glass-backed plates coated with Merck Kieselgel 60 GF254 or aluminium backed 
plates coated with coated with Merck or Macherey-Nagel G/UV254. Plates were 
visualised under UV light (at 254 nm) or by staining with potassium permangenate, 
phosphomolybdic acid or o-bromocreosol, followed by heating. Flash 
chromatography was carried out using Merck 60 H silica gel (35-70 pm). Samples 
were either pre-absorbed onto silica or loaded as saturated solutions in an appropriate 
solvent.
Anhydrous tetrahydofuran and diethyl ether were obtained by distillation from 
sodium benzophenone ketyl radical under nitrogen. Anhydrous toluene was obtained 
by distillation from sodium wire under nitrogen. Anhydrous dichloromethane was 
obtained by distillation from calcium hydride under nitrogen. Commercially available 
anhydrous benzene and acetone were dried over 3A molecular sieves for two days 
prior to use. Were relevant, solvents were degassed under nitrogen using standard 
freeze/thaw techniques. Petrol refers to the fraction of petroleum ether boiling at 
40°C-60°C. Ether refers to diethyl ether. Solvents were evaporated on a Buchi 
Rotorvapor.
All commercially available compounds were used as obtained from the chemical 
suppliers.
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Reactions requiring anhydrous conditions were performed under nitrogen in flame- 
dried apparatus. All temperatures that are quoted are external.
Chapter 3.1 General procedures for the synthesis 
of chiral l,3-oxazinane-2,4-diones
3.1.1 (S)-4-Benzyloxazolidin-2-one (Evans’ Auxiliary) 113
The preparation of the title compound was adapted from the previously published 
procedure. 182 Diethyl carbonate (2 equivalents) was added to a (S)-phenylalaninol, (1 
equivalent) immediately followed by the addition sodium ethoxide in one portion in a 
three-necked flask fitted with standard distillation equipment, under nitrogen. The 
reaction was stirred for 10 minutes, then heated to 125°C for eight hours, or until 
ethanol ceased to distil from the reaction. The reaction was quenched with saturated 
aqueous ammonium chloride solution (5 cm3), extracted with ether (3 x 20 cm3), 
washed with brine (10 cm3) and dried (MgS04). The solvent was removed under 
reduced pressure to give the crude product. Purification via recrystallisation (Et2 0 , 
hexane) gave 113 as a white solid in 73% yield, which matched the previously 
published data for this compound; 183 Rf (CH2CI2) = 0.21; mp = 83-85°C (Et2 0 , 
Hexane); [cc] D25 = -56 (c = 0.45, CHC13); 5H (300 MHz, CDC13) 7.39-7.14 (5H, m, 
Ph), 5.70 (1H, broad s, NH), 4.45 (1H, m, CHN), 4.18-4.03 (2H, m, OCH2), 2.88 (2H, 
app. d, J = 6.5 Hz, CH2Ph); 5C (75MHz, CDC13) 159.1, 136.3, 129.4, 129.7, 27.7, 
70.1, 54.2,41.9; IR (KBr / cm'1) 3292 (broad N-H), 1752 (C=Q).
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3.1.2 (S)-4-Benzyl-3-propionyloxazolidin-2-one 88
rc-BuLi (1.01 equivalents, 2.5 mol dm ' 3 solution in hexane) was added to a solution of 
(S)-4-benzyloxazolidin-2-one 113 (1 equivalent) in THF (20 cm3) at -78°C under 
nitrogen and stirred for 30 minutes. Propionyl chloride (1.1 equivalents) was then 
added dropwise to the stirred solution over approximately five minutes and stirred for 
a further two hours, during which time the reaction was allowed to warm to 0°C. The 
reaction was then quenched with aqueous saturated ammonium chloride solution (5 
cm3) and allowed to room temperature, diluted with ether ( 1 0  cm3), washed with 
aqueous saturated sodium hydrogen carbonate solution, sufficient to dissolve the 
white precipitate, extracted with ethyl acetate (3 x 20 cm3), and dried (MgSCU). The 
solvent was removed under reduced pressure to give the crude product. Purification 
via recrystallisation (Et2 0 , hexane) gave 8 8  as a white solid in 75% yield, which 
matched the previously published data for this compound; 184 Rf (CH2CI2) = 0.74; mp 
= 37-39°C (Et20 , Hexane); [oc] D25 = +81 (c = 0.59, CHCI3); 5H (300 MHz, CDC13) 
7.37-7.18 (5H, m, Ph), 4.67 (1H, app. ddd, J = 13.0 Hz, 7.0 Hz and 3.5 Hz, CHN), 
4.24-4.14 (2H, m, OCH2), 3.30 (1H, dd, J = 13.0 Hz and 3.0 Hz, C //AHBPh), 3.07- 
2.85 (2H, m, Ctf2CH3), 2.77 (1H, dd, J = 13.0 Hz and 10.0 Hz, CHAtfBPh), 1.21 (3H, 
t, J = 7.5 Hz, CH3); 8 C (75MHz, CDC13) 174.5, 153.9, 135.7, 129.8, 129.4, 127.8,
6 6 .6 , 55.6, 38.3, 29.6, 8.7; IR (K B r/cm 1) 1783 (C=0ox), 1702 (C=0).
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9BBN-OTf (1.1 equivalents, 0.5 mol dm ' 3 solution in hexane) was added dropwise to 
a stirred solution of (S)-4-benzyl-3-propionyloxazolidin-2-one 8 8  (1 equivalent) in 
dry dichloromethane at 0°C, under nitrogen. After 30 minutes, diisopropylethylamine 
(1 .2  equivalents) was added dropwise and the resulting solution stirred for a further 
30 minutes. The solution was cooled to -78°C and isobutyraldehyde (1.1 equivalents) 
was added dropwise. The reaction was stirred at this temperature for 1 hour and then 
warmed to 0°C and stirred for one further hour. The reaction was quenched with 
Na2P0 4 /NaH2PC>4 buffer solution (pH7, 10 cm3), and stirred for 10 minutes before the 
addition of 2:1 methanol-hydrogen peroxide solution (30%, 10 cm3) and stirred for 2 
hours. The mixture was extracted with dichloromethane (3 x 20 cm3), washed with 
aqueous saturated sodium hydrogen carbonate solution ( 1 0  cm3), brine ( 1 0  cm3) and 
dried (MgS0 4 ). The solvent was removed under reduced pressure to give the crude 
product. The relative and absolute stereochemistry was assumed as drawn from 
literature precedent and from the small a-proton coupling constant (2.5 Hz). The 
diastereomeric excess was determined as >95% by examination of the crude 300 
MHz ^-N M R  spectrum. Purification via column chromatography (Si0 2 , CH2CI2) 
gave 114 as a yellow oil in 85% yield, which matched the previously published data 
for this compound; 185 Rf (CH2C12) = 0.31; [cc] D25 = +36 (c = 0.56, CHC13); 8 H (300 
MHz, CDCI3) 7.38-7.18 (5H, m, Ph), 4.70 (1H, app. ddt, J = 9.5 Hz, 7.0 Hz, and 3.5 
Hz, CHN), 4.27-4.17 (2H, m, CH20), 3.96 (1H, qd, J = 7.0 Hz and 2.5 Hz, COCH), 
3.54 (1H, dd, J = 8.5 Hz and 2.5 Hz, CHOH), 3.26 (1H, dd, J = 13.5 Hz and 3.5 Hz, 
C //AHBPh), 2.79 (1H, dd, J = 13.5 Hz and 9.5 Hz, CHAtfBPh), 1.72 (1H, m, 
isopropyl-CH), 1.52 (1H, broad s, OH), 1.24 (3H, d, J = 7.0 Hz, C //3CH), 1.04 (3H, 
d, J = 6.5 Hz, isopropyl-CH3), 0.90 (3H, d, J = 6.5 Hz, isopropyl-CH3); 5C (75MHz,
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CDCI3); 178.2, 155.3, 135.5, 129.8, 129.4, 127.8, 77.1, 6 6 .6 , 55.6, 40.1, 38.2, 35.1,
19.7, 19.3, 10.4; IR (Film / cm'1) 3538 (broad O-H), 1779 (C=0ox), 1694 (C=0).
3.1.4 (5S,6/?)-3-((S)-l-Hydroxy-3-phenylpropan-2-yl)-6-isopropyl-5- 
methy 1- l,3-oxazinane-2,4-dione 115
a „
h o ^ nA 0
oAyJ'Y"
Diethyl zinc (10 mol%, 1 mol dm' 3 solution in dichloromethane) was added dropwise 
to a solution (S)-4-Benzyl-3-((2S,3R)-3-hydroxy-2,4-dimethyl-pentanoyl)-oxazolidin- 
2-one 114 in dry dichloromethane at room temperature under nitrogen, and stirred for 
1 hour. The reaction was quenched with saturated aqueous sodium sulfite solution (5 
cm ) and hydrochloric acid (1  mol dm' solution in water), sufficient to dissolve the 
white precipitate. Extracted with dichloromethane (3 x 20 cm3), washed with 
saturated sodium hydrogen carbonate solution ( 1 0  cm ), brine ( 1 0  cm ) and dried 
(MgSC>4). The solvent was removed under reduced pressure to give the crude product. 
The diastereomeric excess was determined as >95% by examination of the crude 300 
MHz !H-NMR spectrum. Purification via column chromatography (SiC>2 , CH2CI2) 
gave 115 as a yellow oil in 91% yield; Rf (CH2CI2) = 0.32; [ oc] d 25 = -13 (c = 1.37, 
CH2CI2); 6 H (300 MHz, CDCI3) 7.24-7.09 (5H, m, Ph), 5.02 (1H, app. ddt, J = 14.0 
Hz, 7.0 Hz and 3.5 Hz, CHN), 4.00 (1H, dd, J = 11.5 Hz and 7.0 Hz, CtfAHBOH), 
3.82 (1H, dd, J = 11.5 Hz and 3.5 Hz, CHAHBOH), 3.20-3.06 (2H, obs. dd and m, J =
14.0 Hz and 10.5 Hz, CHAHBPh and OCH), 3.00 (1H, dd, J = 14.0 Hz and 6.5 Hz, 
CHAHBPh), 2.71 (1H, broad s, OH), 2.51 (1H, qd, J = 7.5 Hz and 2.5 Hz, CHCH3), 
1.74 (1H, m, isopropyl-CH), 0.99 (3H, d, J = 7.5 Hz, CH3CH), 0.95 (3H, d, J = 7.0 
Hz, isopropyl-CH3), 0.68 (3H, d, J = 7.0 Hz, isopropyl-CH3); 8 C (75MHz, CDCI3)
174.2, 152.5, 137.4, 129.6, 128.9, 127.1, 85.4, 64.0, 56.6, 38.8, 33.9, 28.3, 19.4, 17.7,
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9.3; IR (Film / c m 1) 3441 (broad O-H), 1751 (C=0ox), 1694 (C=0); HRMS : m/z 
(ES) [M+H]+ requires 306.1700, found 306.1699.
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Chapter 3.2 General procedures for the 






The preparation of the title compound was adapted from the previously published 
procedure. 182 Diethyl carbonate (2 equivalents) was added to (5)-alaninol (1 
equivalent), immediately followed by the addition sodium ethoxide in one portion to 
a three-necked flask fitted with standard distillation equipment, under nitrogen. The 
reaction stirred for 10 minutes then heated to 125°C for eight hours, or until ethanol 
ceased to distil from the reaction. The reaction was quenched with saturated aqueous 
ammonium chloride solution (5 cm3), extracted with ether (3 x 20 cm3), washed with 
brine (10 cm3) and dried (MgSCU). The solvent was removed under reduced pressure 
to give the crude product. Purification via recrystallisation (Et2 0 , hexane) gave 120 as 
a white solid in 85% yield, which matched the previously published data for this 
compound; 186 Rf (CH2C12) = 0.69; mp = 42-44°C (Et20/Hexane) [a ] D25 = +11 (c = 
1.32, CHC13) 5H (300 MHz, CDCI3) 6.53 (1H, broad s, NH), 4.47 (1H, m, CHCH3), 
3.96 (1H, m, OCHaHb), 3.89 (1H, dd, J = 8.5 Hz and 6.5 Hz, OCHAHB), 1.24 (3H, d, 
J = 6.0 Hz, CH3CH); 8 C (75MHz, CDC13) 161.1, 72.6, 49.2, 21.5; IR (KBr / cm '1) 
3256 (broad N-H), 1745 (C=0).
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3.2.2 (5)-4-methyl-3-propionyloxazolidin-2-one 121
(S)-4-methyloxazolidin-2-one 120 (1 equivalent) in THF (20 cm3) at -78°C under 
nitrogen and stirred for 30 minutes. Propionyl chloride (1.1 equivalents) was then 
added dropwise to the stirred solution over approximately 5 minutes and stirred for a 
further two hours, during which time the reaction was allowed to warm to 0°C. The
aqueous saturated sodium hydrogen carbonate solution, sufficient to dissolve the 
white precipitate, extracted with ethyl acetate (3 x 20 cm3), and dried (MgSO4). The 
solvent was removed under reduced pressure to give the crude product. Purification 
by column chromatography (SiC>2, CH2CI2), gave 121 as a yellow oil in 78% yield, Rf 
(CH2CI2) = 0.69; [a ] D25 = +81 (c = 1.21, CH2C12); 5H (300 MHz, CDC13) 4.55 (1H, 
m, CHN), 4.41 (1H, app. t, J = 8.5 Hz, OCtfAHB), 3.97 (1H, dd, J = 8.5 Hz and 3.0 
Hz, OCHaHb), 2.95-2.86 (2H, app. td, J = 7.0 Hz and 2.5 Hz, CH2CH3), 1.41 (3H, d, 
J = 6.0 Hz, CH3CH), 1.15 (3H, t, J = 7.0 Hz, Ctf3CH2); SC (75MHz, CDC13) 174.4, 
154.0, 69.5,50.8,29.6, 19.7, 8.7; IR (Film / c m 1) 1775 (C=0„x), 1702 (C=0); LRMS 
: m/z (Cl) 175.1 (100%) [M+NH4]+, 158.0 (20%) [M+H]+; HRMS : m/z (ES) [M+H]+ 
requires 158.0812, found 158.0812.
3.2.3 Tetradecanal 122
DMSO (2 equivalents) was added dropwise to a solution of oxalyl chloride (1.17 
equivalents) in dry dichloromethane (10 cm3) under nitrogen at -40°C and stirred for 
5 minutes. Tetradecanol (1 equivalent) was then added as a solution in dry 
dichloromethane and stirred for 5 minutes. Triethylamine (4 equivalents) was then
o 9
-2
w-BuLi (1.01 equivalents, 2.5 mol dm' solution in hexane) was added to a solution of
reaction was quenched with aqueous saturated ammonium chloride solution (5 cm3) 
and allowed to warm to room temperature, diluted with ether ( 1 0  cm3), washed with
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added dropwise, the solution was allowed to warm to room temperature and stirred 
for an additional hour. The reaction was quenched with distilled water (5 cm ), 
extracted with dichloromethane (3 x 10 cm3), washed with saturated aqueous 
hydrogen carbonate solution (10 cm3) and dried (MgSC>4). The solvent was removed 
under reduced pressure to give the crude product. Purification via column 
chromatography (SiC>2 , CH2CI2) gave 122 as a clear oil 73% yield, which matched the 
previously published data for this compound; 187 Rf (CH2CI2) = 0.89; 8 H (300 MHz, 
CDCI3) 9.76 (1H, t, J = 2.0 Hz, CHO), 2.41 (2H, td, J = 7.0 Hz and 2.0 Hz, 
CHOC//2), 1.35 (2 2 H, m, CnH22), 0 . 8 8  (3H, t, J = 8.5 Hz, CH3); 5C (75MHz, CDC13)






9BBN-OTf (1.1 equivalents, 0.5 mol dm' 3 solution in hexane) was added dropwise to 
a stirred solution of (5)-4-methyl-3-propionyloxazolidin-2-one 121 (1 equivalent) in 
dry dichloromethane (10 cm3) at 0°C, under nitrogen. After 30 minutes, 
diisopropylethylamine ( 1 .2  equivalents) was added dropwise and the resulting 
solution stirred for a further 30 minutes. The solution was cooled to -78°C and 
tetradecanal 1 2 2  (1 .1  equivalents) was added dropwise as a solution in dry 
dichloromethane. The reaction was allowed to warm to room temperature overnight. 
The reaction was quenched with Na2PC>4/NaH2PC)4 buffer solution (pH 7,10 cm3), and 
stirred for 1 0  minutes before the addition of 2 : 1  methanol/hydrogen peroxide solution 
(30%, 10 cm3), and stirred for a further 2 hours. The mixture was extracted with 
dichloromethane (3 x 20 cm3), washed with aqueous saturated sodium hydrogen 
carbonate solution (10 cm3), brine (10 cm3) and dried (MgS0 4 ). The solvent was 
removed under reduced pressure to give the crude product. The diastereomeric excess
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was determined as >95% by examination of the crude 300 MHz !H-NMR spectrum. 
The relative and absolute stereochemistry was assumed as drawn from literature 
precedent and the small a-proton coupling constant (2.5 Hz). Purification via column 
chromatography (SiC>2, CH2CI2) gave 123 as a yellow oil in 81% yield; Rf (CH2CI2) = 
0.63; [a ] D22 = +40 (c = 0.60, CHC13); 8 H (300 MHz, CDCI3) 4.57 (1H, m, CHN), 
4.42 (1H, app. t, J = 8.5 Hz, OCHAHB), 3.98 (1H, dd, J = 8.5 Hz and 3.0 Hz, 
OCHaHb), 3.90 (1 H, m, CHOH), 3.72 (1 H, qd, J = 7.0 Hz and 2.5 Hz, CHCH3), 2.62 
(1H, broad s, OH), 1.38 (3H, d, J = 6.5 Hz, CH3CHN), 1.31-1.15 (26H, m, C13H26),
1.18 (3H, obs. d, J = 7.0 Hz, CH3CH), 0.85 (3H, t, J = 7.0 Hz, alkyl-CH3); 8 C 
(75MHz, CDCI3) 176.5, 152.2, 70.7, 68.4, 49.8, 41.4, 33.2, 31.3, 29.1, 29.0, 28.8,
25.4, 22.1, 18.5, 13.5, 9.7; IR (Film / cm'1) 3428 (broad O-H), 1781 (C=0ox), 1704 
(C=0); LRMS : m/z (Cl) 387.4 (10%) [M+NH4]+, 370.3 (20%) [M+H]+; HRMS : m/z 
(ES) [M+H]+ requires 370.2952, found 370.2950.
3.2.5 (£)-A'-((/()-l-Hydroxyj)ropan-2-yl)-2-methvlhexadec-2- 




Potassium tert-butoxide (1.1 equivalents) was added in one portion to a solution of 
(S)-3-((2S,3R)-3-Hydroxy-2-methyl-hexadecanoyl)-4-methyl-oxazolidin-2-one 123 (1 
equivalent) at -78°C in dry THF under nitrogen, and allowed to warm to room 
temperature overnight. The reaction was quenched with saturated aqueous ammonium 
chloride solution (5 cm3), extracted with ethyl acetate (3 x 20 cm3), washed with 
saturated aqueous sodium hydrogen carbonate solution (10 cm ) and dried (MgSCU). 
The solvent was removed under reduced pressure to give the crude product. The 
diastereomeric excess was determined as >95% by examination of the crude 300 
MHz ^-N M R  spectrum. Purification via column chromatography (SiC>2, CH2CI2) 
gave 119 as a clear oil in 85% yield, which matched the previously published data for 
this compound; 188 Rf (CH2C12) = 0.24; [a ] D25 = - 8  (c = 0.61, CHC13); 8 H (300 MHz,
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CDCI3) 6.37 (1H, app. td, J = 7.5 Hz and 1.5 Hz, CH=C), 5.83 (1H, broad s, NH), 
4.12 (1H, app. qd, J = 6.5 Hz and 3.5 Hz, CHCH3), 3.71 (1H, dd, J = 11.0 Hz and 3.5 
Hz, CHaHbOH), 3.56 (1H, dd, J = 11.0 Hz and 6.0 Hz, CHAHBOH), 2.13 (2H, app. q, 
J = 7.0 Hz, CH2CH=C), 1.42 (1H, broad s, OH), 1.35-1.21 (22H, m, CiiH22), 1.21 
(3H, obs. d, J = 7.0 Hz, Ctf3CH), 0.88 (3H, t, J = 7.0 Hz, alkyl-CH3); 5C (75MHz, 
CDC13) 169.3, 136.1, 129.2, 66.7, 47.1, 30.9, 29.3, 28.7, 28.6, 28.5, 28.4, 28.3, 27.8,
27.4, 21.7, 16.1, 13.1, 11.7; IR (KBr/ cm 1) 3280 (broad O-H), 1621 (C=0); LRMS : 
m/z (Cl) 326.4 (100%) [M+H]+; HRMS : m/z (ES) [M+H]+ requires 326.3054, found 
326.3052.
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Chapter 3.3 General procedures for the synthesis 
of SuperQuat chiral auxiliary




The preparation of the title compound was adapted from the previously published 
procedure. 189 Thionyl chloride (2 equivalents) was added dropwise to a solution of 
(S)-phenylalanine (1 equivalent) in methanol (2 cm3 mmol'1) at 0°C, under nitrogen. 
The reaction was allowed to warm to room temperature and stirred for 24 hours. The 
solvent was removed under reduced pressure to give the crude product, which 
matched the previously published data for this compound. 189 The crude product was 
carried on to the next step without further purification; 8 H (300 MHz, CDCI3) 7.31-
7.19 (5H, m, Ph), 3.75 (1H, dd, J = 8.0 Hz and 5.0 Hz, NH2CH), 3.72 (3H, s, CH3O), 
3.07 (1H, dd, J = 13.5 Hz and 5.0 Hz, CtfAHBPh), 2.87 (1H, dd, J = 13.5 Hz and 5.0 
Hz, CHAtfBPh).




The preparation of the title compound was adapted from the previously published 
procedure. 189 Boc anhydride (1.1 equivalents) was added in one portion to a solution 
of (^-phenylalanine methyl ester 127 in absolute ethanol (sufficient to dissolve the 
compound) at 0°C. Solid sodium hydrogen carbonate (2 equivalents) was added in 
one portion and the reaction was stirred for 48 hours. The solvent was then removed
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under reduced pressure and the crude mixture dissolved in ether (50 cm3). The 
mixture was filtered through a pad of Celite with ether as eluent (3 x 20 cm3). The 
solvent was removed under reduced pressure to give the crude product ,141, which 
matched the previously published data for this compound. 190 The crude product was 
carried on to the next step without further purification; 8 H (300 MHz, CDCI3) 7.33- 
7.09 (5H, m, Ph,), 4.97 (1H, broad d, J = 7.5 Hz, NH), 4.59 (1H, m, NHCH), 3.71 
(3H, s, OCH3), 3.16-2.99 (2H, m, CH2Ph), 1.41 (9H, s, Boc)
3.3.3 ter*-Butyl-(S)-3-hydroxy-3-methyl-l-phenylbutan-2- 
ylcarbamate 129
_ ^ N H B oc  
HO y
Ph
The preparation of the title compound was adapted from the previously published 
procedure. 189 Methyl iodide (1 cm3) was added dropwise with gentle heating to a 
suspension of magnesium turnings (4 equivalents) in dry THF (2 cm3 mmol'1) under 
nitrogen, until the reaction sustained a gentle reflux. Methyl iodide (4 equivalents, 1:5 
solution in THF) was added dropwise over a period of thirty minutes. The solution 
was allowed to cool to room temperature, before (5)-A^-Boc-phenylalanine methyl 
ester 128 (1 equivalent, 1:5 solution in THF) was added dropwise to the reaction over 
a period of thirty minutes. The reaction was stirred for 48 hours, quenched with 
saturated ammonium chloride solution ( 2 0  cm3) and hydrochloric acid ( 2 0  cm3, 1 mol 
dm' 3 solution in water), filtered through Celite with ether as eluent (3 x 30 cm3). The 
solvent was removed under reduced pressure, dissolved in ether (40 cm3), washed 
with brine (10 cm3) and dried (MgS0 4 ). The solvent was removed under reduced 
pressure give the crude product 129, which was carried on to the next step without 
further purification; [a ] D25 = -45 (c = 1.00, CHC13); mp = 101-103°C; 8 H (300 MHz, 
CDCI3) 7.24-7.09 (5H, m, Ph), 4.49 (1H, d, J = 9.0 Hz, NH), 3.62 (1H, m, CHNH),
3.02 (1H, dd, J = 14.0 Hz and 3.5 Hz, CtfAHBPh), 2.53 (1H, m, CHAHBPh), 1.23 (6 H, 
s, gem-dimethyl), 1.22 (9H, s, Boc); 5C (75MHz, CDC13) 156.8, 139.4, 129.5, 128.7,
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126.5, 79.7, 73.4, 60.8, 36.4, 28.6, 27.8, 26.9; IR (KBr / cm'1) 3475 (O-H), 3379 (N- 
H), 1662 (C=0); HRMS : m/z (ES) [M+H]+requires 280.1907, found 280.1911.
3.3.4 (S)-4-benzyl-5,5-dimethyloxazolidin-2-one (SuperQuat) 126
O NH
\ J
The preparation of the title compound was adapted from the previously published
1 O Q
procedure. Potassium terf-butoxide (1.1 equivalents) was added in one portion to a 
solution of fm-butyl-(S)-3-hydroxy-3-methyl-l-phenylbutan-2-ylcarbamate 129 in 
dry THF (40 cm ) under nitrogen, and stirred for thirty minutes at room temperature. 
The reaction was quenched with saturated ammonium chloride solution (10 cm3), 
extracted with ether (3 x 20 cm3), washed with saturated sodium hydrogen carbonate 
solution (10 cm3), brine (10 cm3) and dried (MgS0 4 ). The solvent was removed under 
reduced pressure to give the crude product. Purification by recrystallisation (Et2 0 , 
Hexane) gave 126 as a white solid in 77% yield, which matched the previously 
published data for this compound; 191 Rf (CH2CI2) = 0.15; [ oc] d 25 = -120 (c = 0.78, 
CHCI3); mp = 63-65°C; 5H (300 MHz, CDC13) 7.34-7.08 (5H, m Ph), 5.09 (1H, broad 
s, NH), 3.63 (1H, dd, J = 10.5 Hz and 4.0 Hz, CHN), 2.77 (1H, dd, J = 13.5 Hz and
4.0 Hz, CtfAHBPh), 2.62 (1H, dd, J = 13.5 Hz and 10.0 Hz, CHAtfBPh), 1.39 (3H, s, 
(Ctf3)C(CH3)), 1.38 (3H, s, (CH3)C(CH3)); 8 C (75MHz, CDC13) 158.3, 137.3, 129.5,
129.3, 127.6, 83.6, 63.5, 37.5, 27.9, 22.4.
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The title compound was prepared as the same general procedure for 126 in 43% 
overall yield from the unnatural (fl)-phenylalanine enantiomer, which matched the 
previously described data of the opposite enantiomer of this compound; [ cc] d 25 =  
+115 (c = 0.59, CH2C12).
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Chapter 3.4 General procedure for the 
preparation of iV-acylated SuperQuat 




A  n ^ r
«-BuLi (1.01 equivalents, 2.5 mol dm' 3 solution in hexane) was added to a solution of 
(S)-4-benzyl-5,5-dimethyloxazolidin-2-one (SuperQuat) 126 (1 equivalent) in dry 
THF (20 cm3) at -78°C under nitrogen, and stirred for 30 minutes. The appropriate 
acid chloride or bromide (1 .1  equivalents) was then added dropwise to the stirred 
solution over approximately 5 minutes and stirred for a further 2 hours, during which 
time the reaction was allowed to warm to 0°C. The reaction was quenched with 
aqueous saturated ammonium chloride solution (5 cm3) and allowed to room 
temperature. The mixture was diluted with ethyl acetate (10 cm3), washed with 
aqueous saturated sodium hydrogen carbonate solution, sufficient to dissolve the 
white precipitate, extracted with dichloromethane (3 x 20 cm3), and dried (MgSCU). 
The solvent was removed under reduced pressure to give the crude product, which 
was purified either by silica gel chromatography or recrystallisation.
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3.4.2 (S)-4-benzyl-3-(2-(4-methoxyphenyl)acetyl)-5,5- 
dimethyloxazolidin-2-one 165
The title compound was prepared as the general procedure from 126, using 2-(4- 
methoxyphenyl)acetyl chloride. Purification by recrystallisation (Et2 0 , Hexane) gave 
165 as yellow solid in 80% yield; Rf (CH2C12) = 0.79; [ct] D25 = -30 (c = 0.77, 
CH2C12); mp = 67-69°C (Et20 , Hexane); 8 H (300 MHz, CDC13) 7.31-7.20 (5H, m, 
Ph), 7.20 (2H, d, J = 9.0 Hz, m-MeOPh), 6 . 8 6  (2H, d, J = 9.0 Hz, o-MeOPh), 4.49 
(1H, dd, J = 10.0 Hz and 4.0 Hz, CHN), 4.21 (2H, app. s, CH2PhOMe), 3.81 (3H, s, 
CH30), 3.13 (1H, dd, J = 14.5 Hz and 4.0 Hz, PhC//AHB), 2.85 (1H, dd, J = 14.5 Hz 
and 10.0 Hz, PhCHAtfB), 1.36 (3H, s, (C//3)C(CH3)), 1.31 (3H, s, (CH3)C(C//3)); 5C 
(75MHz, CDC13) 172.2, 159.1, 153.0, 137.3, 131.1, 129.5, 129.0, 127.2, 126.1, 114.4,
82.7, 64.2, 55.7, 41.3, 35.6, 29.0, 22.7; IR (KBr / cm'1) 1768 (C=0ox), 1714 (C=0); 
LRMS : m/z (Cl) 371.3 (70%) [M+NH4]+, 354.1 (90%) [M+H]+; HRMS : m/z (ES) 
[M+H]+ requires 354.1700, found 354.1703.
3.4.3 (5)-4-benzyl-5,5-dimethyl-3-(2-phenylacetyl)oxazolidin-2-one 
164
The title compound was prepared as the general procedure from 126, using 
phenylacetyl chloride. Purification by column chromatography (Si02, Et20:Hexane, 
20:80) gave 143b as clear oil in 73% yield; Rf (CH2C12) = 0.79; [a ] D25 = -16 (c =
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0.55, CH2C12); 5H (300 MHz, CDC13) 7.37-7.17 (10H, m, Ph), 4.50 (1H, dd, J = 10.0 
Hz and 4.0 Hz, CHN), 4.28 (2H, app. s, COCH2), 3.14 (1H, dd, J = 14.5 Hz and 10.0 
Hz, CHAHBPh), 2.86 (1H, dd, J = 14.5 Hz and 4.0 Hz, CHAtfBPh), 1.37 (3H, s, 
(CH3)C(CH3), 1.32 (3H, s, (CH3)C(CH3)); 5C (75MHz, CDC13) 171.9, 153.4, 137.2,
134.1, 130.1, 129.5, 129.1, 129.0, 127.6, 127.2, 82.8, 64.2, 42.2, 35.6, 29.0, 22.7; JR 
(Film / cm'1) 1776 (C=0ox), 1698 (C=0); LRMS : m/z (Cl) 341.2 (100%) [M+NH4]+,





The title compound was prepared as the general procedure from 126, using isovaleryl 
chloride. Purification via column chromatography (Si0 2 ; Et2 0 :Hexane, 20:80) gave 
181 as yellow oil in 76% yield; R, (CH2C12) = 0.82; [afo25 = -34 (c = 0.59, CH2C12); 
8 H (300 MHz, CDCI3) 7.31-7.17 (5H, m, Ph), 4.50 (1H, dd, J = 9.5 Hz and 4.0 Hz, 
CHN), 3.11 (1H, dd, J = 14.5 Hz and 4.0 Hz, PhCHAHB), 2.85 ( 1H, obs. dd, J = 14.5 
Hz and 9.5 Hz, PhCHA//B), 2.78 (2H, app. d, J = 6.5 Hz, COCH2), 2.13 (1H, m, 
isopropyl-CH), 1.34 (3H, s, (Ctf3)C(CH3)), 1.33 (3H, s, (CH3)C(CH3)), 0.94 (6 H, 
app. d, J = 7.0 Hz, 2 x isopropyl-CH3); 8 C (75MHz, CDC13) 173.3, 153.1, 137.4,
129.5, 129.1, 127.2, 82.5, 63.9, 44.6, 44.5, 35.8, 28.9, 25.6, 22.9, 22.7; IR (Film / 
cm'1) 1779 (C=0„x), 1700 (C=0); LRMS : m/z (Cl) 307.2 (100%) [M+NH4]+, 290.1 
(80%) [M+H]+; HRMS : m/z (ES) [M+H]+ requires 290.1751, found 290.1749.
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The title compound was prepared as the general procedure from ent-126 using 
isovaleryl chloride. Purification by column chromatography (Si0 2 l Et2 0 :Hexane, 
20:80) gave ent-181 as yellow oil in 81%, which matched the previously described 




The title compound was prepared as the general procedure from 126, using propionyl 
chloride. Purification by recrystallisation (Et2 0 , Hexane) gave 130 as a white solid in 
89% yield; Rf (CH2C12) = 0.79; [a ] D25 = -31 (c = 0.87, CH2C12); mp = 61-62°C (Et20 , 
Hexane); 8 H (300 MHz, CDC13) 7.32-7.17 (5H, m, Ph), 4.49 (1H, dd, J = 9.5 Hz and
4.0 Hz, CHN), 3.12 (1H, dd, J = 14.5 Hz and 4.0 Hz, PhCHAHB), 2.89 (3H, obs. m, 
CH2CH3 and PhCHA//D), 1.35 (3H, s, (C//3)C(CH3)), 1.33 (3H, s, (CH3)C(CH3)),
1.17 (3H, t, J = 7.5 Hz, CH3); 8 C (75MHz, CDC13) 174.7, 153.1, 137.4, 129.5, 129.1,
127.2, 82.6, 63.9, 35.8, 29.8, 29.0, 22.7, 8 .8 ; IR (KBr / cm 1) 1770 (C=0„x), 1700 
(C=0); LRMS : m/z (Cl) 279.2 (100%) [M+NH,]+, 262.1 (50%) [M+H]+; HRMS : 
m/z (ES) [M+H]+ requires 262.1438, found 262.1442.
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3.4.7 (R)-4-benzyl-5,5-dimethyl-3-propionyloxazolidin-2-one ent-130
The title compound was prepared as the general procedure from ent-126, using 
propionyl chloride. Purification by recrystallisation (Et2 0 , Hexane) gave ent-130 as a 
white in 80%, which matched the previously described data for the opposite 
enantiomer of this compound; [ cc] d 25 = +28 (c = 0.99, CH2CI2).
3.4.8 (S)-4-benzyl-3-(2-chloroacetyl)-5,5-dimethyloxazolidin-2-one
The title compound was prepared as the general procedure from 126, using 
chloroacetyl chloride. Purification by recrystallisation (Et2 0 , Hexane) gave 166 as a 
white solid in 81% yield; Rf (CH2C12) = 0.71; [a ] D25 = -39 (c = 1.00, CHC13); mp =
= 14.5 Hz and 10.0 Hz, CHAHBPh), 1.41 (3H, s, (Ctf3)C(CH3)), 1.39 (3H, s,
LRMS : m/z (Cl) 295.4 (20%) [M+NH*]*, 282.1 (30%) [M+H]+; HRMS : m/z (ES) 




67-70°C (Et20 , Hexane); 8 H (300 MHz, CDC13) 7.36-7.22 (5H, m, Ph), 4.80 (1H, d, J 
= 16.0 Hz, CHaHbCI), 4.67 (1H, d, J = 16.0 Hz, CHAtfBCl), 4.52 (1H, dd, J = 10.0 Hz 
and 4.0 Hz, CHN), 3.22 (1H, dd, J = 14.5 Hz and 4.0 Hz, CtfAHBPh), 2.91 (1H, dd, J
(CH3)C(Ci/3)); 5C (75MHz, CDC13) 166.8, 152.7, 136.8, 129.4, 129.2, 127.4, 84.1,
64.5,44.4, 35.4, 29.0, 22.8; IR (KBr / cm'1) 1788 (C=0„x), 1711 (C=Q), 721 (C-Cl);
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The title compound was prepared as the general procedure from ent-126, using 
chloroacetyl chloride. Purification by recrystallisation (Et2 0 , Hexane) gave ent-166 
as a white solid in 79% yield, which matched the previously described data for the 
opposite enantiomer of this compound; [ cc] d 25 = +37 (c = 1.34, CH2CI2).
3.4.10(S)-4-Benzyl-3-(2-bromoacetyl)-5,5-dimethyloxazolidin-2-one 
167
The title compound was prepared as the general procedure from 126, using 
bromoacetyl bromide. Purification by recrystallisation (Et2 0 , Hexane) gave 167 as a 
yellow solid in 72% yield; Rf (CH2C12) = 0.74; [a ] D25 = - 2 2  (c = 1.34, CH2C12); mp = 
72-75°C (Et20 , Hexane); 8 H (300 MHz, CDC13) 7.34-7.19 (5H, m, Ph), 4.56 (1H, d, J 
= 12.5 Hz, CtfAHBBr), 4.49 (1H, dd, J = 10.0 Hz and 4.0 Hz, CHN), 4.42 (1H, d, J =
12.5 Hz, CHAtfBBr), 3.18, (1H, dd, J = 14.5 Hz and 4.0 Hz, PhCHAHB), 2.89 (1H, dd, 
J = 14.5 Hz and 10.0 Hz, PhCHAHB), 1.38 (3H, s, (Ctf3)C(CH3)), 1.37 (3H, s, 
(CH3)C(CH3)); 8 C (75MHz, CDC13) 166.7, 152.5, 136.9, 129.4, 129.2, 127.4, 83.7,
63.4, 35.4, 29.0, 28.7, 22.7; IR (KBr / cm 1) 1785 (C=0„x), 1700 (C=0), 653 (C-Br); 
LRMS : m/z (Cl) 344.1 (20%) [M+NH,]+; HRMS : m/z (ES) [M+NH4]+ requires 
343.0652, found 343.0653.
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3.4.11(S)-4-benzyl-5,5-dimethyl-3-((E)-3-phenylacryloyl)oxazolidin- 
2-one
The title compound was prepared as the general procedure from 126, using cinnamoyl 
chloride. Purification by column chromatography (SiC>2, Et2 0 :Hexane, 20:80) gave 
the tile compound as a yellow oil in 72% yield; Rf (CH2CI2) = 0.74; [ cc] d 25 = -46 (c = 
1.42, CH2CI2); 6 H (300 MHz, CDCI3) 7.94 (1H, d, J = 16.0 Hz, PhCH=CH), 7.84 
(1H, d, J = 16.0 Hz, PhCtf=CH), 7.65-7.60 (2H, m, Ph), 7.43-7.21 (8 H, m, Ph), 4.64 
(1H, dd, J = 9.5 Hz and 3.5 Hz, CHN), 3.28 (1H, dd, J = 14.5 Hz and 3.5 Hz, 
CHAHBPh), 2.94 (1H, dd, J = 14.5 Hz and 9.5 Hz, CHAtfBPh), 1.41 (3H, s, 
(CH3)C(CH3), 1.40 (3H, s, (CH3)C(CH3); 5C (75MHz, CDC13) 165.9, 153.2, 146.5,
137.5, 135.0, 131.0, 129.5, 129.3, 129.1, 129.0, 127.2, 117.8, 82.7, 64.3, 35.7, 29.0,
22.8 IR (Film / cm'1) 1770 (C=0ox), 1676 (C=0), 1620 (C=C); LRMS : m/z (Cl) 
355.3 (40%) [M+NHff, 336.2 (100%) [M+H]+; HRMS : m/z (ES) [M+H]+ requires 
336.1594, found 336.1597.
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Chapter 3.5 General procedure for the 
preparation of iV-acylated SuperQuat 




In a Schlenk flask, oxalyl chloride (1.2 equivalents) was added to a solution of the 
appropriate acid (1.1 equivalent) in dry THF at 0°C under nitrogen, and stirred for 5 
minutes. DMF was then added (5 mol% with respect to oxalyl chloride) and the 
solution stirred at 0°C for 1 hour. The volatile material was then removed under 
reduced pressure and fresh dry THF (5 cm3) was added. In a separate round-bottomed 
flask (100 cm ), n-BuLi (1.01 equivalents, 2.5 mol dm' solution in hexane) was 
added dropwise to a solution of (S)-4-benzyl-5,5-dimethyl-oxazolidin-2-one 126 in 
dry THF at -78°C under nitrogen and stirred for 30 minutes. The newly formed acid 
chloride was then transferred from the Schlenk flask to the reaction via canella under 
nitrogen; additional dry THF (2 cm3) was added to ensure complete transfer. The 
reaction was allowed to warm to 0°C over two hours before being quenched with 
saturated aqueous ammonium chloride solution (5 cm3) and diluted with ethyl acetate 
(20 cm3). The reaction was washed with saturated aqueous sodium hydrogen 
carbonate solution, sufficient to dissolve the white precipitate, extracted with 
dichloromethane (3 x 10 cm3) and dried (MgS0 4 ). The solvent was removed under 
reduced pressure giving the crude product, which was purified by silica gel 
chromatography.
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3.5.2 (S)-3-(3,3,3,-Trifluoropropanoyl)-4-benzyl-5,5- 
dimethyloxazolidin-2-one 169
0 9> NA / CF3
The title compound was prepared as the general procedure from 126 using 
trifluoropropanoic acid. Purification by column chromatography (SiC>2, CH2CI2) gave 
169 as a clear oil in 52% yield; Rf (CH2C12) = 0.78; [a ] D25 = -26 (c = 1.30, CH2C12); 
5H (300 MHz, CDCI3) 7.35-7.21 (5H, m, Ph), 4.54 (1H, dd, J = 9.5 Hz and 4.0 Hz, 
CHN), 3.95 (1H, dq, J = 16.0 Hz and 10.0 Hz, CtfAHBCF3), 3.80 (1H, dq, J = 16.0 Hz 
and 10.0 Hz, CHAtfBCF3), 3.18, (1H, dd, J = 14.0 Hz and 4.0 Hz, PhCtfAHB), 2.91 
(1H, dd, J = 14.0 Hz and 9.5 Hz, PhCHAHB), 1.41 (3H, s, (CH3)C(CH3)), 1.38 (3H, s, 
(CH3)C(C//3)); 8 C (75MHz, CDC13) 163.8, 152.7, 136.7, 129.4, 129.2, 127.5, 83.5, 
64.1, 40.2 (q, J = 29.8 Hz), 35.5, 28.9, 22.6; IR (Film / cm'1) 1778 (C=0ox), 1713 
(C=0), 1277 (C-F); LRMS : m/z (Cl) 333.2 (100%) [M+NHt]*; HRMS : m/z (ES) 
[M+NH4]+ requires 333.1421, found 333.1423.
3.5.3 (S)-4-benzyl-5,5-dimethyI-3-(2-(methylthio)acetyl)oxazolidin-2- 
one 168
The title compound was prepared as the general procedure from 126 using 2- 
(methylthio)acetic acid. Purification by column chromatography (SiC>2, CH2CI2) gave 
168 as a yellow oil in 48% yield; Rf (CH2C12) = 0.68; [a]D25 = +15 (c = 0.78, 
CH2C12); 8 H (300 MHz, CDC13) 7.32-7.17 (5H, m, Ph), 4.49 (1H, dd, J = 9.5 Hz and
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4.0 Hz, CHN), 3.76 (1H, d, J = 14.0 Hz, CJ7AHBSCH3), 3.70 (1H, d, J = 14.0 Hz, 
CHaHbSCH3), 3.12, (1H, dd, J = 14.0 Hz and 4.0 Hz, PhCHAHB), 2.89 (1H, dd, J =
14.0 Hz and 9.5 Hz, PhCHA//B), 2.11 (3H, s, SCH3) 1.41 (6 H, app. s, (CH3)C(CH3)), 
8 C (75MHz, CDC13) 169.5, 152.8, 137.2, 129.7, 129.5, 129.1, 83.0, 64.0, 37.2, 35.8,
29.0, 22.7, 16.3; IR (Film / cm'1) 1776 (C=0„x), 1694 (C=0), 1358 (C-S); LRMS : 
m/z (Cl) 311.2 (100%) [M+NH4]+, 294.2 (30%) [M+H]+; HRMS : m/z (ES) 
[M+NH4]+ requires 311.1424, found 311.1427.
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Chapter 3.6 General procedure for the syn- 
selective boron aldol reaction
3.6.1 General procedure
a stirred solution of the relevant acylated SuperQuat auxiliary (1 equivalent) in dry 
dichloromethane at 0°C, under nitrogen. After 30 minutes, diisopropylethylamine (1.2 
equivalents) was added dropwise and the resulting solution stirred for a further 30 
minutes. The solution was cooled to -78°C and the appropriate aldehyde (1.1 
equivalents) was added dropwise, either neat or as a solution in dry dichloromethane. 
The reaction was then allowed to warm to room temperature overnight. The reaction 
was quenched with Na2PC>4/NaH2PC)4 buffer solution (pH7, 10 cm3), and stirred for 
10 minutes before the addition of 2:1 methanol-hydrogen peroxide solution (30%, 10 
cm3) and stirred for a further 2 hours. The mixture was extracted with 
dichloromethane (3 x 20 cm3), washed with aqueous saturated sodium hydrogen 
carbonate solution (10 cm3), brine (10 cm3) and dried (MgSO^. The solvent was 
removed under reduced pressure to give the crude product, which was purified either 
by silica gel chromatography or recrystallisation.
9BBN-OTf (1.1 equivalents, 0.5 mol dm' 3 solution in hexane) was added dropwise to
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The title compound was prepared as the general procedure from (E)-dec-2-enal and 
(S)-4-benzyl-5,5-dimethyl-3-propionyloxazolidin-2-one 130. The relative and 
absolute stereochemistry was assumed as drawn from literature precedent and the 
small a-proton coupling constant (4.0 Hz). The diastereomeric excess was 
determined as >95% by examination of the crude 300 MHz !H-NMR spectrum. 
Purification via column chromatography (SiC>2, CH2CI2) gave 137b as a yellow oil in 
81% yield; Rf (CH2C12) = 0.32; [cc] D25 = -5 (c = 0.59, CH2C12); 5H (300 MHz, 
CDCI3) 7.44-7.09 (5H, m, Ph), 5.67 (1H, dtd, J = 15.5 Hz, 7.0 Hz and 1.0 Hz, 
CH=C//C7Hi5), 5.39 (1H, ddt, 15.5, 6.0 and 1 .0  Hz, Ci/=CHC7H15), 4.46 (1H, dd, J =
9.0 and 4.5 Hz, CHN), 4.30 (1H, m, C//OH), 3.83 (1H, qd, J = 7.0 Hz and 4.0 Hz, 
COCH), 2.99 (1H, dd, J = 14.0 and 4.5 Hz, CtfAHBPh), 2.83 (1H, dd, J = 14.0 and 9.0 
Hz, CHAC //BPh), 2.53 (1H, broad s, OH), 1.96 (2H, app. q, J = 7.0 Hz, CH=CHC//2), 
1.32 (3H, s, (C//3)C(CH3)), 1.30 (3H, s, (CH3)C(C//3)), 1.29-1.13 (10H, m, alkyl- 
C5H10), 1.07 (3H, d, J = 7.0 Hz, C //3CH), 0.81 (3H, t, J = 7.0 Hz, alkyl-CH3); 8 C 
(75MHz, CDC13) 177.1, 152.6, 137.7, 134.1, 129.3, 129.2, 129.1, 127.3, 82.7, 73.4,
63.8, 43.3, 35.9, 32.7, 32.2, 29.6, 29.5, 23.1, 14.5, 12.0; IR (film / cm'1) 3517 (broad 
O-H), 1778 (C=0ox), 1698 (C=0); LRMS : m/z (Cl) 175.1 (100%) [M +NILf, 158.0 
(20%) [M+H]+; LRMS : m/z (Cl) 433.4 (90%) [M+NH4]+, 416.3 (100%) [M+H]+; 
HRMS : no molecular ion found.
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The title compound was prepared as the general procedure from (£)-cinnamaldehyde 
and (S)-4-benzyl-5,5-dimethyl-3-propionyloxazolidin-2-one 130. The relative and 
absolute stereochemistry was assumed as drawn from literature precedent and the 
small a-proton coupling constant (4.0 Hz). The diastereomeric excess was 
determined as >95% by examination of the crude 300 MHz ]H-NMR spectrum. 
Purification via column chromatography (SiC>2, CH2CI2) gave 137a as a white solid in 
80% yield; m.p. 148-150°C (Et20); Rf (CH2C12) = 0 .2 1 ; [a ] D25 = +4 (c = 1.07, 
CH2CI2); 5H (300 MHz, CDCI3) 7.36-7.13 (10H, m, Ph), 6.59 (1H, dd, J = 16.0 and
1.5 Hz, CH=CHPh), 6.12 (1H, dd, J = 16.0 Hz and 6.0 Hz, CH=CHPh), 4.54 (1H, m, 
CHOH), 4.47 (1H, dd, J = 9.0 and 5.0 Hz, CHN), 3.94 (1H, qd, J = 7.0 and 4.0 Hz, 
COCH), 3.00 (1H, dd J = 14.0 and 5.0 Hz, CtfAHBPh), 2.84 (1H, dd, J = 14.0 and 9.0 
Hz, CHACtfBPh), 2.74 (1H, broad s, OH), 1.32 (3H, s, (C//3)C(CH3)), 1.30 (3H, s, 
(CH3)C(CH3)), 1.13 (3H, d, J = 7.0 Hz, CH3CH); 5C (75MHz, CDC13) 177.1, 152.6,
137.7, 134.1, 129.3, 129.2, 129.1, 127.3, 82.7, 73.4, 63.8, 43.3, 35.9, 32.7, 32.2, 29.6,
29.5, 23.1, 14.5, 12.0; IR (K B r/cm 1) 3517 (broad O-H), 1778 (C=0ox), 1698 (C=0); 
LRMS : m/z (Cl) 411.4 (100%) [M+NHtf; HRMS : m/z (ES) [M+NH4]+ requires 
411.2278, found 411.2273.
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The title compound was prepared as the general procedure from para- 
methoxycinnamaldehyde and (5')-4-benzyl-5,5-dimethyl-3-propionyloxazolidin-2-one 
130. The relative and absolute stereochemistry was assumed as drawn from literature 
precedent and from the small a-proton coupling constant (4.0 Hz). The 
diastereomeric excess was determined as >95% by examination of the crude 300 
MHz *H-NMR spectrum. Purification via column chromatography (SiC>2, CH2CI2) 
gave 137c as an yellow oil in 77% yield; Rf (CH2CI2) = 0.17; [oc]d25 = +125 (c = 0.73, 
CH3OH); 8 H (300 MHz, CDCI3) 7.34-7.23 (7H, m, Ph), 6.84 (2H, d, J = 8.5 Hz, 
MeOCHACHBC), 6.51 (1H, d, J = 16.0 Hz, CH=CHPhOMe), 5.99 (1H, dd, 16.0 Hz 
and 6.0 Hz, Ctf=CHPhOMe), 4.52-4.44 (2H, obs. m, CHOH and CHN), 3.97 (1H, qd, 
J = 7.0 and 4.0 Hz, CH3CH), 3.73 (3H, s, CH3O), 3.00 (1H, dd J = 14.5 and 4.5 Hz, 
C//AHBPh), 2.84 (1H, dd, J = 14.5 and 9.0 Hz, CHACtfBPh), 2.65 (1H, d, J = 3.0 Hz, 
OH), 1.31 (3H, s, (C//3)C(CH3)), 1.23 (3H, s, (CH3)C(C//3)), 1.13 (3H, d, J = 7.0 Hz, 
C //3CH); 5C (75MHz, CDCI3) 176.1, 159.7, 152.8, 137.0, 131.7, 129.7, 129.5, 129.1,
128.2 127.8, 126.7, 114.4 82.7, 73.6, 63.7, 55.7, 43.4, 35.9, 28.7, 22.6, 12.2; IR (film 
/ cm'1) 3475 (broad O-H), 1773 (C=0ox), 1700 (C=0), 1512 (MeO); LRMS : m/z (Cl)
441.2 (50%) [M+NH4]+; HRMS : m/z (ES) [M+NH4]+ requires 441.2384, found 
441.2382.
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The title compound was prepared as the general procedure from (£)-3-(furan-2- 
yl)acrylaldehyde and (S)-4-benzyl-5,5-dimethyl-3-propionyloxazolidin-2-one 130. 
The relative and absolute stereochemistry was assumed as drawn from literature 
precedent and from the small a-proton coupling constant (4.0 Hz). The 
diastereomeric excess was determined as >95% by examination of the crude 300 
MHz ^-N M R  spectrum. Purification via column chromatography (SiC>2, CH2CI2) 
gave 137e as a white solid in 85% yield; mp = 135-137°C (Et2 0 , Hexane); Rf 
(CH2CI2) = 0.15; [a ] D25 = +122 (c = 0.93, CH3OH); 8 H (300 MHz, CDC13) 7.27-7.12 
(6 H, obs. m, Ph and Furyl-OCH), 6.42 (1H, dd, J = 16.0 Hz and 1.5 Hz, Furan- 
CH=CH), 6.28 (1H, dd, J = 3.0 Hz and 2.0 Hz, Furyl-OCH=CH), 6.15 (1H, d, 3.0 Hz, 
Furyl-CH), 6.04 (1H, dd, J = 16.0 Hz and 5.5 Hz, Furan-CH=CH), 4.59-4.45 (2H, 
obs. m and dd, J = 9.0 Hz and 5.0 Hz, CHOH and CHN), 3.90 (1H, qd, J = 7.0 Hz and
4.0 Hz, CH3CH), 2.99 (1H, dd, J = 14.5 Hz and 5.0 Hz, CHAHBPh), 2.84 (1H, dd, J =
14.5 Hz and 9.0 Hz, CHACHBPh), 2.75 (1H, d, J = 3.0 Hz, OH), 1.32 (3H, s, 
(CH3)C(CH3)), 1.26 (3H, s, (CH3)C(CH3)), 1.12 (3H, d, J = 7.0 Hz, CH3CH); 8 C 
(75MHz, CDCI3) 177.6, 152.8, 152.7, 142.4, 137.0, 129.5, 129.1, 127.6, 127.3 120.2,
111.7, 108.7, 82.8, 72.7, 63.7, 43.8, 35.7, 28.5, 22.6, 12.0; IR (KBr / cm 1) 3444 
(broad O-H), 1770 (C=0ox), 1686 (C=0); LRMS : m/z (Cl) 401.2 (40%) [M+NH4]+; 
HRMS : m/z (ES) [M +NILf requires 401.2071, found 401.2069.
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The title compound was prepared as the general procedure from ortho- 
nitrocinnamaldehyde and (5)-4-benzyl-5,5-dimethyl-3-propionyloxazolidin-2-one 
130. The relative and absolute stereochemistry was assumed as drawn from literature 
precedent and from the small a-proton coupling constant (4.0 Hz). The 
diastereomeric excess was determined as >95% by examination of the crude 300 
MHz ^-N M R  spectrum. Purification via column chromatography (SiC>2, CH2CI2) 
gave 137d as clear oil in 87% yield; Rf (CH2CI2) = 0 .1 2 ; [a]o25 = - 8  (c = 0.79, 
CH2CI2); SH (300 MHz, CDCI3) 7.92 (1H, d, J = 8.0 Hz, o-CHPhN02), 7.61-7.19 
(8 H, m, Ph and Ph-N02), 7.12 (1H, dd, J = 16.0 Hz and 1.5 Hz, N 0 2-PhC//=CH),
6.17 (1H, dd, J = 16.0 Hz and 5.5 Hz, N 0 2-PhCH=CH), 4.67 (1H, m, C//OH), 4.59 
(1H, dd, J = 9.0 Hz and 5.0 Hz, CHN), 4.06 (1H, qd, J = 7.0 and 4.0 Hz, CH3C//),
3.08 (1H, dd J = 14.0 Hz and 5.0 Hz, C //AHBPh), 2.90-2.80 (2H, obs. m, CHACtfBPh 
and OH), 1.40 (3H, s, (CH3)C(CH3)), 1.37 (3H, s, (CH3)C(Ctf3)), 1.21 (3H, d, J = 7.0 
Hz, C //3CH); 8 C (75MHz, CDC13) 176.6, 153.0, 146.2, 136.9, 134.9, 133.6, 133.0, 
129.5, 129.3, 129.1, 128.6, 127.4, 128.3 124.9, 82.9, 72.9, 63.7, 43.1, 35.7, 28.8,
22.6, 12.0; IR (film / cm'1) 3447 (broad OH), 1773 (C=0ox), 1700 (C=0), 1552 
(N02), 1352 (N 02); LRMS : m/z (Cl) 456.2 (100%) [M+NHU]*; HRMS : m/z (ES) 
[M+NH4]+ requires 456.2129, found 456.2123.
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The title compound was prepared as the general procedure from 3- 
methylcrotonaldehyde and (S)-4-benzyl-5,5-dimethyl-3-propionyloxazolidin-2-one 
130. The relative and absolute stereochemistry was assumed as drawn from literature 
precedent and from the small a-proton coupling constant (5.0 Hz). The 
diastereomeric excess was determined as >95% by examination of the crude 300 
MHz !H-NMR spectrum. Purification via column chromatography (SiC>2, CH2CI2) 
gave 137h as a yellow oil in 76% yield; Rf (CH2CI2) = 0.18; [a]o25 = -15 (c = 2.44, 
CH2CI2); 5H (300 MHz, CDCI3) 7.35-7.17 (5H, m, Ph), 5.23 (1H, d, J = 9.0 Hz, 
C=CH), 4.60 (1H, m, C//OH), 4.52 (1H, dd, J = 9.0 Hz and 4.5 Hz, CHN), 3.93 (1H, 
qd, J = 7.0 and 5.0 Hz, CH3CH), 3.05 (1H, dd J = 14.5 Hz and 4.5 Hz, CtfAHBPh), 
2.90 (1H, dd, J = 14.5 Hz and 9.0 Hz, CHAC //BPh), 2.35 (1H, broad s, OH), 1.72 (3H, 
s (C//3)(CH3)C=CH), 1.68 (3H, s (CH3)(C//3)C=CH), 1.39 (3H, s, (Cff3)C(CH3)), 
1.37 (3H, s, (CH3)C(Ctf3)), 1.18 (3H, d, J = 7.0 Hz, C //3CH); 5C (75MHz, CDC13)
176.7, 153.0, 137.2, 137.1, 129.5, 129.1, 127.3, 124.5, 82.6, 69.9, 63.8, 43.4, 35.9,
28.6, 26.4, 22.5, 18.8, 12.6; IR (film / cm 1) 3485 (broad O-H), 1778 (C=0ox), 1695 
(C=0); LRMS : m/z (Cl) 175.1 (100%) [M +NILf, 158.0 (20%) [M+H]+; HRMS: 
m/z (ES) [M+H]+ requires 346.2013, found 346.2011.
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The title compound was prepared as the general procedure from (£)-crotonaldehyde 
and (,S)-4-benzyl-5,5-dimethyl-3-propionyloxazolidin-2-one 130. The relative and 
absolute stereochemistry was assumed as drawn from literature precedent and from 
the small a-proton coupling constant (4.5 Hz). The diastereomeric excess was 
determined as >95% by examination of the crude 300 MHz *H-NMR spectrum. 
Purification via recrystallisation of the crude reaction mixture (Et2 0 , Hexane) gave 
137g as a white solid in 76% yield; Rf (CH2CI2) = 0 .2 0 ; [a]o25 = -14 (c = 0.84, 
CH2CI2); mp = 81-84°C (Et20 , Hexane); 5H (300 MHz, CDC13) 7.39-7.17 (5H, m, 
Ph), 5.74 (1H, dqd, J = 15.5 Hz, 6.5 Hz and 1.0 Hz, CH=CtfCH3), 5.48 (1H, ddd, J =
15.5 Hz, 6.5 Hz and 1.5 Hz, CH=CHCH3) 4.60 (1H, dd, J = 9.0 Hz and 4.5 Hz, 
CHN), 4.53 (1H, m, C//OH), 3.91 (1H, qd, J = 7.0 and 4.5 Hz, CH3CH), 3.05 (1H, dd 
J = 14.5 Hz and 4.5 Hz, CHAHBPh), 2.90 (1H, dd, J = 14.5 Hz and 9.0 Hz, 
CHAC //BPh), 2.60 (1H, d, J = 2.5 Hz, OH), 1.70 (3H, d, J = 6.5 Hz, C //3CH=CH),
1.39 (3H, s, (C//3)C(CH3)), 1.38 (3H, s, (CH3)C(Ctf3)), 1.15 (3H, d, J = 7.0 Hz, 
C //3CH); 8 C (75MHz, CDC13) 176.9, 152.9, 137.1, 130.6, 129.5, 129.1, 128.9, 127.3,
82.7, 73.6, 63.8, 43.2, 35.9, 28.7, 22.5, 18.2, 12.1; IR (KBr / cm'1) 3508 (broad O-H), 
1775 (C=0ox), 1696 (C=0); LRMS : m/z (Cl) 349.3 (90%) [M+NH4]+, 332.3 (100%) 
[M+H]+; HRMS: m/z (ES) [M+H]+ requires 332.1856, found 332.1855.
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The title compound was prepared as the general procedure from (£)-non-2-enal and 
(R)-4-benzyl-5,5-dimethyl-3-propionyloxazolidin-2-one ent-130. The relative and 
absolute stereochemistry was assumed as drawn from literature precedent and from 
the small a-proton coupling constant (4.0 Hz). The diastereomeric excess was 
determined as >95% by examination of the crude 300 MHz !H-NMR spectrum. 
Purification via column chromatography (SiC>2, CH2CI2) gave 180a as a yellow oil in 
81% yield; Rf (CH2C12) = 0.32; [cc] D25 = + 8  (c = 1.36, CH2C12); 8 H (300 MHz, 
CDCI3) 7.35-7.19 (5H, m, Ph), 5.73 (1H, dtd, J = 14.5, 7.0 and 1.0 Hz, 
CH=C//C6Hi3), 5.44 (1H, ddt, J = 15.5, 6.5 and 1.5 Hz, C//=CHC6Hi3), 4.53 (1H, dd, 
J = 9.0 and 5.0 Hz, CHN), 4.37 (1H, m, C//OH), 3.89 (1H, qd, J = 7.0 and 4.0 Hz, 
COCH), 3.06 (1H, dd, J = 14.5 and 5.0 Hz, CHAHBPh), 2.83 (1H, dd, J = 14.5 and 9.0 
Hz, CHAC //BPh), 2.61 (1H, broad s, OH), 2.07-1.97 (2H, app. q, J = 7.0 Hz, 
CH=CHC//2), 1.39 (3H, s, (Ctf3)C(CH3)), 1.38 (3H, s, (CH3)C(C//3)), 1.38-1.12 (8 H, 
m, alkyl-C4H8), 1.15 (3H, d, J = 7.0 Hz, Ctf3CH), 0.88 (3H, t, J = 7.0 Hz, alkyl-CH3); 
5C (75MHz, CDC13) 177.0, 152.5, 136.7, 133.7, 129.1, 128.7, 127.0, 82.3, 73.0, 63.4,
43.0, 35.4, 32.3, 31.8, 29.2, 28.8, 27.3, 22.6, 22.5, 22.1, 14.1, 11.7; IR (film / cm'1) 
3509 (broad O-H), 1777 (C=0ox), 1699 (C=0); LRMS : m/z (ES) 424.2 (100%) 
[M+Na]+; HRMS : no molecular ion found.
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The title compound was prepared as the general procedure using oct-2-ynal and (5)-4- 
benzyl-5,5-dimethyl-3-propionyloxazolidin-2-one 130. The diastereomeric excess 
was determined as >95% by examination of the crude 300 MHz !H-NMR spectrum. 
The relative and absolute stereochemistry was assumed as drawn from literature 
precedent and from the small a-proton coupling constant (4.5 Hz). Purification via 
column chromatography (Si0 2 , CH2CI2) gave 138 as a yellow oil in 83% yield; Rf 
(CH2CI2) = 0.48; [a ] D25 = -7 (c = 0.75, CH2C12); 5H (300 MHz, CDC13) 7.27-7.12 
(5H, m, Ph), 4.60 (1H, m, CHOH), 4.47 (1H, dd, J = 9.0 Hz and 4.5 Hz, CHN), 3.85 
(1H, qd, J = 7.0 and 4.5 Hz, CH3CH), 2.99 (1H, dd J = 14.0 Hz and 4.5 Hz, 
CtfAHBPh), 2.84 (1H, dd, J = 14.0 Hz and 9.0 Hz, CHACtfBPh), 2.60 (1H, d, J = 4.0 
Hz, OH), 2.12 (2H, app. td, J = 7.0 Hz and 2.5 Hz, CCH2), 1.48-1.19 (6 H, m, alkyl- 
C3H6), 1.33 (3H, s, (CH3)C(CH3)), 1.31 (3H, s, (CH3)C(CH3)), 1.25 (3H, d, J = 7.0 
Hz, C //3CH), 0.82 (3H, t, J = 7.0 Hz, alkyl-CH3); 8 C (75MHz, CDC13) 176.2, 152.6,
137.0, 129.6, 129.0, 127.3, 87.0, 82.8, 78.9, 64.0, 63.8, 44.6, 36.0, 31.4, 26.8, 26.5,
22.6, 19.1, 14.3, 12.9; IR (film / cm 1) 3494 (broad O-H), 1778 (C=0ox), 1698 (C=0); 
LRMS : m/z (Cl) 403.4 (80%) [M+NH4]+, 386.4 (100%) [M+H]+; HRMS : m/z (ES) 
[M+H]+ requires 386.2326, found 386.2330.
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The title compound was prepared as the general procedure from 2-ethylacrolein and 
(S)-4-benzyl-5,5-dimethyl-3-propionyloxazolidin-2-one 130. The relative and 
absolute stereochemistry was assumed as drawn from literature precedent and from 
the small a-proton coupling constant (4.0 Hz). The diastereomeric excess was 
determined as >95% by examination of the crude 300 MHz ^-N M R  spectrum. 
Purification via recrystallisation (Et20, Hexane) gave 256 as a white solid in 81% 
yield; Rf (CH2C12) = 0.28; [a]D25 = -36 (c = 1.00, CHC13); mp (Et20 , Hexane) = 52- 
53°C; 5H (300 MHz, CDC13); 7.34-7.20 (5H, m, Ph), 5.16 (1H, app. t, J = 1.1 Hz, 
C H cisH ^C ), 4.98 (1H, app. t, J = 1.1 Hz, C H c ^ a ^ C ) ,  4.53 (1H, dd, J = 9.0 Hz 
and 4.5 Hz, CHN), 4.40 (1H, m, CHOH), 3.96 (1H, qd, J = 7.0 Hz and 4.0 Hz, 
CHCH3), 3.08 (1H, dd, J = 14.5 Hz and 4.5 Hz, CHAHBPh), 2.91 (1H, dd, J =14.5 Hz 
and 9.0 Hz, CHAtfBPh), 2.79 (1H, broad s, OH), 2.02 (2H, m, CH2CH3), 1.40 (3H, s, 
(CH3)C(CH3)), 1.38 (3H, s, (CH3)C(CH3)), 1.11 (3H, d, J = 7.0 Hz, CH3CH), 1.07 
(3H, t, J = 7.5 Hz, CH3CH2); 5C (75MHz, CDC13) 177.2, 152.2, 149.7, 136.5, 129.1,
128.7, 126.9, 100.5, 82.4, 73.6, 63.4, 40.6, 35.4, 28.4, 25.3, 22.8, 12.1, 10.6; IR (KBr 
/ cm'1) 3529 (broad O-H), 1774 (C=0ox), 1683 (C=0); LRMS : m/z (Cl) 363.3 (10%) 
[M+NH4]+, 346.3 (40%) [M+H]+; HRMS : m/z (ES) [M+H]+ requires 386.2326, 
found 386.2330.
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The title compound was prepared as the general procedure from para- 
methoxycinnamaldehyde and (S)-4-benzyl-3-(2-(4-methoxyphenyl)acetyl)-5,5- 
dimethyloxazolidin-2-one 165. The relative and absolute stereochemistry of the major 
diastereomer was assumed as drawn from literature precedent. The diastereomeric 
excess was determined as 76% de by examination of the crude 300 MHz ^-N M R  
spectrum. Purification via column chromatography (SiC>2 , CH2CI2) gave 165a as a 
yellow oil in 73% yield and 76% de; Rf (CH2CI2) = 0.08; [a]o25 = -52 (c = 1.07, 
CH2CI2) at 76% de; 8 H (300 MHz, CDC13) 7.32 (2H, d, J = 8.5 Hz, m-PhOMe), 7.21 
(2H, d, J = 8.5 Hz, m-PhOMe), 7.15-7.02 (5H, m, Ph), 6.82 (2H, d, J = 8.5 Hz, 0 - 
PhOMe), 6.75 (2H, d, J = 8.5 Hz, <?-PhOMe), 5.52 (1H, d, J = 16.0 Hz, 
CH=C//PhOMe), 5.99 (1H, dd, J = 16.0 Hz and 7.0 Hz, CH=CHPhOMe), 5.11 (1H, 
m, CHPhOMe), 4.77 (1H, app. td, J = 7.5 Hz and 2.5 Hz, CHOH), 4.40 (1H, dd, J =
9.0 and 4.0 Hz, CHN), 3.74 (3H, s, PhOC//3), 3.72 (3H, s, PhOCtf3) 2.84 (1H, dd, J =
14.5 Hz and 4.0 Hz, CHAHBPh), 2.62 (1H, dd, J = 14.5 Hz and 9.0 Hz, CHACtfBPh), 
2.26 (1H, broad s, OH), 1.19 (3H, s, (CH3)C(CH3)), 1.08 (3H, s, (CH3)C(CH3)); 5C 
(75MHz, CDC13) 173.3, 159.8, 152.4, 137.0, 132.6, 131.4, 129.6, 129.4, 129.2, 129.0,
128.2, 127.1, 126.7, 126.4, 114.6, 114.3, 82.5, 74.7, 63.7, 55.7, 55.6, 54.9, 35.4, 28.5, 
22.5; IR (film / cm'1) 3502 (broad O-H), 1771 (C=0ox), 1684 (C=0), 1250 (OMe); 
LRMS : m/z (Cl) 533.3 (10%) [M+NKd*; HRMS: m/z (ES) [M+NHtf requires 
533.2646, found 533.2647.
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The title compound was prepared as the general procedure from (£)-non-2-enal and 
(R)-3-(3-methylbutanoyl)-4-benzyl-5,5-dimethyloxazolidin-2-one ent-181. The
relative and absolute stereochemistry was assumed as drawn from literature precedent 
and from the small a-proton coupling constant (6.5 Hz). The diastereomeiic excess 
was determined as >95% by examination of the crude 300 MHz ^-N M R  spectrum. 
Purification via column chromatography (SiC>2, CH2CI2) gave 182a as a yellow oil in 
81% yield; Rf (CH2C12) = 0.48; [a ] D25 = +22 (c = 0.85, CH2C12); 5H (300 MHz, 
CDCI3) 7.27-7.11 (5H, m, Ph), 5.54-5.71 (2H, m, alkyl-CH=CH and alkyl-CH=CH), 
4.53 (1H, dd, J = 10.0 Hz and 4.0 Hz, CHN), 4.36 (1H, app. t, J = 7.0 Hz, CHOH),
4.09 (1H, dd, J = 9.0 Hz and 6.5 Hz, isopropyl-CH), 3.09 (1H, dd, J = 14.5 Hz and 4.0 
Hz, CHAHBPh), 2.81 (1H, dd, J = 14.5 Hz and 10.0 Hz, CHAtfBPh), 2.04-1.88 (4H, 
obs. m, OH, CH=CHCH2 and isopropyl-CH), 1.35-1.12 (8 H, m, alkyl-C4H8), 1.24 
(6 H, app. s, (CH3)C(CH3)), 0.90 (3H, d, J = 7.0 Hz, isopropyl-CH3), 0.82 (3H, obs. d, 
J = 7.0 Hz, isopropyl-CH3), 0.80 (3H, obs. t, J = 7.0 Hz, alkyl-CH3); 5C (75MHz, 
CDC13) 174.7, 153.9, 137.4, 135.8, 129.5, 129.1, 128.9, 127.2, 82.4, 73.8, 64.3, 54.1,
35.9, 32.7, 32.1, 29.5, 29.3, 28.7, 28.6, 23.0, 22.6, 21.0, 20.4, 14.5; IR (film / cm'1) 
3501 (broad O-H), 1778 (C=0ox), 1693 (C=0); LRMS : m/z (Cl) 447.3 (80%) 
[M+NEUf, 430.3 (100%) [M+H]+; HRMS: m/z (ES) [M+NH4]+ requires 447.3217, 
found 447.3213.
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The title compound was prepared as the general procedure from isobutyraldehyde and 
(S)-4-benzyl-5,5-dimethyl-3-propionyloxazolidin-2-one 130. The relative and 
absolute stereochemistry was assumed as drawn from literature precedent and from 
the small a-proton coupling constant (3.0 Hz). The diastereomeric excess was 
determined as >95% by examination of the crude 300 MHz ^-N M R  spectrum. 
Purification via column chromatography (SiC>2, CH2CI2) gave 131 as a clear oil in 
82% yield; Rf (CH2C12) = 0.23; [a ] D25 = -32 (c = 0.56, CH2C12); 5H (300 MHz, 
CDCI3) 7.34-7.20 (5H, m, Ph), 4.53 (1H, dd, J = 8.5 Hz and 4.5 Hz, CHN), 3.92 (1H, 
qd, J = 7.0 Hz and 3.0 Hz, COCH), 3.50 (1H, app. dt, J = 8.5 Hz, and 3.0 Hz, 
CHOH), 3.06 (1H, dd, J = 14.5 Hz and 4.5 Hz, CtfAHBPh), 2.91 (1H, dd, J = 14.5 Hz 
and 8.5 Hz, CHAtfBPh), 2.79 (1H, d, J = 3.0 Hz, OH), 1.70 (1H, m, isopropyl-CH),
1.40 (3H, s, (Ctf3)C(CH3)), 1.38 (3H, s, (CH3)C(CH3)), 1.16 (3H, d, J = 7.0 Hz, 
COCHCH3), 1.01 (3H, d, J = 7.0 Hz, isopropyl-CH3), 0.90 (3H, d, J = 7.0 Hz, 
isopropyl-CH3); 8 C (75MHz, CDC13) 178.4, 156.2, 137.0, 129.5, 129.1, 127.3, 82.7, 
77.0, 63.7, 40.2, 35.9, 31.1, 28.2, 22.6, 19.5, 19.3, 10.7; IR (Film / cm'1) 3522 (broad 
OH), 1778 (C=0ox), 1694 (C=0); LRMS : m/z (Cl) 351.3 (10%) [M+NKU]*, 334.2 
(80%) [M+H]+; HRMS: m/z (ES) [M+H]+ requires 334.2013, found 334.2014.
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The title compound was prepared as the general procedure from decanal and (5)-4- 
benzyl-5,5-dimethyl-3-propionyloxazolidin-2-one 130. The relative and absolute 
stereochemistry was assumed as drawn from literature precedent and from the small 
a-proton coupling constant (3.0 Hz). The diastereomeric excess was determined as 
>95% by examination of the crude 300 MHz !H-NMR spectrum. Purification via 
column chromatography (SiC>2, CH2CI2) gave 134 as a yellow oil in 55% yield; Rf 
(CH2CI2) = 0.41; [a ] D25 = -13 (c = 2.65, CH2C12); 8 H (300 MHz, CDC13) 7.32-7.17 
(5H, m, Ph), 4.52 (1H, dd, J = 9.0 Hz and 4.5 Hz, CHN), 3.87 (1H, m, C//OH), 3.73 
(1H, qd, J = 7.0 Hz and 3.0 Hz, CH3Ctf), 3.04 (1H, dd, J = 14.5 Hz and 4.5 Hz, 
CtfACHBPh), 2.88 (1H, dd, J = 14.5 Hz and 9.0 Hz, CHAtfBPh), 2.75 (1H, broad s, 
OH), 1.64-1.18 (16H, m, alkyl-C8Hi6), 1.38 (3H, s, (Ctf3)C(CH3)), 1.36 (3H, s, 
(CH3)C(CH3)), 1.14 (3H, d, J = 7.0 Hz, CH3CH), 0.85 (3H, t, J = 7.0 Hz, alkyl-CH3); 
8 C (75MHz, CDC13) 178.1, 152.7, 137.0, 129.5, 129.1, 127.3, 82.7, 72.0, 63.7, 42.6,
35.9, 34.1, 32.3, 30.0, 29.9, 29.7, 28.9, 26.4, 23.1, 22.6, 14.5, 11.0; IR (film / cm 1) 
3521 (broad O-H), 1779 (C=0ox), 1683 (C=0); LRMS : m/z (Cl) 418.3 (30%) 
[M+H]+; HRMS: m/z (ES) [M+H]+ requires 418.2952, found 418.2949.
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Diethyl zinc (5 equivalents, 1.0 mol dm' solution in hexane) was added in one 
portion via syringe to a stirred solution of syn-aldol (1 equivalent) in dry 
dichloromethane at -10°C, before the immediate addition of diiodomethane (5 
equivalents) in one portion via syringe, under nitrogen and in the absence of light. 
The solution was allowed to warm to 0°C over 2 hours before being quenched with 
saturated sodium sulfite solution (5 cm3) and stirred for 10 minutes. Hydrochloric 
acid (1.0 mol dm'3 solution in water) was then added, sufficient to dissolve the white 
precipitate. The crude product was extracted with dichloromethane (3 x 10 cm3), 
washed with brine (10 cm3) and dried (MgSCU). The solvent was removed under 
reduced pressure to give the crude product, which was purified either by silica gel 
chromatography or recrystallisation. The all-syn stereochemistry was assigned as 
drawn due to literature precedent in the minimisation the A1,3-strain in the transition 
state.
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The title compound was prepared as the general procedure. The diastereomeric excess 
was determined as >95% by examination of the crude 300 MHz ^-N M R  spectrum. 
Purification via column chromatography (SiC>2, CH2CI2) gave 147b as a yellow oil in 
89% yield; Rf (CH2C12) = 0.28; [a ] D25 = +9 (c = 0.59, CH2C12); 5H (300 MHz, 
CDCI3) 7.30-7.12 (5H, m, Ph), 4.46 (1H, dd, J = 9.5 Hz and 4.5 Hz, CHN), 3.92 (1H, 
qd, J = 7.0 and 3.0 Hz, COCH), 3.15 (1H, dd, J = 8.5 Hz and 3.0 Hz, CHOH), 3.01 
(1H, dd, J = 14.5 and 4.5 Hz, CHAHBPh), 2.82 (1H, dd, J = 14.5 Hz and 9.5 Hz, 
CHACtfBPh), 2.50 (1H, broad s, OH), 1.31 (3H, s, (CH3)C(CH3)), 1.30 (3H, s, 
(CH3)C(CH3)), 1.26-1.14 (12H, obs. m, alkyl-C6Hi2), 1.18 (3H, d, J = 7.0 Hz, 
CH3CH), 0.81 (3H, t, J = 7.0 Hz, alkyl-CH3), 0.68 (1H, app. dtd, J = 12.5 Hz, 8.5 Hz 
and 4.0 Hz, (CH-cyclopropyl-CH)> 0.60 (1H, m, alkyl-cyclopropyl-CH), 0.46 (1H, 
app. dt, J = 8.5 Hz and 4.5 Hz, cyclopropyl-CHAHB), 0.28 (1H, app. dt, J = 8.0 Hz 
and 5.0 Hz, cyclopropyl-CHAHB); 5C (75MHz, CDC13) 177.3, 152.8, 137.1, 129.5,
129.1, 127.2, 82.6, 76.2, 63.9, 43.3, 35.8, 34.0, 32.3, 29.9, 29.8, 29.7, 28.9, 23.1,
22.6, 22.4, 17.0, 14.5, 11.6, 11.1; IR (film / cm'1) 3515 (broad O-H), 1777 (C=0ox), 
1697 (C=0); LRMS : m/z (Cl) 447.4 (70%) [M+NHJ*, 430.4 (100%) [M+H]+; 
HRMS : m/z (ES) [M+H]+ requires 430.4952, found 430.2955.
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The title compound was prepared as the general procedure. The diastereomeric excess 
was determined as >95% by examination of the crude 300 MHz ]H-NMR spectrum. 
Purification via column chromatography (SiC>2, CH2CI2) gave 147a as a yellow oil in 
95% yield; Rf (CH2C12) = 0.29; [a ] D25 = +58 (c = 2.30, CH2C12); 5H (300 MHz, 
CDC13) 7.28-6.93 (10H, m, Ph), 4.35 (1H, dd, J = 9.0 Hz and 5.0 Hz, CHN), 3.97 
(1H, qd, J = 7.0 and 4.5 Hz, COCH), 3.37 (1H, m, CHOH), 3.00 (1H, dd, J = 14.5 Hz 
and 5.0 Hz, C //AHBPh), 2.78 (1H, dd, J = 14.5 and 9.0 Hz, CHAC //BPh), 2.54 (1H, 
broad s, OH), 1.84 (1H, app. dt, J = 9.0 Hz and 5.0 Hz, Ph-cyclopropyl-CH), 1.25 
(3H, s, (CZ/3)C(CH3)), 1.23 (1H, obs. m, CH-cyclopropyl-Ctf), 1.18 (3H, d, J = 7.0 
Hz, C //3CH), 1.04 (3H, s, (CH3)C(C//3)), 1.00 (1H, app. dt, J = 8.5 Hz and 5.5 Hz, 
cyclopropyl-C//AHB), 0.89 (1H, app. dt, J = 8.5 Hz and 5.5 Hz, cyclopropyl-CHA//B); 
5C (75MHz, CDC13) 176.8, 152.8, 142.7, 137.2, 129.5, 129.1, 128.8, 127.3, 126.2,
126.1, 82.6, 75.9, 63.8, 43.8, 35.7, 28.5, 27.0, 22.6, 21.7, 14.4, 12.9; IR (film / cm'1) 
3447 (broad O-H), 1772 (C=0„x), 1685 (C=0); LRMS : m/z (Cl) 425.3 (10%) 
[M+NH,]+; HRMS ; m/z (ES) [M+NHi]+ requires 425.2435, found 425.2439.
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The title compound was prepared as the general procedure. The diastereomeric excess 
was determined as >95% by examination of the crude 300 MHz !H-NMR spectrum. 
Purification via column chromatography (SiC>2, CH2CI2) gave 147c as a yellow oil in 
90% yield; Rf (CH2C12) = 0 .2 2 ; [a ] D25 = +58° (c = 0 .8 6 , CH2C12); 5H (300 MHz, 
CDCI3) 7.34-7.28 (5H, m, Ph), 7.00 (2H, d, J = 8.5 Hz MeOCHCHC), 6.80 (2H, d, J 
= 8.5 Hz, MeOCHCHC), 4.39 (1H, dd, J = 9.0 Hz and 4.0 Hz, CHN), 3.91 (1H, qd, J 
= 7.0 and 4.5 Hz, COCH), 3.68 (3H, s, CH30), 3.36 (1H, m, CtfOH), 3.01 (1H, dd, J 
= 14.5 Hz and 4.0 Hz, CtfAHBPh), 2.81 (1H, dd, J = 14.5 and 9.0 Hz, CHACHBPh), 
2.47 (1H, broad s, OH), 1.78 (1H, app. dt, J = 9.0 Hz and 5.5 Hz, MeOPh- 
cyclopropyl-C//), 1.28 (3H, s, (CH3)C(CH3)), 1.19 (1H, obs. m, CH-cyclopropyl- 
CH), 1.19 (3H, d, J = 7.0 Hz, CH3CR), 1.12 (3H, s, (CH3)C(CH3)), 0.94 (1H, app. dt, 
J = 9.0 Hz and 5.0 Hz, cyclopropyl-CHAHB), 0.85 (1H, app. dt, J = 8.5 Hz and 5.0 Hz, 
cyclopropyl-CHAHB); 8 C (75MHz, CDC13) 177.0, 156.2, 152.8, 137.1, 134.5 129.5,
129.1, 127.3, 120.1, 114.4, 82.6, 75.9, 63.8, 55.7, 43.6, 35.7, 28.5, 26.3, 22.6, 20.6,
13.9, 12.5; IR (film / c m 1) 3452 (broad O-H), 1772 (C=0ox), 1700 (C=0 ), 1516 
(MeO); LRMS : m/z (Cl) 455.2 (40%) [M + N R f, 438.3 (40%) [M+H]+; HRMS: m/z 
(ES) [M+NH,]* requires 455.2540, found 455.2540.
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The title compound was prepared as the general procedure. The diastereomeric excess 
was determined as >95% by examination of the crude 300 MHz !H-NMR spectrum. 
Purification via column chromatography (SiC>2, CH2CI2) gave 147e as a yellow oil in 
92% yield; Rf (CH2C12) = 0.18; [a ] D25 = +56 (c = 1 .0 0 , CH2C12); 6 H (300 MHz, 
CDCI3) 7.29-7.12 (6 H, m, Ph and furyl-OCH), 6.17 (1H, dd, J = 3.0 Hz and 2.0 Hz, 
furyl-OCHCfl), 5.90 (1H, d, J = 3.0 Hz, furyl-CCH), 4.44 (1H, dd, J = 9.0 Hz and 4.5 
Hz, CHN), 3.95 (1H, qd, J = 7.0 and 4.0 Hz, COCH), 3.43 (1H, m, CtfOH), 3.01 (1H, 
dd, J = 14.5 Hz and 4.5 Hz, C //AHBPh), 2.83 (1H, dd, J = 14.5 and 9.0 Hz, 
CHaCHbPIi), 2.48 (1H, broad s, OH), 1.85 (1H, m, furan-cyclopropyl-CH), 1.36 (1H, 
obs. m, CH-cyclopropyl-CH), 1.31 (3H, s, (C//3)C(CH3)), 1.23 (3H, s, (CH3)C(CH3)),
I.21 (3H, d, J = 7.0 Hz, CH3CH), 1.00-0.90 (2H, obs. m, cyclopropyl-CtfAHB and 
cyclopropyl-CHAtfB); 8 C (75MHz, CDC13) 177.0, 156.1, 141.0, 137.1, 129.5, 129.1,
127.3, 110.7, 104.3, 82.7, 74.7, 63.8, 43.6, 35.8, 28.7, 23.9, 22.6, 22.6, 14.6, 12.4,
II.9; IR (film / cm'1) 3502 (broad O-H), 1774 (C=0ox), 1696 (C=0), 1516 (Furan- 
CO); LRMS : m/z (Cl) 415.2 (100%) [M+NHi]+, 398.2 (80%) [M+H]+; HRMS: m/z 
(ES) [M+NH4]+ requires 415.2227, found 415.2226.
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The title compound was prepared as the general procedure. The diastereomeric excess 
was determined as >95% by examination of the crude 300 MHz ^-N M R  spectrum. 
Purification via recrystallisation (Et2 0 ) gave 147d as a white solid in 91% yield; Rf 
(CH2C12) = 0.11; [cc] D25 = +57 (c = 0 .8 6 , CH2C12); mp = 101-104°C (Et20); 5H (300 
MHz, CDCI3) 7.81 (1H, d, J = 8.0 Hz, N 0 2C-o-CH), 7.49 (1H, app. td, J = 8.0 Hz and
1.5 Hz, N 0 2C-p-CH), 7.35-7.19 (6 H, obs. m, Ph and N 0 2CCHCCtf), 7.16 (1H, d, J =
8.0 Hz, NO2CCCH), 4.53 (1H, dd, J = 9.5 Hz and 4.5 Hz, CHN), 4.04 (1H, qd, J = 7.0 
Hz and 3.5 Hz, COCH), 3.75 (1H, m, CHOH), 3.07 (1H, dd, J = 14.5 Hz and 4.5 Hz, 
CHAHBPh), 2.90 (1H, dd, J = 14.5 and 9.5 Hz, CHACHBPh), 2.43 (1H, d, J = 2.5 Hz, 
OH), 2.25 (1H, app. dt, J = 8.5 Hz and 5.5 Hz, N 0 2Ph-cyclopropyl-Ctf), 1.38 (3H, s, 
(C//3)C(CH3», 1.33 (3H, s, (CH3)C(Ctf3)), 1.28 (3H, d, J = 7.0 Hz, CH3CH), 1.23 
(2H, obs. m, cyclopropyl-CHAHB and CH-cyclopropyl-CH), 0.75 (1H, app. dt, J = 8.5 
Hz and 5.5 Hz, cyclopropyl-CHA/ /B); 5C (75MHz, CDC13) 177.2, 152.8, 151.1,
137.2, 137.0, 133.2, 129.5, 129.1, 128.2, 127.3, 127.0, 124.7, 82.7, 73.7, 63.7, 43.2,
35.9, 28.8, 25.5, 22.6, 17.4, 12.7, 12.3; IR (KBr / cm'1) 3431 (broad O-H), 1769 
(C=0ox), 1684 (C=0), 1528 (N02), 1370 (N02); LRMS : m/z (Cl) 470.2 (100%) 
[M+NH4]+, 453.2 (30%) [M+H]+; HRMS: m/z (ES) [M+NH4]+ requires 470.2286, 
found 470.2287.
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The title compound was prepared as the general procedure. The diastereomeric excess 
was determined as >95% by examination of the crude 300 MHz !H-NMR spectrum. 
Purification via recrystallisation (Et2 0 , hexane) gave 147h as a white solid in 99% 
yield; Rf (CH2C12) = 0.30; [a ] D25 = + 8  (c = 0.66, CH2C12); mp = 105-108°C (Et20 , 
hexane); 8 H (300 MHz, CDC13) 7.28-7.14 (5H, m, Ph) 4.47 (1H, dd, J = 9.0 Hz and
4.5 Hz, CHN), 3.89 (1H, qd, J = 7.0 Hz and 3.5 Hz, COCH), 3.47 (lH,dd, J = 9.5 Hz 
and 3.5 Hz, CHOH), 3.03 (1H, dd, J = 14.0 Hz and 4.5 Hz, CtfAHBPh), 2.83 (1H, dd, 
J = 14.0 and 9.0 Hz, CHACHBPh), 2.69 (1H, broad s, OH), 1.32 (3H, s, 
(CH3)C(CH3)), 1.31 (3H, s, (CH3)C(CH3)), 1.18 (3H, d, J = 7.0 Hz, C //3CH), 1.01 
(3H, s, (C//3)(CH3)-cyclopropane), 0.98 (3H, s, (CH3)(C//3)-cyclopropane), 0.77 (1H, 
app. td, J = 8.5 Hz and 5.5 Hz, cyclopropyl-CH), 0.51 (1H, dd, J = 8.5 Hz and 4.0 Hz, 
cyclopropyl-CHAHB), 0.25 (1H, app. t, J = 5 Hz, cyclopropyl-CHAHB); 8 C (75MHz, 
CDC13) 177.6, 152.8, 137.1, 129.5, 129.1, 127.3, 82.6, 73.1, 63.9, 43.2, 35.8, 28.8,
27.8, 27.6, 23.1, 22.0, 19.5, 18.9, 11.7; IR (KBr / cm'1) 3515 (broad O-H), 1781 
(C=0ox), 1685 (C=0); LRMS : m/z (Cl) 455.2 (40%) [M+NH,]+, 438.3 (40%) 
[M+H]+; HRMS: m/z (ES) [M+NHJ* requires 377.2435, found 377.2434.
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The title compound was prepared as the general procedure. The diastereomeric excess 
was determined as >95% by examination of the crude 300 MHz ]H-NMR spectrum. 
Purification via recrystallisation (Et2 0 , hexane) gave 147g as a white solid in 95% 
yield; Rf (CH2C12) = 0.21; [a ] D25 = + 6  (c = 0.86, CH2C12); mp = 98-101°C (Et20 , 
hexane); 5H (300 MHz, CDC13) 7.39-7.19 (5H, m, Ph) 4.54 (1H, dd, J = 9.0 Hz and
4.0 Hz, CHN), 4.00 (1H, qd, J = 7.0 Hz and 3.5 Hz, COCH), 3.21 (1H, dd, J = 8.5 Hz 
and 3.5 Hz, CHOH), 3.09 (1H, dd, J = 14.5 Hz and 4.0 Hz, C //AHBPh), 2.91 (1H, dd, 
J = 14.5 and 9.0 Hz, CHACtfBPh), 2.47 (1H, broad s, OH), 1.39 (3H, s, 
(CH3)C(CH3)), 1.38 (3H, s, (CH3)C(CH3)), 1.26 (3H, d, J = 7.0 Hz, CH3CH), 1.04 
(3H, s, C //3-cyclopropane), 0.78-0.63 (2H, m, CH3-cyclopropyl-C// and CH- 
cyclopropyl-C//), 0.53 (1H, app. dt, J = 8.5 Hz and 4.5 Hz, cyclopropyl-C/7AHB), 
0.33 (1H, app. dt, J = 8.0 Hz and 5.0 Hz, cyclopropyl-CHAHB); SC (75MHz, CDC13)
176.7, 152.5, 136.7, 129.1, 128.7, 126.9, 82.2, 76.6, 76.1, 63.5, 42.9, 35.4, 28.5, 23.1, 
22.2,18.3,11.5,10.9; IR (KBr/ cm'1) 3488 (broad O-H), 1778 (C=0„x), 1687 (C=0); 
HRMS: m/z (ES) [M+NHif requires 363.2278, found 363.2281.
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The title compound was prepared as the general procedure from the from ent-130. 
The diastereomeric excess was determined as >95% by examination of the crude 300 
MHz ^-N M R  spectrum. Purification via column chromatography (SiC>2, CH2CI2) 
gave 180b as a yellow oil in 93% yield; Rf (CH2CI2) = 0.31; [ o i] d 25 = -5 (c = 0.89, 
CH2CI2); 6 H (300 MHz, CDCI3) 7.29-7.11 (5H, m, Ph), 4.46 (1H, dd, J = 9.0 Hz and
4.0 Hz, CHN), 3.92 (1H, qd, J = 7.0 Hz and 3.0 Hz, COCH), 3.15 (1H, dd, J = 8.5 Hz 
and 3.0 Hz, CHOH), 3.03 (1H, dd, J = 14.5 and 4.0 Hz, CtfAHBPh), 2.83 (1H, dd, J =
14.5 and 9.0 Hz, CHACtfBPh), 2.47 (1H, broad s, OH), 1.32 (3H, s, (Ctf3)C(CH3)), 
1.30 (3H, s, (CH3)C(CH3)), 1.30-1.06 (12H, m, alkyl-C6Hi2), 1.20 (3H, d, J = 7.0 Hz, 
CH3CH), 0.81 (3H, t, J = 7.0 Hz, alkyl-CH3), 0.68 (1H, m, CH-cyclopropyl-CH), 0.60 
(1H, m, alkyl-cyclopropyl-CH), 0.46 (1H, app. dt, J = 8.5 Hz and 4.5 Hz, 
cyclopropyl-CHAHB), 0.29 (1H, app. dt, J = 8.0 Hz and 3.0 Hz, cyclopropyl-CHAHB); 
5C (75MHz, CDC13) 177.4, 152.8, 137.1, 129.5, 129.1, 127.3, 82.6, 76.2, 63.9, 43.2,
35.8, 34.0, 32.3, 29.8, 29.6, 28.9, 23.1, 22.7, 22.3, 17.0, 14.5, 11.6, 11.1; IR (film / 
c m 1) 3531 (broad OH), 1779 (C=0ox), 1699 (C=0); HRMS: m/z (El) [M]+ requires 
415.2717, found 415.2720.
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The title compound was prepared as the general procedure from ent-181. The 
diastereomeric excess was determined as >95% by examination of the crude 300 
MHz *H-NMR spectrum. Purification via column chromatography (SiC>2, CH2CI2) 
gave 182b as a yellow oil in 94% yield; Rf (CH2CI2) = 0.41; [ o c ] d 25 = -21 (c = 0.62, 
MeOH); 5H (300 MHz, CDC13) 7.34-7.18 (5H, m, Ph), 4.56 (1H, dd, J = 10.0 Hz and
3.5 Hz, CHN), 4.22 (1H, dd, J = 8.5 and 6.0 Hz, COCH), 3.39 (1H, dd, J = 8.5 Hz and
6.0 Hz, CHOH), 3.23 (1H, dd, J = 14.5 and 3.5 Hz, CtfAHBPh), 2.86 (1H, dd, J = 14.5 
Hz and 10.0 Hz, CHAC //BPh), 2.31 (1H, m, isopropyl-CH), 1.85 (1H, broad s, OH), 
1.44-1.20 (10H m, alkyl-C5Hi0), 1.34 (3H, s, (Ctf3)C(CH3)), 1.33 (3H, s, 
(CH3)C(CH3)), 1.02 (3H, d, J = 7.0 Hz, isopropyl-CH3), 1.00 (1H, obs. m, CH- 
cyclopropyl-CH), 0.93 (3H, d, J = 7.0 Hz, isopropyl-CH3), 0.88 (3H, t, J = 7.0 Hz, 
alkyl-CH3), 0.76 (1H, m, alkyl-cyclopropyl-C//), 0.43 (1H, app. dt, J = 8.5 Hz and 4.5 
Hz, cyclopropyl-CHAHB), 0.28 (1H, app. dt, J = 8.5 Hz and 5.0 Hz, cyclopropyl- 
CHaHb); 5C (75MHz, CDC13) 175.1, 153.7, 137.5, 129.4, 129.1, 127.2, 82.2, 75.5,
64.4, 54.5, 35.8, 34.2, 32.3, 29.6, 29.5, 28.8, 28.6, 23.1, 22.8, 22.2, 21.4, 21.1, 18.8, 
14.5,9.6; IR (film / cm 1) 3516 (broad O-H), 1778 (C=0„x), 1693 (C=0); HRMS: m/z 
(ES) [M+NH4]+ requires 461.3374 found 461.3370.
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Chapter 3.8 General procedure for the anionic 
rctro-aldol reaction of a-methyl cyclopropyl syn- 
aldols
3.8.1 General procedure
nitrogen, LHMDS (1.1 equivalents, 1 mol dm' 3 solution in THF) was added in one 
portion at -10°C to 10°C depending on specific substrate and stirred for 2 hours. The 
reaction was quenched dropwise with a cooled solution of saturated aqueous 
ammonium chloride solution (5 cm3) and allowed to warm to room temperature over 
a period of thirty minutes. Saturated aqueous sodium hydrogen carbonate solution 
was added, sufficient to dissolve the resulting white precipitate. The mixture was 
extracted with dichloromethane (3 x 10 cm3), washed with brine (10 cm3) and dried 
(MgSCU). The solvent was removed under reduced pressure to give the crude product, 
which was purified by silica gel chromatography.
The title compound was prepared as the general procedure from 147b. The retro- 
aldol reaction was optimised at 10°C. The diastereomeric excess was determined as 
>95% by examination of the crude 300 MHz !H-NMR spectrum. Purification via 
column chromatography (SiC>2, Et2 0 :Pentane, 2:98) gave 148b as a yellow oil in 73% 
yield; Rf (Et20:Pentane, 2:98) = 0.71; [ct] D25 = +45 (c = 1.22, CHC13); 5H (300 MHz,
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CDCI3) 9.00 (1H, d, J = 5.5 Hz, CHO), 1.62 (1H, m, CHO-cyclopropyl-CH), 1.51-
1.18 (13H, m, alkyl-CeHn and alkyl-cyclopropyl-CH), 0.95-0.82 (5H, t and m, J =
7.0 Hz, alkyl-CH3 and cyclopropyl-CH2); SC (75MHz, CDCI3 ) 201.4, 35.0, 32.2,
30.9, 29.6, 29.5, 29.4, 23.1, 23.0, 15.3, 14.5; IR (film / cm'1) 1710 (C=0); HRMS : 




The title compound was prepared as the general procedure from 147a. The retro-aldol 
reaction was optimised at 10°C. The diastereomeric excess was determined as >95% 
by examination of the crude 300 MHz ^-N M R  spectrum. Purification via column 
chromatography (Si02, Et20:Pentane, 2:98) gave 148a as a yellow oil in 75% yield; 
Rf (Et20:Pentane, 2:98) = 0.38; [a ] D25 = +392 (c = 1.44, CHC13); 5H (300 MHz, 
CDC13) 9.33 (1H, d, J = 5.0 Hz, CHO), 7.34-7.09 (5H, m, Ph), 2.63 (1H, ddd, J = 11.0 
Hz, 7.0 Hz and 5.0 Hz, Ph-cyclopropyl-CH), 2.18 (1H, m, CHO-cyclopropyl-C//), 
1.74 (1H, app. dt, J = 10.0 Hz and 5.0 Hz, cyclopropyl-C//AHB), 1.54 (1H, ddd, J =
8.5 Hz, 7.0 Hz and 5.0 Hz); SC (75MHz, CDC13) 200.2, 139.4, 129.0, 127.3, 126.7,




The title compound was prepared as the general procedure from 147c. The retro-aldol 
reaction was optimised at 10°C. The diastereomeric excess was determined as >95% 
by examination of the crude 300 MHz ^-N M R  spectrum. Purification via column 
chromatography (Si02, Et20:Pentane, 10:98) gave 148c as a yellow oil in 63% yield;
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Rf (Et20:Pentane, 10:98) = 0.30; [a]D25 = +228 (c = 0.36, CH2C12); 8 H (300 MHz, 
CDCI3) 9.23 (1H, d, J = 4.5 Hz, CHO), 6.95 (2H, d, J = 8.5 Hz, MeOCHCHC), 6.76 
(2H, d, J = 8.5 Hz, MeOCHCHC), 3.72 (3H, s, CH3O), 2.53 (1H, ddd, J = 9.0 Hz, 7.0 
Hz and 4.0 Hz, MeOPh-cyclopropyl-CH), 2.02 (1H, m, CHO-cyclopropyl-CH), 1.63 
(1H, app. dt, J = 9.5 Hz and 5.0 Hz, cyclopropyl-CHAHB), 1.41 (1H, ddd, J =11.5 Hz,
7.0 Hz and 5.0 Hz); 8 C (75MHz, CDCI3) 200.2, 159.0, 131.3, 127.9, 114.4, 55.7, 
34.1,26.5,16.6; IR (film / c m 1) 1698 (C=0), 1517 (MeO); HRMS: m/z (ES) [M+H]+ 




The title compound was prepared as the general procedure from 147e. The retro-aldol 
reaction was optimised at 10°C. The diastereomeric excess was determined as >95% 
by examination of the crude 300 MHz !H-NMR spectrum. Purification via column 
chromatography (SiC>2, Et2 0 :Pentane, 10:90) gave 148e as a yellow oil in 71% yield; 
Rf (Et20:Pentane, 10:90) = 0.69; [cc] D25 = +320 (c = 0.50, CH2C12); 5H (300 MHz, 
CDCI3 ) 9.30 (1H, d, J = 4.0 Hz, CHO), 7.20 (1H, dd, J = 2.0 Hz and 1.0 Hz, furyl- 
OCH), 6.23 (1H, dd, J = 3.0 Hz and 3.0 Hz, furyl-OCHCH), 6.04 (1H, m, furyl- 
OCCH), 2.55 (1H, ddd, J = 9.0 Hz, 7.0 Hz and 4.0 Hz, furan-cyclopropyl-CH), 2.22 
(1H, app. ddt, J = 8.5 Hz, 5.5 Hz and 4.0 Hz, CHO-cyclopropyl-CH), 1.59 (1H, m, 
cyclopropyl-C//AHB), 1.52 (1H, ddd, J =8.5 Hz, 6.5 Hz and 5.0 Hz); 8 C (75MHz, 
CDCI3 ) 199.7, 152.8, 141.8, 111.0, 106.21, 31.7, 20.5, 15.0; IR (film / cm'1) 1694 
(C=0); HRMS : m/z (El) [M]+ requires 136.0519, found 136.0517.
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3.8.6 (lS,2S)-2-(2-nitrophenyl)cyclopropanecarbaldehyde 148d
The title compound was prepared as the general procedure from 147d. The retro- 
aldol reaction was optimised at 10°C. The diastereomeric excess was determined as 
>95% by examination of the crude 300 MHz !H-NMR spectrum. Purification via 
column chromatography (SiC>2, Et2 0 :Pentane, 10:90) gave 148d as a yellow oil in 
53% yield; Rf (Et20:Pentane, 10:90) = 0.25; [a ] D25 = +109 (c = 0.68, CH2C12); 8 H 
(300 MHz, CDC13) 9.38 (1H, d, J = 4.5 Hz, CHO), 7.97 (1H, dd, J = 8.0 Hz and 1.0 
Hz, NO2CCH), 7.57 (1H, app. dt, J = 8.0 Hz and 2.0 Hz, N 0 2C-p-CH), 7.42 (1H, app. 
dt, J = 8.5 Hz and 1.5 Hz, N 0 2CCCH), 7.28 (1H, app. d, J = 9.0 Hz, N 0 2CCHCH), 
3.11 (1H, ddd, J = 8.5 Hz, 7.0 Hz and, 4.0 Hz, N 0 2Ph-cyclopropyl-CH), 2.12 (1H, m, 
CHO-cyclopropyl-CH), 1.79 (1H, app. dt, J = 9.5 Hz and 5.5 Hz, cyclopropyl- 
CHaHb) 1.51 (1H, ddd, J = 8.5 Hz, 7.0 Hz and 5.5 Hz, cyclopropyl-CHAHfi); 5C 
(75MHz, CDCI3) 194.4, 150.8, 134.2, 133.6, 129.5, 128.5, 125.3, 32.0, 24.1, 15.2; IR 
(film / cm'1) 1708 (C=0), 1519 (N 02), 1344 (N02); HRMS : m/z (El) [M]+ requires 
191.0577 found, 191.0572.
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Chapter 3.9 General procedures for the 





LHMDS (1.1 equivalents, 1 mol dm' 3 solution in toluene-d8) was added in one 
portion to a stirred solution of 147g (1 equivalent) in dry toluene-d8 (5 cm3) at 10°C 
under nitrogen. The reaction was stirred for 2 hours and was then quenched dropwise 
with the minimum amount of a cooled solution of saturated aqueous ammonium 
chloride solution (5 drops) and the mixture was allowed to warm to room temperature 
over a period of thirty minutes. The reaction mixture was dried (3A molecular 
sieves), filtered, and the filtrate washed with toluene-d8 (1 cm3). The resulting 
mixture was distilled at atmospheric pressure (120°C) to give 148g as solution in 
toluene-d8. The diastereomeric excess was determined as >95% by examination of the 
crude 300 MHz !H-NMR spectrum. The concentration of the resulting solution was 
determined by the addition of a known of amount of 2,4-dimethylfuran as an internal 
standard to !H-NMR spectrum and comparing the intensities of the relevant integrals, 
to give 148g in 51% yield; [cc]d25 = +54 (c = 0.71, toluene-d8); 8 H (300 MHz, 
Toluene-d8) 8.67 (1H, d, J = 5.0 Hz, CHO), 1.11 (1H, app. sextet, J = 4.5 Hz, CHO- 
cyclopropyl-C//), 0.98-0.87 (2H, m, CH3-cyclopropyl-C// and cyclopropyl-C//AHB), 
0.80 (1H, m, cyclopropyl-CHAtfB), 0.67 (3H, d, J = 6.0 Hz, CH3); 5C (75MHz, 
Toluene-d8) 197.3, 29.9, 15.8, 14.8, 14.0.
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3.9.2 (S)-2,2-Dimethylcyclopropanecarbaldehyde 148h
H
LHMDS (1.1 equivalents, 1 mol dm' 3 solution in toluene-d8) was added in one 
portion at 10°C to a stirred solution of 147h (1 equivalent) in dry toluene-d8 (5 cm3), 
under nitrogen. The reaction was stirred for 2 hours and was then quenched dropwise 
with the minimum amount of a cooled solution of saturated aqueous ammonium 
chloride solution (5 drops) and allowed to warm to room temperature over a period of 
thirty minutes. The reaction mixture was dried (3A molecular sieves), filtered, and the
O O
filtrate washed with toluene-d (1 cm ). The resulting mixture was distilled at 
atmospheric pressure (130°C) to give 148h as solution in toluene-d8. The 
concentration of the resulting solution was determined by the addition of a known of 
amount of 2,4-dimethylfuran as an internal standard to !H-NMR spectrum, by 
comparing the intensities of the relevant integrals, to give 148h in 61% yield; the 
enantiomeric excess was determined as >95% ee by derivatisation of the aldehyde 
with chirally pure (li^/^-A ^^-dim ethyl-l^-diphenylethane- 1,2-diamine 151 and 
examination of the crude 300 MHz !H-NMR spectrum; [a]o25 = +63 (c = 1.22, 
toluene-d8); 8 H (300 MHz, Toluene-d8) 9.13 (1H, d, J = 5.0 Hz, CHO), 1.11 (1H, qd, 
J = 8.0 Hz and 5.0 Hz, CHO-cyclopropyl-CH), 0.96 (1H, obs. m, cyclopropyl- 
CHaHb), 0.94 (3H, s, (Ctf3)(CH3)-cyclopropane), 0.75 (3H, s, (CH3)(CH3)- 
cyclopropane), 0.50 (1H, dd J = 8.0 Hz and 4.5 Hz, cyclopropyl-CHA#B); SC 
(75MHz, Toluene-d8) 197.6, 34.9, 25.8, 23.9, 21.3, 15.8.
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Chapter 3.10 General procedures for the 





2-one 138 was dissolved in dry methanol (10 cm ), Lindlar’s catalyst (10 mol%) was 
added and stirred for 5 minutes. The heterogeneous mixture was purged with a 
balloon of hydrogen three times before being kept under hydrogen (1  atm.) and 
vigorously stirred, such as to generate a deep vortex in the solution. After one hour, or 
when thin layer chromatography had shown complete consumption of the starting 
material, the hydrogen balloon was removed and the reaction mixture was filtered 
through Celite with dichloromethane (3 x 10 cm3) as eluent. The solvent was removed 
under reduced pressure to give the crude product. The diastereomeric excess was 
determined as >95% by examination of the crude 300 MHz ^-N M R  spectrum. The 
ds-stereochemistry of the olefin functionality was determined from literature 
precedent and the alkene protons coupling constant (JCiS = 1 1  Hz). Purification via 
column chromatography (SiC>2, CH2CI2) gave the title compound 137f as a yellow oil 
in 95% yield; Rf (CH2C12) = 0.41; [cc] D25 = -27 (c = 0.70, CH2C12); 8 H (300 MHz, 
CDCI3) 7.27-7.12 (5H, m, Ph), 5.48 (1H, dtd, J = 11.0 Hz, 7.0 Hz and 1.0 Hz, 
CH=CHC5Hn), 5.36 (1H, ddt, 11.0 Hz, 8.5 Hz and 1.5 Hz, C//=CHC5Hn), 4.62 (1H, 
dd, J = 8.5 Hz and 5.0 Hz, CHOH), 4.45 (1H, dd, J = 9.0 and 4.5 Hz, CHN), 3.89
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(1H, qd, J = 7.0 and 5.0 Hz, COCH), 3.00 (1H, dd, J = 14.5 and 4.5 Hz, C//AHBPh), 
2.83 (1H, dd, J = 14.5 and 9.0 Hz, CHACtfBPh), 2.28 (1H, broad s, OH), 2.01 (2H, m, 
CH=CHCH2), 1.33-1.17 (6 H, obs. m, alkyl-CsHe), 1.32 (3H, s, (Ctf3)C(CH3)), 1.31 
(3H, s, (CH3)C(CH3)), 1.12 (3H, d, J = 7.0 Hz, CH3CH), 0.82 (3H, t, J = 7.0 Hz, 
alkyl-CH3); 5C (75MHz, CDC13) 176.6, 152.9, 137.1, 131.4, 129.6, 129.1, 128.9, 
127.2, 82.6, 69.0, 64.0, 43.5, 35.9, 32.0, 29.6, 29.5, 28.2, 22.9, 22.6, 14.4, 12.7; IR 
(film / cm'1) 3497 (broad OH), 1778 (C=0ox), 1698 (0=0); HRMS: m/z (ES) 





Diethyl zinc (5 equivalents, 1.0 mol dm' 3 solution in hexane) was added in one 
portion via syringe to a stirred solution of 137f (1 equivalent) in dry dichloromethane 
at -10°C, before the immediate addition of diiodomethane (5 equivalents) in one 
portion via syringe, under nitrogen and in the absence of light. The solution was 
allowed to warm to 0°C over 2 hours before being quenched with saturated sodium 
sulfite solution (5 cm3) and stirred for 10 minutes. Hydrochloric acid (1.0 mol dm ' 3 
solution in water) was added, sufficient to dissolve the white precipitate. The crude 
product was extracted with dichloromethane (3 x 10 cm3), washed with brine (10 
cm3) and dried (MgS0 4 ). The solvent was removed under reduced pressure to give 
the crude product. The all-syn stereochemistry was assigned as drawn due to literature 
precedent and the minimisation the A1,3-strain in the transition state. The 
diastereomeric excess was determined as >95% by examination of the crude 300 
MHz *H-NMR spectrum. Purification via column chromatography (Si0 2 , CH2CI2)
223
Temporary stereocentres for the asymmetric synthesis of chiral aldehydes
Experimental -  Chapter 3.10
gave 147f as a yellow oil in 96% yield; Rf (CH2CI2) = 0.44; [a]o25 = -29 (c = 0.69, 
CH2CI2); 8 H (300 MHz, CDCI3) 7.34-7.19 (5H, m, Ph), 4.53 (1H, dd, J = 9.0 Hz and
4.5 Hz, CHN), 3.95 (1H, qd, J = 7.0 and 3.0 Hz, COCH), 3.55 (1H, app. dt, J = 9.0 Hz 
and 3.0 Hz, CHOH), 3.09 (1H, dd, J = 14.5 and 4.5 Hz, CHAHBPh), 2.91 (1H, dd, J =
14.5 and 9.0 Hz, CHAC //BPh), 2.74 (1H, d, J = 2.5 Hz, OH), 1.63-1.21 (8 H, obs. m, 
alkyl-C4H8), 1.40 (3H, s, (Ctf3)C(CH3)), 1.37 (3H, s, (CH3)C(CH3)), 1.29 (3H, d, J =
7.0 Hz, C //3CH), 1.07-0.93 (2H, m, cyclopropyl-CH), 0.88 (3H, t, J = 7.0 Hz, alkyl- 
CH3), 0.86-0.76 (1H, m, cyclopropyl-CH2); 5C (75MHz, CDC13) 177.9, 152.7, 137.1,
129.5, 129.1, 127.3, 82.6, 72.4, 70.0, 43.8, 35.8, 32.1, 30.2, 29.3, 28.8, 28.1, 22.6,
19.4, 16.7, 15.0, 11.6, 10.2; IR (film / cm'1) 3522 (broad O-H), 1779 (C=0ox), 1703 
(C=0); HRMS: m/z (ES) [M+H]+ requires 402.2639, found 402.2637.
3.10.3 (15,2/?)-2-pentylcyclopropanecarbaldehyde 148f
H
LHMDS (1.1 equivalents, 1 mol dm' 3 solution in THF) was added in one portion to a 
stirred solution of 147f (1 equivalent) in dry toluene (10 ml) at 0°C, under nitrogen. 
The reaction mixture was stirred for 2 hours and was then quenched dropwise with a
-3
cooled solution of saturated aqueous ammonium chloride solution (5 cm ) and 
allowed to warm to room temperature over a period of 30 minutes. Saturated aqueous 
sodium hydrogen carbonate solution was added, sufficient to dissolve the white 
precipitate. The resulting mixture was extracted with dichloromethane (3 x 10 cm ), 
washed with brine (10 cm3) and dried (MgS04). The solvent was removed under 
reduced pressure to give the crude product. The diastereomeric excess was 
determined as >95% by examination of the crude 300 MHz ]H-NMR spectrum. 
Purification via column chromatography (SiC>2, Et2 0 , Pentane) gave 148f as a yellow 
oil in 61% yield; Rt (Et20:Pentane, 3:97) = 0.31; [a ] D25 = -10 (c = 1.01, CH2C12); 8 H 
(300 MHz, CDCI3) 9.35 (1H, d, J = 5.5 Hz, CHO), 1.62 (1H, m, CHO-cyclopropyl- 
CH), 1.51-1.18 (13H, m, alkyl-C6Hi2 and alkyl-cyclopropyl-C//)> 0.95-0.82 (5H, t 
and m, J = 7.0 Hz, alkyl-CH3 and cyclopropyl-CTfe); 5C (75MHz, CDC13) 200.8,
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30.4, 29.5, 28.6,27.2, 23.8,21.6, 13.7,13.0; IR (film / cm'1) 1704 (C=0). HRMS: No 
molecular ion found
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Chapter 3.11 Representative procedures for 
alternative retro-aldol reactions




In a Kugelrohr, syn-aldol 147a was heated to 220°C under reduced pressure (400 mb) 
for 1 hour. The aldehyde was distilled directly from the reaction mixture and 
collected in the second bulb of the Kugelrohr (0°C), to afforded spectroscopically 
pure 148a in 93% yield, which matched the previously described data for this 
compound. The first bulb contained spectroscopically pure (S)-4-benzyl-5,5- 
dimethyl-3-propionyloxazolidin-2-one 130 in 91% yield, which matched the 
previously described data for this compound.




Silica or activated carbon (20 mol%) was added to a solution of syn-aldol 147a (1 
equivalent) in toluene ( 1 0  cm3) and the mixture was refluxed for 8  hours or when thin 
layer chromatography indicated that all the starting material had been consumed. The 
mixture was allowed to cool to room temperature and filtered through Celite with 
ethyl acetate as eluent (3 x 10 cm3). The solvent was removed under reduced 
pressure, which gave the crude product. The diastereomeric excess was determined as
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>95% by examination of the crude 300 MHz ]H-NMR spectrum. Purification via 
column chromatography (Si02, Et20:Pentane, 3:97) gave 148a as a yellow oil in 81% 
yield, which matched the previously described data for this compound.




Samarium(II) iodide (1.1 equivalents, 0.1 mol dm'3 solution in THF) was added 
dropwise over a 30 minute period to a solution of 147a in dry degassed THF (10 cm3) 
under nitrogen at room temperature, and the solution was stirred for 2 hours. The 
reaction was quenched with hydrochloric acid (5 cm3, 1 mol dm'3 solution in water), 
extracted with ether (3 x 20 cm3), washed with aqueous saturated sodium thiosulphate 
solution (5 cm ) and dried (MgSO^. The solvent was removed under reduced 
pressure to give the crude product. Purification via column chromatography (SiC>2, 
Et20:Pentane, 3:97) gave 148a as a yellow oil in 73% yield, which matched the 
previously described data for this compound.
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Chapter 3.12 General procedures for the 
asymmetric synthesis of Cascarillic acid
3.12.1 (lR,2/£)-2-hexylcyclopropanecarbaldehyde 180c
KHMDS (1.1 equivalents, 0.5 mol dm' 3 solution in toluene) was added dropwise to a 
solution of sy«-aldol 182b in dry THF under nitrogen at -40°C, and stirred for 2 
hours. The reaction was quenched with saturated aqueous ammonium chloride 
solution ( 2  cm3) and saturated aqueous sodium hydrogen carbonate solution, 
sufficient to dissolve the white precipitate. The solution was extracted with ether (3 x 
10 cm3), washed with brine (10 cm3) and dried (MgSO^. The solvent was removed 
under reduced pressure to give the crude product. The diastereomeric excess was 
determined as >95% by examination of the crude 300 MHz !H-NMR spectrum. 
Purification via column chromatography (SiC>2, Et2 0 :Pentane, 2:98) gave 180c as a 
clear oil in 87% yield; Rf (Et2 0 :Pentane, 3:97) = 0.31; [ oc] d 25 = -26 (c = 0.35, 
CH2C12); 5H (300 MHz, CDC13) 8.98 (1H, d, J = 5.5 Hz, CHO), 1.61 (1H, m, CHO- 
cyclopropyl-CH), 1.51-1.20 (11H, m, alkyl-cyclopropyl-C// and C5H 10), 0.96-0.83 
(5H, m, cyclopropyl-CH2 and CH3); 5C (75MHz, CDC13) 201.2, 32.6, 31.7, 30.6,
29.0, 28.9, 22.7, 22.6, 14.9, 14.1; IR (Film / cm'1) 1713 (C=0); HRMS : m/z (ES) 
[M+NH4]+requires 172.1696, found 172.1696.
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3.12.22-(((ll?,2l?)-2-hexylcyclopropyl)methylene)-l,3-dithiane 183
rc-BuLi (1.02 equivalents, 2.5 mol dm' 3 solution in hexane) was added in one portion 
to a solution of (l,3-dithian-2-yl)trimethylsilane (1.3 equivalents) in dry THF (5 cm3) 
at 0°C under nitrogen and stirred for 1 hour. The reaction was then cooled to -30°C 
and (lR,2 R)-2 -hexylcyclopropanecarbaldehyde 180c ( 1  equivalent) was added in one 
portion as a solution in dry THF (2 cm3). The reaction was allowed to warm to room 
temperature over 2  hours, then quenched with aqueous saturated ammonium chloride 
solution (2 cm3), extracted with ether (3 x 10 cm3), washed with aqueous saturated 
sodium hydrogen carbonate solution (10 cm3), and dried (MgS0 4 ). The solvent was 
removed under reduced pressure to give the crude product. The diastereomeric excess 
was determined as >95% by examination of the crude 300 MHz !H-NMR spectrum. 
Purification via column chromatography (SiC>2, Hexane:CH2Cl2, 95:5) gave 183 as a 
clear oil in 85% yield; Rf (Et2 0 :Pentane, 3:97) = 0.31; [a]o25 = -20 (c = 0.30, 
CH2C12); 5H (300 MHz, CDCI3) 5.42 (1H, d, J = 10.0 Hz, CH=C), 2.91 (4H, m, 2 x 
SCH2), 2.22-2.13 (2H, m, SCH2CH2), 1.58 (1H, m, cyclopropyl-C//CH=C), 1.41-1.20 
(10H, m, alkyl-C5Hio), 0.88 (3H, t, J = 7.0 Hz, alkyl-CH3), 0.79 (1H, m, cyclopropyl- 
CH), 0.65-0.56 (2H, m, cyclopropyl-CH2); 5C (75MHz, CDCI3) 140.4, 121.6, 34.1,
32.3, 31.3, 30.5, 29.7, 29.5, 26.0, 23.1, 22.2, 20.3, 15.2, 14.5; IR (Film / cm'1) 1678 
(C=C), (C-S); HRMS: m/z (ES) [M+H]+ requires 257.1392, found 257.1393.
3.12.32-((lS,2i?)-2-hexylcyclopropyl)acetic acid (Cascarillic acid) 111
para-Toluene sulphonic acid ( 1 0  mol%) was added in one portion to a solution of 2 - 
(((lJR,2R)-2-hexylcyclopropyl)methylene)-l,3-dithiane 183 (1 equivalent) in
THF/water (8:1). The reaction was refluxed (75°C) for six hours, before cooling to 
room temperature. The volatile material was then removed under reduced pressure,
229
Temporary stereocentres for the asymmetric synthesis of chiral aldehydes
Experimental -  Chapter 3.12
before the mixture was re-dissolved in acetone/water (8 :1 ) and solid potassium 
hydroxide (5 equivalents) was added. The reaction was refluxed (85°C) for two hours, 
before cooling to room temperature. The reaction was then cautiously acidified with 
concentrated hydrochloric acid, extracted with ethyl acetate (3 x 10 cm3) and dried 
(MgSCU). The solvent was removed under reduced pressure to give the crude product. 
The diastereomeric excess was determined as >95% by examination of the crude 300 
MHz !H-NMR spectrum. Purification via column chromatography (SiC>2 , 
Hexane:Et2 0 , 80:20), gave 177 as a clear oil in 73% yield, which matched the 
previously published data for this compound; 126 Rf (CH2CI2) = 0.15; [cx]d25 = -11 (c = 
0.41, CHCI3); 5H (300 MHz, CDC13) 2.26 (2H, app. d, J = 7.0 Hz, Ctf2C 0 2H), 1.41-
1.18 (10H, m, alkyl-C5Hio), 0.88 (3H, t, J = 7.0 Hz, alkyl-CH3), 0.77 (1H, m, 
cyclopropyl-CH-CH2C0 2 H), 0.56 (1H, m, cyclopropyl-CH-CeHn), 0.33 (2H, m, 
cyclopropyl-CH2) 5C (75MHz, CDC13) 176.6, 37.5, 32.8, 30.9, 28.3, 28.1, 21.6, 17.7,
13.1, 13.0, 10.6; IR (Film / cm*1) 1711 (C=0); HRMS : m/z (El) [M]+ requires 
184.1458, found 184.1458.
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Chapter 3.13 General procedures for the 




Dibutyl boron triflate (1.1 equivalents, of a 1.0 mol dm ' 3 solution in hexane) was 
added dropwise to a stirred solution of (/?)-4-benzyl-3-(2-chloroacetyl)-5,5- 
dimethyloxazolidin-2-one 166 (1 equivalent) in dry dichloromethane at 0°C under 
nitrogen. After 30 minutes, diisopropylethylamine (1.2 equivalents) was added a 
dropwise and the resulting solution stirred for a further 30 minutes. The solution was 
cooled to -78°C and (£)-cinnamaldehyde (1.1 equivalents) was added dropwise. The 
reaction was allowed to warm to room temperature overnight. The reaction was 
quenched with Na2P0 4 /NaH2PC>4 buffer solution (pH7, 10 cm3), and stirred for 10 
minutes before the addition of 2:1 methanol-hydrogen peroxide solution (30%, 10 
c m ) and stirred for a further 2 hours. The mixture was extracted with 
dichloromethane (3 x 20 cm ), washed with saturated aqueous sodium hydrogen 
carbonate solution (10 cm3), brine (10 cm3) and dried (MgSCU). The solvent was 
removed under reduced pressure to give the crude product. The relative and absolute 
stereochemistry was assumed as drawn from literature precedent and from the small 
a-proton coupling constant (5.5 Hz). The diastereomeric excess was determined as 
92% by examination of the crude 300 MHz !H-NMR spectrum. Purification via 
recrystallisation (Et2 0 , hexane) gave 195a as a white solid in 83% yield and in >95%
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de; m.p. = 173-176°C (Et20 , hexane); Rf (CH2C12) = 0.21; [a ] D25 = +44 (c = 0.54, 
CH2C12); 8 H (300 MHz, CDC13) 7.41-7.20 (10H, m, Ph), 6.72 (1H, d, J = 16.0, 
CH=CHPh), 6.23 (1H, dd, 16.0 and 7.0 Hz, CH=CHPh), 5.84 (1H, d, J = 5.5 Hz, 
CHC1), 4.77 (1H, app. td, J = 7.0 Hz and 1.0 Hz, CHOH), 4.48 (1H, dd, J = 9.5 Hz 
and 4.0 Hz, CHN), 3.17 (1H, dd, J = 14.5 and 4.0 Hz, CtfAHBPh), 2.92 (1H, dd, J =
14.5 and 9.5 Hz, CHACHBPh), 2.82 (1H, broad s, OH), 1.37 (3H, s, (CH3)C(CH3)),
1.19 (3H, s, (CH3)C(Cfl'3)); 6 C (75MHz, CDC13) 168.4, 152.3, 136.7, 136.2, 134.6,
129.5, 129.2, 129.0, 128.7, 127.4, 127.2, 125.9, 83.5, 73.6, 64.4, 59.7, 35.3, 28.7, 
22.6; IR (KBr / cm 1) 3468 (broad O-H), 1774 (C=0„x), 1701 (C=0), 693 (C-Cl); 





Diethyl zinc (5 equivalents, 1.0 mol dm' 3 solution in hexane) was added in one 
portion via syringe to a stirred solution of (/?)-4-Benzyl-3-((£)-(2/?,3iS)-2-chloro-3- 
hydroxy-dodec-4-enoyl)-5,5-dimethyl-oxazolidin-2-one 195a (1 equivalent) in dry 
dichloromethane at -10°C, before the immediate addition of diiodomethane (5 
equivalents) in one portion via syringe, under nitrogen and in the absence of light. 
The solution was allowed to warm to 0°C over 2 hours, before being quenched with 
saturated sodium sulfite solution (5 cm3) and stirred for 10 minutes. Hydrochloric 
acid (1 .0  mol dm ' 3 solution in water) was added, sufficient to dissolve the white 
precipitate. The crude product was extracted with dichloromethane (3 x 20 cm ), 
washed with brine (10 cm3) and dried (MgS0 4 ). The solvent was removed under 
reduced pressure to give the crude product. The all-syn stereochemistry was assigned
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as drawn due to literature precedent and by the minimisation the A1,3-strain in the 
transition state. The diastereomeric excess was determined as >95% by examination 
of the crude 300 MHz ]H-NMR spectrum. Purification via column chromatography 
(SiC>2 , CH2CI2) gave 195b as a yellow oil in 94% yield; Rf (CH2CI2) = 0.17; [ o c ] d 2 2  =  
+30 (c = 0.52, CHCI3); 8 H (300 MHz, CDCI3) 7.36-7.04 (10H, m, Ph), 5.88 (1H, d, J 
= 5.0 Hz, C1CH), 4.39 (1H, dd, J = 10.0 Hz and 4.0 Hz, CHN), 3.68 (1H, dd, J = 8.5 
Hz and 5.5 Hz, CtfOH), 3.22 (1H, dd, J = 14.5 Hz and 4.0 Hz, CtfAHBPh), 2.87 (1H, 
dd, J = 14.5 and 10.0 Hz, CHACtfBPh), 2.64 (1H, broad s, OH), 2.02 (1H, app. dt, J =
9.5 Hz and 5.5 Hz, Ph-cyclopropyl-C//)> 1-48 (1H, m, CH-cyclopropyl-CH), 1.35 
(3H, s, (CH3)C(CH3)), 1.19 (1H, app. dt, J = 9.0 Hz and 5.5 Hz, cyclopropyl-CHAHB)
1.0 (3H, s, (CH3)C(C//3)), 1.04 (1H, m, cyclopropyl-CHA/ /B); 8 C (75MHz, CDC13)
168.4, 152.3, 141.9, 136.8, 129.2, 128.9, 128.8, 127.4, 126.4, 125.9, 83.4, 75.5, 64.4,
60.2, 34.9, 28.5, 25.5, 22.7, 21.9, 15.5; IR (film / cm'1) 3472 (broad OH), 1770 





Dibutyl boron triflate (1.1 equivalents, of a 1.0 mol dm' 3 solution in hexane) was 
added dropwise to a stirred solution of (R)-4-benzyl-3-(2-chloroacetyl)-5,5- 
dimethyloxazolidin-2-one ent~ 166 (1 equivalent) in dry dichloromethane at 0°C under 
nitrogen. After 30 minutes, diisopropylethylamine (1.2 equivalents) was added 
dropwise and the resulting solution stirred for a further 30 minutes. The solution was 
cooled to -78°C and (£)-dec-2-enal (1.1 equivalents) was added dropwise. The 
reaction was then allowed to warm to room temperature overnight. The reaction was
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quenched with Na2P0 4 /NaH2PC>4 buffer solution (pH7, 10 cm3), and stirred for 10 
minutes, before the addition of 2:1 methanol-hydrogen peroxide solution (30%, 10 
c m ) and stirred for a further 2 hours. The mixture was extracted with 
dichloromethane (3 x 20 cm ), washed with saturated aqueous sodium hydrogen 
carbonate solution (10 cm3), brine (10 cm3) and dried (MgSCU). The solvent was 
removed under reduced pressure to give the crude product. The relative and absolute 
stereochemistry was assumed as drawn from literature precedent and from the small 
a-proton coupling constant (3.5 Hz). The diastereomeric excess was determined as 
92% by examination of the crude 300 MHz ^-N M R  spectrum. Purification via 
column chromatography (SiC>2, CH2CI2) gave 195a as a yellow oil in 74% yield; Rf 
(CH2CI2) = 0.36; [oc] D25 = +11 (c = 1.00, CHC13); 5H (300 MHz, CDC13) 7.28-7.14 
(5H, m, Ph), 5.79 (1H, dtd, J = 15.5 Hz, 6.5 Hz and 1.0 Hz, C//=CHCH2), 5.65 (1H, 
d, J = 3.5 Hz, CHC1), 5.44 (1H, ddt, J = 15.5 Hz, 6.5 Hz and 1.5 Hz, CH=C//CH2), 
4.49 (1H, m, C//OH), 4.44 (1H, dd, J = 10.0 Hz and 4.0 Hz, CHN), 3.11 (1H, dd, J =
14.5 Hz and 4.0 Hz, C //AHBPh), 2.85 (1H, dd, J = 14.5 Hz and 10.0 Hz, CHAHBPh), 
2.59 (1H, d, J = 3.5 Hz, OH), 1.98 (2 H, m, CH=CHCH2), 1.34 (3H, s, (Ctf3)C(CH3)), 
1.29 (3H, s, (CH3)C(C//3)), 1.26-1.18 (10H, m, alkyl-C5H10), 0.81 (3H, t, J = 7.0 Hz, 
alkyl-CH3); 5C (75MHz, CDC13) 168.5, 152.3, 137.0, 136.7, 129.5, 129.2, 127.4,
126.7, 83.4, 73.2, 64.4, 59.8, 35.2, 32.7, 32.2, 29.5, 29.2, 28.9, 23.0, 22.6, 14.5; IR 
(Film / cm'1) 3496 (broad O-H), 1778 (C=0ox), 1708 (C=0), 1605 (C=C); HRMS : 
m/z (ES) [M+NH4]+ requires 453.2515, found 453.2515.
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Diethyl zinc (5 equivalents, 1.0 mol dm' 3 solution in hexane) was added in one 
portion via syringe to a stirred solution of (R)-4-Benzyl-3-(CE)-(2R,3,S)-2-chloro-3- 
hydroxy-dodec-4-enoyl)-5,5-dimethyl-oxazolidin-2-one 195a (1 equivalent) in dry 
dichloromethane at -10°C, before the immediate addition of diiodomethane (5 
equivalents) in one portion via syringe, under nitrogen and in the absence of light. 
The solution was allowed to warm to 0°C over 2 hours, before being quenched with 
saturated sodium sulfite solution (5 cm3) and stirred for 10 minutes. Hydrochloric 
acid (1 .0  mol dm' solution in water) was added, sufficient to dissolve the white 
precipitate. The crude product was extracted with dichloromethane (3 x 20 cm3), 
washed with brine (10 cm3), and dried (MgS0 4 ). The solvent was removed under 
reduced pressure to give the crude product. The all-syn stereochemistry was assigned 
as drawn due to literature precedent and by the minimisation the A1,3-strain in the 
transition state. The diastereomeric excess was determined as >95% by examination 
of the crude 300 MHz ^-N M R  spectrum. Purification via column chromatography 
(SiC>2, CH2CI2) gave 195b as a yellow oil in 98% yield; Rf (CH2CI2) = 0.25; [a]o25 = 
+11 (c = 1.00, CHCI3); 5H (300 MHz, CDC13) 7.32-7.17 (5H, m, Ph), 5.78 (1H, d, J =
3.0 Hz, CHC1), 4.48 (1H, dd, J = 10.0 Hz and 3.5 Hz, CHN), 3.40 (1H, dd, J = 8.0 Hz 
and 3.0 Hz, CtfOH), 3.20 (1H, dd, J = 14.5 Hz and 3.5 Hz, CtfAHBPh), 2.87 (1H, dd, 
J = 14.5 Hz and 10.0 Hz, CHAtfBPh), 2.61 (1H, broad s, OH), 1.36 (3H, s, 
(Cff3)C(CH3)), 1.32 (3H, s, (CH3)C(Ctf3)), 1.27-1.12 (1 2 H, m, alkyl-C6Hi2), 0.90 
(1H, m, cyclopropyl-Ctf-CHOH), 0.85 (3H, t, J = 7.0 Hz, alkyl-CH3), 0.79 (1H, m, 
cyclopropyl-CH-CvHis)), 0.61 (1H, m, cyclopropyl-C//AHB), 0.40 (1H, m, 
cyclopropyl-CHA/7B); 8 C (75MHz, CDC13) 168.3, 151.8, 136.4, 129.0, 128.7, 126.9,
235
Temporary stereocentres for the asymmetric synthesis of chiral aldehydes
Experimental -  Chapter 3.13
83.0, 75.1, 64.2, 60.6, 34.6, 33.4, 31.8, 29.4, 29.3, 29.2, 28.6, 22.6, 22.3, 21.7, 16.6,
14.0, 10.8; JR (Film / cm'1) 3500 (broad O-H), 1770 (C=0ox), 1716 (C=0); HRMS: 




propionyl]-5,5-dimethyl-oxazolidin-2-one 195b was dissolved in neat 
phenylethylamine (5 cm3) and stirred for 12 hours at room temperature. The crude 
reaction solution was then purified by column chromatography (SiC>2, 
EtOAc:Hexane; 20:80) to give 196 as a white solid in 89% yield. The diastereomeric 
excess was determined as >95% by examination of the 300 MHz JH-NMR spectrum. 
Rf (CH2C12) = 0.11; [a ] D25 = -23 (c = 1.00, CHCI3); mp (EtOAc/Hexane) = 64-65°C; 
5H (300 MHz, CDCI3) 7.34-7.18 (5H, m, Ph), 6.77 (1H, broad s, NH), 4.43 (1H, d, J 
= 2.5 Hz, CHC1), 3.55 (1H, m, CHOH), 3.49 (2H, m, NCH2), 2.83 (2H, m, CH2Ph), 
1.34-1.13 (12H, m, alkyl-C6Hi2), 0.88 (1H, m, cyclopropyl-CH-CHOH), 0.87 (3H, t, 
J = 7.0 Hz, alkyl-CHs), 0.70 (1H, m, cyclopropyl-C/Z-CvHis), 0.59 (1H, m, 
cyclopropyl-C//AHB), 0.39 (1H, m, cyclopropyl-CHAHB); 5C (75MHz, CDCI3) 168.3,
138.8, 129.2, 129.0, 127.0, 76.3, 64.9, 41.5, 35.8, 33.8, 32.2, 29.8, 29.7, 23.0, 22.3,
17.2, 14.6, 11.3; IR (KBr / c m 1) 3277 (broad O-H), 2921 (N-H), 1647 (C=0), 1557 
(C-Cl); HRMS: m/z (ES) [M+H]+ requires 366.2194, found 366.2198.
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3.13.6(J^)-3-((IR,2/?)-2-heptylcyclopropyl)-A^-phenethylacrylamide
197
Samarium(II) iodide (2.5 equivalents, 0.1 mol dm ' 3 solution in THF) was added in 
one portion to (2R,3iS)-2-chloro-3-((li?,2R)-2-heptylcyclopropyl)-3-hydroxy-iV- 
phenethylpropanamide 196 (1 equivalent) in dry degassed THF under nitrogen and 
stirred for 2 hours. The reaction was quenched with hydrochloric acid (5 cm3, 1 mol 
dm ' 3 solution in water) and saturated sodium thiosulphate solution (5 cm3), extracted 
with dichloromethane (3 x 10 cm3), washed with brine (10 cm3), dried (MgS0 4 ). The 
solvent was removed under reduced pressure to give the crude product. The 
diastereomeric excess was determined as >95% by examination of the crude 300 
MHz ^-N M R  spectrum. Purification via column chromatography (SiC>2, CH2CI2) 
gave 197 as a yellow oil in 85% yield; Rf (CH2CI2) = 0.29; [cc]d25 = -37 (c = 0.99, 
CHCI3); mp (EtOAc/Hexane) = 65-66°C; 5H (300 MHz, CDC13) 7.34-7.16 (5H, m, 
Ph), 6.35 (1H, dd, J = 15.0 Hz and 10.0 Hz, COCH=CH), 5.71 (1H, d, J = 15.0 Hz, 
COCtf=CH), 5.43 (1H, broad s, NH), 3.57 (2H, app. dd, J = 13.0 Hz and 7.0 Hz, 
CH2NH), 2.83 (2H, app. t, J = 7.0 Hz, PhCtf2), 1.40-1.17 (13H, m, alkyl-C6Hi2 and 
cyclopropyl-C//CH=CH), 0.94 (1H, m, cyclopropyl-C//-C7Hi3), 0.87 (3H, t, J = 7.2 
Hz, alkyl-CH3), 0.75 (1H, m, cyclopropyl-Gf/AHfi), 0.67 (1H, m, cyclopropyl- 
CHa//b); 8 C (75MHz, CDCI3) 166.5, 149.9, 139.4, 129.2, 129.0, 126.8, 120.0, 40.9,
36.1, 34.0, 32.2, 29.8, 29.7, 29.6, 23.2, 23.0, 22.2, 15.9, 14.5; IR (KBr / cm'1) 2923 
(broad N-H), 1663 (C=0), 1547 (C=C); HRMS: m/z (ES) [M+H]+ requires 314.2477, 
found 314.2478.
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Chapter 3.14 General procedures for the
Diphenyl phosphanylidene acetaldehyde (1.9 equivalents) was added in one portion 
to a solution of glyoxal in DMF and heated to 80°C for two hours. The reaction was 
then cooled to room temperature and the crude mixture was pushed through a plug of
washed with distilled water (3 x 20 cm3), dried (MgSCU) and the solvent removed 
under reduced pressure to give the crude product, The diastereomeric excess was 
determined as >95% by examination of the crude 300 MHz !H-NMR spectrum. 
Purification via column chromatography (SiC>2, CH2CI2) gave 216 as a yellow solid in 
62% yield, which matched the previously published data for the compound; 159 Rf 
(CH2CI2) = 0.17; mp = decomposed >50°C (CH2C12) 5H (300 MHz, CDC13) 9.72 (2H,





silica (2 cm3) with ether (10 cm3) as eluent. The volatile materials were removed 
under reduced pressure and the crude DMF solution dissolved in toluene (10 cm3),
d, J = 7.5 Hz, CHO), 7.28 (2 H, m, CHOCH=Ctf), 6.51 (2 H, m, CHOCH=CH), 5C 
(75MHz, CDCI3) 191.4, 145.3, 137.0; IR (KBr / c m 1) 1675 (C=0).
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Dibutyl boron triflate (1.1 equivalents, of a 1.0 mol dm' solution in hexane) was 
added dropwise to a stirred solution of (5)-4-benzyl-3-(2-chloroacetyl)-5,5- 
dimethyloxazolidin-2-one 166 (1 equivalent) in dry dichloromethane at 0°C, under 
nitrogen. After 30 minutes, diisopropylethylamine (1.2 equivalents) was added 
dropwise and the resulting solution stirred for a further 30 minutes. The solution was 
cooled to -78°C and acrolein (1.1 equivalents, 90% solution) was added dropwise. 
The reaction was allowed to warm to 0°C over two hours. The reaction was quenched 
with Na2P0 4 /NaH2PC>4 buffer solution (pH7, 10 cm3), and stirred for 10 minutes 
before the addition of 2:1 methanol-hydrogen peroxide solution (30%, 10 cm ) and 
stirred for 2 hours The mixture was extracted with dichloromethane (3 x 50 cm3), 
washed with saturated aqueous sodium hydrogen carbonate solution ( 1 0  cm3), brine 
(10 cm3) and dried (MgSC>4). The solvent was removed under reduced pressure to 
give the crude product. The relative and absolute stereochemistry was assumed as 
drawn from literature precedent and from the small a-proton coupling constant (5.0 
Hz). The diastereomeric excess was determined as >95% by examination of the crude 
300 MHz XH-NMR spectrum. Purification via column chromatography (CH2CI2) gave 
223 as a yellow oil in 63% yield; Rf (CH2C12) = 0.18; [cc] D25 = +19 (c = 0.48, 
CH2CI2); 5H (300 MHz, CDCI3) 7.33-7.19 (5H, m, Ph), 5.88 (1H, ddd, J = 17.0 Hz,
10.5 Hz and 5.5 Hz, 0 7 = 1 1 ^ ^ ) ,  5.73 (1H, d, J = 5.0 Hz, C1CH), 5.42 (1H, app. dt, 
J = 17.0 Hz and 1.5 Hz, CH^dsHtrans), 5.30 (1H, app. dt, J = 10.0 Hz and 1.0 Hz, 
CH=HciS//trans), 4.66 (1H, m, CHOH), 4.49 (1H, dd, J = 9.5 Hz and 4.0 Hz, CHN),
3.15 (1H, dd, J = 14.5 Hz and 4.0 Hz, PhC#AHB), 2.90 (1H, dd, J = 14.5 Hz and 9.5 
Hz, PhCHAtfB), 2.82 (1H, broad s, OH), 1.38 (3H, s, (Ctf3)C(CH3)), 1-35 (3H, s, 
(CH3)C(CH3)); 5C (75MHz, CDC13) 168.3, 152.4, 136.7, 135.3, 129.5, 129.2, 127.4,
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119.3, 83.6, 73.3, 64.4, 59.5, 35.3, 28.9, 22.6; IR (Film / cm'1) 3473 (broad OH), 









To a solution of (S)-4-Benzyl-3-((2S,3R)-2-chloro-3-hydroxy-pent-4-enoyl)-5,5- 
dimethyl-oxazolidin-2-one 223 (1 equivalent) in dry degassed dichloromethane (10 
cm3) under nitrogen was added 2nd generation Grubbs’ catalyst (2 mol%) and the 
solution refluxed for 5 hours. The reaction was allowed to cool to room temperature 
and the solution was pushed through a plug of silica ( 2  cm3), with ether as eluent ( 1 0  
cm3). The solvent was removed under reduced pressure to give the crude product. The 
relative and absolute stereochemistry was assumed as drawn from literature. The 
diastereomeric excess was determined as >95% by examination of the crude 300 
MHz !H-NMR spectrum. Purification via column chromatography (Et2 0 :Hexane, 
60:40) gave 224 as a yellow oil in 91% yield; Rf (CH2CI2) = 0 .1 0 ; [ cc] d 25  = - 1 0  (c = 
1.15, CH2CI2); 6 H (300 MHz, CDCI3) 7.28-7.13 (10H, m, 2 x Ph), 5.92 (2H, d, J =
2.5 Hz, 2 x CHC1), 5.64 (2H, d, J = 4.0 Hz, CH=CH), 4.64 (2H, m, 2 x CtfOH), 4.47 
(2H, dd, J = 10.0 Hz and 4.0 Hz, 2 x CHN), 3.12 (2H, dd, J = 14.5 Hz and 4.0 Hz, 2 x 
PhCtfAHB), 2.89 (2H, broad s, 2 x OH), 2.84 (2H, dd, J = 14.5 Hz and 10.0 Hz, 2 x 
PhCHAtfB), 1.33, (6 H, s, 2 x (CH3)C(CH3)), 1.32 (6 H, s, 2 x (CH3)C(CH3)); 5C 
(75MHz, CDC13) 168.2, 152.4, 136.8, 131.1, 129.5, 129.2, 127.4, 83.7, 71.8, 64.4,
59.3, 35.1, 28.9, 22.7; IR (Film / cm'1) 3481 (broad OH), 1773 (C=0ox), 1700 (C=0); 
HRMS: m/z (ES) [M+NH4]+ requires 664.2187, found 664.2194.
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Diethyl zinc (5 equivalents, 1.0 mol dm' 3 solution in hexane) was added in one 
portion via syringe to a stirred solution of 224 (1 equivalent) in dry dichloromethane 
at -40°C, before the immediate addition of diiodomethane (5 equivalents) in one 
portion via syringe, under nitrogen and in the absence of light. The solution was 
allowed to warm to 0°C over 6  hours. The reaction was maintained at this temperature 
for 12 hours before being quenched with saturated sodium sulfite solution (5 cm3) and 
stirred for 10 minutes. Hydrochloric acid (1.0 mol dm ' 3 solution in water), sufficient 
to dissolve the white precipitate, was added and the mixture was extracted with 
dichloromethane (3 x 10 cm3), washed with brine (10 cm3) and dried (MgSCU). The 
solvent was removed under reduced pressure to give the crude product. The all-syn 
stereochemistry was assigned as drawn due to literature precedent in the minimisation 
the A1,3-strain in the transition state. The diastereomeric excess was determined as 
81% by examination of the crude 300 MHz !H-NMR spectrum. Purification via 
column chromatography (Et2 0 :Hexane, 60:40) gave 225 as a yellow oil in 55% yield; 
Rf (CH2C12) = 0.10; [a ] D25 = +38 (c = 0.60, CH2C12); 5H (300 MHz, CDC13) 7.31- 
7.16 (10H, m, 2 x Ph), 5.82 (2H, d, J = 3.5 Hz, 2 x CHC1), 4.51 (2H, dd, J = 10.0 Hz 
and 3.5 Hz, 2 x CHN), 3.62 (2H, m, 2 x CHOH), 3.21 (2H, dd, J = 14.5 Hz and 3.5 
Hz, 2 x PhCHAHB), 2.86 (2H, dd, J = 14.5 Hz and 10.0 Hz, 2 x PhCHAHB), 2.84 (2H, 
broad s, 2 x OH), 1.36 (6 H, s, 2 x (Ctf3)C(CH3)), 1.33 (6 H, s, 2 x (CH3)C(CH3)), 1.32 
(2H, obs. m, cyclopropyl-CH), 0.85 (2H, app. t, J = 7.0 Hz, cyclopropyl-CTH); 5C 
(75MHz, CDC13) 168.5, 152.4, 136.9, 129.4, 129.2, 127.4, 83.7, 74.0, 64.6, 61.1, 
35.0, 29.0, 22.8 19.3, 9.6; IR (Film / cm'1) 3480 (broad O-H), 1772 (C=0ox), 1713 
(C=0); HRMS: m/z (ES) [M+Na]+ requires 683.1897, found 683.1901.
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O H  O
AlMe3 (4 equivalents, 1 mol dm' 3 solution in toluene) was added dropwise to a 
suspension of MeNHOMe (4 equivalents) in dry THF at 0°C under nitrogen and 
stirred for thirty minutes, until a homogeneous solution formed. (25,3R,4R,5R,6R,75)- 
l,8-fr/s-((5)-4-benzyl-5,5-dimethyl-2-oxo-oxazolidin-3-yl)-2,7-dichloro-3,6- 
dihydroxy-4,5-cyclopropyl-oct-l,8-dione 225 (1 equivalent) as a solution in dry THF 
was then added dropwise, the solution allowed to warm to room temperature and 
stirred for 12 hours. The reaction was cautiously quenched with saturated aqueous 
tartaric acid (2 cm3), extracted with dichloromethane (3 x 20 cm3), washed with brine 
(10 cm3) and dried. The solvent was removed under reduced pressure to give the 
crude product. The diastereomeric excess was determined as >95% by examination of 
the crude 300 MHz ^-N M R  spectrum. Purification via column chromatography 
(EtOAc:Hexane, 80:20) gave 232 as a yellow oil in 55% yield; Rf (EtOAc:Hexane, 
80:20) = 0.15; [cc] D25 = -2 (c = 1.08, CH2C12); 5H (300 MHz, CDC13) 5.13 (2H, broad 
s, OH), 4.73 (2H, d, J = 1.5 Hz, CHC1), 3.38 (2H, dd, J = 8.3 Hz and 1.5 Hz, C//OH),
3.15 (6 H, s, CH30), 2.99 (6 H, s, CH3N), 1.08 (2H, m, cyclopropyl-CH), 0.97 (2H, m, 
cyclopropyl-CH2); 8 C (75MHz, CDC13) 169.9, 75.5, 56.6, 38.0, 36.3, 18.4, 13.1; IR 
(Film / cm'1) 3401 (broad OH), 1640 (C=0); HRMS: no molecular ion found.
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Samarium(II) iodide (2.5 equivalents, 0.1 mol dm ' 3 solution in THF) was added 
dropwise to solution of (2S,3/?,4/?,5/?,6/?,7S)-l,8-2h',s-((S)-4-benzyl-5,5-dimethyl-2- 
oxo-oxazolidin-3-yl)-2,7-dichloro-3,6-dihydroxy-4,5-cyclopropyl-oct-l,8-dione 225 
(1 equivalent) in dry degassed THF (10 cm3) at room temperature under nitrogen and 
stirred for two hours. The reaction was then quenched with hydrochloric acid (5 cm , 
1 mol dm solution in water), washed with sodium thiosulphate (5 cm , saturated
-3
solution in water), extracted with ethyl acetate (3 x 10 cm ), washed with brine (10 
cm ) and dried (MgSO^. The solvent was removed under reduced pressure to give 
crude product. The diastereomeric excess was determined to be >95% by examination 
of the crude 300 MHz ’H-NMR spectrum. Purification by recrystallisation 
(EtOAc/Hexane) gave 226 as a white solid in 37% yield; Rf (EtOAc:Hexane, 20:80) 
= 0.56; [a ] D25 = +193 (c = 0.28, CH2C12); mp (EtOAc/Hexane) = 193-196°C; 8 H (300 
MHz, CDC13) 7.35 (2H, d, J = 15.0 Hz, 2 x COCH=CH), 7.31-7.17 (10H, m, 2 x Ph), 
6.59 (2H, dd, J = 15.0 Hz and 9.5 Hz, 2 x COCH=CH), 4.52 (2H, dd, J = 10.0 Hz and
4.0 Hz, 2 x CHN), 3.18 (2H, dd, J = 14.5 Hz and 4.0 Hz, 2 x CHAHBPh), 2.86 (2H, 
dd, J = 14.5 Hz and 10.0 Hz, 2 x CHA//BPh), 1.97 (2H, app. q, J = 8.0 Hz, 2 x 
cyclopropyl-CH), 1.39-1.27 (2H, obs. m, cyclopropyl-CH2), 1.35 (6 H, s, 2 x 
(Ctf3)C(CH3)), 1.33 (6 H, s, 2 x (CH3)C(CH3)); 8 C (75MHz, CDC13) 165.2, 153.0,
151.9, 137.5, 129.5, 129.1, 127.2, 119.8, 82.6, 64.2, 35.7, 29.0, 26.9, 22.7, 18.8; IR 
(KBr / c m 1) 1760 (C=0ox), 1684 (C=0); HRMS: m/z (ES) [M+H]+ requires 
557.2646, found 557.2649.
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3.14.7 (JE)-3-[(ll?,2/?)-2-((2£)-3-Hydroxy-propenyl)-cyclopropyl]-
propenol 241
226 was dissolved in CH2CI2 (2 cm3) at -78°C under nitrogen and DIBAL-H (4 
equivalents) was added in one portion. The reaction was stirred for 2 hours before 
being quenched with saturated aqueous ammonium chloride solution (5 cm ) at 
-78°C, before allowing the reaction to warm to room temperature over 2 hours. The 
crude mixture was washed with saturated aqueous hydrogen carbonate solution (5 
cm3), extracted with CH2CI2 ( 3 x 5  cm3) and dried MgS0 4 ; the solvent was removed 
under reduced pressure to give the crude product, which was not further isolated. The 
crude reaction mixture was then further reduced by the addition of sodium 
borohydride (2.5 equivalents) in THF (5 cm3) at room for 1 hour. The reaction was 
then quenched with saturated aqueous sodium hydrogen carbonate solution (5 cm3), 
extracted with ethyl acetate ( 3 x 5  cm3) and dried (MgSO^. The solvent was removed 
under reduced pressure to give the crude product. Purification by silica gel 
chromatography gave 241 in 39% overall yield which matched the previously 
published data for this compound169; Rf (EtOAciHexane, 80:20) = 0.32; [a]o25 = -105 
(c = 0.10, EtOH); 5H (300 MHz, CDC13) 5.71 (2H, dt, J = 15.0 Hz and 6.0 Hz, 2 x 
C//=CH-cyclopropane), 5.32 (2H, dd, J = 15.0 Hz and 8.5 Hz, 2 x CH=CH- 
cyclopropane), 4.09 (4H, app. d, J = 6.5 Hz, 2 x CH2OH), 1.65-1.40 (2H, m, 2 x 
cyclopropyl-CH), 0.87 (2H, app. t, J = 7.0 Hz, cyclopropyl-CH2).
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Chapter 3.15 General procedures for the 
electrophilic ring opening of cyclopropanes
3.15.1(1K, 2/?)-2-methyl-l-((lS,2S)-2-methylcyclopropyl)propane-l, 3- 
diol 249
UAIH4 (2.2 equivalents, 1 mol dm' 3 solution in THF) was added dropwise to a 
solution of 147g (1 equivalent) in dry THF (10 cm3) at 0°C under nitrogen. The 
reaction was stirred for 1 hour, and then quenched with sodium hydroxide solution (1  
cm3, 5 mol dm' 3 solution in water), filtered through Celite with ethyl acetate as eluent 
(10 cm3), and then extracted with ethyl acetate (3 x 10 cm3). The crude reaction 
mixture was washed with brine (10 cm3) and dried (MgS0 4 ). The solvent was 
removed under reduced pressure to give the crude product. The diastereomeric excess 
was determined as >95% by examination of the crude 300 MHz ^-N M R  spectrum. 
Purification via column chromatography (SiC>2, EtOAc:hexane, 50:50) gave 249 as a 
yellow oil in 92% yield; Rf (EtOAc:Hexane; 50:50) = 0.34; [a]o25 = +32 (c = 0.34, 
CH2CI2); 5H (300 MHz, CDCI3) 3.76 (1H, dd, J = 10.5 Hz and 7.0 Hz, C //AHBOH), 
3.64 (1H, dd, J = 10.5 Hz and 6.0 Hz, CHAtfBOH), 2.5 (2H, broad s, 2 x OH), 1.99 
(1H, m, C//CH2OH), 1.03 (3H, d, J = 6.0 Hz, CH3-cylopropane), 0.98 (3H, d, J = 7.0 
Hz, CH3), 0.71 (1H, m, cyclopropyl-CH-CHOH), 0.61 (1H, m, cyclopropyl-C//- 
CH3), 0.46 (1H, app. dt, J = 8.5 Hz and 4.5 Hz, cyclopropyl-CHAHB), 0.30 (1H, app. 
dt, J = 8.0 Hz and 5.0 Hz, cyclopropyl-CHAHB); 5C (75MHz, CDC13) 78.5, 75.6,
65.6, 38.8, 17.2, 10.6, 10.3, 10.0; IR (film / cm'1) 3368 (broad O-H); HRMS: m/z 
(ES) [M+NH4]+ requires 162.1489, found 162.1491.
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3.15.2(2/?, 3Sy4/?, 5/?)-tetrahydro-2,3,5-trimethyl-2H-pyran-4-ol 251
OH
Mercury trifluoroacetate (2.5 equivalents) was added in one portion to a solution of 
(lR,2R)-2-methyl-1 -((1 S,2S)-2-methylcyclopropyl)propane-1,3-diol 249 (1
equivalent) in dry dichloromethane under nitrogen at room temperature and stirred for 
24 hours. Saturated aqueous sodium chloride solution was then added (2 cm3) and the 
solution was stirred for 1 hour. The mixture was extracted with dichloromethane (3 x 
1 0  cm3), washed with saturated aqueous sodium hydrogen carbonate solution ( 1 0  
cm3). The solvent removed under reduced pressure to give the crude organomercury 
product, which was carried onto the next step without further purification.
AIBN (2 mol%) was added to a solution of the crude organomercury product in dry 
THF under nitrogen at room temperature. Bu3SnH (4 equivalents) was then added in 
one portion and stirred for 2 hours, which lead to the precipitation of mercury. The 
reaction was quenched with saturated aqueous sodium fluoride solution ( 2  cm3), 
diluted with EtOAc (10 cm3) and filtered through Celite. The solution was dried 
(MgSC>4) and the solvent removed under reduced to give the crude product. The 
diastereomeric excess was determined as >95% by examination of the crude 300 
MHz ^-N M R  spectrum. Purification via column chromatography (SiC>2, 
EtOAc:Hexane, 30:70) gave 251 as a yellow oil in 91% yield; Rf (CH2CI2) = 0.18; 
[oc] D25 = -3 (c = 0.67, CH2CI2); 5H (300 MHz, CDC13) 3.81 (1H, dd, J = 11.5 Hz and
5.0 Hz, OC//aHb), 3.13- 3.01 (2 H, app. t and obs. m, J = 11.5 Hz, OCHAHB and 
OCHCH3), 2.83 (1H, app. t, J = 10.0 Hz, CHOH), 1.78 (1H, broad s, OH), 1.64 (1H, 
m, CHCH2), 1.24 (1H, obs. m, CHCH3), 1.20 (3H, d, J = 6.5 Hz, CH3CHO), 0.96 
(3H, d, J = 6.5 Hz, CH3), 0.90 (3H, d, J = 6.5 Hz, CH3); 5C (75MHz, CDC13) 79.3,
78.6, 72.3, 45.9, 39.6, 20.0, 13.8, 13.7; IR (film / cm'1) 3400 (broad O-H); HRMS: no 
molecular ion found
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Chapter 3.16 General procedure for the hydroxyl- 





VO(acac)2  ( 1 0  mol%) was added in one portion to a solution of 147h in dry benzene 
(5 cm ) under nitrogen, at room temperature and stirred for 5 minutes. terf-Butyl 
hydrogen peroxide (1.1 equivalents, 5-6 mol dm' 3 solution in decane) was then via 
syringe in one portion and the reaction stirred for 2 hours. The solvent was then 
removed under reduced pressure and the residue was dissolved in dichloromethane 
(10 cm3), washed with distilled water (10 cm3) and dried (MgSC>4). The solvent was 
removed under reduced pressure to give the crude product in a non-optimised 72% 
de, as determined by examination of the crude 300 MHz ^-N M R  spectrum. The 
relative and absolute stereochemistry was assumed as drawn from literature precedent 
and minimisation A1,3-strain in the transition state. Purification by recrystallisation 
(Et2 0 , Hexane) gave 261 in 73% yield and in >95% de. Rf (CH2CI2) = 0.25; [ o c ]d 25 =  -  
10 (c = 0.48, CH2CI2); mp = decomposed >50°C; 8 H (300 MHz, Benzene-d6) 7.23- 
6.96 (5H, m, Ph), 4.41 (1H, dd, J = 7.0 Hz and 5.5 Hz, C//OH), 4.33 (1H, dd, J = 9.5 
Hz and 4.0 Hz, CHN), 3.80 (1H, m, CHCH3), 3.00 (1H, d, J = 7.0 Hz, epoxide-CH), 
2.88 (1H, dd, J = 14.5 Hz and 4.0 Hz, CHAHBPh), 2.37 (1H, obs. dd, J = 14.5 Hz and
9.5 Hz, CHAHBPh), 2.36 (1H, obs. d, J = 4.0 Hz, OH), 1.25 (1H, d, J = 7.0 Hz,
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CH3CH), 1.17 (3H, s, (CH3)C(CH3)), 1.03 (3H, s, (CH3)C(CZ/3)), 0.86 (3H, s, 
epoxide-CH3), 0.85 (3H, s, epoxide-CH3); 6 C (75MHz, Benzene-d6) 175.3, 152.9, 
137.9, 129.8, 129.2, 127.3, 82.1, 71.4, 65.5, 64.1, 59.6, 42.1, 35.7, 28.2, 25.2, 22.2,





VO(acac)2  ( 1 0  mol%) was added in one portion to a solution of 255 in dry benzene (5 
cm ) under nitrogen, at room temperature and stirred for 5 minutes, tert-Butyl 
hydrogen peroxide (1.1 equivalents, 5-6 mol dm' solution in decane) was then added 
via syringe in one portion and the reaction stirred for 2 hours. The solvent was 
removed under reduced pressure and the residue was dissolved in dichloromethane 
( 1 0  ml), washed with distilled water ( 1 0  cm3) and dried (MgSCU). The organic 
solvent was removed under reduced pressure to give (5)-4-Benzyloxazolidin-2-one 
126 in 78% yield, which matched the previously described data for this compound. 
The aqueous solvent was saturated with sodium chloride, extracted with ethyl acetate 
(3 x 20 cm3) and dried (MgS0 4 ). The solvent was removed under reduced pressure to 
give the crude product in a non-optimised 81% de. The relative and absolute 
stereochemistry was assumed as drawn from literature precedent and minimisation 
A1,3-strain in the transition state. Purification by recrystallisation (EtOAc, Hexane) 
gave 258 in 71% yield and in >95% de. Rf (CH2C12) = 0.12; [a ] D25 = -19 (c = 0.16, 
CH2C12); mp = 76-77°C; 5H (300 MHz, D20 ) 3.91 (1H, d, J = 9.5 Hz, CHOH), 3.71 
(1H, d, J = 13.0 Hz, CHaHbOH), 3.52 (1H, d, J = 13.0 Hz, CHAHBOH), 2.77 (1H, dq, 
J = 10.0 Hz and 7.0 Hz, CHCH3), 1.59-1.47 (2H, app. qd, J = 7.0 Hz and 2.5 Hz, 
CH2CH3), 1.03 (3H, d, J = 7.0 Hz, Ctf3CH), 0.72 (3H, t, J = 7.5 Hz, CH3CH2); 8 C
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(75MHz, D20 ) 181.0, 89.7, 77.9, 62.5, 43.3, 27.4, 12.8, 6.9; IR (KBr / cm’1) 3348 
(broad O-H), 1751 (C=0); HRMS: m/z (ES) [M+NH4]+ requires 192.1230, found 
192.1233.
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Final R indices [I>2sigma(I)])] 
R indices (all data)
Absolute structure parameter
Extinction coefficient 
Largest diff. peak and hole
R1 = 0.0382, wR2 = 0.0792 
R1 = 0.0568, wR2 = 0.0862 
0.6(7)
0.033(3)
0.242 and -0.263 e.A' 3
Table 2. Atomic coordinates ( x 10^) and equivalent isotropic displacement parameters (A^x 
103) for 152b. U(eq) is defined as one third of the trace of the orthogonalized UU tensor.
Atom X y z U(eq)
0(3) 2664(1) 3554(1) 787(1) 30(1)
0 (1) 7197(2) 3212(1) 1909(1) 37(1)
0(5) 10441(2) 1007(1) 2374(1) 39(1)
0 (2 ) 7620(2) 4631(1) 1568(1) 36(1)
0 (6 ) 11954(2) -118(1) 2004(1) 43(1)
0(4) 5197(1) 2138(1) 65(1) 31(1)
N(2) 10569(2) 237(1) 2165(1) 31(1)
C(15) 2771(2) 1741(1) 1094(1) 29(1)
C(20) 7548(2) 40(1) 1771(1) 26(1)
C(l) 6725(2) 3856(1) 1599(1) 32(1)
0(16) 5874(2) 2034(1) 707(1) 26(1)
N(l) 5224(2) 3947(1) 1 2 2 1 (1) 28(1)
C(19) 7640(2) 921(1) 1418(1) 26(1)
C(18) 8434(2) 905(1) 740(1) 30(1)
C(23) 7549(2) -1692(1) 2345(1) 34(1)
C(13) 3988(2) 3294(1) 1055(1) 26(1)
C(17) 6515(2) 1084(1) 827(1) 26(1)
C(24) 9019(2) -1160(1) 2386(1) 31(1)
0(7) 2817(2) 6191(1) 1127(1) 31(1)
0 (6 ) 3607(2) 5363(1) 1436(1) 32(1)
0(5) 4984(2) 4889(1) 1014(1) 29(1)
0 (2 1 ) 6088(2) -519(1) 1749(1) 33(1)
0(14) 4407(2) 2315(1) 1179(1) 25(1)
0(4) 7160(2) 6182(1) 1277(1) 39(1)
0 (1 2 ) 2188(2) 6172(1) 491(1) 38(1)
0(3) 7868(2) 5008(1) 433(1) 43(1)
C(22) 6088(2) -1365(1) 2033(1) 38(1)
0 (2 ) 6885(2) 5220(1) 1055(1) 32(1)
0(25) 8976(2) -312(1) 2109(1) 26(1)
0 (8 ) 2604(2) 6980(1) 1483(1) 41(1)
0 (1 0 ) 1190(3) 7699(1) 577(1) 57(1)
0 (1 1 ) 1372(2) 6918(1) 216(1) 50(1)
0(9) 1805(3) 7732(1) 1209(1) 53(1)
253
Temporary stereocentres for the asymmetric synthesis of chiral aldehydes
Appendices
Table 3. Bond lengths [A] and angles [°] for 147d.
0(3)-C(13) 1.2175(18) C(17)-H(17) 1.0000
0(1)-C(1) 1.2036(19) C(24)-C(25) 1.380(2)
0(5)-N(2) 1.2246(18) C(24)-H(24) 0.9500
0(2)-C(l) 1.3409(19) C(7)-C(8) 1.390(2)
0(2)-C(2) 1.4801(19) C(7)-C(12) 1.391(2)
0(6)-N(2) 1.2312(18) C(6)-C(5) 1.535(2)
0(4)-H(l) 0.9785 C(6 )-H(6 A) 0.9900
N(2)-C(25) 1.473(2) C(6 )-H(6 B) 0.9900
C(15)-C(14) 1.526(2) C(5)-C(2) 1.541(2)
C(15)-H(15A) 0.9800 C(5)-H(5) 1.0000
C(15)-H(15B) 0.9800 C(21)-C(22) 1.384(2)
C(15)-H(15C) 0.9800 C(21)-H(21) 0.9500
C(20)-C(21) 1.393(2) C(14)-H(14) 1.0000
C(20)-C(25) 1.398(2) C(4)-C(2) 1.513(2)
C(20)-C(19) 1.496(2) C(4)-H(4A) 0.9800
C(l)-N(l) 1.395(2) C(4)-H(4B) 0.9800
C(16)-C(17) 1.513(2) C(4)-H(4C) 0.9800
C(16)-C(14) 1.542(2) C(12)-C(ll) 1.391(2)
C(16)-H(16) 1.0000 C(12)-H(12) 0.9500
N(l)-C(13) 1.3977(19) C(3)-C(2) 1.515(2)
N(l)-C(5) 1.4718(19) C(3)-H(3A) 0.9800
C(19)-C(17) 1.509(2) C(3)-H(3B) 0.9800
C(19)-C(18) 1.519(2) C(3)-H(3C) 0.9800
C(19)-H(19) 1.0000 C(22)-H(22) 0.9500
C(18)-C(17) 1.506(2) C(8)-C(9) 1.392(3)
C(18)-H(18A) 0.9900 C(8 )-H(8 ) 0.9500
C(18)-H(18B) 0.9900 C(10)-C(9) 1.380(3)
C(23)-C(24) 1.378(2) C(10)-C(ll) 1.383(3)
C(23)-C(22) 1.379(2) C(10)-H(10) 0.9500
C(23)-H(23) 0.9500 C(ll)-H(ll) 0.9500
C(13)-C(14) 1.509(2) C(9)-H(9) 0.9500
C(l)-0(2)-C(2) 110.19(12) 0(1)-C(1)-N(1) 128.27(14)
C(16)-0(4)-H(l) 110.9 0(2)-C(l)-N(l) 108.24(12)
0(5)-N(2)-0(6) 124.24(14) 0(4)-C(16)-C(17) 111.67(12)
0(5)-N(2)-C(25) 118.52(13) 0(4)-C(16)-C(14) 106.59(12)
0(6)-N(2)-C(25) 117.23(13) C( 17)-C( 16)-C( 14) 112.76(12)
C( 14)-C( 15)-H( 15 A) 109.5 0(4)-C(16)-H(16) 108.6
C(14)-C(15)-H(15B) 109.5 C(17)-C(16)-H(16) 108.6
H(15A)-C(15)-H(15B) 109.5 C( 14)-C( 16)-H( 16) 108.6
C( 14)-C( 15 )-H( 15 C) 109.5 C(l)-N(l)-C(13) 128.90(12)
H(15A)-C(15)-H(15C) 109.5 C(l)-N(l)-C(5) 110.82(12)
H(15B)-C(15)-H(15C) 109.5 C(13)-N(l)-C(5) 120.23(12)
C(21 )-C(20)-C(25) 115.07(13) C(20)-C( 19)-C( 17) 120.12(13)
C(21 )-C(20)-C( 19) 122.82(13) C(20)-C( 19)-C( 18) 116.61(12)
C(25)-C(20)-C(19) 121.96(14) C(17)-C(19)-C(18) 59.66(10)
0(l)-C(l)-0(2) 123.48(14) C(20)-C( 19)-H( 19) 116.2
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C( 17)-C( 19)-H( 19) 116.2 C(15)-C(14)-C(16) 1 1 2 .2 2 (1 2 )
C(18)-C(19)-H(19) 116.2 C( 13)-C( 14)-H( 14) 108.8
C(17)-C(18)-C(19) 59.82(10) C(15)-C(14)-H(14) 108.8
C( 17)-C( 18)-H( 18 A) 117.8 C( 16)-C( 14)-H( 14) 108.8
C( 19)-C( 18)-H( 18 A) 117.8 C(2)-C(4)-H(4A) 109.5
C( 17)-C( 18)-H( 18B) 117.8 C(2)-C(4)-H(4B) 109.5
C( 19)-C( 18)-H( 18B) 117.8 H(4A)-C(4)-H(4B) 109.5
H(18A)-C(18)-H(18B) 114.9 C(2)-C(4)-H(4C) 109.5
C(24)-C(23)-C(22) 119.44(14) H(4A)-C(4)-H(4C) 109.5
C(24)-C(23)-H(23) 120.3 H(4B)-C(4)-H(4C) 109.5
C(22)-C(23)-H(23) 120.3 C(ll)-C(12)-C(7) 121.33(17)
0(3)-C(13)-N(l) 117.07(13) C(ll)-C(12)-H(12) 119.3
0(3)-C(13)-C(14) 124.00(13) C(7)-C(12)-H(12) 119.3
N(l)-C(13)-C(14) 118.82(12) C(2)-C(3)-H(3A) 109.5
C(18)-C(17)-C(19) 60.52(10) C(2)-C(3)-H(3B) 109.5
C(18)-C(17)-C(16) 117.55(13) H(3A)-C(3)-H(3B) 109.5
C(19)-C(17)-C(16) 117.75(13) C(2)-C(3)-H(3C) 109.5
C( 18)-C( 17)-H( 17) 116.5 H(3A)-C(3)-H(3C) 109.5
C( 19)-C( 17)-H( 17) 116.5 H(3B)-C(3)-H(3C) 109.5
C( 16)-C( 17)-H( 17) 116.5 C(23)-C(22)-C(21) 120.92(15)
C(23)-C(24)-C(25) 118.53(14) C(23 )-C(22)-H(22) 119.5
C(23)-C(24)-H(24) 120.7 C(21 )-C(22)-H(22) 119.5
C(25)-C(24)-H(24) 120.7 0(2)-C(2)-C(4) 106.86(13)
C(8)-C(7)-C(12) 118.04(15) 0(2)-C(2)-C(3) 106.67(13)
C(8)-C(7)-C(6) 120.71(15) C(4)-C(2)-C(3) 112.33(14)
C(12)-C(7)-C(6) 121.14(14) 0(2)-C(2)-C(5) 102.13(12)
C(7)-C(6)-C(5) 114.31(13) C(4)-C(2)-C(5) 116.67(14)
C(7)-C(6)-H(6A) 108.7 C(3)-C(2)-C(5) 111.08(13)
C(5)-C(6)-H(6A) 108.7 C(24)-C(25)-C(20) 124.25(14)
C(7)-C(6)-H(6B) 108.7 C(24)-C(25 )-N(2) 116.89(13)
C(5)-C(6)-H(6B) 108.7 C(20)-C(25)-N(2) 118.84(13)
H( 6  A)-C(6 )-H(6 B) 107.6 C(7)-C(8)-C(9) 120.87(19)
N(l)-C(5)-C(6) 111.02(13) C(7)-C(8)-H(8) 119.6
N(l)-C(5)-C(2) 99.73(12) C(9)-C(8)-H(8) 119.6
C(6)-C(5)-C(2) 118.32(13) C(9)-C(10)-C(ll) 119.85(18)
N(l)-C(5)-H(5) 109.1 C(9)-C(10)-H(10) 1 2 0 .1
C(6)-C(5)-H(5) 109.1 C(ll)-C(10)-H(10) 1 2 0 .1
C(2)-C(5)-H(5) 109.1 C(10)-C(ll)-C(12) 119.7(2)
C(22)-C(21 )-C(20) 121.73(14) C(10)-C(ll)-H(ll) 1 2 0 .1
C(22)-C(21 )-H(21) 119.1 C(12)-C(ll)-H(ll) 1 2 0 .1
C(20)-C(21 )-H(21) 119.1 C(10)-C(9)-C(8) 120.18(18)
C(13)-C(14)-C(15) 110.03(12) C(10)-C(9)-H(9) 119.9
C(13)-C(14)-C(16) 108.04(12) C(8)-C(9)-H(9) 119.9
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Table 4. Anisotropic displacement parameters (A^x 10^)for h04sdb01. The anisotropic 
displacement factor exponent takes the form: -2n^[ h^a*^U^ 1 + ... + 2  h k a* b*
Atom U ll U22 U33 U23 U13 U12
0(3) 29(1) 30(1) 32(1) -1(1) -6 (1) 2 (1)
0 (1) 40(1) 30(1) 42(1) 3(1) -16(1) 0 (1)
0(5) 44(1) 34(1) 39(1) -1(1) -1 0 (1) -6 (1)
0 (2 ) 36(1) 30(1) 44(1) 3(1) -13(1) -6 (1)
0 (6 ) 25(1) 48(1) 56(1) 16(1) 3(1) 4(1)
0(4) 30(1) 38(1) 25(1) 5(1) 3(1) 8 (1)
N(2) 27(1) 37(1) 28(1) 9(1) -4(1) -2 (1)
C(15) 27(1) 27(1) 34(1) 1(1) 4(1) -2 (1)
C(20) 25(1) 28(1) 25(1) -1(1) 2 (1) 3(1)
C(l) 32(1) 29(1) 35(1) -2 (1) -7(1) -2 (1)
C(16) 24(1) 26(1) 28(1) 4(1) -1 (1) -KD
N(l) 30(1) 2 2 (1) 31(1) 0 (1) -7(1) 0 (1)
C(19) 23(1) 27(1) 27(1) 0 (1) -KD -KD
C(18) 27(1) 32(1) 31(1) 5(1) 2 (1) 2 (1)
C(23) 37(1) 28(1) 36(1) 9(1) 1(1) -3(1)
C(13) 27(1) 29(1) 2 2 (1) -2 (1) 0 (1) -1(1)
C(17) 23(1) 27(1) 28(1) 2 (1) -3(1) -KD
C(24) 31(1) 33(1) 29(1) 5(1) -1(1) 3(1)
C(7) 27(1) 28(1) 40(1) 1(1) 5(1) -3(1)
C(6 ) 37(1) 31(1) 29(1) 0 (1) KD -3(1)
C(5) 32(1) 24(1) 29(1) KD -2 (1) -2 (1)
C(21) 25(1) 37(1) 36(1) 6 (1) -2 (1) -KD
C(14) 24(1) 26(1) 25(1) 2 (1) -2 (1) 1(1)
C(4) 40(1) 30(1) 48(1) 2 (1) -7(1) -8 (1)
C(12) 35(1) 35(1) 44(1) 2 (1) 2 (1) 1(1)
C(3) 37(1) 46(1) 47(1) -1(1) 5(1) -4(1)
C(22) 33(1) 37(1) 44(1) 8 (1) -3(1) -9(1)
0 (2 ) 32(1) 29(1) 36(1) 1(1) -6 (1) -2 (1)
C(25) 2 2 (1) 31(1) 25(1) 2 (1) KD -KD
C(8 ) 40(1) 32(1) 52(1) -6 (1) 9(1) -2 (1)
C(1 0 ) 42(1) 41(1) 87(2) 19(1) 1 0 (1) 8 (1)
C(ll) 40(1) 50(1) 59(1) 15(1) KD 8 (1)
C(9) 45(1) 27(1) 8 8 (2 ) -2 (1) 18(1) 3(1)
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Data / restraints / parameters 
Goodness-of-fit on F2 
Final R indices [I>2sigma(I)])] 
R indices (all data)
Absolute structure parameter 








a = 5.4370(2)A a  = 90° 
b = 14.1610(6)A p = 101.723(2)° 






0.18 x 0.18 x 0.03 mm 
5.46 to 27.47°
-9<=h<=9, -19<=k<=19, -25<=1<=26 
8674




Full-matrix least-squares on F2
2025/ 1 / 116
1.149
R‘ = 0.0554 wR2 = 0.0926 
R1 = 0.0679 w R 2 = 0.0959 
0.3(13)
0.191 and-0.154 eA'3
Table 2. Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (A2 x 
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0 (2 ) 9941(3) 7395(1) 8907(3) 37(1)
0(3) 3756(3) 8476(2) 12861(2) 41(1)
0(4) 3461(3) 8491(1) 7400(2) 39(1)
0 (1) 6453(4) 9224(2) 10561(4) 32(1)
0 (2 ) 8566(4) 7873(2) 9808(3) 31(1)
0(3) 6985(4) 7555(2) 11478(4) 33(1)
0(4) 6210(4) 8485(2) 12435(3) 31(1)
0(5) 8376(5) 6859(2) 13253(4) 45(1)
0 (6 ) 4074(4) 9335(2) 8710(4) 35(1)
0(7) 7494(5) 10172(2) 11493(4) 40(1)
0 (8 ) 5845(5) 10676(2) 12916(5) 47(1)
Table 3. Bond lengths [A] and angles [°] for 258.
0(1)-C(2) 1.335(3) 0(1)-C(1) 1.474(2)
0(2)-C(2) 1.210(3) 0(3)-C(4) 1.407(2)
0(4)-C(6) 1.427(3) C(l)-C(7) 1.517(3)
C(l)-C(6 ) 1.525(3) C(l)-C(4) 1.550(3)
C(2)-C(3) 1.506(3) C(3)-C(5) 1.526(3)
C(3)-C(4) 1.527(3) C(7)-C(8) 1.527(3)
0(2)-O(l)-C(l) 111.29(17) 0(1)-C(1)-C(7) 106.57(17)
0(1)-C(1)-C(6) 106.11(16) C(7)-C(l)-C(6) 111.7(2)
0(1)-C(1)-C(4) 103.15(18) C(7)-C(l)-C(4) 114.57(19)
C(6)-C(l)-C(4) 113.71(19) 0(2)-C(2)-0(l) 1 2 0 .8 (2 )
0(2)-C(2)-C(3) 127.5(2) O(l)-0(2)-C(3) 1 1 1 .6 (2 )
C(2)-C(3)-C(5) 1 1 2 .2 (2 ) C(2)-C(3)-C(4) 102.95(18)
C(5)-C(3)-C(4) 115.90(18) O(3)-0(4)-C(3) 113.69(19)
0(3)-C(4)-C(l) 110.93(18) C(3)-C(4)-C(l) 104.21(16)
0(4)-C(6)-C(l) 1 1 2 .0 (2 ) C(l)-C(7)-C(8) 113.45(19)
Table 4. Anisotropic displacement parameters (A2 x 1 0 3) for 258. The anisotropic 

































































































Hydrogen coordinates ( x 104) and isotropic displacement parameters (A2
Atom X y z U(eq)
H(3) 3822 8436 14286 60(8)
H(4A) 2238 8224 7801 41(7)
H(3A) 5445 7238 10591 39
H(4) 7423 8644 13891 38
H(5A) 9903 7157 14124 67
H(5B) 8828 6297 12464 67
H(5C) 7289 6676 14311 67
H(6A) 2658 9506 9449 41
H(6B) 4312 9856 7662 41
H(7A) 7681 10581 10186 48
H(7B) 9185 10075 12464 48
H(8A) 5700 10286 14248 71
H(8B) 4172 10782 11963 71
H(8C) 6606 11285 13450 71
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a l d e h y d e s .  T h e s e  e l i m i n a t i o n  r e a c t i o n s  p r o c e e d  via r e a r r a n g e m e n t  o f  t h e  p o t a s s i u m  a l k o x i d e  o f  t h e  s y « - a l d o l  t o  a
1 , 3 - o x a z i n a n e - 2 , 4 - d i o n e  e n o l a t e  i n t e r m e d i a t e  t h a t  s u b s e q u e n t l y  e l i m i n a t e s  c a r b o n  d i o x i d e  t o  a f f o r d  a  t r i s u b s t i t u t e d  
( £ ) - a , p - u n s a t u r a t e d  a m i d e .  T h e  ( £ ) - s e l e c t i v i t y  o b s e r v e d  d u r i n g  t h e  E l c B - t y p e  e l i m i n a t i o n  s t e p  h a s  b e e n  r a t i o n a l i s e d  
u s i n g  a  s i m p l e  c o n f o r m a t i o n a l  m o d e l  t h a t  e m p l o y s  a  c h a i r - l i k e  t r a n s i t i o n  s t a t e  t o  e x p l a i n  t h e  o b s e r v e d  s t e r e o c o n t r o l .
Introduction
( £ ) - 2 , 3 - T r i s u b s t i t u t e d - a , p - u n s a t u r a t e d  c a r b o x y l i c  a c i d  d e r i v a ­
t i v e s  a r e  v e r s a t i l e  s y n t h e t i c  f r a g m e n t s  f o r  n a t u r a l  p r o d u c t  
s y n t h e s i s ,1 t h a t  a l s o  f u n c t i o n  a s  u s e f u l  s u b s t r a t e s  f o r  a  w i d e  r a n g e  
o f  a s y m m e t r i c  m e t h o d o l o g y .2 T h e y  a r e  m o s t  o f t e n  p r e p a r e d  
u s i n g  h i g h l y  s t e r e o s e l e c t i v e  W i t t i g  r e a c t i o n s ,  w h e r e  r e a c t i o n  o f  
a n  a - s u b s t i t u t e d - e s t e r - y l i d  w i t h  a n  a l d e h y d e  a f f o r d s  t h e  d e s i r e d  
t r i s u b s t i t u t e d  ( £ ) - a , P - u n s a t u r a t e d  e s t e r  i n  e x c e l l e n t  y i e l d .3 S i m i ­
l a r  e x c e l l e n t  l e v e l s  o f  s t e r e o c o n t r o l  a r e  a l s o  o b s e r v e d  f o r  H o r n e r -  
W a d s w o r t h - E m m o n s  r e a c t i o n s ,  w h e r e  a n i o n s  o f  a - s u b s t i t u t e d -  
p h o s p h o n a t e  e s t e r s  a l s o  r e a c t  w i t h  a l d e h y d e s  i n  a  h i g h l y  ( £ ) -  
s e l e c t i v e  m a n n e r .4 W h i l s t  l e s s  w i d e l y  u s e d  i n  n a t u r a l  p r o d u c t  
s y n t h e s i s ,  n u m e r o u s  o t h e r  s t r a t e g i e s  h a v e  b e e n  d e v e l o p e d  f o r  
t h e i r  s t e r e o s e l e c t i v e  s y n t h e s i s ,  i n c l u d i n g  h y d r o c a r b o x y i a t i o n  o f  
a l k y n e s ,5 a d d i t i o n  o f  c a r b a n i o n s  t o  B a y l i s - H i l l m a n  a d d u c t s ,6 
c r o s s - m e t a t h e s i s  a p p r o a c h e s ,7 a n d  t h e  r e a r r a n g e m e n t  o f  l i t h i u m  
y n o l a t e s .8
A  w i d e  r a n g e  o f  a l d o l  m e t h o d o l o g y  i s  n o w  a v a i l a b l e  f o r  t h e  
s t e r e o s e l e c t i v e  s y n t h e s i s  o f  syn-  o r  a « / / - a - a l k y l - P - h y d r o x y - a c i d  
d e r i v a t i v e s ,  a n d  a s  a  c o n s e q u e n c e ,  a  n u m b e r  o f  e l i m i n a t i o n  
p r o t o c o l s  h a s  b e e n  d e v e l o p e d  f o r  t h e i r  s t e r e o s e l e c t i v e  c o n v e r s i o n  
i n t o  t r i s u b s t i t u t e d  ( £ ) - a , P - u n s a t u r a t e d  a c i d  d e r i v a t i v e s .  F o r  
e x a m p l e ,  O h m i z u  el al. h a v e  s h o w n  t h a t  t r e a t m e n t  o f  anti- 
a - a l k y l - P - h y d r o x y - e s t e r s  w i t h  E D C I  a n d  C u C l ,  i n  t o l u e n e  a t  
8 0  ° C  r e s u l t s  i n  . y j w - e l i m i n a t i o n  t o  a f f o r d  t r i s u b s t i t u t e d  ( £ ) -  
a , p - u n s a t u r a t e d  e s t e r s ,  w h i l s t  t r e a t m e n t  o f  t h e  c o r r e s p o n d i n g  
. s ^ n - a - a l k y l - P - h y d r o x y - e s t e r s  g a v e  t h e  a l t e r n a t i v e  t r i s u b s t i t u t e d  
( Z ) - a , P - u n s a t u r a t e d  e s t e r  i n  h i g h  d e .9 A l t e r n a t i v e l y ,  t r e a t m e n t  
o f  a - a l k y l - p - h y d r o x y - e s t e r s  w i t h  e x c e s s  t r i p h e n y l p h o s p h i n e  a n d  
d i e t h y l  a z o d i c a r b o x y l a t e  r e s u l t s  i n  a n  a n / / - s e l e c t i v e  e l i m i n a t i o n  
r e a c t i o n ,  w i t h  . y w - a - a l k y l - P - h y d r o x y - e s t e r s  a f f o r d i n g  t r i s u b s t i ­
t u t e d  ( £ ) - a , P - u n s a t u r a t e d  e s t e r s ,  w h i l s t  a « / / - a - a l k y l - P - h y d r o x y -  
e s t e r s  g a v e  t h e i r  c o r r e s p o n d i n g  ( Z ) - i s o m e r s .10 B a r t o l i  et al. 
h a v e  r e p o r t e d  t h a t  t r e a t m e n t  o f  d i a s t e r e o i s o m e r i c  m i x t u r e s  
o f  5^ r t - / a « / / - a - a l k y l - P - h y d r o x y  e s t e r s  w i t h  C e C l ,  a n d  N a l  i n  
r e f l u x i n g  a c e t o n i t r i l e  g a v e  t r i s u b s t i t u t e d  ( £ ) - e s t e r s  i n  h i g h  
d e .11 S i m i l a r l y ,  C o n c e l l o n  et al. h a v e  d e s c r i b e d  s i m i l a r  g o o d  
l e v e l s  o f  ( £ ) - s e l e c t i v i t y  w h e n  s a m a r i u m  i o d i d e  i s  e m p l o y e d  
f o r  t h e  r e d u c t i v e  e l i m i n a t i o n  o f  m i x t u r e s  o f  syn-/anti- a - h a l o -  
P - h y d r o x y - a c i d  d e r i v a t i v e s .12 M i x t u r e s  o f  . v j7? - A w / / - a - a l k y l - P -  
h y d r o x y - e s t e r s  m a y  a l s o  b e  d e h y d r a t e d  via s t e p - w i s e  p r o t o c o l s  
i n v o l v i n g  c o n v e r s i o n  t o  t h e i r  c o r r e s p o n d i n g  t o s y l a t e s / m e s y l a t e s ,
f o l l o w e d  b y  b a s e - c a t a l y s e d  e l i m i n a t i o n  t o  a f f o r d  t r i s u b s t i t u t e d  
( £ ) - a , P - u n s a t u r a t e d  e s t e r s  i n  g o o d  d e .13 O n l y  a  f e w  r e p o r t s  o n  t h e  
u s e  o f  s t e r e o s e l e c t i v e  v e r s i o n s  o f  t h e  P e r k i n  r e a c t i o n  h a v e  b e e n  
d e s c r i b e d ,  a l t h o u g h  V e r k a d e  et al. h a v e  d e s c r i b e d  a  p o t e n t i a l l y  
u s e f u l  ‘ o n e - p o t ’ p r o t o c o l  t h a t  e m p l o y s  a  p r o - a z a p h o s p h a t r a n e  
b a s e  f o r  t h e  d e h y d r a t i v e  a l d o l - c o n d e n s a t i o n  o f  a n  e s t e r  w i t h  a n  
a l d e h y d e  t o  a f f o r d  t r i s u b s t i t u t e d  ( £ ) - a , p - u n s a t u r a t e d  e s t e r s  i n  
h i g h  d e .14
N a t u r a l  p r o d u c t s  t h a t  c o n t a i n  t r i s u b s t i t u t e d  ( £ ) - a , P -  
u n s a t u r a t e d - a m i d e  f r a g m e n t s  a l s o  o c c u r  w i d e l y  i n  n a t u r e ,15 
w h i l s t  t h e y  h a v e  o f t e n  b e e n  e m p l o y e d  a s  s t r u c t u r a l  m o t i f s  f o r  
t h e  p r e p a r a t i o n  o f  m e d i c i n a l l y  a c t i v e  c o m p o u n d s .16 A  n u m b e r  o f  
d i f f e r e n t  s y n t h e t i c  r o u t e s  i s  a v a i l a b l e  f o r  t h e i r  s t e r e o s e l e c t i v e  s y n ­
t h e s i s ,  i n c l u d i n g  d i r e c t  a m i d e  f o r m a t i o n  f r o m  t h e i r  c o r r e s p o n d ­
i n g  ( £ ) - a c i d s 17 o r  ( £ ) - e s t e r s , " '  H o r n e r - W a d s w o r t h - E m m o n s  
m e t h o d o l o g y , '9 a l d o l  d e h y d r a t i o n ,20 S m l 2 m e d i a t e d  e l i m i n a t i o n  
o f  a - c h l o r o - p - h y d r o x y - a m i d e s  o r  a , p - e p o x y - a m i d e s ,21 o r  r e a r ­
r a n g e m e n t  o f  l i t h i u m  y n o l a t e s .22 T h e  d e v e l o p m e n t  o f  v e r s a t i l e  
p r o t o c o l s  f o r  t h e i r  s y n t h e s i s  i s  t h e r e f o r e  o f  g r e a t  i n t e r e s t  t o  
t h e  s y n t h e t i c  c o m m u n i t y .  C o n s e q u e n t l y ,  w e  n o w  r e p o r t  h e r e i n  
t h a t  p o t a s s i u m  a l k o x i d e s  o f  A - a c y l - o x a z o l i d i n - 2- o n e - . v y w - a l d o l s  
u n d e r g o  s t e r e o s e l e c t i v e  e l i m i n a t i o n  r e a c t i o n s  t o  a f f o r d  a  h i g h l y  
p r a c t i c a l  r o u t e  t o  t r i s u b s t i t u t e d  ( £ ) - a , p - u n s a t u r a t e d  a m i d e s  
w i t h  g o o d  l e v e l s  o f  s t e r e o c o n t r o l .  P a r t  o f  t h i s  w o r k  h a s  b e e n  
c o m m u n i c a t e d  p r e v i o u s l y .23
Results and discussion
W e  h a v e  r e c e n t l y  r e p o r t e d  a  n o v e l  a l d o l / c y c l o p r o p a n a t i o n /  
r c / r a - a l d o l  s t r a t e g y  f o r  t h e  a s y m m e t r i c  s y n t h e s i s  o f  c h i r a l  
c y c l o p r o p a n e  c a r b o x a l d e h y d e s  i n  h i g h  d e .24 T h e  s u c c e s s  o f  
t h i s  m e t h o d o l o g y  r e q u i r e d  t h e  d e v e l o p m e n t  o f  c o n d i t i o n s  t h a t  
w o u l d  r e s u l t  i n  P - h y d r o x y - A - a c y l - o x a z o l i d i n - 2 - o n e s  u n d e r g o i n g  
a  c l e a n  retro- a l d o l  r e a c t i o n  t o  a f f o r d  t h e i r  r e s p e c t i v e  A - a c y l -  
o x a z o l i d i n - 2 - o n e  a n d  a l d e h y d e  f r a g m e n t s .  I n  o r d e r  t o  e s t a b l i s h  
o p t i m a l  c o n d i t i o n s  f o r  t h i s  t y p e  o f  retro- a l d o l  r e a c t i o n ,  i t  
w a s  d e c i d e d  t o  e m p l o y  a  s e r i e s  o f  r a c e m i c  P - h y d r o x y - A - a c y l -  
o x a z o l i d i n - 2 - o n e s  3a-j a s  s i m p l e  m o d e l  s u b s t r a t e s  t o  p r o b e  
t h e  s t e r i c  a n d  e l e c t r o n i c  r e q u i r e m e n t s  o f  t h i s  f r a g m e n t a t i o n  
p a t h w a y .  C o n s e q u e n t l y ,  a  s e r i e s  o f  f o u r  j V - a c y l - o x a z o l i d i n - 2 -  
o n e s  2a-d w e r e  p r e p a r e d  i n  6 2 - 7 4 %  y i e l d  via t r e a t m e n t  o f  
o x a z o l i d i n - 2 - o n e  1  i n  T H F  w i t h  1.1 e q u i v a l e n t s  o f  « - B u L i  a t
O r g .  B i o m o l .  C h e m . ,  2 0 0 5 , 3 , 2 9 7 6 - 2 9 8 9 T h i s  j o u r n a l  i s  ©  T h e  R o y a l  S o c i e t y  o f  C h e m i s t r y  2 0 0 5
Tabic I Yields o f .vy/?-aldols 3a-j
Aldol R R, de (%) Yield (%)"
3a Pr Cyclohexyl >95 58
3b Me Ph >95 69
3c Me Et >95 31
3d Bn Me(CH2)*- >95 74
3e Pr Et >95 48
3f 'Pr Ph >95 50
3g 'Pr />MeOCtH4- >95 60
3h Ph Et >95 37
3i 'Pr (£)-M eC H =C H >95 72
3j Me (£)-P h C H = C H - >95 8 8
" Yields o f  s.'vn-aldol products obtained1 in <70% were a result o f
unreacted /V-acyl-oxazolidin-2-one 2a-d being recovered 
the aldol reaction.
at the end o f
— 7 8  ° C ,  f o l l o w e d  b y  a d d i t i o n  o f  t h e  a p p r o p r i a t e  a c i d  c h l o r i d e .  
A f t e r  s c r e e n i n g  a  r a n g e  o f  b o r o n  s o u r c e s  a n d  c o n d i t i o n s ,  i t  w a s  
f o u n d  t h a t  t r e a t m e n t  o f  i V - a c y l - o x a z o l i d i n - 2 - o n e s  2a-d w i t h  9 -  
B B N  t r i f l a t e  ( i n  h e x a n e s )  a n d  P r 3 N E t  i n  C H : C 1 2 ,  f o l l o w e d  b y  
a d d i t i o n  o f  t h e  a p p r o p r i a t e  a l d e h y d e  a t  — 7 8  ° C ,  r e s u l t e d  i n  t h e  
f o r m a t i o n  o f  t h e  d e s i r e d  . v y « - a l d o l  p r o d u c t s  3a-j.25 E x a m i n a t i o n  
o f  t h e  ' H  N M R  s p e c t r u m  o f  e a c h  c r u d e  r e a c t i o n  p r o d u c t  
r e v e a l e d  t h e  p r e s e n c e  o f  d e s i r e d  . v y w - a l d o l s  3a-j i n  > 9 5 %  d e ,  
w h i c h  w e r e  p u r i f i e d  t o  h o m o g e n e i t y  b y  c h r o m a t o g r a p h y  i n  p o o r  
t o  u n o p t i m i s e d  3 1 - 8 8 %  y i e l d s  ( S c h e m e  1 ,  T a b l e  1 ) .  T h e  r e l a t i v e  
c o n f i g u r a t i o n  o f  e a c h  o f  t h e  r a c e m i c  a l d o l  p r o d u c t s  3a-j w a s  
a s s i g n e d  a s  syn-  b y  a n a l o g y  w i t h  l i t e r a t u r e  p r e c e d e n t  f o r  t h e  
r e a c t i o n  o f  ( Z ) - b o r o n - e n o l a t e s  o f  A - a c y l - o x a z o l i d i n - 2 - o n e s  i n  
t h e s e  t y p e s  o f  a l d o l  r e a c t i o n s .26 T h i s  s t e r e o c h e m i c a l  a s s i g n m e n t  
w a s  s u b s e q u e n t l y  c o n f i r m e d  f o r  . s y v t - a l d o l  3b w h o s e  ' H  N M R  
s p e c t r u m  w a s  i d e n t i c a l  t o  t h e  d a t a  p r e v i o u s l y  r e p o r t e d  f o r  t h i s  
d i a s t e r e o i s o m e r  (Ja.i) =  3 . 0  H z ) ,  w h i l s t  b e i n g  c l e a r l y  d i f f e r e n t  
f r o m  t h e  ' H  N M R  s p e c t r u m  o f  i t s  c o r r e s p o n d i n g  anti- a l d o l  
d i a s t e r e o i s o m e r  = 8 . 5  H z ).27
(•')
O
AO Nv _ y
0 o O o o on
O'^NH ^ » O^N
J
1 2a R = Me, 72% 3a-j
2b R Tr, 74%
2c R = Bn, 73%
2d R = Ph, 62%
Scheme 1 Reagents and conditions: (i) n-BuLi, THF, - 7 8  °C, 
RCfTCOCl; (ii) 9-BBN-OTf, 'Pr,NEt, CH,C1„ 0 to - 7 8  °C, R,CHO. 
CH :C1:.
A t t e m p t s  t o  e s t a b l i s h  a n i o n i c  c o n d i t i o n s  t h a t  w o u l d  r e s u l t  
i n  , v>77- a l d o l  3a u n d e r g o i n g  a  retro- a l d o l  r e a c t i o n  u n d e r  a n i o n i c  
c o n d i t i o n s  w e r e  u n s u c c e s s f u l ,  s i n c e  t r e a t m e n t  o f  . v y « - a l d o l  3a 
w i t h  1 . 5  e q u i v a l e n t s  o f  K H M D S  i n  T H F  a t  — 7 8  ° C  o v e r  a  p e r i o d  
o f  2 h o u r s  r e s u l t e d  i n  a n  u n e x p e c t e d  s t e r e o s e l e c t i v e  e l i m i n a t i o n  
r e a c t i o n  t o  a f f o r d  t h e  t r i s u b s t i t u t e d  a , p - u n s a t u r a t e d  a m i d e  ( £ ) -  
4a i n  9 4 % d e ,  a n d  i n  7 7 %  i s o l a t e d  y i e l d  ( S c h e m e  2 ) .  T h e  g e o m e t r y  
o f  t h e  a l k e n e  f u n c t i o n a l i t y  o f  (£)-4a w a s  c o n f i r m e d  via X - r a y  
c r y s t a l l o g r a p h i c  a n a l y s i s  t h a t  c l e a r l y  r e v e a l e d  t h e  m - o r i e n t a t i o n  
o f  t h e  a - i s o - p r o p y l  g r o u p  a n d  t h e  p - c y c l o h e x a n e  g r o u p  ( F i g .  1 ) .  
O t h e r  a s p e c t s  o f  t h e  X - r a y  c r y s t a l  s t r u c t u r e  o f  (£)-4a w e r e
.vi’/;-3a (£> 4a 
77% yield 
94% d.e.





Fig. I One of the two molecules which comprise the asymmetric unit 
in the crystal structure o f  (£>4a. Ellipsoids are depicted at the 30% 
probability level.
u n r e m a r k a b l e ,  w i t h  c r y s t a l  p a c k i n g  o c c u r r i n g  via i n t e r m o l e c u l a r  
h y d r o g e n  b o n d i n g  b e t w e e n  t h e  p r i m a r y  h y d r o x y l  g r o u p s  o f  
a d j a c e n t  ( £ ) - a m i d e  m o l e c u l e s .
I n  o r d e r  t o  d e t e r m i n e  w h e t h e r  t h i s  e l i m i n a t i o n  r e a c t i o n  
w a s  g e n e r a l  i n  s c o p e ,  t h e  r e m a i n i n g  s e r i e s  o f  . s y / t - a l d o l s  3b- 
g w a s  t r e a t e d  w i t h  1 . 5  e q u i v a l e n t s  o f  K H M D S  i n  T H F  a t  
—  7 8  ° C  f o r  2  h o u r s ,  a f t e r  w h i c h  t i m e  t h e  r e a c t i o n  w a s  w o r k e d  
u p  w i t h  s a t u r a t e d  N H 4C l ( i i q) . E x a m i n a t i o n  o f  t h e  c r u d e  ' H  
N M R  s p e c t r u m  o f  e a c h  c r u d e  r e a c t i o n  p r o d u c t  r e v e a l e d  t h a t  
t r i s u b s t i t u t e d  ( £ ) - a , P - u n s a t u r a t e d  a m i d e s  4b-g h a d  b e e n  f o r m e d  
i n  > 9 0 %  d e  i n  e a c h  c a s e ,  w h i c h  w e r e  s u b s e q u e n t l y  o b t a i n e d  
i n  6 7 - 9 9 %  y i e l d  a f t e r  c h r o m a t o g r a p h i c  p u r i f i c a t i o n  ( S c h e m e  3 ,  
T a b l e  2 ) .  T h e  s t r u c t u r e  o f  e a c h  ( £ ) - a , p - u n s a t u r a t e d  a m i d e  
4b-g f o l l o w e d  f r o m  c o m p a r i s o n  o f  t h e i r  s p e c t r o s c o p i c  d a t a  
w i t h  t h a t  o f  ( £ ) - a m i d e  4a, w h i l s t  t h e  a l k e n e  g e o m e t r y  o f  ( £ ) -  
a m i d e s  4a-c w a s  c o n f i r m e d  via a c i d i c  h y d r o l y s i s  t o  t h e i r  k n o w n  
( £ ) - a c i d s  26a-c (vide infra). I t  i s  n o t e w o r t h y  t h a t  t h i s  s i m p l e  
e l i m i n a t i o n  m e t h o d o l o g y  a p p e a r e d  g e n e r a l  i n  s c o p e  w i t h  l i n e a r  
a n d  b r a n c h e d  R  s u b s t i t u e n t s  b e i n g  t o l e r a t e d  a t  t h e  a - p o s i t i o n  o f  
■ y y y z - a l d o l s  3a-g, a n d  w i t h  a l i p h a t i c  a n d  a r o m a t i c  ( n e u t r a l  a n d  
e l e c t r o n  r i c h )  R , - s u b s t i t u e n t s  b e i n g  t o l e r a t e d  a t  t h e i r  P - p o s i t i o n  
( S c h e m e  1 ,  T a b l e  1 ) .  A t t e m p t s  t o  c a r r y  o u t  t h e s e  e l i m i n a t i o n  
r e a c t i o n s  a t  0  ° C  r e s u l t e d  i n  t h e  d e s i r e d  ( £ ) - a m i d e s  4 b e i n g  
p r o d u c e d  i n  i n f e r i o r  d e ;  f o r  e x a m p l e ,  t r e a t m e n t  o f  . v j T j - a l d o l  3b 
w i t h  K H M D S  i n  T H F  a t  0  ° C  r e s u l t e d  i n  ( £ ) - a m i d e  4b b e i n g  










Scheme 3 Reagents and conditions4, (i) KHMDS. THF, —78 °C.
Table 2 Yields for synthesis o f  (£)-amides 4b-g
Amide R Ri de (%) Yield (%)
4b Me Ph >95 91
4c Me Et >95 67
4d Bn M e(C H A - 92 91
4e Pr Et >95 99
4f 'Pr Ph 92 90
4g 'Pr /»MeOC6 H4- 90 8 8
O r g .  B i o m o l .  C h e m . ,  2 0 0 5 , 3 , 2 9 7 6 - 2 9 8 9 2 9  7 7
F u r t h e r  i n v e s t i g a t i o n s  r e v e a l e d  t h a t  e l i m i n a t i o n  o f  . n w - a l d o l  
3h c o n t a i n i n g  a n  a - p h e n y l  g r o u p  u n d e r  t h e s e  c o n d i t i o n s ,  g a v e  
a  m i x t u r e  o f  t h e  d e s i r e d  ( £ ) - a m i d e  4h ( > 9 5 %  d e )  a n d  N - 
p h e n y l a c e t y l - o x a z o l i d i n - 2- o n e  2d i n  a  2 : 1 r a t i o ,  w h i c h  w a s  
p u r i f i e d  b y  c h r o m a t o g r a p h y  t o  a f f o r d  (£)-4h i n  4 7 %  y i e l d .  
P r e s u m a b l y ,  7 V - p h e n y l a c e t y l - o x a z o l i d i n - 2 - o n e  2d a r i s e s  f r o m  a  
c o m p e t i n g  retro - a l d o l  r e a c t i o n  a s  o r i g i n a l l y  c o n c e i v e d ,  w h e r e  t h e  
p o t a s s i u m  a l k o x i d e  o f  n w - a l d o l  3h h a d  f r a g m e n t e d  t o  a f f o r d  ( £ ) -  
4h a n d  p r o p i o n a l d e h y d e  ( n o t  i s o l a t e d ) .  I t  i s  l i k e l y  t h a t  t h e  retro- 
a l d o l  r e a c t i o n  o f  t h e  a l k o x i d e  o f  . v y w - a l d o l  4h i s  m o r e  f a v o u r e d  
t h a n  f o r  t h e  o t h e r  . s y n - a l d o l s  4a-g i n v e s t i g a t e d  i n  t h i s  s t u d y ,  
b e c a u s e  t h e  e n o l a t e  o f  A - p h e n y l a c e t y l o x a z o l i d i n - 2- o n e  2d i s  
s t a b i l i s e d  b y  t h e  p r e s e n c e  o f  i t s  a - p h e n y l  s u b s t i t u e n t  ( S c h e m e  4 ) .
T r e a t m e n t  o f  s v a - a l d o l s  3i a n d  3j w i t h  K H M D S  i n  C H 2C 1 2 a t  
— 7 8  ° C  a f f o r d e d  ( 2 £ , 4 £ ) - a , p , y , 8 - u n s a t u r a t e d  a m i d e s  4i a n d  4j i n  
a  s t e r e o s e l e c t i v e  m a n n e r ,  h o w e v e r  t h e y  w e r e  b o t h  f o r m e d  w i t h  
p o o r e r  l e v e l s  o f  s t e r e o c o n t r o l .  T h u s ,  t r e a t m e n t  o f  s y n - a l d o l  3 i  
w i t h  K H M D S  a t  — 7 8  ° C  r e s u l t e d  i n  ( 2 £ , 4 £ ) - a , p , y , 8 - u n s a t u r a t e d  
a m i d e  4 i ,  a n d  i t s  g e o m e t r i c  i s o m e r  ( 2 Z , 4 £ ) - a , p , y , 8 - u n s a t u r a t e d  
a m i d e  5 ,  i n  a  4 :  1 r a t i o ,  a n d  i n  a  c o m b i n e d  9 3 %  y i e l d  ( S c h e m e  5 ) .  
A t t e m p t e d  c h r o m a t o g r a p h i c  p u r i f i c a t i o n  o f  t h e s e  g e o m e t r i c  
i s o m e r s  o v e r  s i l i c a  g e l  w a s  u n s u c c e s s f u l ,  h o w e v e r  ( 2 £ , 4 £ ) - 4 i  a n d  
( 2 Z , 4 £ ) - 5  c o u l d  b e  p a r t i a l l y  s e p a r a t e d  via c h r o m a t o g r a p h y  o v e r  
s i l i c a  g e l  d o p e d  w i t h  s i l v e r  n i t r a t e .28 T h e  p r e s e n c e  o f  t h e  ( 2 Z ) -  
a l k e n e  g e o m e t r y  o f  ( 2 Z , 4 £ ) - 5  w a s  c o n f i r m e d  f r o m  e x a m i n a t i o n  
o f  i t s  ' H  N M R  s p e c t r u m  w h i c h  r e v e a l e d  a  c o u p l i n g  c o n s t a n t  
o f  .7(4,5,  =  1 5 . 0  H z ,  t h a t  w a s  s i m i l a r  i n  v a l u e  t o  t h a t  o b s e r v e d  
f o r  ( 2 £ , 4 £ ) - 4 i  o f  7 , 4 5 , =  1 3 . 0  H z .  S i m i l a r l y ,  t r e a t m e n t  o f  syn- 
a l d o l  3j w i t h  K H M D S  i n  T H F  a t  - 7 8  ° C  a l s o  g a v e  a  4  : 
1 m i x t u r e  o f  ( 2 £ , 4 £ ) - 4 j  a n d  ( 2 Z , 4 £ ) - 6  i n  a  c o m b i n e d  9 7 %  
y i e l d  (  S c h e m e  5 ).29 F r a c t i o n a l  r e c r y s t a l l i s a t i o n  o f  t h i s  m i x t u r e  o f  
g e o m e t r i c  i s o m e r s  f r o m  e t h y l  a c e t a t e  a f f o r d e d  t h e  m a j o r  a m i d e  
( 2 £ , 4 £ ) - 4 j  i n  6 4 %  i s o l a t e d  y i e l d ,  w h o s e  a l k e n e  g e o m e t r y  w a s  
c o n f i r m e d  via h y d r o l y s i s  t o  i t s  k n o w n  p a r e n t  ( 2 £ , 4 £ ) - a c i d  27 
(vide infra). T h e r e f o r e ,  i t  a p p e a r s  t h a t  e l i m i n a t i o n  o f  ^ « - a l d o l s  
d e r i v e d  f r o m  a , P - u n s a t u r a t e d  a l d e h y d e s  u n d e r  t h e s e  c o n d i t i o n s  
o c c u r s  w i t h  i n t r i n s i c a l l y  p o o r e r  l e v e l s  o f  s t e r e o c o n t r o l  t h a n  f o r  
t h e  o t h e r  . v y w - a l d o l s  3a-g i n v e s t i g a t e d  i n  t h i s  s t u d y .
I n  o r d e r  t o  d e m o n s t r a t e  t h a t  t h i s  e l i m i n a t i o n  m e t h o d o l o g y  
w a s  a p p l i c a b l e  t o  t h e  s t e r e o s e l e c t i v e  s y n t h e s i s  o f  t r i s u b s t i t u t e d -  
( £ ) - a m i d e s  o f  p o t e n t i a l  u s e  a s  b u i l d i n g  b l o c k s  f o r  n a t u r a l  
p r o d u c t  s y n t h e s i s ,  w e  n e x t  e x p l o r e d  i t s  u s e  f o r  t h e  p r e p a r a t i o n  
o f  t h r e e  t r i s u b s t i t u t e d  ( £ ) - a , p - u n s a t u r a t e d  a m i d e s  lOa-c d e r i v e d  
f r o m  c h i r a l  a l d e h y d e s  ( S c h e m e  6 ) .  R e a c t i o n  o f  t h e  ( Z ) - b o r o n  
e n o l a t e  o f  A - p r o p i o n y l - o x a z o l i d i n - 2 - o n e  2a w i t h  p e r i l l a l d e h y d e  
( / ? ) - 7  ( 9 0 %  p u r e )  r e s u l t e d  i n  a  1 : 1 m i x t u r e  o f  5y n - a l d o l  
d i a s t e r e o i s o m e r s  8a/9a  i n  6 4 %  y i e l d .30 T r e a t m e n t  o f  t h i s  m i x t u r e  
o f  s y w - a l d o l s  8a/9a  w i t h  K H M D S  i n  T H F  a t  — 7 8  ° C  r e s u l t e d  i n  
a  c l e a n  e l i m i n a t i o n  r e a c t i o n  t o  a f f o r d  a , p , y , 5 - u n s a t u r a t e d  a m i d e  
(£ ,£ ,/? )-!0a i n  5 0 %  d e ,  w h i c h  w a s  p u r i f i e d  t o  h o m o g e n e i t y  via 
c h r o m a t o g r a p h y  i n  5 1 %  y i e l d .  S i n c e  e l i m i n a t i o n  o f  . v y / i - a l d o l s  
d e r i v e d  f r o m  a , P - u n s a t u r a t e d  a l d e h y d e s  h a d  b e e n  s h o w n  t o  
a f f o r d  ( £ , £ ) - u n s a t u r a t e d - a m i d e s  i n  i n f e r i o r  d e ,  w e  n e x t  r e a c t e d  
t h e  ( Z ) - b o r o n  e n o l a t e  o f  2a w i t h  c i t r o n e l l a l  ( S ' ) - !  1 ( 9 6 %  p u r e )  
t o  a f f o r d  a n  i n s e p a r a b l e  1 : 1 m i x t u r e  o f  d i a s t e r e o i s o m e r i c  syn- 
a l d o l s  8b/9b i n  9 3 %  y i e l d .  T h i s  m i x t u r e  w a s  s u b s e q u e n t l y  t r e a t e d  
w i t h  K H M D S  i n  T H F  a t  - 7 8  ° C  t o  a f f o r d  ( £ , S ) - a m i d e  10b i n  
6 0 %  d e ,  t h a t  w a s  p u r i f i e d  t o  h o m o g e n e i t y  via c h r o m a t o g r a p h y  
i n  5 5 %  y i e l d .  T h e  m o d e r a t e  d i a s t e r e o c o n t r o l  o b s e r v e d  i n  t h i s  
e l i m i n a t i o n  r e a c t i o n  w a s  s o m e w h a t  s u r p r i s i n g ,  s i n c e  e l i m i n a t i o n  
o f  t h e  r e l a t e d  ^ « - a l d o l  3d, w h i c h  a l s o  c o n t a i n e d  a  l o n g  a l k y l  
c h a i n  a t  i t s  P - p o s i t i o n ,  g a v e  i t s  c o r r e s p o n d i n g  ( £ ) - a m i d e  4d i n  
9 2 %  d e .  F i n a l l y ,  r e a c t i o n  o f  t h e  ( Z ) - b o r o n  e n o l a t e  o f  2a w i t h  
1 . 1  e q u i v a l e n t s  o f  D - g l y c e r a l d e h y d e  a c e t o n i d e  ( / ? ) - !  2 a f f o r d e d  
a  2  : 1 m i x t u r e  o f  . v y w - a l d o l  d i a s t e r e o i s o m e r s  8c/9c t h a t  w e r e  
c o - i s o l a t e d  i n  5 8 %  y i e l d  a f t e r  c h r o m a t o g r a p h y  o v e r  s i l i c a .31 T h e  
2  : 1 m i x t u r e  o f  . v y / z - a l d o l s  8c/9c  p r o d u c e d  i n  t h i s  r e a c t i o n  i s  
l i k e l y  t o  r e s u l t  f r o m  a t t a c k  o f  t h e  b o r o n - e n o l a t e  o f  2a a t  t h e  
c a r b o n y l  o f  (/?)-12 o c c u r r i n g  u n d e r  s u b s t r a t e  c o n t r o l ,  w h e r e  
f o r m a t i o n  o f  t h e  m a j o r  a l d o l  d i a s t e r e o i s o m e r  ( s t e r e o c h e m i s t r y  
n o t  d e t e r m i n e d )  i s  f a v o u r e d  b y  t h e  s t e r e o d i r e c t i n g  e f f e c t  o f  
t h e  a - s t e r e o g e n i c  c e n t r e  o f  a l d e h y d e  (£)-12. G e n e r a t i o n  o f  t h e  
p o t a s s i u m  a l k o x i d e s  o f  s j w - a l d o l s  8 c/9c  via t r e a t m e n t  o f  t h i s  
m i x t u r e  w i t h  K H M D S  i n  T H F  a t  — 7 8  ° C ,  r e s u l t e d  i n  t h e  
f o r m a t i o n  o f  ( £ , S ) - a m i d e  10c i n  8 0 %  d e ,  w h i c h  w a s  p u r i f i e d  
t o  h o m o g e n e i t y  via c h r o m a t o g r a p h y  i n  4 2 %  i s o l a t e d  y i e l d .32











Scheme 4 Reagents and conditions: (i) KHMDS, THF, —78 °C.
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Scheme 5 Reagents and conditions: (i) KHMDS, THF, —78 °C.
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Scheme 6 Reagents and conditions: (i) 2a, 9-BBN-OTf, 'Pr:NEt, CH,C1,, 0 to -78  °C; (ii) KHMDS, THF, -78  °C.
T h e r e f o r e ,  w h i l s t  t h e  p o t a s s i u m  a l k o x i d e s  o f  . ? y « - a l d o l s  8a- 
c /9 a -c  d e r i v e d  f r o m  c h i r a l  a l d e h y d e s  e l i m i n a t e d  t o  a f f o r d  t h e i r  
d e s i r e d  t r i s u b s t i t u t e d  a , P - u n s a t u r a t e d  a m i d e s  (£)-10a-c, i t  i s  
c l e a r  t h a t  t h e s e  r e a c t i o n s  h a d  p r o c e e d e d  w i t h  i n f e r i o r  l e v e l s  o f  
( £ ) - s t e r e o c o n t r o l  t o  t h o s e  p r e v i o u s l y  o b s e r v e d  f o r  t h e  s i m p l e r  
• s j w - a l d o l s  4a-g.
Mechanism of the stereoselective elimination reaction of
,vv/f-aldols
I t  i s  w e l l  k n o w n  t h a t  s t e r i c a l l y  u n h i n d e r e d  j V - a c y l o x a z o l i d i n - 2 -  
o n e s  c a n  u n d e r g o  e n d o c y c l i c  r i n g  c l e a v a g e  via e i t h e r  i n t e r -  o r  i n ­
t r a m o l e c u l a r  a t t a c k  o f  a l k o x i d e  n u c l e o p h i l e s  a t  t h e i r  o x a z o l i d i n -
2 - o n e  c a r b o n y l  g r o u p s . ”  C o n s e q u e n t l y ,  i t  w a s  p r o p o s e d  t h a t  
t h e  h i g h  d i a s t e r e o s e l e c t i v i t i e s  o b s e r v e d  f o r  t h e  e l i m i n a t i o n  o f  
. v y w - a l d o l s  3  c o u l d  b e  e x p l a i n e d  b y  a  n o v e l  i n t r a m o l e c u l a r  
c y c l i s a t i o n / E l c B - t y p e  e l i m i n a t i o n  m e c h a n i s m  a s  s h o w n  i n  
F i g .  2 .  I n  t h i s  m e c h a n i s m ,  d e p r o t o n a t i o n  o f  . s j T t - a l d o l  1 1  w o u l d  
r e s u l t  i n  p o t a s s i u m  a l k o x i d e  12,  t h a t  w o u l d  t h e n  u n d e r g o  
i n t r a m o l e c u l a r  a t t a c k  a t  t h e  o x a z o l i d i n - 2- o n e  c a r b o n y l  r e s u l t i n g  
i n  0 - 0  c a r b o n y l  m i g r a t i o n  t o  a f f o r d  1 , 3 - o x a z i n a n e - 2 , 4 - d i o n e  
a l k o x i d e  i n t e r m e d i a t e  13. S u b s e q u e n t  a n i o n  e q u i l i b r a t i o n  o f  
a l k o x i d e  13 w o u l d  t h e n  g i v e  l , 3 - o x a z i n a n e - 2 , 4 - d i o n e  e n o l a t e  14 
t h a t  w o u l d  t h e n  u n d e r g o  s t e r e o s e l e c t i v e  e l i m i n a t i o n  o f  c a r b o n  
d i o x i d e  t o  a f f o r d  t h e  t r i s u b s t i t u t e d  s e c o n d a r y  a m i d e  (£)-15 i n  
h i g h  d e  ( F i g .  2 ) .
I n  o r d e r  t o  p r o v i d e  e v i d e n c e  f o r  t h i s  m e c h a n i s m ,  i t  w a s  
p r o p o s e d  t h a t  t r e a t m e n t  o f  1 , 3 - o x a z i n a n e - 2 , 4 - d i o n e  16 w i t h  
K H M D S  i n  T H F  a t  — 7 8  ° C  s h o u l d  r e s u l t  i n  s t e r e o s e l e c t i v e  
e l i m i n a t i o n  t o  a f f o r d  t r i s u b s t i t u t e d  a m i d e  (£)-4b i n  a n  i d e n t i c a l  
d e  t o  t h a t  o b s e r v e d  f o r  e l i m i n a t i o n  o f  i t s  p a r e n t  s y T j - a l d o l  3b. 
W e  h a v e  r e p o r t e d  p r e v i o u s l y  t h a t  z i n c  a l k o x i d e s  o f  a - a l k y l -  
P - h y d r o x y - T V - a c y l - o x a z o l i d i n - 2 - o n e s  u n d e r g o  c l e a n  r e a r r a n g e ­
m e n t  t o  a f f o r d  1 , 3 - o x a z i n a n e - 2 , 4 - d i o n e s ,34 a n d  a s  a  c o n s e q u e n c e  
j ' j « - l , 3 - o x a z i n a n e - 2 , 4 - d i o n e  16 w a s  p r e p a r e d  i n  9 7 %  y i e l d  via 
t r e a t m e n t  o f  s j T i - a l d o l  3b w i t h  1 0  m o l %  o f  E t , Z n  i n  C H , C 1 ,  a t  
r o o m  t e m p e r a t u r e .  S u b s e q u e n t  t r e a t m e n t  o f  . s y n - l , 3 - o x a z i n a n e -
2 . 4 - d i o n e  16 w i t h  K H M D S  i n  T H F  a t  — 7 8  ° C  g a v e  a m i d e  
(£)-4b i n  a n  i d e n t i c a l  > 9 5 %  d e  t o  t h a t  p r e v i o u s l y  o b s e r v e d  
f o r  e l i m i n a t i o n  o f  t h e  p o t a s s i u m  a l k o x i d e  o f  . r y / i - a l d o l  3b 
( S c h e m e  7 ).35 T h i s  o b s e r v a t i o n  t h e r e f o r e  p r o v i d e s  g o o d  e v i d e n c e  
t h a t  t h e  p o t a s s i u m  a l k o x i d e  o f  1 , 3 - o x a z i n a n e - 2 , 4 - d i o n e s  13, a n d  
t h e i r  c o r r e s p o n d i n g  e n o l a t e s  1 4 ,  a r e  k e y  i n t e r m e d i a t e s  i n  t h e s e  
s t e r e o s e l e c t i v e  e l i m i n a t i o n  r e a c t i o n s  ( F i g .  2 ) .
W e  n e x t  c o n f i r m e d  t h a t  t h e  l o s s  i n  s t e r e o s e l e c t i v i t y  o b s e r v e d  
d u r i n g  e l i m i n a t i o n  o f  t h e  p o t a s s i u m  a l k o x i d e s  o f . v y n - a l d o l  3i w a s  
o c c u r r i n g  d u r i n g  e l i m i n a t i o n  o f  c a r b o n  d i o x i d e  f r o m  t h e  e n o l a t e  
o f . v j > H - l  , 3 - o x a z i n a n e - 2 , 4 - d i o n e  i n t e r m e d i a t e  1 7 .  T h u s ,  t r e a t m e n t  
o f s y H - a l d o l  3i w i t h  1 0  m o l %  E t : Z n  i n  C H : C 1 2 r e s u l t e d  i n  a  z i n c  
a l k o x i d e  t h a t  c l e a n l y  r e a r r a n g e d  t o  a f f o r d  i t s  syti-1 , 3 - o x a z i n a n e -
2 . 4 - d i o n e  17 i n  > 9 5 %  d e  w i t h  n o  l o s s  o f  s t e r e o c h e m i c a l  i n t e g r i t y  
a t  e i t h e r  i t s  a -  o r  P - s t e r e o c e n t r e s .  5_ y « - l , 3- O x a z i n a n e - 2, 4 - d i o n e  
17 w a s  t r e a t e d  w i t h  K H M D S  i n  T H F  a t  - 7 8  ° C  u n d e r  
c o n d i t i o n s  u s e d  p r e v i o u s l y  f o r  t h e  d i r e c t  e l i m i n a t i o n  o f  . v j w - a l d o l  
3i, t o  a f f o r d  a n  i d e n t i c a l  4  : 1 r a t i o  o f  ( 2 £ , 4 £ ) - a , p - u n s a t u r a t e d  
a m i d e  4i a n d  ( 2 Z , 4 £ ) - a , P - u n s a t u r a t e d .  a m i d e  5 i n  a n  e x c e l l e n t  
88%  y i e l d  ( S c h e m e  8) .  T h e r e f o r e ,  i t  a p p e a r s  t h a t  t h e  l o s s  o f  
s t e r e o c o n t r o l  o b s e r v e d  f o r s y r t - a l d o l  3i o c c u r s  e x c l u s i v e l y  d u r i n g  
e l i m i n a t i o n  o f  c a r b o n  d i o x i d e  f r o m  t h e  e n o l a t e  d e r i v e d  f r o m  
. v y « - l , 3 - o x a z i n a n e - 2 , 4 - d i o n e  i n t e r m e d i a t e  17.
F i n a l l y ,  w e  e x p l o r e d  t h e  e l i m i n a t i o n  o f  t h e  c o r r e s p o n d i n g  anti- 
a l d o l  18 w h i c h  w a s  p r e p a r e d  via t r e a t m e n t  o f  2a w i t h  M g C h ,  
T M S C 1 ,  E t , N  a n d  b e n z a l d e h y d e  i n  E t O A c  i n  a n  u n o p t i m i s e d  
3 3 %  y i e l d ,  a c c o r d i n g  t o  E v a n s ’ r e c e n t l y  p u b l i s h e d  p r o c e d u r e .36 
T r e a t m e n t  o f  anti- a l d o l  1 8  w i t h  K H M D S  i n  T H F  a t  — 7 8  ° C  
a f f o r d e d  a m i d e  (£)-4b i n  > 9 5 %  d e ,  a  v a l u e  i d e n t i c a l  t o  t h a t
KHMDS
Fig. 2 Intramolecular cyclisation/ElcB-elimination mechanism for the stereoselective elimination o f sy/i-aldol 1 1 .











Scheme 8 Reagents and conditions: (i) 10 mol% Et:Zn, THF, rt; (ii) KHMDS, THF, —78 °C.
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Fig. 3 Simple conformational model to explain (£)-selectivity in elimination reaction.
o b s e r v e d  p r e v i o u s l y  f o r  e l i m i n a t i o n  o f  t h e  c o r r e s p o n d i n g  syn- 
a l d o l  3b u n d e r  t h e  s a m e  c o n d i t i o n s  ( S c h e m e  9 ) .  F u r t h e r m o r e ,  
t r e a t m e n t  o f  anti- a l d o l  18 w i t h  E b Z n  i n  C H : C U  r e s u l t e d  i n  
r e a r r a n g e m e n t  t o  a f f o r d  t h e  c o r r e s p o n d i n g  anti-1 , 3 - o x a z i n a n e -
2 , 4 - d i o n e  19 i n  > 9 5 %  d e ,  w h i c h  o n  t r e a t m e n t  w i t h  K H M D S  
i n  T H F  a t  - 7 8  ° C  a l s o  a f f o r d e d  a m i d e  (£)-4b i n  > 9 5 %  d e  
( S c h e m e  9 ) .  T h e s e  o b s e r v a t i o n s  a r e  t h e r e f o r e  c l e a r l y  c o n s i s t e n t  
w i t h  t h e  k e y  e l i m i n a t i o n  s t e p  o f  b o t h  « n / / - a l d o l  18 a n d  syn- 
a l d o l  3b o c c u r r i n g  via a n  E l c B - t y p e  m e c h a n i s m ,  i n  w h i c h  a  
c o m m o n  e n o l a t e  i n t e r m e d i a t e  20 e l i m i n a t e s  C 0 2 t o  a f f o r d  t h e  
a , P - u n s a t u r a t e d  a m i d e  (£)-4b i n  h i g h  d e  ( S c h e m e  9 ) .
W h i l s t  i t  i s  l i k e l y  t h a t  t h e  k e y  E l c B - t y p e  e l i m i n a t i o n  r e a c ­
t i o n s  o f  t h e  l , 3 - o x a z i n a n e - 2 , 4 - d i o n e  e n o l a t e  23 o c c u r  via a  
c o n c e r t e d  r e a c t i o n  m e c h a n i s m ,  t h e  o b s e r v e d  ( £ ) - s e l e c t i v i t y  i n  
t h e s e  e l i m i n a t i o n  r e a c t i o n s  m a y  b e  r a t i o n a l i s e d  u s i n g  a  s i m p l e
c o n f o r m a t i o n a l  m o d e l  t h a t  c o m p a r e s  t h e  r e l a t i v e  e n e r g i e s  o f  
t r a n s i t i o n  s t a t e  i n t e r m e d i a t e s  22 a n d  24 ( F i g .  3 ) .  I n  t h e  c a s e  
o f  t r a n s i t i o n  s t a t e  22 t h a t  l e a d s  t o  ( £ ) - a m i d e  21 ,  c o n c e r t e d  
e l i m i n a t i o n  o f  c a r b o n  d i o x i d e  f r o m  a  c y c l i c  r i n g  s y s t e m  r e q u i r e s  
o v e r l a p  o f  a n  e q u a t o r i a l  C 5 - c a r b a n i o n  w i t h  t h e  o * - o r b i t a l  o f  t h e  
C 6 - 0  b o n d ,  w h i c h  c a n  o n l y  o c c u r  f r o m  a  c h a i r  c o n f o r m e r  i n  
w h i c h  t h e  C 5 - R  g r o u p  o c c u p i e s  a n  a x i a l  p o s i t i o n ,  a n d  t h e  C 6 -  
R ,  g r o u p  o c c u p i e s  a n  e q u a t o r i a l  p o s i t i o n .  T h i s  c o m p a r e s  w i t h  
t r a n s i t i o n  s t a t e  24 t h a t  l e a d s  t o  ( Z ) - a m i d e  25, w h e r e  a  s i m i l a r  
o r b i t a l  a l i g n m e n t  r e s u l t s  i n  a  c h a i r  c o n f o r m e r  i n  w h i c h  b o t h  t h e  
C 5 R  g r o u p  a n d  C , , - R |  s u b s t i t u e n t s  b o t h  o c c u p y  a x i a l  p o s i t i o n s .  
S i n c e  t r a n s i t i o n  s t a t e  22 c o n t a i n s  o n l y  o n e  a x i a l  s u b s t i t u e n t ,  i t  
i s  l i k e l y  t o  b e  l o w e r  i n  e n e r g y  t h a n  t r a n s i t i o n  s t a t e  24 w h i c h  
c o n t a i n s  t w o  a x i a l  s u b s t i t u e n t s ,  a n d  a s  a  c o n s e q u e n c e  f o r m a t i o n  
o f  ( £ ) - a m i d e  21 i s  f a v o u r e d .  W h i l s t  t h i s  ‘ c a r b a n i o n ’ m o d e l
2 a
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Scheme 9 Reagents and conditions: (i) MgCl:. TMSC1, Et,N, PhCHO, EtOAc; (ii) KHMDS, THF, -7 8  °C; (iii) 10 mol% Et:Zn, THF, rt.
i s  c l e a r l y  a n  o v e r - s i m p l i f i c a t i o n  o f  t h e  c o n c e r t e d  e l i m i n a t i o n  
p r o c e s s e s  t h a t  a r e  l i k e l y  t o  b e  o c c u r r i n g  i n  t h e s e  e l i m i n a t i o n  
r e a c t i o n s ,  s i m i l a r  e l e c t r o n i c  a n d  s t e r i c  c o n s i d e r a t i o n s  a r e  l i k e l y  
t o  b e  o p e r a t i n g  t o  m a x i m i s e  o r b i t a l  o v e r l a p  i n  t h e  t r a n s i t i o n  
s t a t e  t h a t  p r e f e r e n t i a l l y  l e a d s  t o  t h e  f o r m a t i o n  o f  ( £ ) - a m i d e s  i n  
t h e s e  r e a c t i o n s .  H o w e v e r ,  i t  i s  a l s o  c l e a r  f r o m  t h e  p o o r e r  l e v e l s  
o f  s t e r e o c o n t r o l  ( 5 0 - 8 0 %  d e )  o b s e r v e d  f o r  t h e  e l i m i n a t i o n  o f  
j y / j - a l d o l s  d e r i v e d  f r o m  a , | 3 - u n s a t u r a t e d  a l d e h y d e s  a n d  c h i r a l  
a l d e h y d e s ,  t h a t  s u b t l e  c h a n g e s  i n  t h e  c o n f o r m a t i o n  a n d / o r  
e l e c t r o n  d e n s i t y  o f  t h e  t r a n s i t i o n  s t a t e s  o f  t h e s e  E l t B - t y p e  
r e a c t i o n s  c a n  r e s u l t  i n  s i g n i f i c a n t  l o s s e s  i n  ( £ ) - s e l e c t i v i t y .
S y n t h e s i s  o f  ( £ ) - « , P - u n s a t u r a t e d  c a r b o x y l i c  a c i d s  a n d  
( £ ) - a , p - u n s a t u r a t e d  o x a z o l i n c s
H a v i n g  s h o w n  t h a t  t h i s  e l i m i n a t i o n  m e t h o d o l o g y  a f f o r d e d  a n  
e x c e l l e n t  g e n e r a l  r o u t e  t o  ( £ ) - t r i s u b s t i t u t e d  a , P - u n s a t u r a t e d  
a m i d e s ,  t h e i r  c o n v e r s i o n  t o  o t h e r  c a r b o x y l i c  a c i d  d e r i v a t i v e s  
w a s  e x p l o r e d  i n  o r d e r  t o  d e m o n s t r a t e  t h e  s y n t h e t i c  v e r s a t i l i t y  
o f  t h i s  m e t h o d o l o g y .  F i v e  r e p r e s e n t a t i v e  ( £ ) - u , p - u n s a t u r a t e d  
a m i d e s  4 a - d  a n d  4 j  w e r e  r e f l u x e d  i n  6 M  H C l (aq )  f o r  5  h o u r s  t o  
a f f o r d  t h e i r  c o r r e s p o n d i n g  ( £ ) - a , p - u n s a t u r a t e d  a c i d s  2 6 a - d  a n d  
2 7  r e s p e c t i v e l y  i n  7 7 - 9 9 %  i s o l a t e d  y i e l d  ( S c h e m e  1 0 ,  T a b l e  3 ).37 
I m p o r t a n t l y ,  e x a m i n a t i o n  o f  t h e  ' H  N M R  s p e c t r a  o f  t h e  c r u d e  
r e a c t i o n  p r o d u c t s  o f  t h e s e  h y d r o l y s i s  r e a c t i o n s  r e v e a l e d  t h a t  a l l  
o f  t h e  a , p - u n s a t u r a t e d  a c i d s  h a d  b e e n  p r o d u c e d  a s  s i n g l e  i s o m e r s  
w i t h  n o  e v i d e n c e  o f  a n y  a l k e n e  m i g r a t i o n  h a v i n g  o c c u r r e d  u n d e r  
t h e  s t r o n g  a c i d  c o n d i t i o n s  u s e d  f o r  h y d r o l y s i s .  T h e  s t r u c t u r e s  
o f  a , P - u n s a t u r a t e d  a c i d s  ( £ ) - 2 6 b  a n d  ( £ ) - 2 6 c  w e r e  c o n f i r m e d  
via c o m p a r i s o n  w i t h  c o m m e r c i a l l y  a v a i l a b l e  s a m p l e s  o f  ( £ ) - 2-  
m e t h y l p e n t e n o i c  a c i d  a n d  ( £ ) - 2 - m e t h y l - 3 - p h e n y l p r o p e n o i c  a c i d  
r e s p e c t i v e l y ,  w h i l s t  s p e c t r o s c o p i c  d a t a  f o r  ( £ ) - 2 6 a  a n d  ( £ ) - 2 7  
w e r e  i d e n t i c a l  t o  p r e v i o u s  l i t e r a t u r e  r e p o r t s .38,39
o o
R R
4a-d, 4j 26a-d, 27
Scheme 10 Reagents and c onditions: (i)6 M HCl(Iiq,.
Table 3 Yields for synthesis of (£)-acids 26a-d and 27
A c i d R R > d e  ( % ) Y i e l d  ( % )
26a , P r C y c l o h e x y l > 9 5 9 9
26b M e P h > 9 5 9 5
26c M e E t > 9 5 9 1
26d B n M e ( C H , ) „ - > 9 5 9 5
27 M e ( £ ) - P h C H = C H - > 9 5 7 7
T h e  s y n t h e t i c p o t e n t i a l  o f  t h i s  m e t h o d o l o g y w a s  f u r t h e r
d e m o n s t r a t e d  via c y c l i s a t i o n  o f  t h e  j V - h y d r o x y a m i d e  f r a g m e n t  
o f  ( £ ) - a m i d e s  4 b  o r  4 c  t o  a f f o r d  t h e i r  c o r r e s p o n d i n g  t r i s u b s t i ­
t u t e d  ( £ ) - a , P - u n s a t u r a t e d  o x a z o l i n e s  ( £ ) - 2 8  a n d  ( £ ) - 2 9 .  T h u s ,  
a d d i t i o n  o f  t h i o n y l  c h l o r i d e  ( 5  e q . )  i n  a  d r o p w i s e  f a s h i o n  t o  a n  
i c e - c o l d  s o l u t i o n  o f  a , P - u n s a t u r a t e d  a m i d e s  4 b  a n d  4 c  i n  C H : C 1 2 , 
r e s u l t e d  i n  t h e  d e s i r e d  o x a z o l i n e s  ( £ ) - 2 8  a n d  ( £ ) - 2 9  i n  9 7 %  a n d  
88%  y i e l d  r e s p e c t i v e l y  ( S c h e m e  1 1 ) .  I t  s h o u l d  b e  n o t e d  t h a t  t h e s e  
t y p e s  o f  ( £ ) - a , p - u n s a t u r a t e d  o x a z o l i n e s  a r e  u s e f u l  s y n t h e t i c  
i n t e r m e d i a t e s  t h a t  a r e  e a s i l y  c o n v e r t e d  i n t o  t h e i r  c o r r e s p o n d i n g  
( £ ) - a , P - u n s a t u r a t e d  a c i d s ,  a l c o h o l s  a n d  a l d e h y d e s  u s i n g  k n o w n  
l i t e r a t u r e  p r o c e d u r e s .40
Conclusion
I n  c o n c l u s i o n ,  w e  h a v e  d e m o n s t r a t e d  t h a t  p o t a s s i u m  a l k o x i d e s  
o f  ( V - a c y l - o x a z o l i d i n - 2 - o n e  d e r i v e d - . s y w - a l d o l s  u n d e r g o  s t e r e o s ­
e l e c t i v e  e l i m i n a t i o n  r e a c t i o n s  t o  a f f o r d  a  r a n g e  o f  t r i s u b s t i t u t e d  
( £ ) - a , P - u n s a t u r a t e d  a m i d e s  i n  e x c e l l e n t  d e ,  t h a t  c o u l d  b e  e a s i l y  
c o n v e r t e d  i n t o  t h e i r  c o r r e s p o n d i n g  ( £ ) - a , p - u n s a t u r a t e d  a c i d s  o r
(£)-4c (£->-29
S c h e m e  11 Reagents and conditions: ( i )  S O C K ,  C f - L C K ,  0  ° C .
( £ ) - « , P - u n s a t u r a t e d  o x a z o l i n e s  i n  g o o d  y i e l d .  A l k o x i d e s  o f  syn- 
a l d o l s  d e r i v e d  f r o m  a , p - u n s a t u r a t e d  a l d e h y d e s  w e r e  e l i m i n a t e d  
t o  a f f o r d  t h e i r  c o r r e s p o n d i n g  t r i s u b s t i t u t e d  ( £ ) - a , P - u n s a t u r a t e d -  
a m i d e s  i n  a n  i n f e r i o r  8 0 %  d e ,  w h i l s t  t h e r e  w a s  a l s o  a  s i m i l a r  
l o s s  i n  ( £ ) - s e l e c t i v i t y  d u r i n g  e l i m i n a t i o n  o f  m o r e  c o m p l e x  syn- 
a l d o l s  d e r i v e d  f r o m  c h i r a l  a l d e h y d e s .  T h e s e  e l i m i n a t i o n  r e a c t i o n s  
p r o c e e d  via r e a r r a n g e m e n t  o f  t h e i r  . r y w - a l d o l  a l k o x i d e  t o  a
1 , 3 - o x a z i n a n e - 2 , 4 - d i o n e  e n o l a t e  i n t e r m e d i a t e  t h a t  s u b s e q u e n t l y  
e l i m i n a t e s  c a r b o n  d i o x i d e  t o  a f f o r d  a  t r i s u b s t i t u t e d  ( £ ) - a , P -  
u n s a t u r a t e d  a m i d e .  T h e  ( £ ) - s e l e c t i v i t y  o b s e r v e d  d u r i n g  t h e  
c r i t i c a l  E l c B - t y p e  e l i m i n a t i o n  s t e p  o f  t h i s  r e a c t i o n  h a s  b e e n  
r a t i o n a l i s e d  u s i n g  a  s i m p l e  c o n f o r m a t i o n a l  m o d e l  t h a t  e m p l o y s  
c h a i r - l i k e  t r a n s i t i o n  s t a t e s  t o  e x p l a i n  t h e  o b s e r v e d  s t e r e o c o n t r o l .
Experimental
G e n e r a l  e x p e r i m e n t a l
A l l  r e a c t i o n s  w e r e  c a r r i e d  o u t  u n d e r  n i t r o g e n  o r  a r g o n  u s i n g  
s t a n d a r d  v a c u u m  l i n e  t e c h n i q u e s  a n d  g l a s s w a r e  t h a t  w a s  f l a m e  
d r i e d  a n d  c o o l e d  u n d e r  n i t r o g e n .  T H F  w a s  d i s t i l l e d  f r o m  
s o d i u m / b e n z o p h e n o n e  k e t y l ,  w h i l s t  C H : C 1 :  w a s  d i s t i l l e d  f r o m  
C a H :  u n d e r  n i t r o g e n .  A l l  o t h e r  r e a g e n t s  w e r e  u s e d  a s  s u p p l i e d  
w i t h o u t  f u r t h e r  p u r i f i c a t i o n .  F l a s h  c o l u m n  c h r o m a t o g r a p h y  w a s  
p e r f o r m e d  o n  s i l i c a  g e l  ( K i e s e l g e l  6 0 ) .  T L C  w a s  p e r f o r m e d  
o n  M e r c k  a l u m i n i u m  s h e e t s  c o a t e d  w i t h  0 . 2  m m  s i l i c a  g e l  6 0  
F 2 5 4 .  P l a t e s  w e r e  v i s u a l i s e d  e i t h e r  b y  U V  l i g h t  ( 2 5 4  n m ) ,  i o d i n e ,  
a m m o n i u m  m o l y b d a t e  ( 7 %  s o l u t i o n  i n  e t h a n o l )  o r  p o t a s s i u m  
p e r m a n g a n a t e  ( 1 %  i n  2 %  a q u e o u s  a c e t i c  a c i d ,  c o n t a i n i n g  7 %  
p o t a s s i u m  c a r b o n a t e ) .  I n f r a  r e d  s p e c t r a  w e r e  r e c o r d e d  a s  t h i n  
f i l m s  o r  K B r  d i s c s  u s i n g  a  P e r k i n - E l m e r  P A R A G O N  1 0 0 0  
F T - I R  s p e c t r o m e t e r ,  w i t h  s e l e c t e d  p e a k s  r e p o r t e d  i n  c m 1 . 
' H  a n d  l 3 C  N M R  s p e c t r a  w e r e  r e c o r d e d  o n  a  B r u k e r  A M -  
3 0 0  s p e c t r o m e t e r .  C h e m i c a l  s h i f t s  a r e  r e p o r t e d  i n  p a r t s  p e r  
m i l l i o n  ( p p m )  a n d  a r e  r e f e r e n c e d  t o  t h e  r e s i d u a l  s o l v e n t  p e a k ,  
w i t h  c o u p l i n g  c o n s t a n t s  ( J )  m e a s u r e d  i n  H e r t z .  L o w  r e s o l u t i o n  
m a s s  s p e c t r a  ( m /z )  w e r e  r e c o r d e d  o n  e i t h e r  a  F i n n i g a n  M A T  
8 3 4 0  i n s t r u m e n t  o r  a  F i n n i g a n  M A T  9 0 0  X L T  i n s t r u m e n t .  
M a j o r  p e a k s  a r e  l i s t e d  w i t h  i n t e n s i t i e s  q u o t e d  a s  p e r c e n t a g e s  
o f  t h e  b a s e  p e a k .  A c c u r a t e  m a s s  m e a s u r e m e n t s  w e r e  r e c o r d e d  
o n  a  F i n n i g a n  M A T  9 0 0  X L T  i n s t r u m e n t .  O p t i c a l  r o t a t i o n s  
w e r e  r e c o r d e d  o n  a n  O p t i c a l  A c t i v i t y  L t d  A A - 1 0  a u t o m a t i c  
p o l a r i m e t e r ,  u s i n g  a  p a t h  l e n g t h  o f  10 c m ,  i n  s p e c t r o s c o p i c  
g r a d e  s o l v e n t s  ( A l d r i c h ) ,  w i t h  c o n c e n t r a t i o n s  ( c )  g i v e n  i n  g  
p e r  1 0 0  c m ’ ,  s o l v e n t  a n d  t e m p e r a t u r e  a s  r e c o r d e d .  M e l t i n g  
p o i n t s  w e r e  r e c o r d e d  o n  a  B i i c h i  5 3 5  m e l t i n g  p o i n t  a p p a r a t u s  
a n d  a r e  u n c o r r e c t e d .  E l e m e n t a l  a n a l y s e s  w e r e  p e r f o r m e d  u s i n g  
a n  E x e t e r  A n a l y t i c a l  I n c  C E - 4 4 0  E l e m e n t a l  a n a l y s e r .  S i n g l e  
c r y s t a l  X - r a y  d i f f r a c t i o n  d a t a  w e r e  c o l l e c t e d  o n  a  N o n i u s  K a p p a  
C C D  m a c h i n e .  S t r u c t u r a l  d e t e r m i n a t i o n  a n d  r e f i n e m e n t  w e r e  
a c h i e v e d  u s i n g  t h e  S H E L Z  s u i t e  o f  p r o g r a m m e s ;  d r a w i n g s  w e r e  
p r o d u c e d  u s i n g  O R T E X .
General procedure A: p r e p a r a t i o n  o f  A - a c y l - o x a z o l i d i n - 2 - o n e s
A  s o l u t i o n  o f  n - b u t y l l i t h i u m  i n  h e x a n e s  ( 1 . 1  e q . )  w a s  a d d e d  
d r o p w i s e  via s y r i n g e  t o  a  s t i r r e d  s o l u t i o n  o f  o x a z o l i d i n - 2- o n e
O r  g .  B i o m o  I. C h e m . ,  2 0 0 5 , 3 , 2 9 7 6 - 2 9 8 9  2 9 8 1
1  ( 1  e q . )  i n  T H F  a t  — 7 8  ° C  u n d e r  a  n i t r o g e n  a t m o s p h e r e  a n d  
t h e  m i x t u r e  w a s  a l l o w e d  t o  s t i r  f o r  1 5  m i n u t e s .  T h e  a p p r o p r i a t e  
a c i d  c h l o r i d e  ( 1 . 1  e q . )  w a s  t h e n  a d d e d  a t  — 7 8  ° C .  T h e  r e a c t i o n  
w a s  s t i r r e d  a t  t h i s  t e m p e r a t u r e  f o r  2 h o u r s  a n d  a l l o w e d  t o  w a r m  
t o  r o o m  t e m p e r a t u r e  o v e r  a  1 h o u r  p e r i o d .  S a t u r a t e d  N H 4C l ( aq , 
w a s  a d d e d  a n d  t h e  r e a c t i o n  e x t r a c t e d  w i t h  C H 2C 1 2 ( x  3 ) .  T h e  
c o m b i n e d  o r g a n i c  e x t r a c t s  w e r e  w a s h e d  w i t h  N a H C O , , a q ) ,  d r i e d  
( M g S 0 4 ) ,  a n d  c o n c e n t r a t e d  in vacuo t o  a f f o r d  t h e  d e s i r e d  ( V - a c y l  
o x a z o l i d i n - 2- o n e .
General procedure B: p r e p a r a t i o n  o f  
A - a c y l - o x a z o l i d i n - 2- o n e - . v y / i - a l d o l s
A  0 . 5  M  s o l u t i o n  o f  9 - B B N - O T f  i n  h e x a n e s  ( 1 . 2  e q . )  w a s  a d d e d  
via s y r i n g e  t o  a  s t i r r e d  s o l u t i o n  o f  / V - a c y l o x a z o l i d i n - 2 - o n e  ( 1  
e q . )  i n  C H 2C 1 2 a t  0  ° C  a n d  a l l o w e d  t o  s t i r  a t  t h i s  t e m p e r a t u r e  
f o r  5  m i n u t e s .  A L / V - d i i s o p r o p y l e t h y l a m i n e  ( 1 . 4  e q . )  w a s  a d d e d ,  
t h e  r e a c t i o n  w a s  s t i r r e d  f o r  2 5  m i n u t e s  a t  0  ° C  b e f o r e  c o o l i n g  
t o  — 7 8  ° C .  A n  a l d e h y d e  ( 1 . 1  e q . )  w a s  t h e n  a d d e d ,  t h e  r e a c t i o n  
w a s  s t i r r e d  f o r  2  h o u r s  a n d  a l l o w e d  t o  w a r m  t o  0  ° C  f o r  3 0  
m i n u t e s .  p H  7 . 0  p h o s p h a t e  b u f f e r  w a s  a d d e d ,  a l l o w e d  t o  s t i r  f o r  
5  m i n  a n d  a  2  : 1 s o l u t i o n  o f  m e t h a n o l - h y d r o g e n  p e r o x i d e  a d d e d  
d r o p w i s e .  T h e  r e a c t i o n  w a s  e x t r a c t e d  w i t h  C H 2C 1 2 ( x  3 )  a n d  t h e  
c o m b i n e d  o r g a n i c  e x t r a c t s  w e r e  w a s h e d  w i t h  N a H C O , ( a q „  b r i n e ,  
d r i e d  ( M g S 0 4 )  a n d  c o n c e n t r a t e d  in vacuo t o  a f f o r d  t h e  d e s i r e d  
s j / z i - a l d o l .
General procedure C: p r e p a r a t i o n  o f  t r i s u b s t i t u t e d  
( Z f ) - a , p - u n s a t u r a t e d  a m i d e s
A  0 . 5  M  s o l u t i o n  o f  K H M D S  i n  t o l u e n e  ( 1 . 5  e q . )  w a s  a d d e d  
d r o p w i s e  t o  a  s t i r r e d  s o l u t i o n  o f  s y w - a l d o l  ( 1  e q . )  i n  T H F  a t  
— 7 8  ° C  u n d e r  n i t r o g e n ,  a n d  t h e  r e a c t i o n  w a s  s t i r r e d  a t  — 7 8  ° C  
f o r  t w o  h o u r s .  S a t u r a t e d  N H 4C l (aq l  w a s  a d d e d  a n d  t h e  r e a c t i o n  
w a s  e x t r a c t e d  w i t h  C H 2C 1 2 ( x  3 ) .  T h e  c o m b i n e d  o r g a n i c  e x t r a c t s  
w e r e  w a s h e d  w i t h  b r i n e ,  d r i e d  ( M g S 0 4 ) ,  a n d  c o n c e n t r a t e d  in 
vacuo t o  a f f o r d  t h e  d e s i r e d  (E)-a,p - u n s a t u r a t e d  a m i d e .
General procedure D: p r e p a r a t i o n  o f  l , 3 - o x a / . i n a n e - 2 , 4 - d i o n e s
A  1 . 0  M  s o l u t i o n  o f  E t 2 Z n  i n  t o l u e n e  ( 0 . 1  e q . )  w a s  a d d e d  
d r o p w i s e  t o  a  s t i r r e d  s o l u t i o n  o f  , y > ? z - a l d o l  (1 e q . )  i n  C H 2C 1 2 
a t  r o o m  t e m p e r a t u r e ,  a n d  t h e  r e a c t i o n  w a s  s t i r r e d  f o r  2 h o u r s .  
S a t u r a t e d  N H 4C l (aq )  w a s  a d d e d  a n d  t h e  r e a c t i o n  w a s  e x t r a c t e d  
w i t h  C H 2C 1 2 ( x  3 ) .  T h e  c o m b i n e d  o r g a n i c  e x t r a c t s  w e r e  w a s h e d  
w i t h  b r i n e ,  d r i e d  ( M g S 0 4 ) ,  a n d  c o n c e n t r a t e d  in vacuo t o  a f f o r d  
t h e  d e s i r e d  s _ y « - l , 3 - o x a z i n a n e - 2 , 4 - d i o n e .
General procedure E: p r e p a r a t i o n  o f  t r i s u b s t i t u t e d  
(E )-a ,P - u n s a t u r a t e d  a c i d s
A n  ( £ ) - a , p - u n s a t u r a t e d  a m i d e  w a s  r e f l u x e d  i n  6 . 0  M  H C 1  f o r  
f i v e  h o u r s .  T h e  r e a c t i o n  m i x t u r e  w a s  a l l o w e d  t o  c o o l  t o  r o o m  
t e m p e r a t u r e ,  s a t u r a t e d  w i t h  s o d i u m  c h l o r i d e ,  a n d  e x t r a c t e d  w i t h  
e t h y l  a c e t a t e  ( 5  x  1 0  m l ) .  T h e  c o m b i n e d  o r g a n i c  l a y e r s  w e r e  d r i e d  
o v e r  m a g n e s i u m  s u l f a t e  a n d  t h e  s o l v e n t  w a s  r e m o v e d  in vacuo 
t o  a f f o r d  t h e  d e s i r e d  ( Z T ) - a , P - u n s a t u r a t e d  c a r b o x y l i c  a c i d .
General procedure F: p r e p a r a t i o n  o f  t r i s u b s t i t u t c d  
( E ) - a , p - o x a z o l i n e s
T h i o n y l  c h l o r i d e  ( 5  e q . )  w a s  a d d e d  d r o p w i s e  t o  a  s t i r r e d  s o l u t i o n  
o f  a , p - u n s a t u r a t e d  a m i d e  ( 1  e q . )  i n  C H 2C 1 2 i n  a n  i c e  b a t h ,  a n d  
t h e  r e a c t i o n  m i x t u r e  w a s  s t i r r e d  f o r  2 h o u r s  a t  t h i s  t e m p e r a t u r e .  
A  5 . 0  M  s o l u t i o n  o f  N a O H  ( 3  m L )  w a s  a d d e d  d r o p w i s e  a n d  
t h e  r e a c t i o n  w a s  e x t r a c t e d  w i t h  C H 2C 1 2 ( x  3 ) .  T h e  c o m b i n e d  
o r g a n i c  e x t r a c t s  w e r e  w a s h e d  w i t h  b r i n e ,  d r i e d  ( M g S 0 4 ) ,  a n d  
c o n c e n t r a t e d  in vacuo t o  a f f o r d  t h e  d e s i r e d  (E)-a,P - u n s a t u r a t e d  
o x a z o l i n e .
3 - P r o p i o n y H  , 3 - o x a z o l i d i n - 2 - o n e  2 a 3 3 .  R e a c t i o n  o f o x a z o l i d i n -
2 - o n e  1 ( 5 . 0  g ,  5 7 . 4 7  m m o l )  w i t h  a  2 . 5  M  s o l u t i o n  o f  n- 
b u t y l l i t h i u m  i n  h e x a n e s  ( 2 5 . 3 0  m L ,  6 3 . 2  m m o l )  a n d  p r o p i o n y l
2 O r g .  B i o m o l .  C h e m . ,  2 0 0 5 , 3 , 2 9 7 6 - 2 9 8 9
c h l o r i d e  ( 5 . 1 6  g ,  6 3 . 2  m m o l )  i n  T H F  ( 2 5 0  m L ) ,  a c c o r d i n g  t o  
g e n e r a l  p r o c e d u r e  A ,  a f f o r d e d  a f t e r  r e c r y s t a l l i s a t i o n  f r o m  h o t  
e t h y l  a c e t a t e  t h e  t i t l e  c o m p o u n d  2 a  ( 5 . 9 4 0  g ,  4 1 . 5 4  m m o l )  
i n  7 2 %  y i e l d  a s  a  w h i t e  c r y s t a l l i n e  s o l i d ,  m p  7 7 - 7 9  ° C  ( l i t ,33 
8 0 - 8 1  ° C ) ;  v max  ( K B r  d i s c ) / c m - '  1 7 7 3  ( C = 0 ) o x ,  1 7 0 0  ( C = 0 ) ;  
<5h ( 3 0 0  M H z ,  C D C l , )  1 . 1 7  ( 3 H ,  t ,  J  7 . 5 ,  C H 2C / / , ) ,  2 . 9 4  ( 2 H ,  q ,  
J  7 . 5 ,  C Z Z , C H , ) ,  4 . 0 2  ( 2 H ,  a p p  t ,  J  8 . 0 ,  C H 2N ) ,  4 . 4 2  ( 2 H ,  a p p  t ,  
J  8 . 0 ,  C Z Z , 0 ) ;  S, ( C D C l , )  8 . 7 ,  2 9 . 1 ,  4 2 . 9 ,  6 2 . 4 ,  1 5 4 . 0 ,  1 7 4 . 6 ;  m /z  
( E P * )  1 4 3  ( 4 9 ,  M + * ) ,  5 7  ( 1 0 0 % ,  C H , C H , C O + ) ;  H R M S  ( F A B + )  
C 6H „ N O ,  [ M H + ]  r e q u i r e s  1 4 3 . 0 5 7 7 ;  f o u n d  1 4 3 . 0 5 7 4 .
3 - ( 3 - M e t h y l b u t a n o y  l ) - l  , 3 - o x a z o l i d i n - 2 - o n e  2 b 41.  R e a c t i o n  o f  
o x a z o l i d i n - 2 - o n e  1  ( 9 . 9 0 5  g ,  1 1 3 . 8 5  m m o l )  w i t h  a  2 . 5  M  s o l u t i o n  
o f  « - b u t y l l i t h i u m  i n  h e x a n e s  ( 5 0 . 1 0  m L ,  1 2 5 . 2 3  m m o l )  a n d  i s o -  
v a l e r y l  c h l o r i d e  ( 2 1 . 5 0  m L ,  1 2 5 . 2 3  m m o l )  i n  T H F  ( 5 0 0  m L ) ,  
a c c o r d i n g  t o  g e n e r a l  p r o c e d u r e  A ,  a f f o r d e d  a f t e r  p u r i f i c a t i o n  
t h r o u g h  s i l i c a  g e l  c h r o m a t o g r a p h y  ( 4 0 %  e t h y l  a c e t a t e - p e t r o l )  
t h e  t i t l e  c o m p o u n d  2 b  ( 1 4 . 4 0 8  g ,  8 4 . 2 6  m m o l )  i n  7 4 %  y i e l d  a s  
a  c o l o u r l e s s  o i l ,  v m ax  ( n e a t ) / c m _ l  1 7 7 9  ( C = 0 ) o x ,  1 6 9 9  ( C = 0 ) ;  
<5H ( 3 0 0  M H z ,  C D C l , )  0 . 9 9  ( 6 H ,  d ,  J  7 . 0 ,  C H ( C Z Z , ) 2 ) ,  2 . 1 8  ( 1 H ,  
m ,  J  7 . 0 ,  C Z Z ( C H , ) 2 ) ,  2 . 8 1  ( 2 H ,  d ,  J  7 . 0 ,  C H 2'P r ) ,  4 . 0 3  ( 2 H ,  
a p p  t ,  J  8 . 0 ,  C H ,N ) ,  4 . 4 2  ( 2 H ,  a p p  t ,  J  8 . 0 ,  C Z Z 20 ) ;  <5c ( C D C l , )
2 2 . 8 ,  2 5 . 3 ,  4 2 . 9 ,  4 3 . 9 ,  6 2 . 3 ,  1 5 3 . 9 ,  1 7 3 . 2 ;  m /z  ( C P ,  i s o - b u t a n e )  
1 7 2  ( 8 5 ,  M H + ) ,  1 2 9  ( 8 2 ,  M H + - C H ( C H , ) , ) ,  8 5  ( 1 0 0 % ) ;  H R M S  
( F A B + ) C 8H l4N O ,  [ M H + ]  r e q u i r e s  1 7 2 . 0 9 7 4 ;  f o u n d  1 7 2 . 0 9 7 4 .
3 - ( 3 - P h e n y l p r o p a n o y I ) - l  , 3 - o x a z o l i d i n - 2 - o n e  2 c 4 2 .  R e a c t i o n  
o f  o x a z o l i d i n - 2 - o n e  1 ( 1 . 4 9 6  g ,  1 7 . 2 0  m m o l )  w i t h  a  2 . 5  M  
s o l u t i o n  o f  n - b u t y l l i t h i u m  i n  h e x a n e s  ( 7 . 6 0  m L ,  1 8 . 9 1  m m o l )  
a n d  p h e n y l p r o p i o n y l  c h l o r i d e  ( 2 . 8 0  m L ,  1 8 . 9 1  m m o l )  i n  T H F  
( 9 0  m L ) ,  a c c o r d i n g  t o  g e n e r a l  p r o c e d u r e  A ,  a f f o r d e d  a f t e r  p u ­
r i f i c a t i o n  t h r o u g h  s i l i c a  g e l  c h r o m a t o g r a p h y  ( 20%  e t h y l  a c e t a t e  
p e t r o l )  t h e  t i t l e  c o m p o u n d  2 c  ( 2 . 7 6 5  g ,  1 2 . 6 3  m m o l )  i n  7 3 %  y i e l d  
a s  a  w h i t e  s o l i d ,  m p  1 0 0 - 1 0 1  ° C ;  v , „ ax  ( K B r  d i s c ) / c m _ l  3 0 0 8  
( C - H ) a r ,  1 7 6 5  ( C = 0 ) o x ,  1 6 9 2  ( C = 0 ) ; < 5 H ( 3 0 0  M H z ,  C D C l , )  2 . 9 1  
( 2 H ,  t ,  J  7 . 5 ,  C H 2C / / , P h ) ,  3 . 1 7  ( 2 H ,  t ,  J  7 . 5 ,  C Z E C H , P h ) ,  3 . 9 0  
( 2 H .  a p p  t ,  J  8 . 0 ,  C Z / j N ) ,  4 . 2 9  ( 2 H ,  a p p  t ,  J  8 . 0 ,  C Z Z , O ) ,  7 . 0 9 -
7 . 2 4  ( 5 H ,  m ,  A r - Z Z ) ;  <5c ( C D C I , )  3 0 . 6 ,  3 7 . 2 ,  4 2 . 9 ,  6 2 . 5 ,  1 2 6 . 6 ,
1 2 8 . 8 ,  1 2 8 . 9 ,  1 4 0 . 9 ,  1 5 3 . 9 ,  1 7 2 . 9 ;  m /z  ( E P * )  2 1 9  ( 5 5 ,  M 4 * ) ,  1 3 2  
( 2 7 ,  P h C H , C H X O + ) ,  1 0 4 ( 1 0 0 ) ,  88 ( 8 7 ,  M + - - P h C H , C H 2C O * ) ;  
H R M S  ( E S + )  C l2H l7N , 0 ,  [ M N H p ]  r e q u i r e s  2 3 7 . 1 2 3 4 ;  f o u n d  
2 3 7 . 1 2 3 7 .
3 - ( 2 - P h e n y l a c e t y l ) - 1 , 3 - o x a z o l i d i n - 2 - o n e  2 d 4 3 .  R e a c t i o n  o f  
o x a z o l i d i n - 2 - o n e  1  ( 9 . 9 0  g ,  1 1 3 . 7 9  m m o l )  w i t h  a  1 .6 M  s o l u t i o n  
o f  / i - b u t y l l i t h i u m  i n  h e x a n e s  ( 7 8 . 2 0  m L ,  1 2 5 . 1 7  m m o l )  a n d  
p h e n y l  a c e t y l  c h l o r i d e  ( 2 1 . 5 0  m L ,  1 2 5 . 1 7  m m o l )  i n  T H F  
( 5 0 0  m L ) ,  a c c o r d i n g  t o  g e n e r a l  p r o c e d u r e  A .  a f f o r d e d  a f t e r  
p u r i f i c a t i o n  t h r o u g h  s i l i c a  g e l  c h r o m a t o g r a p h y  ( 20%  e t h y l  
a c e t a t e - p e t r o l )  t h e  t i t l e  c o m p o u n d  2 d  ( 1 4 . 4 0 4  g ,  7 0 . 2 6  m m o l )  
i n  6 2 %  y i e l d  a s  a  w h i t e  s o l i d ,  m p  6 1 - 6 3  ° C  ( l i t ,43 6 4 - 6 5  ° C ) ;  
v m a x ( K B r d i s c ) / c n r '  3 0 1 0 ( C - H ) a r ,  1 7 7 3 ( C = 0 ) o x ,  1 6 9 6 ( C = 0 ) ;  
<5h ( 3 0 0  M H z ,  C D C l , )  3 . 9 2  ( 2 H ,  a p p  t ,  J  8 . 0 ,  C Z Z : N ) ,  4 . 2 5  ( 2 H ,  s ,  
C Z Z 2P h ) ,  4 . 2 9  ( 2 H ,  a p p  t ,  J  8 . 0 ,  C Z Z , O ) ,  7 . 2 6 - 7 . 3 1  ( 5 H ,  m ,  
A r - Z Z ) ;  f5 c ( C D C l , )  4 3 . 2 ,  4 7 . 8 ,  6 3 . 2 ,  1 2 8 . 1 ,  1 2 9 . 4 ,  1 3 0 . 0 ,  1 3 1 . 6 ,
1 5 4 . 7 ,  1 7 2 . 3 ;  m /z  ( E P + )  2 0 5  ( 3 0 ,  M * + ) ,  1 1 8  ( 1 0 0 ) ,  9 1  ( 6 0 % ,  
P h C H P ) ;  H R M S  ( E S + )  C n H „ N O . ,  [ M H + ]  r e q u i r e s  2 0 5 . 0 7 3 9 ;  
f o u n d  2 0 5 . 0 7 4 2 .
sy n - 3 -  {  2  - 1 C y c l o h e x y l (  h y d r o x y  ) m e t h y  11 - 3 -  m e t h y l b u t a n o y  1 }  -
1 . 3 - o x a z o l i d i n - 2 - o n c  3 a .  R e a c t i o n  o f  3 - ( 3 - m e t h y l b u t a n o y l ) -
1 . 3 - o x a z o l i d i n - 2 - o n e  2 b  ( 1 . 5 0 0  g ,  8 . 7 7  m m o l )  w i t h  a  0 . 5  M  
s o l u t i o n  o f  9 - B B N - O T f  i n  h e x a n e s  ( 2 1 . 1 1  m L ,  1 0 . 5 3  m m o l ) ,  
/ V , ( V - d i i s o p r o p y l e t h y l a m i n e  ( 1 . 9 9  m L ,  1 1 . 4 0  m m o l )  a n d  
c y c l o c a r b o x a l d e h y d e  ( 1 . 1 7  m L ,  9 . 6 5  m m o l )  i n  C H 2C 1 2 ( 4 0  m L ) ,  
a c c o r d i n g  t o  g e n e r a l  p r o c e d u r e  B ,  a f f o r d e d  a f t e r  p u r i f i c a t i o n  
t h r o u g h  s i l i c a  g e l  c h r o m a t o g r a p h y  ( g r a d i e n t ,  10- 20%  e t h y l  
a c e t a t e - p e t r o l )  t h e  t i t l e  c o m p o u n d  syn-3 a  ( 1 . 4 5 1  g ,  5 . 1 1  m m o l )  
i n  5 8 %  y i e l d  a s  a  w h i t e  s o l i d ,  m p  1 3 1 - 1 3 3  ° C ;  v m a x  ( K B r  
d i s c ) / c m " '  3 5 1 0  ( s ,  O H ) ,  1 7 7 3  ( C = 0 ) o x ,  1 6 7 6  ( C = 0 ) ;  
( 5 H ( 3 0 0  M H z ,  C D C l , )  1 . 0 2  ( 3 H ,  d ,  J  7 . 0 ,  C H ( C Z Z , ) 2 ) ,  1 . 0 3  
( 3 H ,  d ,  J  7 . 0 ,  C H ( C Z Z , ) 2 ) ,  1 . 1 2 - 1 . 2 7  ( 4 H ,  m ,  C y - Z Z ) ,  1 . 6 1 - 1 . 6 7
( 2 H ,  m ,  C y  H ),  1 . 7 3 - 1 . 7 7  ( 2 H ,  m ,  C y  H ), 1 . 8 3 - 1 . 9 1  ( 2 H .  m ,  
C y - / / ) ,  2 . 0 4 - 2 . 1 0  ( 1 H ,  m ,  C y - / / ) ,  2 . 3 1  ( 1 H ,  m ,  7  7 . 0 ,  5 . 0 ,  
C / / ( C H 3 ) 2 ) ,  3 . 7 2 - 3 . 7 8  ( 1 H ,  m ,  C H O H ) ,  4 . 0 4  ( 2 H ,  a p p  t ,  7  8 . 0 ,  
CH,N) ,  4 . 2 2  ( 1 H ,  d d ,  7  7 . 0 ,  5 . 0 ,  C H ' P r ) ,  4 . 4 1  ( 2 H ,  a p p  t ,  7  8 . 0 ,  
CH,0) ;  <5c ( C D C 1 3 )  1 9 . 6 ,  2 1 . 5 ,  2 6 . 7 ,  2 7 . 4 ,  2 8 . 2 ,  3 0 . 6 ,  4 1 . 7 ,  4 3 . 0 ,
4 9 .3 . 6 1 .9 . 7 6 .0 . 1 5 3 . 7 . 1 7 5 .6 : m / z  ( F A B + )  2 8 4  ( 9 7 ,  M H + ) ,  2 6 6  
( 1 0 0 % ,  M  + - O H ) ;  H R M S  ( F A B + )  C l5H 26N 0 4 [ M H + ]  r e q u i r e s  
2 8 4 . 1 8 6 2 ;  f o u n d  2 8 4 . 1 8 6 8 .
. vv’/ i - 3 - ( 3 - H y d r o x y - 2 - m e t h y l - 3 - p h e n y l p r o p a n o y l ) - 1 , 3 - o x a z o l i d i n -
2 - o n e  3 b 2 7 .  R e a c t i o n  o f  3 - p r o p i o n y l - l , 3 - o x a z o l i d i n - 2 - o n e  2 a  
( 0 . 5 4 5  g ,  3 . 8 1  m m o l )  w i t h  a  0 . 5  M  s o l u t i o n  o f  9 - B B N - O T f  i n  
h e x a n e s  ( 9 . 1 4  m L ,  4 . 5 7  m m o l ) ,  A L A - d i i s o p r o p y l e t h y l a m i n e  
( 0 . 8 6  m L ,  4 . 9 5  m m o l )  a n d  b e n z a l d e h y d e  ( 0 . 4 3  m L ,  4 . 1 9  m m o l )  
i n  C H 2C 1 2 ( 2 0  m L ) ,  a c c o r d i n g  t o  g e n e r a l  p r o c e d u r e  B ,  a f f o r d e d  
a f t e r  p u r i f i c a t i o n  t h r o u g h  s i l i c a  g e l  c h r o m a t o g r a p h y  ( g r a d i e n t ,  
2 0 - 3 0 %  e t h y l  a c e t a t e - p e t r o l )  t h e  t i t l e  c o m p o u n d  . v y « - 3 b  
( 0 . 6 5 3  g ,  2 . 6 2  m m o l )  i n  6 9 %  y i e l d  a s  a  w h i t e  c r y s t a l l i n e  s o l i d ,  
m p  1 0 2 - 1 0 4  ° C  ( l i t ,27 1 0 5 - 1 0 6  ° C ) ;  v m a x  ( K B r  d i s c ) / c n r '  3 5 6 1  
( s ,  O H ) ,  1 7 6 6  ( C = 0 ) o x ,  1 6 8 2  ( C = 0 ) ;  <5H ( 3 0 0  M H z ,  C D C l , )  1 . 1 5  
( 3 H .  d .  J  7 . 0 ,  CH,) .  3 . 0 7  ( 1 H .  d .  J  3 . 0 ,  OH).  3 . 9 5 - A 0 7  ( 2 H ,  
m ,  C / / 2N ) ,  4 . 1 2  ( 1 H ,  q d ,  J  7 . 0 ,  3 . 0 ,  C H C / / , ) ,  4 . 3 1 - 4 . 4 5  ( 2 H ,  
m ,  C H , O ) ,  5 . 1 3  ( 1 H ,  a p p  t ,  J  3 . 0 ,  C / / O H ) ,  7 . 2 4 - 7 . 4 3  ( 5 H ,  m ,  
A r - / / ) ;  <5c ( C D C l , )  1 0 . 8 ,  4 3 . 0 ,  4 4 . 6 ,  6 2 . 4 ,  7 3 . 9 ,  1 2 6 . 4 ,  1 2 7 . 9 ,
1 2 8 . 6 ,  1 4 1 . 6 ,  1 5 3 . 5 ,  1 7 7 . 2 ;  m / z  ( C L ,  N H , )  2 6 7  ( 4 1 ,  M N H / ) ,  
2 5 0  ( 1 0 ,  M H + ) ,  2 3 2  ( 3 8 ,  M * - O H ) ,  2 0 6  ( 2 2 ,  M H + - C 0 2 ) ,  1 6 1  
( 1 0 0 % ) ;  H R M S  ( F A B + )  C , , H l6N 0 4 [ M H + ]  r e q u i r e s  2 5 0 . 1 0 7 9 ;  
f o u n d  2 5 0 . 1 0 8 1 .
.v>’/ i - 3 - ( 3 - H y d r o x y - 2 - m e t h y l p e n t a n o y l ) - l , 3 - o x a z o l i d i n - 2 - o n c
3 c .  R e a c t i o n  o f  3 - p r o p i o n y l - l , 3 - o x a z o l i d i n - 2 - o n e  2 a  ( 0 . 9 9 1  g ,  
6 . 9 3  m m o l )  w i t h  a  1 . 0  M  s o l u t i o n  o f  9 - B B N - O T f  i n  C H 2C 1 2 
( 8 . 3 9  m L ,  8 . 3 9  m m o l ) ,  A L A - d i i s o p r o p y l e t h y l a m i n e  ( 1 . 7 0  m L ,  
9 . 7 9  m m o l )  a n d  p r o p i o n a l d e h y d e  ( 0 . 5 6  m L ,  7 . 6 9  m m o l )  i n  
C H 2C 1 2 ( 3 5  m L ) ,  a c c o r d i n g  t o  g e n e r a l  p r o c e d u r e  B ,  a f f o r d e d  
a f t e r  p u r i f i c a t i o n  t h r o u g h  s i l i c a  g e l  c h r o m a t o g r a p h y  ( g r a d i e n t ,  
2 5 - 4 0 %  e t h y l  a c e t a t e - p e t r o l )  t h e  t i t l e  c o m p o u n d  syn-3 c  
( 0 . 4 2 7  g ,  2 . 1 2  m m o l )  i n  3 1 %  y i e l d  a s  a  w h i t e  s o l i d ,  m p  6 0 - 6 2  ° C ;  
C 9H | 5N 0 4 r e q u i r e s  C ,  5 3 . 7 ;  H ,  7 . 5 1 ;  N ,  6 . 9 6 % ;  f o u n d  C ,  5 3 . 6 ;
I I .  7 . 4 5 :  N ,  6 . 8 9 % :  W K B r  d i s e ) / c m  1 3 4 7 1  ( h r .  O H ) ,  1 7 5 2  
( C = 0 ) „ x ,  1 6 9 6  ( C = 0 ) ;  ^ H ( 3 0 0  M H z ,  C D C l , )  0 . 9 1  ( 3 H ,  t ,  J  7 . 5 ,  
C H 2C / / 3 ) ,  1 . 1 3  ( 3 H ,  d ,  J  7 . 0 ,  C / / C H , ) ,  1 . 4 4  ( 2 H ,  m ,  C / / 2C H 3 ) ,
2 . 7 8  ( 1 H ,  b r  s ,  OH),  3 . 7 9 - 3 . 8 9  ( 2 H ,  m ,  C H  O H ,  C Z / C H , ) ,  
4 . 0 1 - 4 . 0 7  ( 2 H ,  m ,  C / / 2N ) ,  4 . 3 7  ( 2 H ,  a p p  t ,  J  8 . 5 ,  C H , O ) ;  
c>c ( C D C l , )  8 . 3 ,  8 . 5 ,  2 4 . 8 ,  3 9 . 6 ,  4 0 . 8 ,  6 0 . 1 ,  7 1 . 2 ,  1 5 1 . 4 ,  1 7 5 . 6 ;  
m / z  ( C L ,  i s o - b u t a n e )  2 0 2  ( 1 0 0 ,  M H + ) ,  1 8 4  ( 9 5 .  M + - O H ) ,  1 4 3  
( 5 7 % ,  M + - C H , C H 2C H O H ) ;  H R M S  ( F A B + )  C 9H lf, N 0 4 [ M H + ]  
r e q u i r e s  2 0 2 . 1 0 7 9 ;  f o u n d  2 0 2 . 1 0 8 0 .
. v>7/ - 3 - ( 2- B e n z y l - 3 - h y d r o x y d c c a n o y l ) - l , 3 - o x a z o l i d i n - 2- o n c  3 d .
R e a c t i o n  o f  3 - ( 3 - p h e n y l p r o p a n o y l ) - l , 3 - o x a z o l i d i n - 2 - o n e  2 c  
( 0 . 5 0 0  g ,  2 . 2 8  m m o l )  w i t h  a  0 . 5  M  s o l u t i o n  o f  9 - B B N - O T f  
i n  h e x a n e s  ( 5 . 4 8  m L ,  2 . 7 4  m m o l ) ,  A L A - d i i s o p r o p y l e t h y l a m i n e  
( 0 . 5 6  m L ,  3 . 2 0  m m o l )  a n d  o c t a n a l  ( 0 . 3 9  m L ,  2 . 5 1  m m o l )  i n  
C H 2C 1 2 ( 1 0  m L ) ,  a c c o r d i n g  t o  g e n e r a l  p r o c e d u r e  B ,  a f f o r d e d  
a f t e r  p u r i f i c a t i o n  t h r o u g h  s i l i c a  g e l  c h r o m a t o g r a p h y  ( 20%  e t h y l  
a c e t a t e - p e t r o l )  t h e  t i t l e  c o m p o u n d  syn-3 d  ( 0 . 5 8 2  g ,  1 . 6 8  m m o l )  
i n  7 4 %  y i e l d  a s  a  c o l o u r l e s s  o i l ,  v m a x ( n e a t ) / c m _ l  3 4 7 4  ( b r ,  O H ) ,  
1 7 7 5  ( C = 0 ) o x ,  1 6 9 5  ( C = 0 ) ;  <5H ( 3 0 0  M H z ,  C D C l , )  0 . 8 1  ( 3 H ,  t ,  
J  7 . 0 ,  C H 3), 1 . 1 6 - 1 . 2 8  ( 8H , m ,  C H 2), 1 . 4 4 - 1 . 5 2  ( 4 H ,  m ,  CH,) ,
2 . 6 5  ( 1 H ,  b r  s ,  OH),  2 . 9 2  ( 1 H ,  d d ,  J  1 3 . 0 ,  5 . 5 ,  C / / A H „ P h ) ,
2 . 9 9  ( 1 H ,  d d ,  J  1 3 . 0 ,  1 0 . 0 ,  C H A / / „ P h ) ,  3 . 6 2  ( 1 H ,  d d d ,  J  1 0 . 0 ,
9 . 0 ,  6 . 0 ,  C / / a H „ N ) ,  3 . 7 3  4 . 0 0  ( 3 H ,  m ,  C H A / / „ N ,  C / / O H ,  
C / / A H l t O ) ,  4 . 1 8  ( 1 H ,  a p p  d t ,  J  9 . 0 ,  6 . 0 ,  C H A / / n O ) ,  4 . 3 3 - 4 . 4 0  
( 1H ,  m ,  C H C H 2P h ) ,  7 . 1 1 - 7 . 1 9  ( 5 H ,  m ,  A r - / / ) ; < 5 c ( C D C l 3 )  1 4 . 5 ,
2 3 . 0 ,  2 6 . 4 ,  2 9 . 6 ,  2 9 . 9 ,  3 2 . 2 ,  3 3 . 5 ,  3 4 . 4 ,  4 2 . 9 ,  4 9 . 5 ,  6 2 . 1 ,  7 2 . 6 ,
1 2 6 . 8 ,  1 2 8 . 7 ,  1 2 9 . 4 ,  1 3 9 . 3 ,  1 5 3 . 7 ,  1 7 5 . 9 ;  m / z  ( C L ,  N H , )  3 6 5  
( 1 1 ,  M N H 4 + ) ,  3 4 8  ( 1 3 ,  M H + ) ,  2 3 7 . 2  ( 1 0 0 % ) ;  H R M S  ( E S + )  
C 20H w N O 4 [ M H + ]  r e q u i r e s  3 4 8 . 2 1 6 9 ;  f o u n d  3 4 8 . 2 1 7 1 .
. y y / » - 3 - ( 3 - H y d r o x y - 2 - i s o p r o p y l p e n t a n o y l ) - l , 3 - o x a z o l i d i n - 2 - o n e  
3 e 4 1 .  R e a c t i o n  o f  3 - ( 3 - m e t h y l b u t a n o y l ) - l , 3 - o x a z o l i d i n - 2 - o n e
2 b  ( 0 . 9 6 5  m g ,  5 . 8 5  m m o l )  w i t h  a  0 . 5  M  s o l u t i o n  o f  9 - B B N - O T f  
i n  C H 2C 1 2 ( 1 4 . 0  m L ,  7 . 0 2  m m o l ) ,  A L A - d i i s o p r o p y l e t h y l a m i n e  
( 1 . 4 3  m L ,  8 . 1 9  m m o l )  a n d  p r o p i o n a l d e h y d e  ( 0 . 4 7  m L ,
6 . 4 4  m m o l )  i n  C H 2C 1 2 ( 3 0  m L ) ,  a c c o r d i n g  t o  g e n e r a l  p r o c e d u r e
B ,  a f f o r d e d  a f t e r  p u r i f i c a t i o n  t h r o u g h  s i l i c a  g e l  c h r o m a t o g r a p h y  
( g r a d i e n t ,  2 5 - 4 0 %  e t h y l  a c e t a t e - p e t r o l )  t h e  t i t l e  c o m p o u n d  
syn-3 e  ( 0 . 6 4 4  g ,  2 . 8 1  m m o l )  i n  4 8 %  y i e l d  a s  a  w h i t e  s o l i d ,  
m p  6 0 - 6 2  ° C ;  v m a x ( K B r  d i s c ) / c m  1 3 4 6 3  ( b r ,  O H ) ,  1 7 5 2  
( C = 0 ) o x ,  1 6 9 6  ( C = 0 ) ;  <5H ( 3 0 0  M H z ,  C D C l . , )  0 . 8 5  ( 3 H ,  d ,  J  7 . 0 ,  
C H ( C / / 3 ) 2 ) ,  0 . 9 0  ( 3 H ,  d ,  J  7 . 0 ,  C H ( C / / 3 ) 2 ) ,  0 . 9 1  ( 3 H ,  t ,  J  7 . 0 ,  
C H . c z / , ) ,  1 . 3 5  ( 1 H ,  d d q ,  J  1 4 . 0 ,  1 0 . 0 ,  7 . 0 ,  C Z / A H „ C H , ) ,  1 . 5 1  
( 1 H ,  d q d ,  J  1 4 . 0 ,  7 . 0 ,  2 . 3 ,  C H A Z / B C H , ) ,  2 . 1 2  ( 1 H ,  m ,  J  8 . 0 ,
7 . 0 ,  C Z / ( C H , ) 2 ) ,  2 . 5 4  ( 1 H ,  b r  s ,  O H ) ,  3 . 8 3  ( 1 H ,  a p p  t ,  J  7 . 0 ,  
C Z / ' P r ) ,  3 . 9 1 - 4 . 0 2  ( 3 H ,  m ,  C H ,  N ,  C H  O H ) ,  4 . 3 0 ^ 1  3 7  ( 2 H ,  m ,  
C Z / . O ) ;  t> c ( C D C l 3 )  9 . 7 ,  1 9 . 2 ,  1 9 . 9 ,  2 4 . 4 ,  2 7 . 0 ,  4 1 . 8 ,  5 3 . 1 ,  6 0 . 8 ,
7 2 . 1 ,  1 5 3 . 3 ,  1 7 3 . 6 ;  m /z  ( C L ,  i s o - b u t a n e )  2 3 0  ( 5 ,  M H + ) ,  2 1 2  
( 8 ,  M + - O H ) ,  1 7 1  ( 3 4 % ,  M + - C H , C H 2C H O H ) ;  H R M S  ( F A B + )  
C m H m N O ,  [ M H + ]  r e q u i r e s  2 3 0 . 1 3 9 2 ;  f o u n d  2 3 0 . 1 3 9 4 .
s y / i - 3 - {  2 - |  H y d r o x y (  p h e n y l ) m e t h y l | - 3 - m e t h y l b u t a n o y l } - 1 , 3 -  
o x a z o l i d i n - 2 - o n e  3 f .  R e a c t i o n  o f  3 - ( 3 - m e t h y l b u t a n o y l ) - l , 3 -  
o x a z o l i d i n - 2 - o n e  2 b  ( 0 . 9 9 3  g ,  5 . 8 1  m m o l )  w i t h  a  0 . 5  M  s o l u t i o n  
o f  9 - B B N - O T f  i n  h e x a n e s  ( 1 1 . 7  m L ,  5 . 8 5  m m o l ) ,  N,N-  
d i i s o p r o p y l e t h y l a m i n e  ( 1 . 4 0  m L ,  8 . 1 9  m m o l )  a n d  b e n z a l d e h y d e  
( 0 . 6 5  m L ,  6 . 4 3  m m o l )  i n  C H 2C 1 2 ( 3 0  m L ) ,  a c c o r d i n g  t o  
g e n e r a l  p r o c e d u r e  B ,  a f f o r d e d  a f t e r  p u r i f i c a t i o n  t h r o u g h  
s i l i c a  g e l  c h r o m a t o g r a p h y  ( 2 5 %  e t h y l  a c e t a t e - p e t r o l )  t h e  t i t l e  
c o m p o u n d  syn-3f  ( 0 . 8 1 1  g ,  2 . 9 3  m m o l )  i n  5 0 %  y i e l d  a s  a  w h i t e  
s o l i d ,  m p  9 3 - 9 5  ° C ;  v m a x ( K B r  d i s c j / c n r 1 3 4 5 0  ( s ,  O H ) ,  1 7 5 1  
( C = 0 ) o x ,  1 6 9 5  ( C = 0 ) ;  <5h ( 3 0 0  M H z ,  C D C L )  1 . 0 1  ( 3 H , d , 7  7 . 0 ,  
C H ( C Z / , ) 2X  1 0 8  ( 3 H ,  d ,  J  7 . 0 ,  C H ( C Z / 3 ) 2 ) ,  2 . 3 6  ( 1H ,  m ,  J  7 . 0 ,
5 . 5 ,  C Z / ( C H 3 ) 2 ) ,  2 . 4 1  ( 1 H ,  d ,  J  3 . 0 ,  OH),  3 . 6 2  ( 1 H ,  d d d ,  7  1 1 . 0 ,
9 . 5 ,  7 . 0 ,  C Z / A H „ N ) ,  3 . 8 4  ( 1 H ,  d d d ,  7  1 1 . 0 ,  9 . 5 ,  7 . 0 ,  C H A Z / l i N ) ,
4 . 0 7  ( 1 H ,  a p p  d t ,  7  9 . 0 ,  8 . 0 ,  C Z / A H . . O ) ,  4 . 2 4  ( 1 H ,  a p p  d t ,  7
9 . 0 ,  8 . 0 ,  C H a Z / h O ) ,  4 . 4 8  ( 1 H ,  d d ,  7  8 . 0 ,  5 . 5 ,  C Z / ' P r ) ,  5 . 0 1  ( 1 H ,  
d d ,  7  8 . 0 ,  3 . 0 ,  C Z / O H ) ,  7 . 2 5 - 7 . 4 0  ( 5 H ,  m ,  A r - / / ) ;  <5c ( C D C 1 3 )
1 8 . 0 ,  1 9 . 8 , 2 7 . 1 . 4 1 . 3 , 5 3 . 0 ,  6 0 . 3 , 7 2 . 9 ,  1 2 5 . 6 ,  1 2 6 . 7 , 1 2 7 . 1 ,  1 4 0 . 9 ,
1 5 2 . 0 ,  1 7 2 . 7 ;  m / z  ( C L ,  N H , )  2 9 5  ( 8 ,  M N H 4 + ) ,  2 7 8  ( 5 ,  M H + ) ,  
2 6 0  ( 2 8 ,  M * - O H ) ,  2 3 4  ( 9 ,  M + - P r ) ,  1 0 5  ( 1 0 0 % ) ;  H R M S  ( E S + )
C , 5H 23N 20 4 [ M N H 4 + ]  r e q u i r e s  2 9 5 . 1 6 5 2 ;  f o u n d  2 9 5 . 1 6 5 3 .
, v y / » - 3 - { 2 - | H y d r o x y ( 4 - m e t h o x y p h e n y l ) m e t h y i p 3 - m e t h y l b u t a n o y l } -
1 . 3 - o x a z o l i d i n - 2 - o n e  3 g .  R e a c t i o n  o f  3 - ( 3 - m e t h y l b u t a n o y l ) -
1 . 3 - o x a z o l i d i n - 2 - o n e  2 b  ( 1 . 5 0 0  g ,  8 . 7 7  m m o l )  w i t h  a  0 . 5  M  
s o l u t i o n  o f  9 - B B N - O T f  i n  h e x a n e s  ( 2 1 . 1 0  m L ,  1 0 . 5 3  m m o l ) ,  
A L A - d i i s o p r o p y l e t h y l a m i n e  ( 1 . 9 9  m L ,  1 1 . 4 0  m m o l )  a n d  
/ > a n i s a l d e h y d e  ( 1 . 1 7  m L ,  9 . 6 5  m m o l )  i n  C H 2C 1 2 ( 4 0  m L ) ,  
a c c o r d i n g  t o  g e n e r a l  p r o c e d u r e  B ,  a f f o r d e d  a f t e r  p u r i f i c a t i o n  
t h r o u g h  s i l i c a  g e l  c h r o m a t o g r a p h y  ( g r a d i e n t ,  10- 20%  e t h y l  
a c e t a t e - p e t r o l )  t h e  t i t l e  c o m p o u n d  syn-3 g  ( 1 . 5 9 2  g ,  5 . 1 8  m m o l )  
i n  6 0 %  y i e l d  a s  a  w h i t e  c r y s t a l l i n e  s o l i d ,  m p  1 1 7 - 1 1 8  ° C ;  v max  
( K B r  d i s c ) / c n r '  3 4 4 9  ( s ,  O H ) ,  1 7 5 5  ( C = 0 ) o x ,  1 6 9 1  ( C = 0 ) ;  
<5h ( 3 0 0  M H z ,  C D C L )  1 . 0 2  ( 3 H ,  d ,  7  7 . 0 ,  C H ( C Z / , ) 2 ) ,  1 . 0 8  ( 3 H ,  
d ,  7  7 . 0 ,  C H ( C Z / 3 ) 2 ) ,  2 . 2 4  ( 1 H ,  d ,  7  3 . 5 ,  OH),  2 . 3 5  ( 1 H ,  m ,  7  7 . 0 ,
5 . 5 ,  C Z / ( C H , ) 2 ) ,  3 . 6 5  ( 1 H ,  d d d ,  7  1 1 . 0 , 9 . 5 ,  7 . 0 ,  C Z / A H „ N ) ,  3 . 7 9  
( 3 H ,  s ,  A r O CH,) ,  3 . 8 6  ( 1 H ,  d d d ,  7  1 1 . 0 ,  9 . 5 ,  7 . 0 ,  C H A Z / „ N ) ,  
4 . 1 2  ( 1 H ,  a p p  d t ,  7  9 . 0 ,  7 . 0 ,  C Z / A H n O ) ,  4 . 2 6  ( 1 H ,  a p p  t d ,  7
9 . 0 ,  7 . 0 ,  C H a Z / „ 0 ) ,  4 . 4 8  ( 1 H ,  d d ,  7  8 . 0 ,  5 . 5 ,  C Z / ' P r ) ,  4 . 9 7  ( 1 H ,  
d d ,  7  8 . 0 ,  3 . 5 ,  C Z / O H ) ,  6 . 8 4  ( 2 H ,  d ,  7  8 . 5 ,  A r - / / ) ,  7 . 3 0  ( 2 H ,  
d ,  7  8 . 5 ,  A r - / / ) ;  <5c ( C D C I 3 )  1 9 . 5 ,  2 1 . 3 ,  2 8 . 7 ,  4 2 . 9 ,  5 4 . 5 ,  5 5 . 6 ,
6 1 . 8 ,  7 4 . 0 ,  1 1 4 . 0 ,  1 2 8 . 5 ,  1 3 4 . 6 ,  1 5 3 . 6 ,  1 5 9 . 6 ,  1 7 4 . 2 ;  m / z  ( E L * )  
3 0 7  ( 1 2 ,  M + * ) ,  1 7 1  ( 2 8 ,  M + * A r C H O H * ) ,  1 4 9  ( 1 0 0 % ) ;  H R M S  
( F A B + ) C I6H : i N 0 5 [ M H + ]  r e q u i r e s  3 0 7 . 1 4 2 0 ;  f o u n d  3 0 7 . 1 4 2 6 .
5y / i - 3 - ( 3 - H v d r o x y - 2 - p h e n y l p e n t a n o y l ) - 1 , 3 - o x a z o l i d i n - 2 - o n c
3 h .  R e a c t i o n  o f  3 - ( 2 - p h e n y l a c e t y l ) - l  , 3 - o x a z o l i d i n - 2 - o n e  2 d  
( 0 . 9 9 4  g ,  4 . 8 5  m m o l )  w i t h  a  1 . 0  M  s o l u t i o n  o f  9 - B B N - O T f  
i n  C H 2C I 2 ( 5 . 8 6  m L ,  5 . 8 6  m m o l ) ,  7 V , A ^ - d i i s o p r o p y l e t h y l a m i n e  
( 1 . 2 0  m L ,  6 . 8 3  m m o l )  a n d  p r o p i o n a l d e h y d e  ( 0 . 3 9  m L ,
5 . 3 7  m m o l )  i n  C H 2 C L  ( 2 0  m L ) ,  a c c o r d i n g  t o  g e n e r a l  p r o c e d u r e  
B ,  a f f o r d e d  a f t e r  p u r i f i c a t i o n  t h r o u g h  s i l i c a  g e l  c h r o m a t o g r a p h y
O r g . B i o m o l .  C h e m . ,  2 0 0 5 , 3 , 2 9 7 6 - 2 9 8 9  2 9 8 3
( 2 5 %  e t h y l  a c e t a t e - p e t r o l )  t h e  t i t l e  c o m p o u n d  , y y « - 3 h  ( 0 . 4 6 4  g ,
1 . 7 6  m m o l )  i n  3 7 %  y i e l d  a s  a  c o l o u r l e s s  o i l ,  v m a x ( n e a t ) / c r n  1 3 5 1 9  
( b r ,  O H ) ,  1 7 7 1  ( C = 0 ) o x ,  1 6 9 4  ( C = 0 ) ;  <5H ( 3 0 0  M H z ,  C D C l , )  
0 . 9 9  ( 3 H ,  t . . /  7 . 5 .  C H  (  / /  ) .  1 . 3 5  1 . 4 8  ( 2 H .  m .  C H :C H , ) ,  2 . 7 0  
( 1 H ,  d ,  J  3 . 0 ,  OH),  3 . 9 2  ( 1 H ,  d d d ,  J  1 1 . 0 ,  9 . 5 ,  6 . 5 ,  C / / A H „ N ) ,  
4 . 0 6  ( 1 H ,  d d d ,  J  1 1 . 0 ,  9 . 5 ,  7 . 0 ,  C H A / / „ N ) ,  4 . 1 1 - 4 . 1 7  ( 1 H ,  m ,  
C / / O H ) ,  4 . 2 9  ( 1 H ,  a p p  d t ,  J  9 . 5 ,  8 . 0 ,  C / / A H „ 0 ) ,  4 . 3 8  ( 1 H ,  a p p  
d t ,  J  9 . 5 ,  8 . 0 ,  C H a / / () 0 ) ,  5 . 0 4  ( 1 H ,  d ,  J  5 . 5 ,  C / / P h ) ,  7 . 2 6 - 7 . 4 4  
( 5 H ,  m ,  A r - H ) ;  <5c ( C D C l , )  1 0 . 5 ,  2 7 . 6 ,  4 2 . 9 ,  5 3 . 5 ,  6 2 . 0 ,  7 4 . 0 ,
1 2 8 . 1 ,  1 2 8 . 7 ,  1 3 0 . 3 ,  1 3 4 . 2 ,  1 5 3 . 0 , 1 7 4 . 2 ;  m / z  ( C I + ,  N H , )  2 8 1  ( 2 0 ,  
M N H 4 * ) ,  2 6 4  ( 1 9 ,  M H + ) ,  2 2 3  ( 1 0 0 % ) ;  H R M S  ( E S * )  C 14H 1KN 0 4 
[ M H * ]  r e q u i r e s  2 6 4 . 1 2 3 0 ,  f o u n d  2 6 4 . 1 2 2 7 .
s v / i - 3 - | ( £ ) - 3 - H y d r o x y - 2 - i s o p r o p y l - 4 - h e x e n o y l | - l , 3 - o x a z o l i d i n -  
2 - o n e  3 i .  R e a c t i o n  o f  3 - ( 3 - m e t h y l b u t a n o y l ) - l , 3 - o x a z o l i d i n - 2 -  
o n e  2 b  ( 0 . 9 6 5  g ,  5 . 8 5  m m o l )  w i t h  a  0 . 5  M  s o l u t i o n  o f  9 - B B N - O T f  
i n  h e x a n e s  ( 1 4 . 1 0  m L ,  7 . 0 2  m m o l ) ,  A L / V - d i i s o p r o p y l e t h y l a m i n e  
( 1 . 3 2  m L ,  7 . 6 0  m m o l )  a n d  t r a « s - c r o t o n a l d e h y d e  ( 0 . 5 3  m L ,
6 . 4 4  m m o l )  i n  C H 2C 1 2 ( 3 0  m L ) ,  a c c o r d i n g  t o  g e n e r a l  p r o c e d u r e  
B ,  a f f o r d e d  a f t e r  p u r i f i c a t i o n  t h r o u g h  s i l i c a  g e l  c h r o m a t o g r a p h y  
( 2 5 %  e t h y l  a c e t a t e  p e t r o l )  t h e  t i t l e  c o m p o u n d  syn-3\ ( 1 . 0 9 0  g ,
4 . 5 4  m m o l )  i n  7 2 %  y i e l d  a s  a  l o w - m e l t i n g  p o i n t  w h i t e  s o l i d ,  
v m a x ( n u j o l ) / c m “ '  3 4 5 4  ( b r ,  O H ) ,  1 7 7 0  ( C = O ) 0X,  1 6 9 0  ( C = 0 ) ;  
c>h (300  M H z ,  C D C l , )  0 . 9 2  ( 3 H ,  d ,  J  6 . 5 ,  C H ( C / / , ) 2 ) ,  0 . 9 7  
( 3 H ,  d ,  J  6 . 5 ,  C H ( C / / , ) 2 ) ,  1 . 7 2  ( 3 H ,  d ,  J  5 . 5 ,  C H = C H C / / , ) ,  
1 . 9 9 - 2 . 1 1  ( 1 H ,  m ,  C / / ( C H , ) 2 ) ,  2 . 2 3  ( 1 H ,  b r  s ,  OH),  4 . 0 1 - 4 . 1 0  
( 3 H ,  m ,  C H 2N ,  C H ' P r ) ,  4 . 3 4 ^ . 4 8  ( 3 H ,  m ,  C H 20 ,  CHOH),  
5 . 6 0 - 5 . 8 1  ( 2 H ,  m ,  C / / = C / / C H , ) ;  <Sc ( C D C l , )  1 8 . 2 ,  2 0 . 4 ,  2 1 . 1 ,  
2 8 . 6 ,  4 3 . 2 ,  5 4 . 3 ,  6 2 . 0 ,  7 3 . 5 ,  1 3 0 . 0 ,  1 3 0 . 5 ,  1 5 4 . 7 ,  1 7 4 . 7 ;  m / z  
( C I + ,  i s o - b u t a n e )  2 4 2  ( 6 ,  M H * ) ,  2 2 4 . 1  ( 7 5 ,  M * - O H ) ,  1 7 1 . 0  
( 6 4 ,  M * - C H O H C H C H C H , ) ,  1 5 6 . 0  ( 1 0 0 % ) ;  H R M S  ( F A B * )  
C ^ H j o N O ,  [ M H * ]  r e q u i r e s  2 4 2 . 1 3 9 2 ;  f o u n d  2 4 2 . 1 3 9 3 .
. y ) 7i - 3 - | ( £ ) - 3 - H y d r o x y - 2 - m e t h y l - 5 - p h e n y l - 4 - p e n t e n o y l | - l , 3 -  
o x a z o l i d i n - 2 - o n c  3 j .  R e a c t i o n  o f  3 - p r o p i o n y l - 1 , 3 - o x a z o l i d i n - 2 -  
o n e  2 a  ( 0 . 5 0 0  g ,  3 . 5 0  m m o l )  w i t h  a  0 . 5  M  s o l u t i o n  o f 9 - B B N - O T f  
i n  h e x a n e s  ( 8 . 4 0  m L ,  4 . 2 0  m m o l ) ,  A , j V - d i i s o p r o p y l e t h y l a m i n e  
( 0 . 7 9  m L ,  4 . 5 5  m m o l )  a n d  / r a / 7. r - c i n n a m a l d e h y d e  ( 0 . 4 9  m L ,
3 . 8 5  m m o l )  i n  C H 2C 1 2 ( 1 5  m L ) ,  a c c o r d i n g  t o  g e n e r a l  p r o c e d u r e  
B ,  a f f o r d e d  a f t e r  p u r i f i c a t i o n  t h r o u g h  s i l i c a  g e l  c h r o m a t o g r a p h y  
( g r a d i e n t ,  2 0 - 4 0 %  E t O A c - p e t r o l )  t h e  t i t l e  c o m p o u n d  syn-3 j  
( 0 . 8 4 1  g ,  3 . 0 6  m m o l )  i n  88%  y i e l d  a s  a  w h i t e  c r y s t a l l i n e  s o l i d ,  
m p  1 0 0 - 1 0 1  ° C ;  v r a a x ( K B r  d i s c ) / c m - '  3 4 7 6  ( s ,  O H ) ,  1 7 6 2  
( C = 0 ) o x ,  1 6 8 3  ( C = 0 ) ;  t 5 H ( 3 0 0  M H z ,  C D C l , )  1 . 1 7  ( 3 H ,  d ,  J
7 . 0 ,  C / / , ) ,  2 . 9 7  ( 1 H ,  d ,  J  1 . 0 ,  OH),  3 . 8 8 - 3 . 9 9  ( 3 H ,  m ,  C H 2N ,  
C / / C H , ) ,  4 . 2 8 - 4 . 3 4  ( 2 H ,  m ,  C H 2O ) ,  4 . 5 8  ( 1 H ,  d d d ,  J  6 . 0 ,
4 . 0 ,  1 . 0 .  CHOH) ,  6 . 1 4  ( 1 H ,  d d ,  J  1 6 . 0 ,  6 . 0 ,  H C = C H P h ) ,  
6 . 5 9  ( 1 H ,  d ,  J  1 6 . 0 ,  H C = C / / P h ) ,  7 . 1 5 - 7 . 3 4  ( 5 H ,  m ,  A r - / / ) ;  
<5t ( C D C l , )  1 1 . 6 ,  4 3 . 0 ,  4 3 . 5 ,  6 2 . 4 ,  7 3 . 2 ,  1 2 6 . 9 ,  1 2 8 . 1 ,  1 2 9 . 0  
( 2 C ) ,  1 3 1 . 8 ,  1 3 6 . 9 ,  1 5 3 . 8 ,  1 7 6 . 8 ;  m / z  ( E L * )  2 7 5  ( 7 ,  M + * ) ,  1 4 3  
( 4 2 ,  M * *  P h C H C H C H O H ’ ) ,  1 0 4 . 1  ( 1 0 0 % ) ;  H R M S  ( E S * )  
C | 5H 2| N 20 4 [ M N H 4 * ]  r e q u i r e s  2 9 3 . 1 4 9 6 ;  f o u n d  2 9 3 . 1 4 9 5 .
( £ ) - 3 - C y c l o h e x y l - A - ( 2 - h y d r o x y e t h y l ) - 2 - i s o p r o p y l - 2 - p r o p e i i a m i d e
4 a .  R e a c t i o n  o f  s j 7j - 3- { 2 - [ c y c l o h e x y l ( h y d r o x y ) m e t h y l ] - 3-  
m e t h y l b u t a n o y l } - l  , 3 - o x a z o l i d i n - 2 - o n e  3 a  ( 0 . 1 0 0  g ,  0 . 3 5  m m o l )  
w i t h  a  0 . 5  M  s o l u t i o n  o f  K H M D S  i n  t o l u e n e  ( 1 . 0 6  m L ,  
0 . 5 3  m m o l )  i n  T H F  ( 2  m L ) ,  a c c o r d i n g  t o  g e n e r a l  p r o c e d u r e  C ,  
g a v e  t h e  t i t l e  c o m p o u n d  ( £ ) - 4 a  ( 0 . 0 7 5  g ,  0 . 3 1  m m o l )  i n  9 4 %  
d e .  T h e  c r u d e  p r o d u c t  w a s  p u r i f i e d  f o r  a n a l y s i s  b y  s i l i c a  g e l  
c h r o m a t o g r a p h y  ( g r a d i e n t ,  2 0 - 3 0 %  e t h y l  a c e t a t e - p e t r o l ) ,  t o  
a f f o r d  t h e  t i t l e  c o m p o u n d  ( £ ) - 4 a  ( 0 . 0 6 4  g ,  0 . 2 7  m m o l )  i n  7 7 %  
y i e l d  a n d  > 9 5 %  d e  a s  a  w h i t e  s o l i d ,  m p  8 4 - 8 6  ° C ;  v m a x ( K B r  
d i s c ) / c m -1 3 2 9 1  ( b r ,  O H ,  N H ) ,  1 6 5 2  ( C = 0 ) ,  1 6 1 9  ( C = C ) ,  1 5 4 1  
( C = 0 ) ;  <5h ( 3 0 0  M H z ,  C D C l , )  1 . 0 1 - 1 . 3 7  ( 6 H ,  m ,  C y - / / ) ,  1 . 1 8  
( 6H ,  d ,  J  7 . 0 ,  C H ( C / / , ) 2 ) ,  1 . 6 0 - 1 . 7 8  ( 4 H ,  m ,  C y - / / ) ,  2 . 2 5 - 2 . 3 9  
( 1 H ,  m ,  C y - / / ) ,  2 . 8 3  ( 1 H ,  m ,  J  7 . 0 ,  C H ( C H , ) 2 ) ,  2 . 9 5  ( 1 H ,  t ,  
J  4 . 5 ,  OH),  3 . 4 4  ( 2 H ,  a p p  q ,  J  5 . 5 ,  4 . 5 ,  C H 2N H ) ,  3 . 7 4  ( 2 H ,  
a p p  q ,  J  5 . 5 ,  4 . 5 ,  C / / 2O H ) ,  5 . 5 9  ( 1 H ,  d ,  J  1 0 . 0 ,  C=CH),  6 . 0 8  
( ! H ,  b r  s ,  N H);  <5c ( C D C l , )  2 2 . 1 ,  2 6 . 1 ,  2 6 . 2 ,  2 8 . 6 ,  3 3 . 3 ,  3 7 . 0 ,
4 2 . 9 ,  6 3 . 3 ,  1 3 7 . 9 ,  1 4 2 . 0 ,  1 7 3 . 1 ;  m / z  ( E L * )  2 3 9  ( 6 5 ,  M * * ) ,  2 2 4
( 8 5 .  M * * - C H , " ) ,  1 7 9  ( 68% ,  M * *  H O C H 2C H 2N H * ) ;  H R M S  
( F A B * )  C l4H 25N O ;  [ M H * ]  r e q u i r e s  2 3 9 . 1 8 8 5 ;  f o u n d  2 3 9 . 1 8 8 6 .
X - R a y  c r y s t a l  d a t a  f o r  4 a
( C l4H 25N O , ) :  =  2 3 9 . 3 5 ,  T  =  1 5 0 ( 2 )  K ,  m o n o c l i n i c ,  s p a c e
g r o u p  P 2j'c , a =  1 7 . 3 5 4 0 ( 2 ) ,  b =  9 . 7 9 7 0 0 ( 1 0 ) ,  c =  1 7 . 7 3 7 0 ( 2 )  A ,  
P =  1 0 4 . 1 5 3 ( 1 ) ° ,  L  =  2 9 2 4 . 0 6 ( 7 )  A \ Z  =  8, / w , =  1 . 0 8 7  M g m  \  
H =  0 . 0 7 1  m m 1 , A  =  0 . 7 1 0 7 3  A, 0mM =  2 7 . 4 6 ° ,  4 3 2 9 5  m e a s u r e d  
r e f l e c t i o n s ,  6 6 7 6  i n d e p e n d e n t  r e f l e c t i o n s  [ R ( i n t )  =  0 . 0 7 8 7 ] ,  G O F  
o n  F 2 =  1 . 0 0 7 ,  / ? ,  =  0 . 0 4 5 3 ,  w R2 =  0 . 1 0 3 5  ( / > 2 c r ( / ) ) ,  / ? ,  =  
0 . 0 8 1 8 ,  w /?2 =  0 . 1 1 9 8  ( f o r  a l l  d a t a ) ,  l a r g e s t  d i f f e r e n c e  p e a k  a n d  
h o l e  0 . 2 3 2  a n d  — 0 . 2 1 5  e  A ~ \  C r y s t a l  d a t a  w e r e  c o l l e c t e d  o n  a  
N o n i u s  K a p p a  C C D  d i f f r a c t o m e t e r .  T h e  s t r u c t u r e  w a s  s o l v e d  
b y  d i r e c t  m e t h o d s  a n d  r e f i n e d  o n  a l l  F2 d a t a  u s i n g  t h e  S H E L X -  
9 7  s u i t e  o f  p r o g r a m s .44 T h e  a s y m m e t r i c  u n i t  w a s  s e e n  t o  c o n s i s t  
o f  t w o  m o l e c u l e s ,  o n e  o f  w h i c h  e x h i b i t e d  5 5  : 4 5  p o s i t i o n a l  
d i s o r d e r  i n  t h e  c y c l o h e x y l  c a r b o n s .  A l l  h y d r o g e n  a t o m s  w e r e  
i n c l u d e d  a t  c a l c u l a t e d  p o s i t i o n s ,  w i t h  t h e  e x c e p t i o n  o f  t h e  H 1 
a n d  H 1 A  ( h y d r o x y l  g r o u p s ) ,  w h i c h  w e r e  l o c a t e d  a n d  r e f i n e d .  
T h e  s u p r a m o l e c u l a r  a r r a y  i s  d o m i n a t e d  b y  e x t e n s i v e  h y d r o g e n -  
b o n d i n g . t
( £ ) - A - ( 2 - H y d r o x y e t h y l ) - 2 - m e t h y l - 3 - p h e n y l - 2 - p r o p e n a n i i d e
4 b .  R e a c t i o n  o f . y y « - 3 - ( 3 - h y d r o x y - 2 - m e t h y l - 3 - p h e n y l p r o p a n o y l ) -
1 , 3 - o x a z o l i d i n - 2 - o n e  3 b  ( 0 . 2 0 0  g ,  0 . 8 0  m m o l )  w i t h  a  0 . 5  M  
s o l u t i o n  o f  K H M D S  i n  t o l u e n e  ( 2 . 4 1  m L ,  1 . 2 0  m m o l )  i n  T H F  
( 4  m L ) ,  a c c o r d i n g  t o  g e n e r a l  p r o c e d u r e  C ,  a f f o r d e d  t h e  t i t l e  
c o m p o u n d  ( £ ) - 4 b  ( 0 . 1 4 3  g ,  0 . 7 0  m m o l )  i n  9 1 %  y i e l d  a n d  > 9 5 %  
d e  a s  a  w h i t e  s o l i d ,  m p  1 0 1  1 0 3  ° C ;  v ma x  ( K B r  d i s c ) / c m  
3 2 8 4  ( b r ,  O H ,  N H ) ,  1 6 4 4  ( C = 0 ) ,  1 6 2 0  ( C = C ) ,  1 5 7 5  ( C = 0 ) ;  
<5H ( 3 0 0  M H z ,  C D C l , )  2 . 0 4  ( 3 H ,  d ,  J  1 . 0 ,  C = C ( C / / , ) ) ,  3 . 0 8  ( 1 H .  
b r  s ,  OH),  3 . 4 6 - 3 . 5 1  ( 2 H ,  m ,  C H 2N ) ,  3 . 7 4  ( 2 H ,  a p p  t ,  J  5 . 0 ,  
C H 20) ,  6 . 4 8  ( 1 H ,  b r  s ,  N H),  7 . 1 9  ( 1 H ,  s ,  C =CH),  7 . 2 0 - 7 . 3 3  
( 5 H ,  m ,  A r - H ) ;  <5c ( C D C l , )  1 4 . 6 ,  4 3 . 3 , 6 2 . 8 ,  1 2 8 . 3 ,  1 2 8 . 7 ,  1 2 9 . 7 ,
1 3 1 . 7 ,  1 3 5 . 0 ,  1 3 6 . 3 ,  1 7 1 . 2 ;  m / z  ( C L ,  N H , )  2 0 6  ( 1 0 0 % ,  M H * ) ;  
H R M S  ( F A B * )  C , 2H , 6N 0 2 [ M H * ]  r e q u i r e s  2 0 6 . 1 1 7 6 ,  f o u n d  
2 0 6 . 1 1 7 7 .
( £ ) - A - ( 2 - H y d r o x y e t h y l ) - 2 - m e t h y l - 2 - p e n t e n a m i d e  4 c .  R e a c ­
t i o n  o f  . v y « - 3 - ( 3 - h y d r o x y - 2 - m e t h y l p e n t a n o y l ) - l  , 3 - o x a z o l i d i n - 2 -  
o n e  3 c  ( 0 . 0 5 0  g ,  0 . 2 5  m m o l )  w i t h  a  0 . 5  M  s o l u t i o n  o f  K H M D S  
i n  t o l u e n e  ( 0 . 7 5  m L ,  0 . 3 7  m m o l )  i n  T H F  ( 3  m L ) ,  a c c o r d i n g  
t o  g e n e r a l  p r o c e d u r e  C ,  a f f o r d e d  t h e  t i t l e  c o m p o u n d  ( £ ) - 4 c  
( 0 . 0 2 6  g ,  0 . 1 7  m m o l )  i n  6 7 %  y i e l d  a n d  > 9 5 %  d e  a s  a  w h i t e  s o l i d  
o f  l o w  m e l t i n g  p o i n t  ( < 3 0  ° C ) ,  v m a x ( K B r  d i s c ) / c m  1 3 4 0 5  ( b r ,  
O H ,  N H ) ,  1 7 0 1  ( C = 0 ) ,  1 6 1 5 ( C = C ) ,  1 5 3 8  ( C = 0 ) ;  <5H ( 3 0 0  M  H z ,  
C D C l , )  1 . 0 4 ( 3 H ,  t ,  J  7 . 5 ,  C H 2C / / , ) ,  1 . 8 5  ( 3 H ,  s ,  C H }), 2 . 1 7  ( 2 H ,  
a p p  p e n t e t ,  J  7 . 5 ,  C H , C H , ) ,  2 . 8 6  ( 1 H ,  b r  s ,  OH),  3 . 5 0  ( 2 H .  a p p  
q ,  J  6 . 0 ,  5 . 0 ,  C H , N H ) ,  3 . 7 7  ( 2 H ,  a p p  t ,  J  6 . 0 ,  C H 2O H ) ,  6 . 1 9  
( 1H ,  s ,  NH) ,  6 . 3 8  ( 1 H ,  t ,  J  7 . 5 ,  C = C H )\  <5c ( C D C 1 3 )  1 1 . 5 ,  1 2 . 2 ,
2 0 . 6 , 4 1 . 7 , 6 1 . 4 ,  1 2 8 . 7 ,  1 3 7 . 5 ,  1 6 9 . 7 ;  m / z  ( C L ,  N H , )  1 5 8 ( 1 0 0 % ,  
M H * ) ;  H R M S ( E S * ) C s H | ( , N 0 2 [ M H * ]  r e q u i r e s  1 5 8 . 1 1 7 6 ;  f o u n d  
1 5 8 . 1 1 7 9 .
( £ ) - 2 - B e n z y l - N - ( 2 - h y d r o x y e t h y l ) - 2 - d e c e n a m i d e  4 d .  R e a c ­
t i o n  o f  j y 7i - 3- ( 2 - b e n z y l - 3- h y d r o x y d e c a n o y l ) - l , 3- o x a z o l i d i n - 2 -  
o n e  3 d  ( 0 . 1 3 5  g ,  0 . 3 9  m m o l )  w i t h  a  0 . 5  M  s o l u t i o n  o f  K H M D S  
i n  t o l u e n e  ( 1 . 1 7  m L ,  0 . 5 8  m m o l )  i n  T H F  ( 3  m L ) ,  a c c o r d i n g  t o  
g e n e r a l  p r o c e d u r e  C ,  g a v e  t h e  t i t l e  c o m p o u n d  ( £ ) - 4 d  ( 0 . 1 1 0  g ,  
0 . 3 6  m m o l )  i n  9 2 %  d e .  T h e  c r u d e  p r o d u c t  w a s  p u r i f i e d  f o r  
a n a l y s i s  b y  s i l i c a  g e l  c h r o m a t o g r a p h y  ( 6 0 %  e t h y l  a c e t a t e - p e t r o l )  
t o  a f f o r d  t h e  t i t l e  c o m p o u n d  ( £ ) - 4 d  ( 0 . 1 0 8  g ,  0 . 3 6  m m o l )  i n  
9 1 %  y i e l d  a n d  > 9 5 %  d e  a s  a  c o l o u r l e s s  o i l ,  v , n a x ( n e a t ) / c m _ l  
3 3 4 2  ( b r ,  O H ,  N H ) ,  1 6 5 6  ( C = 0 ) ,  1 6 2 0  ( C = C ) ,  1 5 3 7  ( C = 0 ) ;  
<5h ( 3 0 0  M H z ,  C D C l , )  0 . 8 8  ( 3 H ,  t ,  J  7 . 0 ,  C / / , ) ,  1 . 2 3 - 1 . 2 8  ( 8 H ,  
m ,  A i k - / / ) ,  1 . 3 9 - 1 . 4 6  ( 2 H ,  m ,  C H 2), 2 . 2 1  ( 2 H ,  a p p  q ,  J  7 . 5 ,  
C H = C C / / , ) ,  2 . 9 7  ( 1 H ,  b r  s ,  OH),  3 . 3 3  ( 2 H ,  a p p  q ,  J  5 . 5 ,  5 . 0 ,  
C H 2N H ) ,  3 . 5 7  ( 2 H ,  m ,  C / / 2O H ) ,  3 . 6 9  ( 2 H ,  s ,  C H 2P h ) ,  6 . 1 7
tC C D C  reference number 207151. See http://dx.doi.org/10.1039/ 
b503633j for crystallographic data in CIF or other electronic format.
4 O r g .  B i o  m o  I.  C h e m . ,  2 0 0 5 , 3 , 2 9 7 6 - 2 9 8 9
( 1 H.  b r  t ,  J  5 . 0 ,  N H).  6 . 5 4  ( 1 H,  t ,  J  7 . 5 ,  C=CH),  7 . 1 6 - 7 . 3 0  ( 5 H ,  
m ,  Ar-H);  <5c ( C D C l , )  1 4 . 5 ,  2 3 . 0 ,  2 8 . 9 ,  2 9 . 3 ,  2 9 . 5 ,  2 9 . 8 ,  3 2 . 1 ,
3 3 . 1 , 4 3 . 1 , 6 2 . 9 ,  1 2 6 . 8 ,  1 2 8 . 5 ,  1 2 9 . 1 ,  1 3 4 . 0 ,  1 3 9 . 0 ,  1 3 9 . 3 ,  1 7 0 . 5 ;  
m / z  ( E L * )  3 0 3  ( 1 0 ,  M * ‘), 2 4 3  ( 1 3 ,  M** H O C H 2C H 2N H * ) ,  9 1  
( 1 0 0 % ,  P h C H 2 * ) ;  H R M S  ( E S * )  C l9H , 0N O 2 [M H * j  r e q u i r e s  
3 0 4 . 2 2 7 1 ;  f o u n d  3 0 4 . 2 2 7 5 .
(£>A-(2-Hydroxyethyl)-2-isopropvl-2-pcnteiiamide 4e45. R e a c ­
t i o n  o f  j j y t - 3 - ( 3 - h y d r o x y - 2 - m e t h y l p e n t a n o y l ) - l  , 3 - o x a z o l i d i n - 2 -  
o n e  3e ( 0 . 1 0 0  g ,  0 . 4 4  m m o l )  w i t h  a  0 . 5  M  s o l u t i o n  o f  K H M D S  
i n  t o l u e n e  ( 1 . 3 0  m L ,  0 . 6 5  m m o l )  i n  T H F  ( 3  m L ) ,  a c c o r d i n g  
t o  g e n e r a l  p r o c e d u r e  C ,  a f f o r d e d  t h e  t i t l e  c o m p o u n d  (£)-4e 
( 0 . 0 8 0  g ,  0 . 4 3  m m o l )  i n  9 9 %  y i e l d  a n d  > 9 5 %  d e  a s  a  c o l o u r l e s s  
o i l ,  v m a x ( n e a t ) / c r n  1 3 3 3 8  ( b r ,  O H ,  N H ) ,  1 6 5 3  ( C = 0 ) ,  1 6 1 7  
( O C ) ,  1 5 3 4  ( 0 = 0 ) ;  t > H ( 3 0 0  M H z ,  C D C 1 . 0  1 . 0 3  ( 3 H ,  t ,  J  7 . 5 ,  
C H 2C / / . , ) ,  1 . 1 6  ( 6H ,  d ,  J  7 . 0 ,  C H ( C t f , ) 2 ) ,  2 . 1 4  ( 2 H ,  a p p  p e n t e t ,  
J  7 . 5 ,  C / / 2C H , ) ,  2 . 8 1  ( 1 H ,  s e p t e t ,  J  7 . 0 ,  C H ( C H , ) 2 ) ,  3 . 4 3  ( 2 H ,  
a p p  q ,  J  5 . 5 ,  4 . 5 ,  C / / 2N H ) ,  3 . 5 0  ( 1 H ,  b r  s ,  OH),  3 . 7 3  ( 2 H ,  
a p p  t ,  J  5 . 0 ,  C H 2O H ) ,  5 . 7 7  ( 1 H ,  t ,  J  7 . 5 ,  C=CH),  6 . 2 6  ( 1 H ,  
b r  s ,  NH);  <5c ( C D C h )  1 3 . 2 ,  2 0 . 1 ,  2 0 . 7 ,  2 7 . 2 ,  4 1 . 7 ,  6 1 . 8 ,  1 3 3 . 0 ,
1 4 2 . 2 ,  1 7 1 . 9 ;  m / z  ( C L ,  i s o - b u t a n e )  1 8 6  ( 88 ,  M H * ) ,  1 8 5  ( 3 2 ,  M * ) ,  
1 2 5  ( 1 0 0 % ,  M *  H O C H 2C H 2N H ) ;  H R M S  ( F A B * )  C , „ H 20N O 2 
[ M H * ]  r e q u i r e s  1 8 6 . 1 4 9 4 ,  f o u n d  1 8 6 . 1 4 9 5 .
(£)-A-(2-Hydroxyethyl)-2-isopropyl-3-phenyl-2-propenaniide
4f. R e a c t i o n  o f  ^ n - 3 - { 2 - [ h y d r o x y ( p h e n y l ) m e t h y l ] - 3 - m e t h y l -  
b u t a n o y l } - l , 3 - o x a z o l i d i n - 2 - o n e  3f ( 0 . 0 8 5  g ,  0 . 3 1  m m o l )  w i t h  a  
0 . 5  M  s o l u t i o n  o f  K H M D S  i n  t o l u e n e  ( 1 . 0 8  m L ,  0 . 5 4  m m o l )  i n  
T H F  ( 3  m L ) ,  a c c o r d i n g  t o  g e n e r a l  p r o c e d u r e  C ,  a f f o r d e d  t i t l e  
c o m p o u n d  (£)-4f ( 0 . 0 6 8  g ,  0 . 2 9  m m o l )  i n  9 2 %  d e .  T h e  c r u d e  
p r o d u c t  w a s  p u r i f i e d  f o r  a n a l y s i s  b y  s i l i c a  g e l  c h r o m a t o g r a p h y  
( 4 0 %  e t h y l  a c e t a t e - p e t r o l )  t o  a f f o r d  t h e  t i t l e  c o m p o u n d  (£)-4f 
( 0 . 0 6 5  g ,  0 . 2 2  m m o l )  i n  9 0 %  y i e l d  a n d  > 9 5 %  d e  a s  a  w h i t e  
s o l i d ,  m p  1 0 1 - 1 0 3  ° C ;  v m ax  ( K B r  d i s c ) / c m ~ '  3 3 1 7  ( s ,  O H .  N H ) ,  
1 6 4 1  ( C = 0 ) ,  1 6 1 2  ( C = C ) ,  1 5 3 8  ( C = 0 ) ; < 5 H ( 3 0 0  M H z .  C D C l , )
1 . 2 4  ( 6 H ,  d ,  J  7 . 0 ,  C H ( C / / , ) , ) ,  2 . 9 5  ( 1 H ,  b r  s ,  OH),  3 . 0 7  ( 1 H .  
s e p t e t ,  J  7 . 0 ,  C / / ( C H , ) : ) ,  3 . 5 2  ( 2 H ,  a p p  q ,  J  5 . 5 ,  5 . 0 ,  C / / 2N H ) ,
3 . 7 9  ( 2 H ,  a p p  t ,  J  5 . 0 ,  C H 2OH),  6 . 3 3  ( 1 H ,  b r  s ,  NH) ,  6 . 7 9  
( 1 H ,  b r  s ,  C = C H),  7 . 2 5 - 7 . 3 9  ( 5 H .  m ,  Ar-H);  Sc(CD C\}) 2 1 . 9 ,
2 8 . 5 ,  4 2 . 8 ,  6 3 . 0 ,  1 2 8 . 0 ,  1 2 8 . 8 ,  1 2 9 . 1 ,  1 3 0 . 1 ,  1 3 6 . 1 ,  1 4 5 . 7 ,  1 7 2 . 4 ;  
m /z  ( E l * * )  2 3 3  ( 1 9 ,  M * * ) ,  1 7 3  ( 4 8 ,  M * '  H O C H , C H , N H * ) ,  
1 4 5 ( 5 7 ,  M * *  H 0 C H 2 C H 2 N H C 0 * ) , 9 1  ( 1 0 0 % ,  P h C H , * ) ;  H R M S  
( E S * )  C , 4H 20N O 2 [ M H * ]  r e q u i r e s  2 3 4 . 1 4 8 9 ,  f o u n d  2 3 4 . 1 4 8 9 .
(£)-./V-(2-Hydroxyertiyl)-2-isopropyl-3-(4-mcthoxyphenyl)-2- 
propcnamidc 4g. R e a c t i o n  o f  s y w - 3 - { 2 - [ h y d r o x y ( 4 - m e t h -  
c x y p h e n y l ) m e t h y l ] - 3 - m e t h y l b u t a n o y l } - 1 , 3 - o x a z o l i d i n - 2 - o n e  3g 
( 0 . 2 0 0  g ,  0 . 6 5  m m o l )  w i t h  a  1 . 0  M  s o l u t i o n  o f  K H M D S  i n  
t o l u e n e  ( 1 . 9 5  n i L ,  0 . 9 8  m m o l )  i n  T H F  ( 4  m L ) ,  a c c o r d i n g  t o  
g e n e r a l  p r o c e d u r e  C ,  g a v e  t h e  t i t l e  c o m p o u n d  (£)-4g ( 0 . 1 5 5  g ,  
0 . 5 9  m m o l )  i n  9 0 %  d e .  T h e  c r u d e  p r o d u c t  w a s  p u r i f i e d  f o r  
a n a l y s i s  b y  s i l i c a  g e l  c h r o m a t o g r a p h y  ( 4 0 %  e t h y l  a c e t a t e - p e t r o l )  
t o  a f f o r d  t h e  t i t l e  c o m p o u n d  (£)-4g ( 0 . 1 4 9  g ,  0 . 5 7  m m o l )  i n  88%  
y i e l d  a n d  > 9 5 %  d e  a s  a  w h i t e  s o l i d ,  m p  9 1 - 9 3  ° C ;  v ma x  ( K B r  
d i s c ) / c m  1 3 2 7 9  ( s ,  O H ) ,  3 0 6 4  ( C = C ) a r ,  2 8 3 4  ( C - H ) O M c ,  1 6 4 5  
( C = 0 ) ,  1 6 2 0  ( C = C ) ,  1 6 0 6  ( C = C ) a r ,  1 5 4 2 ( C = 0 ) ,  1 5 1 0 ( C = C ) a r ; 
<5h ( 3 0 0  M H z ,  C D C l . , )  1 . 2 4  ( 6H ,  d ,  J  7 . 0 ,  C H ( C / / , ) 2 ) ,  3 . 0 9  ( 1H .  
s e p t e t ,  J  7 . 0 ,  C H (C H , ) 2 ) ,  3 . 1 8  ( 1 H ,  b r  s ,  OH),  3 . 5 0  ( 2 H ,  a p p  d t ,  
J  5 . 5 ,  5 . 0 ,  C H :NH),  3 . 7 5 - 3 . 8 5  ( 2 H ,  m ,  C / / 2O H ) ,  3 . 8 2  ( 3 H ,  s ,  
A r O C H y), 6 . 3 8  ( 1 H ,  b r  s ,  NH) ,  6 . 7 3  ( 1 H ,  s ,  C=CH),  6 . 8 9  ( 2 H ,  
d ,  J  9 . 0 ,  A r-H ),  7 . 2 1  ( 2 H ,  d ,  J  9 . 0 .  A r  / / ) u > t  ( C D C l , )  2 1 . 9 , 2 8 . 4 ,
4 2 . 8 ,  5 5 . 7 ,  6 2 . 9 ,  1 1 4 . 2 ,  1 2 8 . 5 ,  1 2 9 . 7 ,  1 3 0 . 5 ,  1 4 4 . 1 ,  1 5 9 . 4 ,  1 7 2 . 6 ;  
m /z  ( E L * )  2 6 3  ( 3 5 ,  M * ‘ ) ,  2 0 3  ( 2 6 ,  M * * - H O C H 2C H 2N H * ) ,  8 4  
( 1 0 0 % ) ;  H R M S  ( F A B * )  C 15H , , N O ,  [ M H * ]  r e q u i r e s  2 6 3 . 1 5 2 1 ;  
f o u n d  2 6 3 . 1 5 1 8 .
(FFA^-Hydroxyethyl^-phenyl^-pentenamide 4h. R e a c ­
t i o n  o f  s y « - 3 - ( 3 - h y d r o x y - 2 - p h e n y I p e n t a n o y l ) - 1 , 3 - o x a z o l i d i n - 2 -  
o n e  3h ( 0 . 2 0 0  g ,  0 . 7 6  m m o l )  w i t h  a  0 . 5  M  s o l u t i o n  o f  K H M D S  
i n  t o l u e n e  ( 2 . 2 4  m L ,  1 . 1 2  m m o l )  i n  T H F  ( 2  m L ) ,  a c c o r d i n g  
t o  g e n e r a l  p r o c e d u r e  C ,  g a v e  a  m i x t u r e  o f  t h e  t i t l e  c o m p o u n d  
(£)-4h ( 8 0 % )  i n  > 9 5 %  d e  a n d  t h e  p a r e n t  / V - a c y l  o x a z o l i d i n -
2 - o n e  2d  ( 2 0 % ) .  T h e  c r u d e  p r o d u c t  w a s  p u r i f i e d  b y  s i l i c a  g e l  
c h r o m a t o g r a p h y  ( 4 0 %  e t h y l  a c e t a t e  p e t r o l )  t o  a f f o r d  t h e  t i t l e  
c o m p o u n d  ( £ ) - 4 h  ( 0 . 0 7 8  g ,  0 . 3 5  m m o l )  i n  4 7 %  y i e l d  a n d  > 9 5 %  
d e  a s  a  c o l o u r l e s s  o i l ,  v max  ( n e a t ) / c m -1 3 4 1 8  ( b r ,  O H ,  N H ) ,  1 6 5 7  
( C = 0 ) ,  1 6 1 7  ( C = C ) ,  1 5 2 2  ( C = 0 ) ;  <5H ( 3 0 0  M H z ,  C D C l , )  0 . 9 9  
( 3 H ,  t ,  J 7 . 5 ,  C H 2C H 2), 1 . 9 8  ( 2 H ,  a p p  p e n t e t ,  J  7 . 5 ,  C H 2C H , ) ,  
3 . 1 6  ( 1 H ,  b r  s ,  OH),  3 . 3 9  ( 2 H ,  a p p  q ,  J 5 . 5 ,  5 . 0 ,  C H 2N H ) ,
3 . 6 6  ( 2 H ,  a p p  t ,  J  5 . 0 ,  C / / 2O H ) ,  5 . 7 9  ( 1 H ,  b r  s ,  NH) ,  7 . 0 3  
( 1 H .  t .  . /  7 . 5 .  C = C H ),  7 . 1 7  7 . 2 1  ( 2 H .  m ,  A r  H). 7 . 3 5  7 . 4 6  
( 3 H ,  m ,  A r-H );  <5c ( C D C 1 3 )  1 3 . 4 ,  2 3 . 1 ,  4 3 . 4 ,  6 2 . 8 ,  1 2 8 . 6 ,  1 2 9 . 0 ,
1 3 0 . 2 ,  1 3 5 . 1 ,  1 3 5 . 8 ,  1 4 3 . 8 ,  1 6 8 . 8 ;  m /z  ( E l * * )  2 1 9  ( 1 8 ,  M * * ) ,  
1 5 9  ( 2 2 ,  M * *  H O C H 2C H 2N H - ) ,  7 7  ( 1 0 0 % ) ;  H R M S  ( F A B * )  
C , . , H 18N 0 2 [ M H * ]  r e q u i r e s  2 2 0 . 1 3 3 2 ;  f o u n d  2 2 0 . 1 3 3 2 .
^ F ^ F f - A - ^ - H y d r o x y e t h y O ^ - i s o p r o p y l ^ d - h e x a d i e n a m i d e  
4 i  a n d  ( 2 Z , 4 £ ) - A , - ( 2 - h y d r o x y c t h y l ) - 2 - i s o p r o p y l - 2 , 4 - h e x a d i c n a m i d e
5 .  R e a c t i o n  o f  ^ y « - 3 - [ ( £ ) - 3 - h y d r o x y - 2 - i s o p r o p y l - 4 - h e x e n o y l ] -
1 . 3 - o x a z o l i d i n - 2 - o n e  3 i  ( 0 . 2 0 0  g ,  0 . 8 3  m m o l )  w i t h  a  0 . 5  M  
s o l u t i o n  o f  K H M D S  i n  t o l u e n e  ( 2 . 5 0  m L ,  1 . 2 5  m m o l )  i n  
T H F  ( 5  m L ) ,  a c c o r d i n g  t o  g e n e r a l  p r o c e d u r e  C ,  g a v e  t h e  
t i t l e  c o m p o u n d  ( £ , £ ) - 4 i  ( 0 . 1 5 3  g ,  0 . 7 8  m m o l )  i n  9 3 %  y i e l d  
a n d  i n  6 0 %  d e  w h i c h  w a s  p u r i f i e d  t h r o u g h  s i l i c a  ( p r e - c o a t e d  
w i t h  s i l v e r  n i t r a t e )  g e l  c h r o m a t o g r a p h y  t o  a f f o r d  t h e  t i t l e  
c o m p o u n d  ( £ , £ ) - 4 i  ( 0 . 0 1 6  g ,  0 . 0 8  m m o l )  i n  1 0 %  y i e l d  a s  a  
p a l e  o i l ,  <5h ( 3 0 0  M H z ,  C D C l , )  1 . 2 0  ( 6H ,  d ,  J  7 . 0 ,  C H ( C / / , ) 2 ) ,  
1 . 8 3  ( 3 H ,  d d ,  J  7 . 0 ,  1 . 5 ,  C H = C H C H 3), 2 . 9 5  ( 1 H ,  s e p t e t ,  
J 7 . 0 ,  C / / ( C H , ) 2 ) ,  3 . 2 0  ( 1 H ,  b r  s ,  OH),  3 . 4 5  ( 2 H ,  a p p  d t ,  
J 5 . 5 .  4 . 0 ,  C 7 / 2N H ) ,  3 . 7 4  ( 2 H ,  a p p  t ,  J 5 . 0 ,  C H 2O H ) ,  5 . 8 9  
( 1 H ,  d q ,  J  1 3 . 0 ,  7 . 0 ,  C H = C / / C H , ) ,  6 . 2 1  ( 1 H ,  b r  s ,  NH) ,
6 . 3 3  ( 1 H ,  b r  d ,  J  1 0 . 5 ,  C / / - C H = C H C H , ) ,  6 . 3 9  ( 1 H ,  d d q ,  
J 1 3 . 0 ,  1 0 . 5 ,  1 . 5 ,  C H - C / / = C H C H , ) ;  <5c ( C D C l , )  1 9 . 0 ,  2 1 . 8 ,
2 8 . 6 ,  4 2 . 8 ,  6 3 . 0 ,  1 2 6 . 6 ,  1 3 0 . 6 ,  1 3 5 . 2 ,  1 4 1 . 0 ,  1 7 2 . 5 ;  m / z  ( E l * * )  
1 9 7  ( 2 3 ,  M * * ) ,  1 8 2  ( 3 3 ,  M * * - C H / ) ,  1 6 9  ( 3 8 ,  M * * - C H , C H * ) ,  
1 5 4  ( 1 0 0 ,  M **-(C H 02C H *), 1 3 7  ( 2 8 ,  M * ' - H O ( C H 2) 2N H * ) ,  
1 0 9  ( 4 3 ,  M * '  H O ( C H : ) : N H C O ' ) ,  a n d  i t s  g e o m e t r i c  i s o m e r  
( Z , £ ) - 5  ( 0 . 0 1 5  g ,  0 . 0 8  m m o l )  i n  9 %  y i e l d ,  <SH ( 3 0 0  M H z ,  C D C h )
1 . 0 8  ( 6H ,  d ,  J 7 . 0 ,  C H ( C / £ ) 2 ) ,  1 . 7 7  ( 3 H ,  d d ,  J 7 . 0 ,  1 . 5 ,  
C H = C H CH,) ,  2 . 6 4  ( 1 H ,  s e p t e t ,  J 7 . 0 ,  C H ( C H , ) 2 ) ,  3 . 0 0  ( 1 H ,  
b r  s ,  OH),  3 . 5 3  ( 2 H ,  a p p  d t ,  J  5 . 5 ,  4 . 5 ,  C H 2N H ) ,  3 . 7 8  ( 2 H ,  a p p  
t ,  J  5 . 0 ,  CH^ O H ) ,  5 . 7 9  ( 1 H ,  d q ,  J 1 5 . 0 ,  7 . 0 ,  C H C H = C / / C H , f
5 . 9 9  ( 1H ,  d ,  J  11. 0 .  C H -C H = C H C H , ) ,  6 . 1 3  ( 1H ,  b r  s ,  NH) .  
6 . 2 8  ( I H ,  d d q ,  J 1 5 . 0 ,  11. 0 ,  1. 5 ,  C H - C / / = C H C H , ) .
( 2 £ , 4 £ ) - / V - ( 2 - H y d r o x y e t h y l ) - 2 - m e t h y l - 5 - p h e n y l - 2 , 4 - p e n t a -  
d i c n a m i d c  4 j .  R e a c t i o n  o f  j y n - 3 - [ ( £ ) - 3 - h y d r o x y - 2 - m e t h y l -  
5 - p h e n y l - 4 - p e n t e n o y l ] - l , 3 - o x a z o l i d i n - 2 - o n e  4 j  ( 0 . 2 7 5  g ,
1 . 0 0  m m o l )  w i t h  a  0 . 5  M  s o l u t i o n  o f  K H M D S  ( 3 . 0 0  m L ,  
1 . 5 0  m m o l )  i n  T H F  ( 5  m L ) ,  a c c o r d i n g  t o  g e n e r a l  p r o c e d u r e  
C ,  g a v e  t h e  t i t l e  c o m p o u n d  ( £ ) - 4 j  ( 0 . 2 2 3  g ,  0 . 9 7  m m o l )  i n  
9 7 %  y i e l d  a n d  i n  6 0 %  d e  T h e  c r u d e  p r o d u c t  w a s  p u r i f i e d  f o r  
a n a l y s i s  b y  r e c r y s t a l l i s a t i o n  f r o m  h o t  e t h y l  a c e t a t e ,  t o  a f f o r d  t h e  
t i t l e  c o m p o u n d  ( £ ) - 4 j  ( 0 . 1 4 7  g ,  0 . 6 4  m m o l )  i n  6 4 %  y i e l d  a n d  
> 9 5 %  d e  a s  a  w h i t e  s o l i d ,  m p  1 4 1  1 4 2  ° C ;  v m a x ( K B r  d i s c ) / c m "1 
3 2 9 3  ( b r ,  O H ) ,  3 2 5 0  ( b r ,  N H ) ,  1 6 4 2  ( C = 0 ) ,  1 5 8 5  ( C = C ) ,  1 5 4 2  
(C = 0);  r $ H ( 3 0 0  M H z ,  C D C l , )  2 . 0 8  ( 3 H ,  s ,  C H , ) ,  2 . 8 7  ( 1 H ,  t ,  
J 5 . 0 ,  OH),  3 . 5 5  ( 2 H ,  a p p  q ,  J  5 . 5 ,  5 . 0 ,  C H 2N H ) ,  3 . 8 0  ( 2 H ,  
a p p  q ,  J  5 . 0 ,  5 . 0 ,  C / / 2O H ) ,  6 . 3 2  ( 1 H ,  b r  s ,  NH) ,  6 . 8 3  ( 1 H ,  d ,  J
1 5 . 0 ,  C / / - C H = C H P h ) ,  7 . 0 1  ( 1 H ,  d ,  J 1 1 . 0 ,  C H C H = C / / P h ) ,  
7 . 1 0  ( 1 H ,  d d ,  J 1 5 . 0 ,  1 1 . 0 ,  C H C £ = C H P h ) ,  7 . 2 8 - 7 . 4 8  ( 5 H ,  m ,  
A r-H );  <5c ( C D C I 3 )  1 3 . 6 ,  4 3 . 3 ,  6 3 . 1 ,  1 2 4 . 0 ,  1 2 7 . 3 ,  1 2 8 . 9 ,  1 2 9 . 1 ,
1 2 9 . 9 ,  1 3 4 . 9 ,  1 3 7 . 0 ,  1 3 8 . 6 ,  1 7 0 . 5 ;  m /z  ( E l * * )  2 3 1  ( 3 3 ,  M * ‘ ) ,  
1 7 1  ( 8 0 ,  M H * * - H O C H 2C H 2N H * ) ,  1 5 4  ( 7 8 ,  M * * - P h * ) ,  1 4 1  
( 4 7 ,  M * *  P h C H * ) ,  1 2 8  ( 1 0 0 ,  M * * - P h C H C H * ) ,  1 1 5  ( 3 8 % ,  M * *  
P h C H C H C H * ) ;  H R M S  ( F A B * )  C l4H l8N 0 2 [ M H * ]  r e q u i r e s  
2 3 2 . 1 3 3 2 ,  f o u n d  2 3 2 . 1 3 3 0 .
3 - { ( 2 / ? , 3 / ? ) - 3 - H y d r o x y - 3 - [ ( 4 £ ) - 4 - i s o p r o p e n y l - l - c y c l o h e x e n -
1 - y l | - 2 - m e t h y l p r o p a n o y l } - l , 3 - o x a z o  l i d - i n - 2 - o n e  8a  a n d  3 - { ( 2 5 , 3 5 >
3 - h y d r o x y - 3 - | ( 4 / ? ) - 4 - i s o p r o p e n y l - l - c y c l o h c x e n - l - y l | - 2 - m e t h y l -  
p r o p a n o y l } - l , 3 - o x a z o l i d i n - 2 - o n c  9 a .  R e a c t i o n  o f  3 - p r o p i o n y l -
1 . 3 - o x a z o l i d i n - 2 - o n e  2 a  ( 0 . 5 0 0  g ,  3 . 5 0  m m o l )  w i t h  a  0 . 5  M
O r g .  B i o  m o  I. C h e m . ,  2 0 0 5 , 3 , 2 9 7 6 - 2 9 8 9  2 9 8 5
s o l u t i o n  o f  9 - B B N - O T f  i n  h e x a n e s  ( 8 . 4 0  m L ,  4 . 2 0  m m o l ) ,  
A A y V - d i i s o p r o p y l e t h y l a m i n e  ( 0 . 8 5  m L ,  4 . 9 0  m m o l )  a n d  L -  
( — ) - p e r i l l a l d e h y d e  ( 0 . 6 0  m L ,  3 . 8 5  m m o l )  i n  C H 2C 1 2 ( 2 0  m L ) ,  
a c c o r d i n g  t o  g e n e r a l  p r o c e d u r e  B ,  a f f o r d e d  a f t e r  p u r i f i c a t i o n  
t h r o u g h  s i l i c a  g e l  c h r o m a t o g r a p h y  ( 20%  e t h y l  a c e t a t e - p e t r o l )  
t h e  t i t l e  c o m p o u n d s  8a /9a  ( 0 . 6 5 6  g ,  2 . 2 4  m m o l )  i n  6 4 %  y i e l d  a s  
a  w h i t e  s o l i d ,  a s  a  1 : 1 m i x t u r e  o f  d i a s t e r e o m e r s ,  m p  8 7 - 8 8  ° C ;  
v m , x ( K B r  d i s c ) / c m  1 3 4 9 5  ( s ,  O H ) ,  1 7 6 9  ( C = 0 ) o x ,  1 6 9 1  ( C = 0 ) ;  
( 5 H ( 3 0 0  M H z ,  C D C l . , )  1 . 1 3  ( 3 H ,  d ,  J  6 . 0 ,  C / / „  8a), 1 . 1 5  ( 3 H ,  
d ,  J  6 . 0 ,  C H }, 9a), 1 . 3 8 - 1 . 5 5  ( 2 H ,  m ,  C y - / / ) ,  1 . 7 4  ( 6 H ,  s ,  2  x  
C H j C = C H 2 ) ,  1 . 8 2 - 1 . 8 8  ( 2 H ,  m ,  C y - / / ) ,  1 . 9 2 - 2 . 0 6  ( 4 H ,  m ,  
C y - / / ) ,  2 . 1 1 - 2 . 2 4  ( 4 H ,  m ,  C y - / / ) ,  2 . 7 6  ( 1 H ,  s ,  OH,  8a), 2 . 7 8  
( 1 H ,  s ,  O H,  9a), 3 . 7 5  ( 1 H ,  m ,  C / / C H , .  8a), 3 . 9 6 - 4 . 0 0  ( 1 H ,  m ,  
C / / C H , ,  9a). 4 . 0 5  ( 4 H ,  a p p  t ,  J 8 . 0 ,  C H 2N ) ,  4 . 3 5 - 4 . 4 5  ( 2 H ,  
m ,  CHOH) ,  4 . 4 4  ( 4 H ,  a p p  t ,  J 8 . 0 ,  C H 2O ) ,  4 . 7 0 - 4 . 7 6  ( 4 H ,  m ,  
C H 2=C),  5 . 8 0 - 5 . 8 3  ( 2 H ,  m ,  CH=C);  <5c ( C D C l j )  1 0 . 2 ,  1 0 . 9 ,
2 1 . 2 ,  2 1 . 3 ,  2 5 . 7 ,  2 6 . 0 ,  2 6 . 5 ,  2 7 . 7 ,  2 7 . 8 ,  3 0 . 6 ,  3 0 . 9 ,  4 0 . 4 ,  4 0 . 8 ,
4 1 . 2 , 4 1 . 7 , 4 3 . 1 , 6 2 . 4 ,  6 8 . 4 ,  7 4 . 3 , 7 4 . 6 ,  1 0 9 . 0 ,  1 0 9 . 1 ,  1 2 2 . 4 ,  1 2 3 . 0 ,
1 3 6 . 2 ,  1 3 6 . 7 ,  1 4 9 . 9 ,  1 5 0 . 2 ,  1 5 3 . 6 ,  1 7 7 . 5 ,  1 7 7 . 6 ;  m / z  ( C L .  N H , )  
3 1 1  ( 9 ,  M N H / ) ,  2 9 4  ( 1 5 ,  M H + ) ,  2 7 6  ( 4 0 ,  M + - O H ) ,  1 6 1  ( 1 0 0 ) ,  
1 4 4  ( 3 9 % ,  M H + - C H O H C y ) ;  H R M S  ( F A B + )  C l6H 24N 0 4 [ M H + ] 
r e q u i r e s  2 9 4 . 1 7 0 0 ;  f o u n d  2 9 4 . 1 6 9 5 .
3-(2/?, 3 5 ,55)-3-H ydroxy-2,5,9-trimethyl-8-decenoy I ) -1,3- 
oxazolidin-2-one 8b and 3-(25,3/?,55)-3-hydroxy-2,5,9-trimethyl-
8-decenoyl)-l,3-oxazolidin-2-one 9b. R e a c t i o n  o f  3 - p r o p i o n y l -
l , 3 - o x a z o l i d i n - 2 - o n e  2a ( 0 . 3 0 0  g ,  2 . 1 0  m m o l )  w i t h  a  0 . 5  M  
s o l u t i o n  o f  9 - B B N - O T f  i n  h e x a n e s  ( 5 . 0 3  m L ,  2 . 5 2  m m o l ) ,  
/ V , y V - d i i s o p r o p y l e t h y l a m i n e  ( 0 . 5 1  m L ,  2 . 9 4  m m o l )  a n d  ( S ) -  
c i t r o n e l l a l  ( 0 . 4 2  m L ,  2 . 3 1  m m o l )  i n  C H 2C 1 2 ( 1 0  m L ) ,  a c c o r d i n g  
t o  g e n e r a l  p r o c e d u r e  B ,  a f f o r d e d  a f t e r  p u r i f i c a t i o n  t h r o u g h  s i l i c a  
g e l  c h r o m a t o g r a p h y  ( g r a d i e n t ,  2 0 - 3 0 %  e t h y l  a c e t a t e - p e t r o l )  
t h e  t i t l e  c o m p o u n d s  8b/9b ( 0 . 5 7 6  g ,  1 . 9 4  m m o l )  i n  9 3 %  
y i e l d  a s  a  l o w  v i s c o s i t y  c o l o u r l e s s  o i l ,  a s  a  1 : 1 m i x t u r e  o f  
d i a s t e r e o i s o m e r s ,  v m a x ( n e a t ) / c n v '  3 5 0 2  ( b r ,  O H ) ,  1 7 7 1  ( C = 0 ) o x ,  
1 6 9 5  ( C = 0 ) ;  <5H ( 3 0 0  M H z ,  C D C l , )  0 . 9 2  ( 6H ,  a p p  t ,  J 7 . 0 ,  
C H C / / , ,  8b +  9b), 1 . 0 5 - 1 . 2 8  ( 4 H ,  m ,  A i k - / / ) ,  1 . 2 0  ( 3 H ,  d ,  J
7 . 0 ,  0 = C C H C / / , .  8b), 1 . 2 1  ( 3 H ,  d ,  J  7 . 0 ,  0 = C C H C / / , .  9b), 
1 . 3 0 - 1 . 4 8  ( 4 H , m ,  A i k - / / ) ,  1 . 6 0  ( 6H ,  s ,  C H = C ( C H , ) C / / , ) ,  1 . 6 8  
( 6H ,  s ,  C H = C ( C H , ) C / / , ) ,  1 . 5 4 - 1 . 7 0  ( 2 H ,  m ,  C / / C H , ) ,  1 . 9 2 -
2 . 0 8  ( 4 H ,  m ,  C H 2C H = C ( C H , ) 2 ) ,  2 . 7 3  ( 1 H ,  d ,  J 2 . 3 ,  O H .  8b).
2 . 8 0  ( 1 H ,  d ,  J  3 . 0 ,  OH,  9b), 3 . 7 3 - 3 . 8 3  ( 2 H ,  m ,  0 = C C / / C H , ) ,  
4 . 0 0 - 4 . 1 1  ( 6 H ,  m ,  C / / O H ,  C / / 2N ) ,  4 . 4 4  ( 4 H ,  a p p  t ,  J 8 . 0 ,  
C H 2O ) ,  5 . 1 0  ( 2 H ,  t ,  J  7 . 0 ,  C / / = C ( C H , ) 2 ) ;  <5c ( C D C l , )  1 0 . 6 ,
1 1 . 0 ,  1 8 . 1 ,  1 9 . 3 ,  2 0 . 6 ,  2 5 . 7 ,  2 5 . 9 ,  2 6 . 0 ,  2 6 . 1  ( 2 C ) ,  2 9 . 3 ,  2 9 . 6 ,
3 6 . 9 ,  3 8 . 3 ,  4 1 . 4 ,  4 1 . 5 ,  4 2 . 2  ( 2 C ) ,  4 2 . 9 ,  4 3 . 0 ,  6 2 . 3 ,  6 8 . 4 ,  6 9 . 6 ,
6 9 . 8 ,  1 2 5 . 1 .  1 3 1 . 6 ,  1 3 1 . 6 ,  1 5 3 . 6 ,  1 5 3 . 6 ,  1 7 7 . 9 ,  1 7 8 . 0 ;  m / z  ( E I + )  
2 9 7 . 2  ( 1 1 ,  M + ‘ ) ,  1 4 3  ( 1 0 0 % ) ;  H R M S  ( E S + )  C l(SH 28N 0 4 [ M H * ]  
r e q u i r e s  2 9 8 . 2 0 1 3 ;  f o u n d  2 9 8 . 2 0 0 9 .
(2/?,3/?)-3-{3-|(4/?)-2,2-Dimethyl-1,3-dioxolan-4-yl|-3-hydroxy- 
2-methylpropanoyl}-l,3-oxazol-idin-2-one 8c and (25,3S)-3-{3- 
|(4/?)-2,2-dimethyl-l,3-dioxolan-4-yl|-3-hydroxy-2-mcthyIpropan- 
oyl}-l,3-oxazolidin-2-one 9c. R e a c t i o n  o f  3 - p r o p i o n y l - l , 3 -  
o x a z o l i d i n - 2 - o n e  2a ( 0 . 2 0 0  g ,  1 . 4 0  m m o l )  w i t h  a  0 . 5  M  
s o l u t i o n  o f  9 - B B N - O T f  i n  C H 2C 1 2 ( 3 . 3 6  m L ,  1 . 6 8  m m o l ) ,  
A 2, A - d i i s o p r o p y l e t h y l a m i n e  ( 0 . 3 4  m L ,  1 . 9 6  m m o l )  a n d  ( / ? ) -  
( + ) - 2 , 2 - d i m e t h y l - l , 3 - d i o x o l a n e - 4 - c a r b o x a l d e h y d e  ( 0 . 1 9  m L ,
1 . 5 4  m m o l )  i n  h e x a n e s  ( 7  m L ) ,  a c c o r d i n g  t o  g e n e r a l  p r o c e d u r e  
E ,  a f f o r d e d  a f t e r  p u r i f i c a t i o n  t h r o u g h  s i l i c a  g e l  c h r o m a t o g r a p h y  
( g r a d i e n t ,  4 0 - 5 0 %  e t h y l  a c e t a t e - p e t r o l )  t h e  t i t l e  c o m p o u n d s  
8 c /9 c  ( 0 . 2 2 2  g ,  0 . 8 1  m m o l )  i n  5 8 %  y i e l d  a s  a  t h i c k  c o l o u r l e s s  o i l ,  
a s  a  2  : 1 m i x t u r e  o f  d i a s t e r e o i s o m e r s ,  v m a x ( n e a t ) / c n r '  3 4 4 7  ( b r ,  
O H ) ,  1 7 7 1  ( C = 0 ) o x ,  1 6 9 9  ( C = 0 ) ;  <5H ( 3 0 0  M H z ,  C D C l , )  1 . 2 8  
( 3 H ,  d ,  J  6 . 5 ,  C H C / / , .  8c). 1 . 3 4  ( 6 H ,  s ,  C H , ) ,  1 . 3 8  ( 3 H ,  d ,  J  6 . 5 ,  
C H C / / , ,  9c), 1 . 4 3  ( 6 H ,  s ,  C H , ) ,  2 . 5 5  ( 1 H ,  d ,  J  6 . 5 ,  OH,  8c), 3 . 1 1  
( 1 H ,  d ,  J  3 . 0 ,  OH,  9c), 3 . 7 2 - 4 . 1 8  ( 1 0 H .  m ,  C / / C H , ,  CHOH,  
C H  O H ,  2  x  C H 2 O ) ,  4 . 0 5  ( 4 H ,  a p p  t ,  J  7 . 5 ,  C H : N ) ,  4 . 4 4  ( 4 H .  
a p p  t ,  J  7 . 5 ,  C H 2O ) ; < 5 c ( C D C l , )  1 1 . 2 , 1 2 . 1 ,  2 5 . 6 , 2 5 . 8 , 2 6 . 8 , 2 7 . 1 ,
3 9 . 5 ,  4 1 . 3 ,  4 3 . 1 ,  6 2 . 3 ,  6 2 . 4 ,  66 . 6 ,  6 7 . 8 ,  6 8 . 4 ,  7 2 . 0 ,  7 3 . 1 ,  7 5 . 6 ,
7 7 . 2 ,  1 0 9 . 8 ,  1 1 0 . 1 ,  1 5 3 . 2 ,  1 5 3 . 6 ,  1 7 5 . 6 ,  1 7 8 . 0 ;  m / z  ( C L ,  N H . , )
2 9 1  ( 3 0 % ,  M N H / ) ,  2 7 4  ( 4 6 ,  M H * ) ,  2 5 6  ( 5 ,  M + - O H ) ,  2 3 0  ( 2 0 ,  
M H + - C O , ) .  1 4 4  ( 1 3 ,  M H + - C H O H R ) ,  1 0 5 . 0  ( 1 0 0 % ) ;  H R M S  
( E S + )  C 12H 20N O 6 [ M H * ]  r e q u i r e s  2 7 4 . 1 2 8 5 ,  f o u n d  2 7 4 . 1 2 8 2 .
( £ , £ > / V - ( 2 - H y d r o x y e t h y l ) - 3 - | ( 4 / ?  ) - 4 - i s o p r o p e n y l - l - c y c l o h e x e n -
1 - y l | - 2 - m e t h y l - 2 - p r o p e n a m i d e  1 0 a .  R e a c t i o n  o f  t h e  m i x t u r e  
o f  a l d o l s  8 a / 9 a  ( 0 . 1 0 0  g ,  0 . 3 4  m m o l )  w i t h  a  0 . 5  M  s o l u t i o n  
o f  K H M D S  i n  t o l u e n e  ( 2 . 0 5  m L ,  1 . 0 2  m m o l )  i n  T H F  ( 4  m L ) ,  
a c c o r d i n g  t o  g e n e r a l  p r o c e d u r e  C ,  g a v e  t h e  t i t l e  c o m p o u n d  
(R,E,E)-  1 0 a  i n  5 0 %  d e .  T h e  c r u d e  m i x t u r e  w a s  p u r i f i e d  b y  
s i l i c a  g e l  c h r o m a t o g r a p h y  ( 6 0 %  e t h y l  a c e t a t e - p e t r o l )  t o  a f f o r d  
t h e  t i t l e  c o m p o u n d  (R,E,E)-  1 0 a  ( 0 . 0 4 3  m g ,  0 . 1 7  m m o l )  i n  5 1 %  
i s o l a t e d  y i e l d  a n d  > 9 5 %  d e  a s  a  w h i t e  s o l i d ,  [ a ],,21 — 7 2 . 2  ( c  0 . 9 0 ,  
C H 2C 1 2 ) ;  m p  6 7 - 6 9  ° C ;  v m a x ( K B r  d i s c ) / c t T r '  3 3 0 0  ( b r ,  N H ) ,  3 2 9 2  
( s ,  O H ) ,  1 6 3 4  ( C = 0 ) ,  1 6 0 3  ( C = C ) ,  1 5 3 8  ( C = 0 ) ;  <5H ( 3 0 0  M H z ,  
C D C l , )  1 . 3 5 - 1 . 4 8  ( 1 H ,  m ,  C y - / / ) ,  1 . 6 8  ( 3 H ,  s ,  C H , = C H C / / , ) ,  
1 . 7 5 - 1 . 8 4  ( 1 H ,  m ,  C y - / / ) ,  1 . 9 5  ( 3 H ,  s ,  C H = C C / / , ) ,  2 . 0 0 - 2 . 1 1  
( 2 H ,  m ,  C y - / / ) ,  2 . 1 6 - 2 . 2 4  ( 3 H ,  m ,  C y - / / ) ,  3 . 2 8  ( 1 H ,  s ,  OH),  3 . 4 2  
( 2 H ,  a p p  q ,  J  5 . 0 ,  C / / 2N H ) ,  3 . 6 8  ( 2 H ,  a p p  t ,  J  5 . 0 ,  C H 2O H ) ,
4 . 6 7  ( 2 H ,  d ,  J  7 . 0 ,  C = C / / , ) ,  5 . 7 6  ( 1 H ,  m ,  C = C H C H 2 ) ,  6 . 3 3  
( 1 H .  b r  s ,  NH) ,  6.66 ( 1 H ,  s ,  C H }C =CH );  c5c ( C D C l , )  1 4 . 7 ,
2 1 . 2 ,  2 8 . 0 ,  2 9 . 4 ,  3 1 . 6 ,  4 0 . 8 ,  4 3 . 3 ,  6 2 . 9 ,  1 0 9 . 3 ,  1 2 8 . 5 ,  1 3 1 . 5 ,
1 3 4 . 6 ,  1 3 7 . 4 ,  1 4 9 . 7 ,  1 7 1 . 8 ;  m /z  ( E I + > )  2 4 9  ( 1 6 ,  M + * ) ,  2 0 8  
( 11, M ”  C H , C H ( C H 2 ) * ) ,  1 8 9  ( 1 0 % ,  M + * - H O C H 2C H 2N H * ) ,  
1 2 1  ( 5 5 % ,  C y + ) ,  9 1  ( 1 0 0 % ) ;  H R M S  ( E S + )  C 15H 24N 0 2 [ M H * ]  
r e q u i r e s  2 5 0 . 1 8 0 2 ,  f o u n d  2 5 0 . 1 8 0 2 .
( 2 £ , 5 . S ' H V - ( 2 - H y d r o x y e t h y l ) - 2 , 5 , 9 - t r i m e t h y l - 2 , 8 - d e c a d i c n a m i d e
1 0 b .  R e a c t i o n  o f  a l d o l s  8 b / 9 b  ( 0 . 1 5 0  m g ,  0 . 5 1  m m o l )  w i t h  a  
0 . 5  M  s o l u t i o n  o f  K H M D S  i n  t o l u e n e  ( 1 . 5 2  m L ,  0 . 7 6  m m o l )  
i n  T H F  ( 3  m L ) ,  a c c o r d i n g  t o  g e n e r a l  p r o c e d u r e  C ,  g a v e  t h e  
t i t l e  c o m p o u n d  ( S , £ ) - 1 0 b  ( 0 . 1 2 1  m g ,  0 . 4 8  m m o l )  i n  6 0 %  d e .  
T h e  c r u d e  p r o d u c t  w a s  p u r i f i e d  b y  s i l i c a  g e l  c h r o m a t o g r a p h y  
( 6 0 %  e t h y l  a c e t a t e - p e t r o l )  t o  a f f o r d  t h e  t i t l e  c o m p o u n d  
( 5 , £ ) - 1 0 b  ( 0 . 0 7 1  g ,  0 . 2 8  m m o l )  i n  5 5 %  y i e l d  a n d  > 9 5 %  d e  a s  
a  c o l o u r l e s s  o i l ,  [ a ],)21 + 2 . 7  ( c  2 . 6 1 ,  C H 2C 1 2 ) ,  v n i a x ( n e a t ) / c n r  1 
3 4 0 2  ( b r ,  O H ,  N H ) ,  1 6 5 7  ( C = 0 ) ,  1 6 1 5  ( C = C ) ,  1 5 3 8  ( C = 0 ) ;  
<5h ( 3 0 0  M H z ,  C D C l , )  0 . 9 0  ( 3 H ,  d ,  J  6 . 5 ,  C H C / / , ) ,  1 . 1 2 -  
1 . 2 7  ( 1 H ,  m ,  C / / A H „ C H 2C H = C ( C H , ) 2 ) ,  1 . 3 0 - 1 . 4 2  ( 1 H ,  m ,  
C H a / / „ C H 2C H = C ( C H , ) 2) ,  1 . 5 5 - 1 . 6 5  ( 1H ,  m ,  C H  C H , ) ,  1 . 6 0  
( 3 H ,  s ,  C H = C ( C / / , ) 2 ) ,  1 . 6 8  ( 3 H ,  s ,  C H = C ( C / / , ) 2 ) ,  1 . 8 5  ( 3 H ,  s ,  
C H = C C / / , ) ,  1 . 9 0  2 . 0 5  ( 2 H ,  m ,  C / / 2C H = C ( C H , ) 2 ) ,  2 . 1 0 - 2 . 1 9  
( 2 H ,  m ,  C / / 2C H = C C H , ) ,  3 . 4 8  ( 2 H ,  a p p  q ,  J  5 . 5 ,  5 . 0 ,  C / / 2N H ) ,  
3 . 6 1  ( 1 H ,  b r  s ,  OH),  3 . 7 2 - 3 . 7 6  ( 2 H ,  m ,  C / / 2O H ) ,  5 . 0 7  ( 1 H ,  
t ,  J 7 . 0 ,  C H = C (C H , ) 2 ) ,  6 . 4 1  ( 1 H ,  b r  s ,  NH),  6 . 4 4  ( 1 H ,  t ,  J
6 . 5 ,  C / / = C ) ; < 5 c ( C D C l , )  1 3 . 2 ,  1 8 . 1 , 2 0 . 0 ,  2 6 . 0 ,  2 6 . 1 , 3 3 . 1 , 3 6 . 1 ,
3 7 . 2 , 4 3 . 1 , 6 2 . 8 ,  1 2 4 . 9 ,  1 3 1 . 1 ,  1 3 1 . 8 ,  1 3 6 . 6 ,  1 7 1 . 0 ;  m /z  ( E L )  2 5 3  
( 4 6 ,  M + * ) ,  2 3 8  ( 1 8 ,  M + * - C H , * ) ,  1 9 3  ( 5 ,  M * '  H O C H 2C H 2N H ' ) ,  
1 7 0  ( 4 1 ,  M + ' - ( C H , ) 2C = C H C H 2C H 2 ' ) ,  1 0 9  ( 1 0 0 % ) ;  H R M S  
( E S + )  C , 5H 2!(N 0 2 [ M H * ]  r e q u i r e s  2 5 4 . 2 1 1 5 ;  f o u n d  2 5 4 . 2 1 1 2 .
( £ > 3 - | ( 4 5 > 2 , 2 - D i m e t h y l - l , 3 - d i o x o l a n - 4 - y l | - A , - ( 2 - h y d r o x y e t h y l ) -
2 - m c t h y l - 2 - p r o p e n a m i d c  1 0 c .  R e a c t i o n  o f  a l d o l s  8 c / 9 c  
( 0 . 1 0 0  g ,  0 . 3 7  m m o l )  w i t h  a  0 . 5  M  s o l u t i o n  o f  K H M D S  
( 1 . 1 0  m L ,  0 . 5 5  m m o l )  i n  T H F  ( 2  m L ) ,  a c c o r d i n g  t o  g e n e r a l  
p r o c e d u r e  C ,  g a v e  t h e  t i t l e  c o m p o u n d  ( 5 , , £ ) - 1 0 c  i n  8 0 %  d e .  T h e  
c r u d e  m i x t u r e  w a s  p u r i f i e d  b y  s i l i c a  g e l  c h r o m a t o g r a p h y  ( 7 0 %  
e t h y l  a c e t a t e - p e t r o l )  t o  a f f o r d  t h e  t i t l e  c o m p o u n d  (S,E)-  1 0 c  
( 0 . 0 3 5  g ,  0 . 1 5  m m o l )  i n  4 2 %  y i e l d  a n d  > 9 5 %  d e  a s  a  c o l o u r l e s s  
o i l ,  [ a ]D21 + 4 . 5  ( c  1 . 5 4 ,  C H 2C 1 2 ) ;  v m a x ( n e a t ) / c i T r '  3 3 0 5  ( b r ,  O H ,  
N H ) ,  1 6 6 8  ( C = 0 ) ,  1 6 2 2  ( C = C ) ,  1 5 3 8  ( C = 0 ) ;  r 5 H ( 3 0 0  M H z ,  
C D C l , )  1 . 4 1  ( 3 H ,  s ,  C H 3), 1 . 4 4  ( 3 H ,  s ,  C H 3), 1 . 9 3  ( 3 H ,  d ,  J
1 . 2 ,  C = C ( C / / , ) ) ,  3 . 2 7  ( 1 H ,  s ,  OH),  3 . 4 7  ( 2 H ,  a p p  q ,  J 5 . 0 ,  
C H 2NH),  3 . 6 1  ( 1 H ,  a p p  t ,  J 8 . 0 ,  C / / A H b O ) ,  3 . 7 4  ( 2 H ,  a p p  t ,  
J  5 . 0 ,  C / / 2O H ) ,  4 . 1 5  ( 1 H ,  d d ,  J  8 . 0 ,  6 . 0 ,  C H A / / l t O ) ,  4 . 8 4  ( 1 H ,  
t d ,  J  8 . 0 ,  6 . 0 ,  C / / O C H = ) ,  6 . 2 5  ( 1 H ,  d q ,  J  8 . 0 ,  1 . 2 ,  CH=C),
6 . 5 2  ( 1 H ,  b r  s ,  NH);  <5c ( C D C l , )  1 3 . 8 ,  2 6 . 2 ,  2 7 . 0 ,  4 3 . 0 ,  6 2 . 3 ,
6 9 . 2 ,  7 2 . 9 .  1 1 0 . 1 .  1 3 2 . 8 ,  1 3 5 . 1 ,  1 7 0 . 1 ;  m / z  ( C l * ,  i s o - b u t a n e )  
2 3 0  ( 9 8 ,  M H * ) ,  2 1 4  ( 2 0 ,  M + - C H , * ) ,  1 7 2  ( 68 ,  M + - ( C H , ) 2C O ) ,  
1 4 1  ( 6 3 ,  M * - H O C H 2C H 2N H C O ) ,  88 ( 1 0 0 % ) ;  H R M S  ( E S + )  
C n H ^ N O ,  [ M H * ]  r e q u i r e s  2 3 0 . 1 3 8 7 ;  f o u n d  2 3 0 . 1 3 8 9 .
1 6  O r g .  B i o  m o  I.  C h e m . ,  2 0 0 5 , 3 , 2 9 7 6 - 2 9 8 9I  i  _________________
vv«-3-(2-l lydroxyethyl )-5-methyl-6-phenyl-1,3-oxazinane-
2,4-dione 1627. R e a c t i o n  o f  5^ n - 3- ( 3- h y d r o x y - 2- m e t h y l - 3-  
p h e n v l p r o p a n o y l ) - l  , 3 - o x a z o l i d i n - 2 - o n e  3b ( 0 . 15 0  g ,  0 . 6 0  m m o l )  
w i t h  a  1 . 0  M  s o l u t i o n  o f  E t 2 Z n  i n  t o l u e n e  ( 0 . 0 6  m L ,  0 . 0 6  m m o l )  
i n  C H 2C 1 2 ( 3  m L ) ,  a c c o r d i n g  t o  g e n e r a l  p r o c e d u r e  D ,  a f f o r d e d  
t h e  t i t l e  c o m p o u n d  synA b  ( 0 . 1 4 7  g ,  0 . 5 8  m m o l )  i n  9 7 %  y i e l d  
a n d  9 5 %  d e  a s  a  c o l o u r l e s s  o i l ,  v m a x ( n e a t ) / c m _ l  3 4 4 7  ( b r ,  O H ) ,  
1 7 5 5  ( C = 0 ) o x ,  1 7 0 3  ( C = 0 ) ;  <5H ( 3 0 0  M H z ,  C D C L )  1 . 0 1  ( 3 H ,  
d ,  J  7 . 5 ,  CH, ) ,  2 . 1 7  ( 1 H ,  s ,  OH),  2 . 9 9  ( 1 H ,  q d ,  J  7 . 5 ,  3 . 5 ,  
C H C H , ) ,  3 . 7 5 - 3 . 8 2  ( 2 H ,  m ,  C / / 2O H ) ,  3 . 9 7  ( 1 H ,  a p p  d t ,  J  1 4 . 0 ,
5 . 5 ,  C / / A H „ N ) ,  4 . 0 5  ( 1 H ,  a p p  d t ,  J  1 4 . 0 ,  5 . 5 ,  C H A / / „ N ) ,  5 . 6 2  
( 1 H .  d ,  J  3 . 5 ,  C / / P h ) ,  7 . 2 4 - 7 . 3 8  ( 5 H ,  m ,  A r - / / ) ;  <5c ( C D C 1 3 )  
1 0 . 4 ,  4 1 . 5 ,  4 4 . 6 ,  6 1 . 2 ,  7 8 . 1 ,  1 2 6 . 0 ,  1 2 9 . 2 ,  1 2 9 . 4 ,  1 3 4 . 4 ,  1 5 2 . 4 ,  
1 7 3 . 2 :  m / z  ( C P .  N H , )  2 6 7  ( 1 5 ,  M N H / ) ,  2 0 6  ( 4 7 ,  M H + - C 0 2 ) ,  
1 0 5  ( 1 0 0 % ) ;  H R M S  ( E S * )  C l3H l f iN 0 4 [ M H + ]  r e q u i r e s  2 5 0 . 1 0 7 9 ,  
f o u n d  2 5 0 . 1 0 8 1 .  R e a c t i o n  o f  s y « - l , 3 - o x a z i n a n e - 2 , 4 - d i o n e  16 
( 0 . 1 0 0  g ,  0 . 4 0  m m o l )  w i t h  a  0 . 5  M  s o l u t i o n  o f  K H M D S  i n  
t o l u e n e  ( 0 . 9 1  m L ,  0 . 6  m m o l )  i n  T H F  ( 3  m L ) ,  a c c o r d i n g  t o  
g e n e r a l  p r o c e d u r e  C ,  g a v e  (£)-4b ( 0 . 0 6 8  g ,  0 . 3 3  m m o l )  i n  8 2 %  
y i e l d  a n d  i n  9 5 %  d e .
A>7»-3-(2-Hydroxyethyl)-5-isopropyl-6-[(£)-1 -propenyl|-l,3- 
oxazinane-2,4-dione 17. R e a c t i o n  o f  5> ' « - 3- [ ( £ ) - 3- h y d r o x y -  
2 - i s o p r o p y l - 4 - h e x e n o y l ] - l , 3 - o x a z o l i d i n - 2 - o n e  3i ( 0 . 2 0 0  g ,  
0 . 8 3  m m o l )  w i t h  a  1 . 0  M  s o l u t i o n  o f  E t 2 Z n  i n  t o l u e n e  ( 0 . 0 8  m L ,  
0 . 0 8  m m o l )  i n  C H 2C 1 2 ( 5  m L ) ,  a c c o r d i n g  t o  g e n e r a l  p r o c e d u r e  
D ,  a f f o r d e d  t h e  t i t l e  c o m p o u n d  sy n A l  ( 0 . 1 2 9  g ,  0 . 5 4  m m o l )  i n  
6 5 %  y i e l d  a n d  > 9 5 %  d e  a s  a  c o l o u r l e s s  o i l ,  v m a x ( n e a t ) / c i r r '  3 4 3 0  
( b r ,  O H ) ,  1 7 5 5 ( C = 0 ) o x ,  1 6 9 9 ( C = O ) ; < 5 H ( 3 0 0  M H z ,  C D C l , ) 0 . 9 7  
( 3 H ,  d ,  J  7 . 0 ,  C H ( C / / , ) 2 ) ,  1 - 0 3  ( 3 H ,  d ,  J  7 . 0 ,  C H ( C / / , ) 2 ) ,  1 . 7 1  
( 3 H .  d ,  J  7 . 0 ,  C / / , C H = C H ) ,  1 . 9 7  ( 1 H ,  t ,  J  5 . 5 ,  OH),  2 . 1 0  ( 1 H ,  
m ,  J  7 . 0 ,  4 . 5 ,  CH(CH, ) , ) ,  2 . 5 5  ( 1 H ,  d d ,  J  7 . 0 ,  4 . 5 ,  CH ' P r ) ,  3 . 7 4  
( 2 H ,  a p p  d t ,  J  5 . 5 ,  5 . 5 ,  C / / , O H ) ,  3 . 9 4 - 3 . 9 8  ( 2 H ,  m ,  C H , N ) ,  
4 . 9 2  ( 1 H ,  a p p  t ,  J  7 . 0 ,  C H C H = C H C H , ) ,  5 . 4 7  ( 1 H ,  d d ,  J  1 5 . 0 ,
7 . 0 ,  C H , C H = C H),  5 . 9 1  ( 1 H ,  d q ,  J  1 5 . 0 ,  7 . 0 ,  C H , C / / = C H ) ;  
<5c ( C D C 1 3 )  1 7 . 0 ,  1 9 . 7 ,  2 0 . 3 ,  2 4 . 8 ,  4 3 . 2 ,  4 9 . 5 ,  6 0 . 1 ,  7 6 . 6 ,  1 2 2 . 1 ,
1 3 2 . 7 ,  1 5 1 . 3 ,  1 6 9 . 7 ;  m / z  ( E P * )  2 4 1  ( 4 1 ,  M * * ) ,  1 9 8 ( 1 0 0 % ,  M * *  
C 0 2 * ) ;  H R M S  ( E S * )  C l 2H 19N 0 4 [ M H * ]  r e q u i r e s  2 4 1 . 1 3 1 4 ,  
f o u n d  2 4 1 . 1 3 1 3 .  R e a c t i o n  o f  . y y « - l , 3 - o x a z i n a n e - 2 , 4 - d i o n e  17 
( 0 . 0 1 0  g ,  0 . 0 4  m m o l )  w i t h  a  0 . 5  M  s o l u t i o n  o f  K H M D S  i n  
t o l u e n e  ( 0 . 0 9  m L ,  0 . 0 6  m m o l )  i n  T H F  ( 3  m L ) ,  a c c o r d i n g  t o  
g e n e r a l  p r o c e d u r e  C ,  g a v e  ( 2 £ , 4 £ ) - 4 i  ( 0 . 0 0 7  g ,  0 . 0 3 5  m m o l )  i n  
88%  y i e l d  a n d  i n  6 0 %  d e .
<i/i//-3-(3-Hydroxy-2-methyl-3-pheiiylpropanoyl)-l,3-oxazolidin- 
2-one 1827. M a g n e s i u m  c h l o r i d e  ( 0 . 0 3 3  g ,  0 . 3 5  m m o l ) ,  
t r i e t h y l a m i n e  ( 0 . 9 7  m L ,  6 . 9 9  m m o l ) ,  b e n z a l d e h y d e  ( 0 . 4 3  m L ,
4 . 1 9  m m o l )  a n d  t r i m e t h y l s i l y l  c h l o r i d e  ( 0 . 6 7  m L ,  5 . 2 4  m m o l )  
w e r e  a d d e d  t o  a  s o l u t i o n  o f  3 - p r o p i o n y l - l , 3 - o x a z o l i d i n - 2 - o n e  
2a ( 0 . 5 0 0  g ,  3 . 5 0  m m o l )  i n  e t h y l  a c e t a t e  ( 7  m L ) .  T h e  r e a c t i o n  
m i x t u r e  w a s  s t i r r e d  f o r  2 4  h o u r s ,  a n d  t h e n  f i l t e r e d  t h r o u g h  a  p l u g  
o f  s i l i c a  w h i c h  w a s  t h e n  w a s h e d  w i t h  E t 2 0  ( 1 0  m l ) .  T h e  o r g a n i c  
l a y e r  w a s  c o n c e n t r a t e d  in vacuo, b e f o r e  a d d i t i o n  o f  m e t h a n o l  (2 
d r o p s )  a n d  t r i f l u o r o a c e t i c  a c i d .  T h e  s o l v e n t  w a s  t h e n  r e m o v e d  
b e f o r e  p u r i f i c a t i o n  t h r o u g h  s i l i c a  g e l  c h r o m a t o g r a p h y  ( 3 0 %  
e t h y l  a c e t a t e - p e t r o l )  t o  a f f o r d  t h e  t i t l e  c o m p o u n d  antiA8  
( 0 . 2 9 0  g .  1 . 1 6  m m o l )  i n  3 3 %  y i e l d  a s  a  w h i t e  c r y s t a l l i n e  s o l i d ,  
m p  1 0 2 - 1 0 4  ° C  ( l i t ,27 1 0 7 - 1 0 7 . 5  ° C ) ;  v m a x ( K B r  d i s c ) / c m - '  3 4 4 6  
( s ,  O H ) ,  1 7 8 3  ( C = 0 ) o x ,  1 6 6 5  ( C = 0 ) ; < 5 H ( 3 0 0  M H z ,  C D C L )  1 . 0 5  
( 3 H ,  d ,  J  7 . 0 ,  CH,) ,  2 . 8 7  ( 1 H ,  d ,  J  5 . 0 ,  OH),  4 . 0 0 - 4 . 0 6  ( 2 H ,  
m ,  C H , N ) ,  4 . 2 8  ( 1 H ,  d q ,  J  8 . 5 ,  7 . 0 ,  C H C H , ) ,  4 . 3 6 ^ 1 . 4 5  ( 2 H ,  
m .  C H , O ) ,  4 . 7 8  ( 1 H ,  d d ,  J  8 . 5 ,  5 . 0 .  C / / O H ) ,  7 . 2 6 - 7 . 4 3  ( 5 H ,  
m ,  A r  / / ) ;  <5c ( C D C I , )  1 5 . 2 ,  4 3 . 1 , 4 4 . 8 ,  6 2 . 4 ,  7 7 . 5 ,  1 2 7 . 1 ,  1 2 8 . 5 ,
1 2 9 . 0 ,  1 4 2 . 1 ,  1 5 3 . 9 ,  1 7 6 . 9 ;  m / z  ( C P ,  N H , )  2 6 7  ( 9 4 ,  M N H 4 + ) ,  
2 5 0  ( 4 8 ,  M H * ) ,  1 0 5 . 1  ( 1 0 0 % ) ;  H R M S  ( E S * )  C , . , H l f lN 0 4 [ M H * ]  
r e q u i r e s  2 5 0 . 1 0 7 9 ,  f o u n d  2 5 0 . 1 0 7 9 .  R e a c t i o n  o f  a « / / ' - a l d o l  18 
( 0 . 1 0 0  g .  0 . 4  m m o l )  w i t h  a  0 . 5  M  s o l u t i o n  o f  K H M D S  i n  
t o l u e n e  ( 1 . 2 0  m L ,  0 . 6  m m o l )  i n  T H F  ( 3  m L ) ,  a c c o r d i n g  t o  
g e n e r a l  p r o c e d u r e  C ,  g a v e  ( £ ) - 4 b  ( 0 . 0 6 1  g ,  0 . 3  m m o l )  i n  7 4 %  
y i e l d  a n d  i n  9 5 %  d e .
a//fr‘-3-(2-Hydroxyethyl)-5-methyl-6-phenyl-l,3-oxazinanc-
2,4-dionc 1 9 2 7 .  R e a c t i o n  o f  a « / / ' - 3 - ( 3 - h y d r o x y - 2 - m e t h y l - 3 -  
p h e n y l p r o p a n o y l ) - l , 3 - o x a z o l i d i n - 2 - o n e  1 8  ( 0 . 0 5 0  g ,  0 . 2 0  m m o l )  
w i t h  a  1 . 0  M  s o l u t i o n  o f  E t 2 Z n  i n  t o l u e n e  ( 0 . 0 2  m L ,  0 . 0 2  m m o l )  
i n  C H 2C 1 2 ( 1  m L ) ,  a c c o r d i n g  t o  g e n e r a l  p r o c e d u r e  D ,  a f f o r d e d  
t h e  t i t l e  c o m p o u n d  antiA9  ( 0 . 0 4 7  g ,  0 . 1 9  m m o l )  i n  9 6 %  y i e l d  
a n d  > 9 5 %  d e  a s  a  w h i t e  s o l i d ,  v m a x ( n e a t ) / c m  1 3 4 3 5  ( b r ,  O H ) ,  
1 7 5 5  ( C = O ) 0 x ,  1 6 9 4  ( C = 0 ) ;  <5H ( 3 0 0  M H z ,  C D C l , )  1 . 0 2  ( 3 H ,  
d ,  J  7 . 0 ,  CH,) ,  2 . 2 1  ( 1 H ,  b r  s ,  OH),  2 . 8 9  ( 1 H ,  q d .  J  1 1 . 5 ,  7 . 0 ,  
C / / ( C H , ) ) ,  3 . 7 7 - 3 . 8 0  ( 2 H ,  a p p  t ,  J  5 . 5 ,  C H , O H ) ,  3 . 9 4  ( 1 H ,  
d d d ,  J  1 4 . 0 ,  6 . 0 ,  4 . 5 ,  C / / A H „ N ) ,  4 . 0 6  ( 1 H ,  a p p  d t ,  J  1 4 . 0 ,  5 . 5 ,  
C H A / / B N ) ,  5 . 0 4  ( I H ,  d , . /  11. 5 . C / / P 1-1) .  7 . 2 4  7 . 3 8  ( 5 H ,  m .  A r  
H);  <5c ( C D C L )  10. 1,  4 0 . 4 ,  4 3 . 5 ,  5 9 . 6 ,  8 0 . 5 ,  1 2 6 . 1 ,  1 2 7 . 9 ,  1 2 8 . 7 ,
1 3 4 . 2 ,  1 5 1 . 1 .  1 7 0 . 5 ;  m / z  ( C P ,  N H , )  2 6 7  ( M N H . , \  1 0 0 % ) .  2 5 0  
( 4 6 ,  M H * ) ,  2 0 8  ( 5 5 ) ,  2 0 6  ( 8 7 % ,  M H * - C 0 2 ) ;  H R M S  C „ H l(, N 0 4 
( E S * )  [ M H * ]  r e q u i r e s  2 5 0 . 1 0 7 9 ,  f o u n d  2 5 0 . 1 0 7 7 .  R e a c t i o n  o f  
anti-1 , 3 - o x a z i n a n e - 2 , 4 - d i o n e  1 9  ( 0 . 0 2 0  g ,  0 . 0 7 5  m m o l )  w i t h  a  
0 . 5  M  s o l u t i o n  o f  K H M D S  i n  t o l u e n e  ( 0 . 1 8  m L ,  0 . 0 1 2  m m o l )  
i n  T H F  ( 3  m L ) ,  a c c o r d i n g  t o  g e n e r a l  p r o c e d u r e  C ,  g a v e  (£)-4b  
( 0 . 0 1 2  g ,  0 . 0 0 6  m m o l )  i n  8 0 %  y i e l d  a n d  i n  9 5 %  d e .
(£)-3-Cyclohexyl-2-isopropyl-2-propenoic acid 26a38. H y ­
d r o l y s i s  o f  ( £ ) - 3 - c y c l o h e x y l - A - ( 2 - h y d r o x y e t h y l ) - 2 - i s o p r o p y l - 2 -  
p r o p e n a m i d e  4a ( 0 . 0 5 3  g ,  0 . 2 2  m m o l )  i n  6 . 0  M  H C 1  ( 2  m L ) ,  
a c c o r d i n g  t o  g e n e r a l  p r o c e d u r e  E ,  a f f o r d e d  t h e  t i t l e  c o m p o u n d  
(£)-26a ( 0 . 0 4 3  g ,  0 . 2 2  m m o l )  i n  9 9 %  y i e l d  a n d  > 9 5 %  d e  a s  a  
c o l o u r l e s s  o i l ,  v m a I ( n e a t ) / c m _ l  3 4 5 0  ( b r ,  O H ) ,  1 6 7 7  ( C = 0 ) ,  1 6 2 1  
( C = C ) c o n j ;  r ) H ( 3 0 0  M H z ,  C D C l , )  0 . 9 0 - 1 . 3 0  ( 6H ,  m ,  C y - / / ) ,  1 . 1 3  
( 6 H ,  d ,  J  7 . 0 ,  C H ( C / / , ) 2 ) ,  1 . 5 2 - 1 . 7 2  ( 4 H ,  m ,  C y - / / ) ,  2 . 3 3  ( 1 H ,  
d t t ,  J  1 0 . 5 ,  1 0 . 0 ,  3 . 5 ,  CH),  2 . 8 4  ( 1 H ,  s e p t e t ,  J  7 . 0 ,  C / / ( C H , ) 2 ) ,
6 . 5 4  ( 1 H ,  d ,  J  1 0 . 0 ,  C H = C C H , ) ,  1 0 . 2 6  ( 1 H ,  b r  s ,  C O O / / ) ;  
^ c ( C D C L )  2 0 . 2 ,  2 4 . 5 ,  2 6 . 4 , 3 1 . 3 , 3 1 . 9 ,  3 6 . 4 ,  1 3 4 . 1 ,  1 4 8 . 2 ,  1 7 2 . 7 . ;  
m / z ( E P * )  1 9 7 . 3 ( 1 5 % ,  M H * * ) ,  1 9 6 . 3 ( 1 5 % ,  M * * ) ;  H R M S  ( E S * )  
C | , H 20O 2 [ M H * ]  r e q u i r e s  1 9 6 . 1 4 5 8 ;  f o u n d  1 9 6 . 1 4 5 4 .
(£)-2-Methyl-3-phenyl-2-propenoic acid 26b. H y d r o l y s i s  o f  
( £ ) - j V - ( 2 - h y d r o x y e t h y l ) - 2 - m e t h y l - 3 - p h e n y l - 2 - p r o p e n a m i d e  4b 
( 0 . 0 4 8  g ,  0 . 2 3  m m o l )  i n  6 . 0  M  H C 1  ( 3  m L ) ,  a c c o r d i n g  t o  g e n e r a l  
p r o c e d u r e  E ,  a f f o r d e d  t h e  t i t l e  c o m p o u n d  (£)-26b ( 0 . 0 3 6  g ,
0 . 2 2  m m o l )  i n  9 5 %  y i e l d  a n d  > 9 5 %  d e  a s  a  c o l o u r l e s s  o i l ,  
v m a x ( n e a t ) / c n r ‘ 3 4 4 5  ( b r ,  O H ) ,  1 6 6 8  ( C = 0 ) ,  1 6 1 6  ( C = C ) c o n j ; 
<5h ( 3 0 0  M H z ,  C D C l , )  2 . 0 8  ( s ,  3 H ,  C H = C C / / , ) ,  7 . 2 6 - 7 . 3 6  ( 5 H ,  
m ,  A r - / / ) ,  7 . 7 7  ( 1 H ,  s ,  C / / = C C H , ) ,  1 1 . 3 6  ( 1 H ,  b r  s ,  C O O H); 
t ) ' c ( C D C l 3 )  1 2 . 7 ,  1 2 6 . 5 ,  1 2 7 . 4 ,  1 2 7 . 7 ,  1 2 8 . 8 ,  1 3 4 . 5 ,  1 4 0 . 1 ,  1 7 3 . 4 ;  
m / z  ( E P )  1 6 2 . 1  ( 68% .  M * " ) .  1 6 1 . 0  ( 3 6 % ,  M * * - H * ) ,  1 1 7 . 2  
( 5 8 % ,  M * * - C O O H ’ ) ;  H R M S  ( E S * )  C , „ H 10O 2 [ M H * ]  r e q u i r e s  
1 6 2 . 0 6 7 5 ;  f o u n d  1 6 2 . 0 6 7 2 .
(£)-2-Mcthylpenten-2-oic acid 26c. H y d r o l y s i s  o f  ( £ ) - / V - ( 2 -  
h y d r o x y e t h y l ) - 2 - m e t h y l - 2 - p e n t e n a m i d e  4c ( 0 . 3 0 0  g ,  1 . 9 1  m m o l )  
i n  6 . 0  M  H C 1  ( 5  m L ) ,  a c c o r d i n g  t o  g e n e r a l  p r o c e d u r e  E ,  a f f o r d e d  
t h e  t i t l e  c o m p o u n d  (£)-26c ( 0 . 2 3 0  g ,  2 . 0 2  m m o l )  i n  9 1  %  y i e l d  a n d  
> 9 5 %  d e  a s  a  l o w - m e l t i n g  w h i t e  s o l i d ,  v m a x ( n e a t ) / c m " '  3 4 2 9  ( b r ,  
O H ) ,  1 7 0 0 ( C = O ) ,  1 6 4 6  ( C = C ) ; < 5 H ( 3 0 0  M H z ,  C D C l , )  0 . 9 9  ( 3 H ,  
t ,  J  7 . 5 ,  C H 2C / / , ) ,  1 . 7 6  ( 3 H ,  d ,  J  1 . 0 ,  C H = C CH,) ,  2 . 1 4  ( 2 H ,  
a p p  p e n t e t ,  J  7 . 5 ,  C H ,C H , ) ,  6 . 8 3  ( 1 H ,  t q ,  7 . 5 ,  1 . 0 ,  C H = C C H , ) ,
1 1 . 7 0  ( 1 H ,  b r  s ,  C O O / / ) ;  <5c ( C D C l , )  1 2 . 2 ,  1 3 . 2 ,  2 2 . 6 ,  1 2 6 . 8 ,
1 4 7 . 2 ,  1 7 4 . 3 .
(£)-2-BcnzyL2-dccenoic acid 26d. H y d r o l y s i s  o f  ( £ ) - 2 - b e n z y l -  
/ V - ( 2 - h y d r o x y e t h y l ) - 2 - d e c e n a m i d e  4d ( 0 . 2 0 0  g ,  0 . 5 8  m m o l )  i n
6 . 0  M  H C 1  ( 5  m L ) ,  a c c o r d i n g  t o  g e n e r a l  p r o c e d u r e  E ,  a f f o r d e d  
t h e  t i t l e  c o m p o u n d  (£)-26d ( 0 . 1 4 3  m g ,  0 . 5 5  m m o l )  i n  9 5 %  y i e l d  
a n d  > 9 5 %  d e ,  <5H ( 3 0 0  M H z ,  C D C l , )  0 . 8 0  ( 3 H ,  t ,  J  7 . 0 ,  CH,) ,  
1 . 1 2 - 1 . 2 5  ( 8H ,  m ,  A i k - / / ) ,  1 . 2 9 - 1 . 3 8  ( 2 H ,  m ,  C / / 2C H 2C H = C ) ,
2 . 1 9  ( 2 H ,  a p p  q ,  J  7 . 5 ,  C H , C H = C ) ,  3 . 5 8  ( 2 H ,  s ,  C H , P h ) ,  6 . 7 0  
( 1 H ,  s ,  C / / = C B n ) ;  6 . 9 7 - 7 . 1 7  ( 5 H ,  m ,  A r - / / ) ;  1 0 . 7 0  ( 1 H ,  b r  s ,  
C O O / / ) ;  ( 5c ( C D C l , )  1 3 . 0 ,  2 1 . 6 ,  2 7 . 5 ,  2 8 . 0 ,  2 8 . 2 , 2 8 . 3 ,  3 0 . 7 ,  3 1 . 2 ,
1 2 5 . 0 ,  1 2 7 . 2 ,  1 2 7 . 3 ,  1 2 9 . 2 ,  1 3 8 . 5 ,  1 4 6 . 1 ,  1 7 1 . 9 ;  m / z  ( E P * )  2 6 0 . 3  
( 66 ,  M * * ) ,  2 4 2  ( 9 ,  M * * - H 20 ) ,  1 6 1  ( 1 4 ,  M * * - C H , ( C H 2 ) 6 * ) ,  9 1  
( 1 0 0 % ) ;  H R M S  ( E S * )  C , 7H 2s N 0 2 [ M N H 4 * ]  r e q u i r e s  2 7 8 . 2 1 2 0 ;  
f o u n d  2 7 8 . 2 1 1 8 .
O r g .  B i o  m o l .  C h e m . ,  2 0 0 5 , 3 , 2 9 7 6 - 2 9 8 9 2 9 8 7
(2£,4£)-2-Methyl-5-phcnyl-2,4-pcntadienoic acid 2739. H y ­
d r o l y s i s  o f  ( £ , £ ) - A - ( 2 - h y d r o x y e t h y l ) - 2 - m e t h y l - 5 - p h e n y l - 2 , 4 -  
p e n t a d i e n a m i d e  4j ( 0 . 2 0 0 g ,  0 . 8 5  m m o l )  i n  6 . 0  M  H C 1  ( 5  m L ) ,  
a c c o r d i n g  t o  g e n e r a l  p r o c e d u r e  E ,  a f f o r d e d  t h e  t i t l e  c o m p o u n d  
(£ ,£ )-27  ( 0 . 1 5 8  g ,  0 . 4 5  m m o l )  i n  7 7 %  y i e l d  a n d  > 9 5 %  d e  a s  
a  p a l e  b r o w n  s o l i d ,  m p  1 5 8 - 1 6 0  ° C  ( l i t ,39 1 6 0 . 0 - 1 6 2 . 5  ° C ) ;  
v m a x ( K B r  d i s c ) / c r r r 1 3 4 4 5  ( b r ,  O H ) ,  1 6 8 3 ( 0 = 0 ) ,  1 6 2 2 ( C = C ) c o n j ; 
<5h ( 3 0 0  M H z ,  C D C l , )  1 . 9 8  ( 3 H ,  d ,  J  1 . 1 ,  C / / . , ) ,  6 . 8 3  ( 1 H ,  
d  J 1 5 . 5 ,  C H C H = C / / P h ) ,  7 . 0 0  ( 1 H ,  d d ,  J 1 5 . 5 ,  1 1 . 5 ,  
C H - C / / = C H P h ) ,  7 . 1 7 - 7 . 4 5  ( 6 H ,  m ,  C / / - C H = C H P h .  A r
H ) ,  1 1 . 0 0  ( 1 H ,  b r  s ,  C O O / / ) ;  <5c ( C D C l 3 )  1 1 . 5 ,  1 2 2 . 7 ,  1 2 5 . 4 ,
1 2 6 . 2 ,  1 2 7 . 8 ,  1 2 7 . 9 ,  1 3 5 . 4 ,  1 3 9 . 2 ,  1 3 9 . 6 ,  1 7 3 . 0 ;  m / z  ( E I + ‘ )  1 8 8  
( 3 3 ,  M * ' ) ,  1 4 3  ( 6 2 ,  M * *  C O O H * ) ,  1 2 8  ( 8 0 ,  M * * - C O O H - C H , ) ,  
i 1 5  ( 1 0 0 % ,  M * * - C ( C H , ) C O O H - H * ) ;  H R M S  ( E S + )  C | : H 16N 0 2 
[ M N H p ]  r e q u i r e s  2 0 6 . 1 1 7 6 ;  f o u n d  2 0 6 . 1 1 7 5 .
2-|(£)-l-Methyl-2-phenyl-l-ethcnyl|-4,5-dihydro-l,3-oxazole
28. R e a c t i o n  o f  ( £ ) - A - ( 2 - h y d r o x y e t h y l ) - 2 - m e t h y l - 3 - p h e n y l -  
2 - p r o p e n a m i d e  4b ( 0 . 5 7 0  g ,  2 . 7 8  m m o l )  w i t h  t h i o n y l  c h l o r i d e  
( 0 . 8 9  m L ,  1 2 . 2 0  m m o l )  i n  C H 2C 1 2 ( 1 5  m L ) ,  a c c o r d i n g  t o  
g e n e r a l  p r o c e d u r e  F ,  g a v e  t h e  t i t l e  c o m p o u n d  (£)-28 ( 0 . 5 0 3  g ,  
2 . 6 9  m m o l )  i n  9 7 %  y i e l d  a n d  > 9 5 %  d e  a s  a  p a l e  y e l l o w  
o i l ,  v m a x ( n e a t ) / c r n  1 1 7 0 7  ( C = N ) ,  1 6 4 0  ( C = C ) ;  < 5 „ ( 3 0 0  M H z ,  
C D C l , )  2 . 2 1  ( 3 H ,  d ,  J  1 . 5 ,  C H = C C / / , ) ,  4 . 0 1  ( 2H ,  a p p  t ,  J
9 . 5 ,  C H 2N ) ,  4 . 3 6  ( 2 H ,  a p p  t ,  J  9 . 5 ,  C H 2O ) ,  7 . 1 2  ( 1 H ,  d ,  J 1 . 5 ,  
C H = C ( M e ) ) ,  7 . 3 5 - 7 . 4 0  ( 5 H ,  m ,  A r - / / ) ;  <5c ( C D C l 3 )  1 5 . 4 ,  5 5 . 4 ,
6 7 . 9 ,  1 2 5 . 7 .  1 2 8 . 2 ,  1 2 8 . 7 ,  1 2 9 . 9 ,  1 3 5 . 6 ,  1 3 6 . 7 ,  1 6 7 . 3 ;  m / z  ( E P * )  
1 8 7  ( 2 7 ,  M + * ) ,  1 8 6  ( 1 0 0 ,  M * * - H * ) ,  1 2 9  ( 7 ,  M + * - O C H , C H 2N ) ,  
1 1 5  ( 2 5 % ,  C H , C C P h * ) ;  H R M S  ( E S + ) C P H „ N O  [ M H * ]  r e q u i r e s  
1 8 7 . 0 9 9 7 ;  f o u n d  1 8 7 . 0 9 9 8 .
2-|(£)-l-M ethyl-1 -butenyl|-4,5-dihydro-l,3-oxazole 2 9 .  R e ­
a c t i o n  o f  ( £ ) - A r - ( 2 - h y d r o x y e t h y l ) - 2 - m e t h y l - 2 - p e n t e n a m i d e  4c 
( 0 . 1 1 2  g ,  0 . 7 1  m m o l )  w i t h  t h i o n y l  c h l o r i d e  ( 0 . 2 6  m L ,  3 . 5 7  m m o l )  
i n  C H 2C 1 2 ( 4  m L ) ,  a c c o r d i n g  t o  g e n e r a l  p r o c e d u r e  F ,  g a v e  t h e  
t i t l e  c o m p o u n d  ( £ ) - 29 ( 0 . 0 8 7  g ,  0 . 6 3  m m o l )  i n  88%  y i e l d  a n d  
> 9 5 %  d e  a s  a  c o l o u r l e s s  o i l ,  v m a x ( n e a t ) / c m “ ' 1 7 0 0  ( C = N ) ,  1 6 5 3  
( C = C ) ;  r ) H ( 3 0 0  M H z ,  C D C l , )  0 . 9 7  ( 3 H ,  t ,  J  7 . 6 ,  C H 2C / / , ) ,  1 . 8 5  
( 3 H ,  s ,  C H = C C / / , ) ,  2 . 1 2  ( 2 H ,  a p p  p e n t e t ,  J 7 . 5 ,  C H 2C H , ) ,
3 . 8 6  ( 2 H ,  t ,  J  9 . 5 ,  C / / , N ) ,  4 . 2 0  ( 2 H ,  t ,  J  9 . 5 ,  C H 2O ) ,  6 . 3 4  ( 1H .  
t ,  J  7 . 4 ,  C / / = C C H , ) ;  ( 5c ( C D C 1 3 )  1 3 . 5 ,  1 3 . 7 ,  2 2 . 1 ,  5 5 . 1 ,  6 7 . 5 ,
1 2 3 . 9 ,  1 4 0 . 1 ,  1 6 6 . 8 :  m / z  ( E P ’ )  1 3 9 ( 5 5 % ,  M+‘), 1 2 4 ( I ( ) ( ) " „ .  M * *  -  
C H , * ) ;  H R M S  ( E S * )  C x H u N O  [ M H * ]  r e q u i r e s  1 4 0 . 1 0 7 0 ;  f o u n d  
1 4 0 . 1 0 7 2 .
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Stereoselective Rearrangement of P-Hydroxy-A-acyloxazolidin-2-ones to 
Afford iV-2-Hydroxyethyl-l,3-oxazinane-2,4-diones
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Abstract: Z i n c  a l k o x i d e s  o f  syn- o r  a « / / - P - h y d r o x y - / V - a c y l o x a z o l -  
i d i n - 2 - o n e s  u n d e r g o  s t e r e o s e l e c t i v e  r e a r r a n g e m e n t  t o  a f f o r d  t h e i r  
c o r r e s p o n d i n g  syn- o r  a « r / - A - 2 - h y d r o x y e t h y l - l , 3 - o x a z i n a n e - 2 , 4 -  
d i o n e s  i n  g o o d  y i e l d .
K e y  w o r d s :  a l d o l  r e a c t i o n ,  d i a s t e r e o s e l e c t i v e ,  i n t r a m o l e c u l a r  r e a r ­
r a n g e m e n t .  l , 3 - o x a z i n a n e - 2 , 4 - d i o n e .  z i n c  a l k o x i d e
Benzo-1,3-oxazinane-2,4-diones have often been
screened for activity as potential drug candidates,1 and a 
range of synthetic methods is available for their prepara­
tion.2 Synthetic routes towards other types of 1,3-oxazi- 
nane-2,4-dione are less well established, however,3 and as 
a consequence their biological activity is less well ex­
plored. We were interested in preparing new types of 1,3- 
oxazinane-2,4-dione as potential synthetic intermediates,4 
or as novel medicinal agents,5 and now report that zinc 
alkoxides of P-hydroxy-N-acyloxazolidin-2-ones undergo 
stereoselective rearrangement to afford their correspond­
ing A-2-hydroxyethyl-5,6-disubstituted-l,3-oxazinane- 
2,4-diones in good yield.
Oxazolidin-2-ones have proven particularly useful as 
chiral auxiliaries in asymmetric aldol reactions for the 
preparation of chiral 3-hydroxy acid derivatives.6 For ex­
ample, boron,7 titanium,8 and germanium enolates9 of 
chiral N-acyloxazolidin-2-ones react with aldehydes to af­
ford ‘Evans’ or ‘non-Evans’ sy/i-aldol products in high de. 
Alternatively, boron enolates of chiral A-acyloxazolidin- 
2-ones in the presence of excess Et2A lC l,10 their chromi­
um enolates,11 or Evans’ recently published magnesium 
halide-catalysed protocol,12 all result in anti-aldol prod­
ucts in high de. Whilst these procedures normally afford 
their respective aldol products in good yield and high de, 
a number of reports has described the formation of N-2- 
hydroxyethyl-l,3-oxazinane-2,4-diones as unexpected 
rearrangement products.13,14 For example, reaction of a tin 
enolate derived from N-acyloxazolidin-2-one 1 with benz­
aldehyde resulted in formation of l,3-oxazinane-2,4-di- 
one 2 in >99% de,15 whilst reaction of the lithium enolate 
of 3 with crotonaldehyde in the presence of T i(0 /-Pr)3Cl 
gave l,3-oxazinane-2,4-dione 4 in >90% de.4 Alternative­
ly, Terashima et al. reported that reaction of a zinc enolate 
derived from 5 with benzaldehyde at 0 °C afforded a
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S c h e m e  1 Reagents and conditions: ( i )  S n C l 2 ,  L i A l H 4 , T H F ,  
P h C H O ,  2 0  ° C ;  ( i i )  L D A ,  T H F ,  - 7 8  ° C ,  T i ( O i - P r ) 3 C l  ( 3 . 3  e q u i v ) ,  
/ r < j / u - c r o t o n a l d e h y d e ;  ( i i i )  Z n ,  T H F ,  P h C H O ,  0  ° C .
62:38 mixture of (rac)-«/rtz-l,3-oxazinane-2,4-dione 6 
and (rac)-5y/z-l,3-oxazinane-2,4-dione 7 in 83% yield 
(Scheme l) .16
W hilst no M-acyloxazolidin-2-one aldol intermediates 
were isolated in these rearrangement reactions, these re­
ports clearly implied that tin-, titanium- or zinc alkoxides 
of 3-hydroxy-A-acyloxazolidin-2-ones could rearrange to 
their corresponding l,3-oxazinane-2,4-diones in high de. 
We therefore decided to investigate whether suitable 
conditions could be identified which would enable the 
stereoselective rearrangement of diastereoisomerically 
pure 3-hydroxy-A-acyloxazolidin-2-ones to occur, thus 
affording the corresponding l,3-oxazinane-2,4-diones in 
good yield and in high de.
Therefore, a series of twelve racemic and enantiomerical- 
ly pure A-acyloxazolidin-2-one-.ry/i-aldols 9a-l was pre­
pared in high de via reaction of the boron enolates of N- 
acyloxazolidin-2-ones 8a-d with a series of commercially 
available aldehydes,17 according to well established liter­
ature precedent.18 Given the precedent of Terashima et 
al.,16 we proposed that conversion of sy/i-aldols 9a-l into 
their corresponding zinc alkoxides would result in clean
LETTER S tereoselective R earrangem ent o f  |3 -H ydroxy-/V -acyloxazolidin-2-ones 1091
rearrangement to afford their corresponding syn- 1,3-ox- 
azinane-2,4-diones 10a-l in high de.19 Consequently, it 
was found that treatment of syn-aldol 9a with a commer­
cially available solution of 10 mol% Et2Zn in CH2C12 at 
room temperature resulted in a clean rearrangement reac­
tion to afford its corresponding sy/i-l,3-oxazinane-2,4-di- 
one 10a in >95% de, and 58% isolated yield.20 The 
structure of Ay/z-l,3-oxazinane-2,4-dione 10a was con­
firmed by carrying out a HMBC ‘H -I3C NMR correlation 
experiment which clearly revealed cross-peaks between 
the l3C resonance of its C-2 carbonyl, and the 'H reso­
nances of its H-6, and N-CH2 protons (Figure 1). Zinc 
alkoxides of seven further racemic and enantiomerically 
pure .yy/i-aldols 9b-h were then generated under identical 
conditions, affording their corresponding syn-1,3-oxazi- 
nane-2,4-diones lOb-h in >95% de and in 65-94%  isolat 
ed yield after chromatographic purification (Scheme 2, 
Table l) .21 The structure of each syn-l,3-oxazinane-2,4- 
dione product was apparent from its 'H NMR spectrum 
['(5,6) = 3 .0-4.5 Hz],22 which also revealed a large upfield 
shift for their C-5 ring protons (<3.0 ppm), when com­
pared to the corresponding resonances of the C-2 protons 
(>3.5 ppm) of their parent sy/i-aldols 9b-h, respectively.
W hilst zinc alkoxides of sy/i-aldols 9a-h rearranged 
cleanly to afford their corresponding sy/i-l,3-oxazinane- 
2,4-diones lOa-h in >95% de, it was found that rearrange­
ment of P-aryl-sy/i-aldols 9i—1 occurred with poorer 
stereocontrol, affording their corresponding sy/i-1,3-ox- 
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S c h e m e  2  Reagents and conditions: ( i )  9 - B B N - O T f ,  / - P r 2N E t ,  
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F i g u r e  1  S e l e c t e d  r e s o n a n c e s  f r o m  a  H M B C  ' H - I 3 C  N M R  c o r r e l a ­
t i o n  e x p e r i m e n t  o n  s y n - l O a .
In order to explain this partial loss in stereocontrol,23 it 
was proposed that rearrangement of the zinc alkoxide of 
(3-aryl-.ryrt-aldol 11 to afford syn-l,3-oxazinane-2,4-dione 
alkoxide 12 was occurring in the presence of a competing 
reversible retro-aldol/aldol reaction pathway (Figure 2).24 
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F i g u r e  2  R e v e r s i b l e  m r o a l d o l / a l d o l  p a t h w a y  t o  e x p l a i n  t h e  f o r ­
m a t i o n  o f  r t « r / - l , 3 - o x a z i n a n e - 2 , 4 - d i o n e s  1 4 .
zinc alkoxide 11 to afford the zinc alkoxide of its respec­
tive P-aryl-awft-aldol 13, which would then rearrange to 
afford the zinc alkoxide of its corresponding anti- 1,3-ox- 
azinane-2,4-dione 14.
Further insight into the mechanism of this rearrangement 
reaction was gained on investigation of the reactivity of 
the zinc alkoxides of a/m'-P-aryl-aldol 15, and the enantio­
merically pure jy/z-aldols 17 and 19 (Scheme 3). Firstly, 
treatment of a/i//-p-aryl-aldoI 1525 with 10 mol% Et2Zn 
resulted in clean rearrangement to afford «/!//-1,3-oxazi- 
nane-2,4-dione 16 [J(St6) = 11.5 Hz]22 as a single product 
in >95% de.26 This clearly demonstrated that the zinc 
alkoxide of a/UKildol 15 had rearranged to its respective
T a b l e  1  Y i e l d s  f o r  R e a r r a n g e m e n t  o f  i V - A c y l - o x a z o l i d i n - 2- o n e - 5y n -  
a l d o l s  9 a - l  t o  A f f o r d  s y n - l , 3 - O x a z i n a n e - 2 , 4 - d i o n e s  1 0 a - l
E n t r y 1 . 3 - O x a z i n a n c - R
2 . 4 - d i o n e
R 1 R 2 d e
( % )
Y i e l d
( % ) a
1 10a H M e E t > 9 5 5 8
2 10b H i- P r E t > 9 5 88
3 10c H / - P r C y c l o h e x y l > 9 5 9 0
4 l O d H / - P r ( £ ) - M e C H = C H - > 9 5 6 5
5 l O e B n M e E t > 9 5 9 4
6 l O f B n M e / - P r > 9 5 9 2
7 l O g B n M e C y c l o h e x y l > 9 5 9 4
8 l O h B n / - P r E t > 9 5 9 0
9 l O i H M e P h 9 0 8 2
10 10. j H / - P r P h 8 0 5 2
11 10k H / - P r p - M e O C 6H 4 8 0 6 1
12 101 H / - P r p - 0 2N C 6H 4 7 0 5 1
a  Y i e l d s  a r e  f o r  p u r e  5y n - l , 3- o x a z i n a n e - 2 , 4 - d i o n e s  1 0 a - l  i s o l a t e d  a f t e r  
c h r o m a t o g r a p h i c  p u r i f i c a t i o n .
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S c h e m e  3  Reagents and conditions : ( i )  1 0  m o l %  E t 2Z n ,  T H F ,  t o l u e n e ,  
r . t .
a/i/t-l,3-oxazinane-2,4-dione 16 with no loss of stereo­
control. Secondly, treatment of (3-aryl-sy«-aldol 17 under 
the same conditions resulted in a mixture of .syrc-1,3-ox- 
azinane-2,4-dione 18 [>90% de, J(5 6) = 3.5 Hz], A-propi- 
onyloxazolidin-2-one 8c, and recovered starting material
17. Therefore, it is proposed that formation of 8c and 
benzaldehyde in this reaction arises from .syrc-aldol 17 
undergoing a re tro -aldol reaction. The existence of this 
re tr o -aldol pathway was confirmed via treatment of a- 
aryl-f3-styryl-syn-aldol 19 with Et2Zn, which resulted in 
formation of jY-phenylacetyloxazolidin-2-one 20, and 
cinnamaldehyde as the only products. Therefore, it ap­
pears that the added electronic stabilisation afforded by 
the a-aryl-fragment of the zinc enolate of 20, coupled with 
the conjugative stabilisation of cinnamaldehyde, is suffi­
cient to ensure that re tro -aldol fragmentation dominates 
the reactivity of the zinc alkoxide of syrc-aldol 19. We 
believe that these results, in conjunction with the observa­
tion that reaction of the zinc alkoxide of 5 with 
benzaldehyde affords a mixture of a n ti-6 and syn -1  
(Scheme l),16 provide good evidence that the partial loss 
of stereocontrol observed for the rearrangement of zinc 
alkoxides of syn-P-aryl-aldols is a consequence of the 
competing re/ro-aldol/aldol pathway described in 
Figure 2.
In conclusion, we have demonstrated that zinc alkoxides 
of readily prepared syn -  or zmft’-P-hydroxy-ALacyloxazol- 
idin-2-ones undergo stereoselective rearrangement to 
afford a highly practical route to their corresponding syn -  
or a«//-l,3-oxazinane-2,4-diones in good de.
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T . ;  M c K e n n a ,  J . ;  R a m s e y ,  T .  M . ;  R e p i c ,  O . ;  R o g e r s ,  L . ;  
S h i e h ,  W . - C . ;  W a n g ,  R . - M . ;  W a y k o l e ,  L .  Org. Proc. Res. 
Dev. 2004, 8, 1 0 7 .  ( b )  K e c k ,  G .  E . ;  L u n d q u i s t ,  G .  D .  J. Org. 
Chem. 1999, 64, 4 4 8 2 .  ( c )  N a r a s a k a ,  K . ;  Y a m a m o t o ,  I. 
Tetrahedron  1992, 48, 5 7 4 3 .
( 1 4 )  F o r  a  r e p o r t  w h e r e  r e a c t i o n  o f  t h e  b o r o n  e n o l a t e  o f  a  r e l a t e d  
A ' - p r o p i o n y l - l , 3 - o x a z i n a n - 2 - o n e  w i t h  b e n z a l d e h y d e  i n  t h e  
p r e s e n c e  o f  e x c e s s  B u 2 B O T f  r e s u l t e d  i n  a  r e a r r a n g e d  1 , 3 -  
o x a z i n a n e - 2 , 4 - d i o n e  p r o d u c t  s e e :  A b b a s ,  T .  R . ;  C a d o g a n ,  J .
I .  G . ;  D o y l e ,  A .  A . ;  G o s n e y ,  I . ;  H o d g s o n ,  P .  K .  G . ;  H o w e l l s ,
G .  E . ;  H u l m e ,  A .  N . ;  P a r s o n s ,  S . ;  S a d l e r ,  I .  H .  Tetrahedron 
Lett. 1997, 38, 4 9 1 7 .
( 1 5 )  K e n d e ,  A .  S . ;  K a w a m u r a ,  K . ;  D e V i t a ,  R .  J .  J. Am. Chem. 
Soc. 1990,112, 4 0 7 0 .
( 1 6 )  I t o ,  Y . ;  T e r a s h i m a ,  S .  Tetrahedron  1991, 47, 2 8 2 1 .
(17) Representative Synthetic Protocol for syn - Aldol 
Reactions.
A  0 . 5  M  s o l u t i o n  o f  9 - B B N - O T f  i n  h e x a n e s  ( 1 . 2 e q u i v )  w a s  
a d d e d  t o  a  s t i r r e d  s o l u t i o n  o f  A r- a c y l o x a z o l i d i n - 2 - o n e  ( 1  
e q u i v )  i n  C H 2C 1 2 a t  0  ° C  a n d  a l l o w e d  t o  s t i r  f o r  5  m i n .  N,N- 
D i i s o p r o p y l e t h y l a m i n e  ( 1 . 4  e q u i v )  w a s  a d d e d ,  t h e  r e a c t i o n  
s t i r r e d  f o r  2 5  m i n  a t  0  ° C  a n d  c o o l e d  t o  - 7 8  ° C .  A n  a l d e h y d e  
( 1.1 e q u i v )  w a s  t h e n  a d d e d ,  t h e  r e a c t i o n  w a s  s t i r r e d  f o r  2 h  
a n d  t h e  r e a c t i o n  t h e n  a l l o w e d  t o  w a r m  t o  0  ° C  f o r  3 0  m i n .  
T h e n ,  p H  7 . 0  p h o s p h a t e  b u f f e r  w a s  a d d e d ,  f o l l o w e d  b y  a  2 : 1  
s o l u t i o n  o f  M e 0 H - H 20 2 . T h e  r e a c t i o n  w a s  e x t r a c t e d  w i t h  
C H 2C 1 2 ( 3  x )  a n d  t h e  c o m b i n e d  o r g a n i c  e x t r a c t s  w a s h e d  w i t h  
a q  N a H C 0 3 ,  b r i n e ,  d r i e d  ( M g S 0 4 )  a n d  c o n c e n t r a t e d  i n  
v a c u o  t o  a f f o r d  t h e  a p p r o p r i a t e  s y n - a l d o l  w h i c h  w a s  t h e n  
p u r i f i e d  b y  c h r o m a t o g r a p h y .
( 1 8 )  T h e s e  c o n d i t i o n s  h a v e  b e e n  e m p l o y e d  p r e v i o u s l y  f o r  
a s y m m e t r i c  s y r c - a l d o l  r e a c t i o n s  u s i n g  i m i d a z o l i d i n - 2 - o n e  
d e r i v e d  g l y c i n e  e n o l a t e s ,  s e e :  C a d d i c k ,  S . ;  P a r r ,  N .  J . ;  
P r i t c h a r d ,  M .  C .  Tetrahedron Lett. 2 0 0 0 ,  41, 5 9 6 3 .
( 1 9 )  W e  h a v e  r e p o r t e d  p r e v i o u s l y  o n  a  s i n g l e  e x a m p l e  o f  t h i s  
r e a r r a n g e m e n t  s e e :  F e u i l l e t ,  F .  J .  P . ;  R o b i n s o n ,  D .  E .  J .  E . ;  
B u l l ,  S .  D .  Chem. Commun. 2003, 2 1 8 4 .
( 2 0 )  Representative Synthetic Protocol for Rearrangement 
Reaction.
A  1 . 0  M  s o l u t i o n  o f  E t 2 Z n  i n  t o l u e n e  ( 0 . 1  e q u i v )  w a s  a d d e d  
d r o p w i s e  t o  a  s t i r r e d  s o l u t i o n  o f  t h e  s y « - a l d o l  (1 e q u i v )  i n  
C H 2C 1 2 a t  r . t .  T h e  r e a c t i o n  w a s  s t i r r e d  f o r  2  h .  T h e n ,  s a t .  a q  
N H 4C 1  w a s  a d d e d  a n d  t h e  r e a c t i o n  e x t r a c t e d  w i t h  C H 2C 1 2 
( 3  x ) .  T h e  c o m b i n e d  o r g a n i c  e x t r a c t s  w e r e  w a s h e d  w i t h  
b r i n e ,  d r i e d  ( M g S 0 4 ) ,  a n d  c o n c e n t r a t e d  i n  v a c u o  t o  a f f o r d  
t h e  d e s i r e d  s y n - l , 3 - o x a z i n a n e - 2 , 4 - d i o n e  w h i c h  w a s  t h e n  
p u r i f i e d  b y  c h r o m a t o g r a p h y .
( 2 1 )  A l l  n e w  c o m p o u n d s  w e r e  f u l l y  c h a r a c t e r i s e d .  S e l e c t e d  d a t a  
f o r  n e w  c o m p o u n d s :
syn-6-Ethyl-3-(2-hydroxyethyl)-5-isopropyl-l,3- 
oxazinane-2,4-dione (10b): ' H  N M R  ( 3 0 0  M H z ,  C D C 1 3 ) :
5  =  0 . 9 7  [ 3  H ,  d ,  J  =  7 . 0  H z ,  C H ( C / / 3 ) 2 ] ,  1 . 0 0  ( 3  H ,  t ,  7 = 7 . 5  
H z ,  C H 2C / 7 3 ) ,  1 . 0 2  [ 3  H ,  d ,  7 =  7 . 0  H z ,  C H ( C / / 3 ) 2 ] ,  1 . 6 0  ( 1
H ,  d q d ,  J  =  1 4 . 0 ,  7 . 5 ,  5 . 0  H z ,  C / / A H B C H 3 ) ,  1 . 8 0  ( 1  H ,  d d q ,  
J =  1 4 . 0 ,  9 . 0 ,  7 . 5  H z ,  C H A / / B C H 3 ) ,  2 . 0 8 - 2 . 2 1  [ 1  H ,  m ,  J  =
7 . 0 ,  5 . 0 ,  C / / ( C H 3 ) 2 ] ,  2 . 2 5  (1 H ,  b r  s ,  OH), 2.52  ( 1  H ,  d d ,  J  =
5 . 0 ,  4 . 0  H z ,  CHi-Pr), 3 . 7 4  ( 2  H ,  a p p  t ,  J  =  5 . 5  H z ,  C / / 2O H ) ,  
3 . 8 9 ( 1  H ,  a p p d t , 7  =  1 4 . 0 ,  5 . 5  H z ,  CHAUBN),  4 . 0 1  ( 1  H ,  a p p  
d t ,  J  =  1 4 . 0 ,  5 . 5  H z ,  C H a / / w N ) ,  4 . 3 9  ( 1  H ,  d d d ,  J  =  9 . 0 ,  5 . 0 ,
4 . 0  H z ,  CHO).  13 C  N M R  ( 1 0 0  M H z ,  C D C 1 3 ) :  5  =  9 . 0 ,  1 8 . 8 ,
2 1 . 2 ,  2 2 . 3 ,  1 4 . 5 ,  4 3 . 1 ,  4 8 . 4 ,  5 9 . 8 ,  7 8 . 0 ,  1 5 1 . 6 ,  1 7 0 . 0 . 1 R :  
3 4 3 6  ( b r ,  O H ) ,  1 7 4 9  ( C = 0 ) ,  1 6 9 1  ( C = 0 )  c m " 1 . 
sy«-3-(2-Hydroxyethyl)-5-isopropyI-6-[(E)-l-propenyl]-
l,3-oxazinane-2,4-dione (10d): ' H  N M R  ( 3 0 0  M H z ,  
C D C 1 3 ) :  5  =  0 . 9 7  [ 3  H ,  d ,  J  =  7 . 0 ,  C H ( C / / 3 ) 2 ] ,  1 . 0 3  [ 3  H ,  d ,  
7  =  7 . 0  H z ,  C H ( C / / 3 ) 2 ] ,  1 . 7 1  ( 3  H ,  d ,  7  =  7 . 0  H z, 
C / / 3C H = C H ) ,  1 . 9 7  ( 1  H ,  t ,  7  =  5 . 5  H z ,  OH),  2 . 1 0  [ 1  H ,  m ,  
7  =  7 . 0  H z ,  C / / ( C H 3 ) 2 ] ,  2 . 5 5  ( 1  H ,  d d ,  7  =  7 . 0 ,  4 . 5  H z ,  CHi- 
Pr), 3 . 7 4  ( 2  H ,  a p p  d t ,  7  =  5 . 5 , 5 . 5  H z ,  C / / 2O H ) ,  3 . 9 4 - 3 . 9 8  ( 2  
H ,  m ,  CH2N),  4 . 9 2  ( 1  H ,  a p p  t ,  7  =  7 . 0  H z ,  CHO),  5 . 4 7  ( 1  H ,  
d d d ,  7 =  1 5 . 0 , 7 . 0 ,  1 . 5  H z ,  C H 3C H = C / / ) ,  5 . 9 1  ( 1  H ,  d q ,  7  =
1 5 . 0 ,  7 . 0  H z ,  C H 3C / / = C H ) .  1 3 C  N M R  ( 7 5  M H z ,  C D C 1 3 ) :  
5 =  1 7 . 0 ,  1 9 . 7 ,  2 0 . 3 , 2 4 . 8 ,  4 3 . 2 ,  4 9 . 5 ,  6 0 . 1 , 7 6 . 6 ,  1 2 2 . 1 ,
1 3 2 . 7 ,  1 5 1 . 3 ,  1 6 9 . 7 .  I R :  3 4 3 0  ( b r ,  O H ) ,  1 7 5 5  ( C = 0 ) ,  1 6 9 9  
( C = 0 )  c m - 1 .
(5S,6R)-3-[(S)-l-Benzyl-2-hydroxyethyl]-6-ethyI-5- 
methyl-l,3-oxazinane-2,4-dione (lOe): [ a ]D20 - 6 . 4  ( c  0 . 4 7 ,  
C H 2C 1 2 ) .  ' H  N M R  ( 3 0 0  M H z ,  C D C 1 3 ) :  5  =  0 . 8 2  ( 3  H ,  t ,  7  =
7 . 5  H z ,  C H 2C H i ), 0 . 9 9  ( 3  H ,  d ,  7  =  7 . 5 ,  C / / 3C H ) ,  1 . 3 3  ( 2  H ,  
m ,  C / / 7C H 3 ) ,  2 . 5 0  ( 1  H ,  q d ,  7  =  7 . 5 ,  3 . 5  H z ,  C / / C H 3 ) ,  2 . 9 9  
( 1  H ,  d d ,  7  =  1 4 . 0 ,  7 . 0  H z ,  P h C / / A C H B ) ,  3 . 1 6  ( 1  H d d , 7  =
1 4 . 0 ,  1 0 . 5  H z ,  P h C H ACHB), 3 . 6 8  ( 2  H ,  o b s c u r e d  m ,  CHO),  
3 . 8 2 ( 1  H ,  d d ,  7 =  1 2 . 0 ,  4 . 0  H z ,  C / / A H B O H ) ,  4 . 0 1  ( 1  H ,  d d ,  
7  =  1 2 . 0 ,  7 . 0  H z ,  CHAHBOH),  5 . 0 4  ( 1  H ,  a p p  d t d ,  7  =  1 0 . 5 ,
7 . 0 ,  4 . 0  H z ,  C H N ) ,  7 . 1 0 - 7 . 1 5  ( 5  H ,  m ,  P h ) .  13C  N M R  ( 7 5  
M H z ,  C D C I 3 ) :  5  =  9 . 2 ,  9 . 5 ,  2 2 . 6 ,  3 3 . 7 ,  3 9 . 2 ,  5 6 . 5 ,  6 3 . 3 ,
7 8 . 4 ,  1 2 6 . 6 ,  1 2 8 . 5 ,  1 2 9 . 1 ,  1 3 7 . 4 ,  1 5 1 . 8 ,  1 7 3 . 1 .  I R :  3 4 6 2  ( b r ,  
O H ) ,  1 7 5 5  ( C = 0 ) ,  1 7 0 0  ( C = 0 )  c m " 1 . 
(5S,6/?)-3-[(S)-l-Benzyl-2-hydroxyethyl]-6-ethyl-5- 
isopropyl-l,3-oxazinane-2,4-dione (lOh): [ a ]D20 - 6.8 ( c  
0 . 5 9 ,  C H 2C 1 2 ) .  ' H  N M R  ( 3 0 0  M H z ,  C D C 1 3 ) :  5  =  0 . 8 4  ( 3  H ,  
t ,  7  =  7 . 5  H z ,  C H 2C H3), 0 . 8 5  [ 3  H ,  d ,  7  =  7 . 0  H z ,  C H ( C / / 3 ) 2 ] ,
0 . 9 2  [ 3  H ,  d ,  7  =  7 . 0  H z ,  C H ( C / / 3 ) 2 ] ,  1 . 3 1 - 1 . 4 6  ( 1  H ,  d q d ,  
7 =  1 4 . 0 ,  7 . 5 ,  5 . 0  H z ,  C / / a H b C H 3 ) ,  1 . 4 5 - 1 . 6 1  ( 1  H ,  m ,  
C H a / / b C H 3 ) ,  1 . 9 4 - 2 . 0 5  [ 1  H ,  m ,  C / / ( C H 3 ) 2 ] ,  2 . 1 8  ( 1  H ,  a p p  
t ,  7  =  4 . 5  H z ,  CHi-Pr),  2 . 5 3  ( 1  H ,  b r  s ,  OH),  2 . 9 9  ( 1  H ,  d d ,  
7 =  1 4 . 0 , 7 . 0  H z ,  C Z / A H B P h ) ,  3 . 1 3 ( 1  H , d d , 7 = 1 4 . 0 ,  1 0 . 5  H z ,  
C H A / / B P h ) ,  3 . 6 4 ( 1  H ,  o b s c u r e d  rr\,CHO), 3 . 8 2 ( 1  H , d d , 7  =
1 2 . 0 ,  4 . 0  H z ,  C / / A H B O H ) ,  4 . 0 2  ( 1  H ,  d d ,  7  =  1 2 . 0 ,  7 . 0  H z ,  
C H a / / b O H ) ,  5 . 0 4 - 5 . 1 4  ( 1  H ,  a p p  d t d ,  7  =  1 0 . 5 ,  7 . 0 ,  4 . 0  H z ,  
CHN),  7 . 0 8 - 7 . 2 2  ( 5  H ,  m ,  P h ) .  1 3 C  N M R  ( 7 5  M H z ,  C D C 1 3 ) :  
5  =  1 0 . 4 ,  2 0 . 2 ,  2 2 . 6 ,  2 3 . 4 ,  2 5 . 5 ,  3 4 . 3 ,  5 0 . 2 ,  5 6 . 5 ,  6 3 . 7 ,  7 9 . 4 ,
1 2 7 . 0 ,  1 2 8 . 9 ,  1 2 9 . 5 ,  1 3 5 . 0 ,  1 5 2 . 5 ,  1 7 1 . 4 .  I R :  3 4 2 3  ( b r ,  O H ) ,  
1 7 5 4  ( C = 0 ) ,  1 6 9 1  ( C = 0 )  c m - 1 . 
syn-3-(2-Hydroxyethyl)-5-methyl-6-phenyl-l,3- 
oxazinane-2,4-dione (lOi): ‘ H  N M R  ( 3 0 0  M H z ,  C D C 1 3 ) :  
8 =  1 . 0 1  ( 3  H ,  d ,  7  =  7 . 5  H z ,  C / / 3 ) ,  2 . 1 7 ( 1  H ,  s ,  OH),  2 . 9 9 ( 1  
H ,  q d ,  7  =  7 . 5 , 3 . 5  H z ,  C / / C H 3 ) ,  3 . 7 5 - 3 . 8 2  ( 2  H ,  m ,  C / / 2O H ) ,  
3 . 9 7 ( 1  H , a p p  d t ,  7 =  1 4 . 0 ,  5 . 5  H z ,  CHAHBN),  4 . 0 5  ( 1  H ,  a p p  
d t ,  7  =  1 4 . 0 ,  5 . 5  H z ,  C H A / / „ N ) ,  5 . 6 2  ( 1  H ,  d ,  7  =  3 . 5  H z ,  
CHO),  7 . 2 4 - 7 . 3 8  ( 5  H ,  m ,  P h - / / ) .  I 3 C  N M R  ( 7 5  M H z ,  
C D C 1 3 ) :  8 =  1 0 . 4 , 4 1 . 5 , 4 4 . 6 , 6 1 . 2 , 7 8 . 1 , 1 2 6 . 0 , 1 2 9 . 2 ,  1 2 9 . 4 ,
1 3 4 . 4 ,  1 5 2 . 4 ,  1 7 3 . 2 .  I R :  3 4 4 7  ( b r ,  O H ) ,  1 7 5 5  ( C = 0 ) ,  1 7 0 3  
( C = 0 )  c m - 1 .
syn-3-(2-Hydroxyethyl)-5-isopropyl-6-(4-methoxy- 
phenyl)-lv3-oxazinane-2,4-dione (10k): mp 7 9 - 8 1  ° C .  ' H  
N M R  ( 3 0 0  M H z ,  C D C I 3 ) :  8 =  0 . 8 7  [ 3  H ,  d ,  7  =  7 . 0  H z ,  
C H ( C / / 3 ) 2 ] ,  0 . 9 8  ( 3  H ,  d ,  7  =  7 . 0  H z ,  C H ( C / / 3 ) 2 ] ,  1 . 9 6  [ 1  H ,  
m ,  7  =  7 . 0 , 4 . 0  H z ,  C / / ( C H 3 ) 2 ] ,  2 . 2 6  ( 1  H ,  b r  s, OH),  2 . 7 9  ( 1  
H ,  t ,  7  =  4 . 0  H z ,  CHi-Pr), 3 . 8 3  ( 3  H ,  s, A r O C / / 3 ) ,  3 . 8 1 - 3 . 8 7  
( 2  H ,  m, CH2OH),  4 . 0 2  ( 1  H ,  app d t ,  7  =  1 4 . 0 ,  5 . 5  H z ,  
CHAHBN),  4 . 1 6  ( 1  H ,  app d t ,  7 =  1 4 . 0 ,  5 . 5  H z ,  C H A / / « N ) ,  
5 . 7 1  ( 1  H ,  d ,  7  =  4 . 0  H z ,  CHO),  6 . 9 4  ( 2  H ,  d ,  7  =  8 . 5  H z ,  A r -  
Z Z ) ,  7 . 2 9  ( 2  H ,  d ,  7  =  8 . 5  H z ,  Ar-H). 1 3 C  N M R  ( 7 5  M H z ,  
C D C 1 3 ) :  8 =  1 9 . 8 ,  2 3 . 1 ,  2 6 . 0 ,  4 4 . 7 ,  5 2 . 0 ,  5 5 . 7 ,  6 1 . 3 ,  7 8 . 4 ,
1 1 4 . 6 ,  1 2 6 . 7 ,  1 2 7 . 1 ,  1 5 2 . 9 ,  1 6 0 . 1 ,  1 7 1 . 4 .  I R :  3 3 5 3  ( b r ,  O H ) ,  
1 7 4 0  ( C = 0 ) ,  1 6 9 1  ( C = 0 )  c m - 1 .
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1 0 9 4  F . J. P . F e u ille t e ta l . LETTER
( 2 2 )  syn- 1 , 3 - O x a z i n a n e - 2 , 4 - d i o n e s  e x h i b i t  7 (S 6 )  c o u p l i n g  
c o n s t a n t s  o f  < 4 . 5  H z ,  w h i l s t  a n / M , 3 - o x a z i n a n e - 2 , 4 - d i o n e s  
e x h i b i t  7 ( 5 6 )  c o u p l i n g  c o n s t a n t s  o f  > 1 0 . 0  H z ;  s e e  r e f .  1 3 c ,  1 4 ,
1 6 .
( 2 3 )  A n  a l t e r n a t i v e  m e c h a n i s m  i n v o l v i n g  z i n c  a l k o x i d e - c a t a l y s e d  
e p i m e r i s a t i o n  o f  t h e  a - s t e r e o c e n t r e s  o f  y y n - P - a r y l - a l d o l s  9i- 
1 ( o r  s y « - P - a r y l - l , 3 - o x a z i n a n e - 2 , 4 - d i o n e s  10i-l) w a s  
d i s c o u n t e d  b e c a u s e  t h e i r  a c i d i t i e s  a r e  s i m i l a r  t o  t h o s e  o f  t h e  
a - s t e r e o c e n t r e s  o f  s y n - P - a l k y l - a l d o l s  9a-k t h a t  h a d  b e e n  
s h o w n  t o  r e a r r a n g e  w i t h  n o  l o s s  o f  s t e r e o c o n t r o l  u n d e r  t h e s e  
c o n d i t i o n s .
( 2 4 )  A  s i m i l a r  r e v e r s i b l e  r c t r o - a l d o l / a l d o l  m e c h a n i s m  h a s  b e e n  
p r o p o s e d  t o  e x p l a i n  t h e  d i a s t e r e o s e l e c t i v i t y  o b s e r v e d  f o r  
r e a c t i o n  o f  m e t a l  e n o l a t e s  o f  A - a c y l - o x a z o l i d i n - 2 - o n e s  w i t h  
k e t o n e s ,  s e e : B a r t r o l i ,  J . ;  T u r m o ,  E . ;  B e l l o c ,  J . ;  F o r n ,  J .  J. 
Org. Chem. 1995, 60, 3 0 0 0 .
( 2 5 )  A r- A c y l - o x a z o l i d i n - 2 - o n e - a n / t - a l d o l  15 w a s  p r e p a r e d  u s i n g  
E v a n s ’ m a g n e s i u m  h a l i d e - c a t a l y s e d  p r o t o c o l ,  s e e  r e f .  1 2 .
( 2 6 )  an/i-3-(2-Hydroxyethyl)-5-methyl-6-phenyl-l,3- 
oxazinane-2,4-dione (16). ' H  N M R  ( 3 0 0  M H z ,  C D C 1 3 ) :
5  =  1 . 0 2  ( 3  H ,  d ,  J  =  7 . 0  H z ,  C / / 3 ) ,  2 . 2 1  ( 1  H ,  b r  s ,  OH),  2 . 8 9  
( 1  H ,  d q ,  J  =  1 1 . 5 ,  7 . 0  H z ,  CHC H 3 ) ,  3 . 7 7 - 3 . 8 0  ( 2  H ,  a p p  t ,  
J  =  5 . 5  H z ,  C / / 2O H ) ,  3 . 9 4  ( 1  H ,  d t ,  J  =  1 4 . 0 ,  5 . 5  H z ,  
CHaHbN),  4 . 0 6  ( 1  H ,  a p p  d t ,  J = 1 4 . 0 ,  5 . 5  H z ,  C H ^ N ) ,
5 . 0 4  ( 1  H ,  d ,  J = 1 1 . 5  H z ,  CHPh),  7 . 2 4 - 7 . 3 8  ( 5  H ,  m ,  P h - / / ) .  
13C  N M R  ( 7 5  M H z ,  C D C 1 3 ) :  5  =  1 0 . 1 , 4 0 . 4 , 4 3 . 5 ,  5 9 . 6 ,  8 0 . 5 ,
1 2 6 . 1 ,  1 2 7 . 9 ,  1 2 8 . 7 ,  1 3 4 . 2 ,  1 5 1 . 1 ,  1 7 0 . 5 .  I R :  3 4 3 5  ( b r ,  O H ) ,  
1 7 5 5  ( C = 0 ) ,  1 6 9 4  ( C = 0 )  c m " 1 .
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COMMUNICATION w w w .rsc.org/chem com m  | ChemComm
A novel strategy for the asym metric synthesis o f  chiral cyclopropane  
carboxa ldehyd est
Matt Cheeseman, Fred J. P. Feuillet, Andrew L. Johnson and Steven D. Bull*
Received (in  Cambridge, UK) 4th February 2005, Accepted 4th March 2005 
First published as an Advance Article on the web 17th March 2005
1 ) 0 1 :  1 0 . 1 0 3 9 / b 5 0 1 8 4 7 a
A  n e w  w a y  o f  c o m b i n i n g  c h i r a l  a u x i l i a r i e s  a n d  s u b s t r a t e -  
d i r e c t a b l e  r e a c t i o n s  f o r  a s y m m e t r i c  s y n t h e s i s  i s  d e s c r i b e d  t h a t  
e m p l o y s  a  t h r e e - s t e p  s e q u e n c e  o f  a l d o l - c y c l o p r o p a n a t i o n - r c r r o -  
a l d o l  r e a c t i o n s  f o r  t h e  s t e r e o s e l e c t i v e  s y n t h e s i s  o f  e n a n t i o p u r e  
c y c l o p r o p a n e  c a r b o x a l d e h y d e s .
C h i r a l  a u x i l i a r i e s '  a n d  s u b s t r a t e - d i r e c t a b l e  r e a c t i o n s 2 h a v e  o f t e n  
b e e n  c o m b i n e d  t o  a f f o r d  p o w e r f u l  s y n t h e t i c  p r o t o c o l s  f o r  t h e  
a s y m m e t r i c  s y n t h e s i s  o f  c h i r a l  b u i l d i n g  b l o c k s  f o r  n a t u r a l  p r o d u c t  
s y n t h e s i s .3 I n  t h e s e  a p p r o a c h e s  a  c h i r a l  a u x i l i a r y  i s  f i r s t  e m p l o y e d  
t o  p r e p a r e  a  c h i r a l  i n t e r m e d i a t e  c o n t a i n i n g  a  n e w  s t e r e o g e n i c  
c e n t r e  i n  h i g h  d e .  T h i s  n e w  s t e r e o c e n t r e  i s  t h e n  e m p l o y e d  t o  
c o n t r o l  t h e  f a c i a l  s e l e c t i v i t y  o f  a  s u b s t r a t e - d i r e c t a b l e  r e a c t i o n  t o  
a f f o r d  a  s e c o n d  c h i r a l  i n t e r m e d i a t e  c o n t a i n i n g  f u r t h e r  s t e r e o g e n i c  
c e n t r e s .  F i n a l l y ,  t h e  s e c o n d  c h i r a l  i n t e r m e d i a t e  i s  t h e n  c l e a v e d  t o  
a f f o r d  t h e  c h i r a l  a u x i l i a r y  a n d  a  c h i r a l  p r o d u c t 4 W e  w e r e  
i n t e r e s t e d  i n  d e v e l o p i n g  n e w  w a y s  o f  c o m b i n i n g  c h i r a l  a u x i l i a r i e s  
a n d  s u b s t r a t e - d i r e c t a b l e  r e a c t i o n s  f o r  a s y m m e t r i c  s y n t h e s i s ,  a n d  
n o w  r e p o r t  h e r e i n  o n  a  n o v e l  t h r e e - s t e p  p r o t o c o l  t h a t  e m p l o y s  a  
s e q u e n c e  o f  a l d o l  c y c l o p r o p a n a t i o n  retro-dk\o\ r e a c t i o n s  f o r  t h e  
s t e r e o s e l e c t i v e  s y n t h e s i s  o f  c h i r a l  c y c l o p r o p a n e  c a r b o x a l d e h y d e s  i n  
e n a n t i o p u r e  f o r m .5
T h e  n o v e l  t h r e e - s t e p  p r o t o c o l  t h a t  w a s  e n v i s a g e d  f o r  t h e  
a s y m m e t r i c  s y n t h e s i s  o f  c h i r a l  c y c l o p r o p a n e  c a r b o x a l d e h y d e s  i s  
d e s c r i b e d  i n  S c h e m e  1 .  F i r s t l y ,  ( S ) - j V - p r o p i o n y l - 5 , 5 - d i m e t h y l -  
o x a z o l i d i n - 2- o n e  l 6 w o u l d  u n d e r g o  a  s t e r e o s e l e c t i v e  a l d o l  r e a c t i o n  
w i t h  a n  a , P - u n s a t u r a t e d  a l d e h y d e  s u b s t r a t e  2 t o  a f f o r d  a  . y j w - a l d o l
M e
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S c h e m e  I  Novel three-step strategy for the asymmetric synthesis of 
chiral cyclopropane carboxaldehydes.
t  Electronic supplementary information (ESI) available: representative 
experimental details and data for the asymmetric synthesis of cyclopro­
pane carboxaldehyde (5,S’)-5d. See http://www.rsc.org/suppdata/cc/b5/ 
b501847a/
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p r o d u c t  3  i n  h i g h  d e  ( S t e p  1 ) .  S e c o n d l y ,  s t e r e o s e l e c t i v e  c y c l o p r o ­
p a n a t i o n  o f  t h e  a l l y l i c  a l c o h o l  f u n c t i o n a l i t y  o f  3  w o u l d  o c c u r  u n d e r  
t h e  s t e r e o d i r e c t i n g  e f f e c t  o f  i t s  ( T h y d r o x y l  f u n c t i o n a l i t y  t o  a f f o r d  
c y c l o p r o p a n e  4  i n  h i g h  d e  ( S t e p  2 ) .  F i n a l l y ,  / x v / o - a l d o l  f r a g m e n t a ­
t i o n  o f  c y c l o p r o p a n e  4  w o u l d  a f f o r d  t h e  d e s i r e d  c h i r a l  c y c l o p r o ­
p a n e  c a r b o x a l d e h y d e  5  a n d  t h e  c h i r a l  a u x i l i a r y  f r a g m e n t  1 t h a t  
c o u l d  t h e n  b e  r e c y c l e d  a s  r e q u i r e d  ( S t e p  3 ).7 T h e  o v e r a l l  o u t c o m e  
o f  t h i s  t h r e e - s t e p  p r o t o c o l  w o u l d  t h e r e f o r e  b e  t h e  s t e r e o s e l e c t i v e  
t r a n s f o r m a t i o n  o f  a n  a c h i r a l  a , P - u n s a t u r a t e d  a l d e h y d e  2 i n t o  a  
c h i r a l  c y c l o p r o p a n e  c a r b o x a l d e h y d e  5  i n  e n a n t i o p u r e  f o r m  
( S c h e m e  1 ) .
T h e  f i r s t  s t e p  o f  t h i s  n e w  s t r a t e g y  w a s  w e l l  p r e c e d e n t e d  s i n c e  i t  
h a d  b e e n  r e p o r t e d  p r e v i o u s l y  t h a t  r e a c t i o n  o f  ( Z ) - b o r o n  e n o l a t e s  
o f  / V - a c y l - o x a z o l i d i n - 2 - o n e s ,  w i t h  a , P - u n s a t u r a t e d  a l d e h y d e s ,  g a v e  
■ s y u - a l d o l  p r o d u c t s  i n  h i g h  d e .8 C o n s e q u e n t l y ,  w e  f o u n d  t h a t  
t r e a t m e n t  o f  ( S ) - / V - p r o p i o n y l - 5 , 5 - d i m e t h y l - o x a z o l i d i n - 2 - o n e  1 w i t h
9 - B B N - O T f  a n d  ' P i s N E t  i n  C H 2C 1 2 a t  0  C ,  f o l l o w e d  b y  c o o l i n g  
t o  - 7 8  C  a n d  a d d i t i o n  o f  t h e  a p p r o p r i a t e  a , P - u n s a t u r a t e d  
a l d e h y d e  2 a - g ,9 g a v e  a  r a n g e  o f  . v v u - a l d o l  p r o d u c t s  3 a - g  i n  > 9 5 %  
d e ,  a n d  i n  a c c e p t a b l e  7 6 - 8 7 %  i s o l a t e d  y i e l d s  ( T a b l e  l ).10 (Z)-syn- 
A l d o l  3 h  w a s  p r e p a r e d  i n  > 9 5 %  d e  a n d  i n  a n  o v e r a l l  6 0 %  y i e l d ,  via 
a n  a l t e r n a t i v e  t w o - s t e p  r e a c t i o n  s e q u e n c e ,  i n v o l v i n g  r e a c t i o n  o f  t h e  
( Z ) - b o r o n  e n o l a t e  o f  1 w i t h  o c t - 2 - y n - a l  6 , "  f o l l o w e d  b y  
h y d r o g e n a t i o n  o f  t h e  r e s u l t a n t  . y y ' / j - a l d o l  p r o d u c t  u s i n g  L i n d l a r ’ s  
c a t a l y s t  ( S c h e m e  2 ).'2
W e  n e x t  d e t e r m i n e d  c o n d i t i o n s  t h a t  w o u l d  e n a b l e  t h e  a l k e n e  
f u n c t i o n a l i t y  o f  syn- a l d o l  p r o d u c t s  3 a - h  t o  b e  c y c l o p r o p a n a t e d  i n  
h i g h  d e .13 I t  w a s  f o u n d  t h a t  t r e a t m e n t  o f  . v > v ? - a l d o l s  3 a - h  w i t h
Tabic I Asymmetric synthesis o f  .yy/z-aldols 3a-g in high de (Step 1)
9-BBN-OTf. Pr2NEt. 
CH iCIi. -78 to o"°C
Entry Aldehyde R 1 R2 Aldol de (%)"•* Yield (%)
1 2a Ph-
2 2b M e(CHqfi-
3 2c p-MeOC(,H4
4 2d a -N 0 2 ChH4-
5 2 c 2-Furyl
6  2 f Me
7 2 g Me
" The des o f  aldols 3a-g were < 
their crude reaction products. b
H 3a > 95  80 
H 3b > 95  81 
H 3c > 9 5  77 
H 3d > 9 5  87 
H 3e > 9 5  85 
Me 3f > 9 5  76 
H 3g > 9 5  76 
determined from 'H NM R spectra o f  
Aldols 3a-g exhibited J^y.V) coupling
constants o f between 2.0 and 6.0 Hz in their H NM R spectra, 
consistent with the assigned .yyn-configuration.
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a) 9-BBN-OTf, 'Pr2NEt, 
CH :C U ,-78 toO °C
b) l b ,  Lindlar’s catalyst, \ __ / M
C 5H n MeOH ' M e T \
Me /  ;
Ph
Scheme 2 Alternative two-step vi’/j-aldol hydrogenation protocol for the 
synthesis o f ,vr/?-aldol 3h.
Table 2 Cyclopropanation occurs under the stereocontrol o f the 
p-hydroxy group to afford syH-cyclopropyl-aldoIs 4a-h in high de 
(Step 2)
O O  OH R2
Me Me  H
“ n? 3a"




Entry Aldol R 1 R“ Cyclopropane de (%)" Yield (%)
1 3a Ph H 4a >95 95
2 3b Me(CI L)(, H 4b >95 89
3 3c />-MeOQ,H4- H 4c >95 90
4 3d o -N 0 2C6H4- H 4d >95 90
5 3e 2-Furyl H 4e >95 92
6 3f Me Me 4f >95 99
7 3g Me H 4g >95 95
8 3h H C5H 1,- 4h >95 96
" The des o f  .mj-cyclopropyl-aldols 4a-h were determined from the 
' ll NM R spectra o f their crude reaction products.
E t 2Z n  a n d  C H 2I 2 i n  C H 2C I 2 a t  a  t e m p e r a t u r e  b e t w e e n  -1 0  a n d  
0  ° C  r e s u l t e d  i n  a  h i g h l y  d i a s t e r e o s e l e c t i v e  c y c l o p r o p a n a t i o n  
r e a c t i o n ,14 a f f o r d i n g  . v v u - c y c l o p r o p y l - a l d o l s  4 a - h  i n  > 9 5 ' / )  d e  a n d  
8 9 - 9 9 %  y i e l d  ( T a b l e  2 ) .  C y c l o p r o p a n a t i o n s  o f  t h i s  t y p e  o f  a l l y l i c  
a l c o h o l  s u b s t r a t e  u n d e r  m o d i f i e d  F u m k a w a  c o n d i t i o n s  a r e  
n o r m a l l y  s p H - s e l e c t i v e  d u e  t o  m i n i m i s a t i o n  o f  A 1,3 s t r a i n  i n  t h e
t r a n s i t i o n  s t a t e ,14 a n d  a s  a  c o n s e q u e n c e  t h e  c o n f i g u r a t i o n s  o f  syn- 
c y c l o p r o p y l - a l d o l s  4 a - h  w e r e  a s s i g n e d  a c c o r d i n g l y .1x16
C o n d i t i o n s  w e r e  n e x t  i d e n t i f i e d  t h a t  w o u l d  e n a b l e  svn- 
c y c l o p r o p y l - a l d o l s  4 a - h  t o  u n d e r g o  retro- a l d o l  c l e a v a g e  t o  a f f o r d  
t h e i r  d e s i r e d  c y c l o p r o p a n e  c a r b o x a l d e h y d e s  5 a —I i . 1 E x t e n s i v e  
s c r e e n i n g  o f  a  r a n g e  o f  b a s e s  a n d  c o n d i t i o n s  r e v e a l e d  t h a t  
t r e a t m e n t  o f  . v i v / - c y c l o p r o p y l - a l d o l s  4 a - e  w i t h  L H M D S  i n  t o l u e n e ,  
a t  t e m p e r a t u r e s  b e t w e e n  0  ° C  a n d  1 0  ° C ,  r e s u l t e d  i n  c l e a n  retro- 
a l d o l  c l e a v a g e  t o  a f f o r d  a  m i x t u r e  o f  t h e  d e s i r e d  c h i r a l  
c y c l o p r o p a n e  c a r b o x a l d e h y d e s  5 a - e ,  ( 5 > j V - p r o p i o n y l - 5 , 5 -  
d i m e t h y l - o x a z o l i d i n - 2 - o n e  1 ,  a n d  5 , 5 - d i m e t h y l - o x a z o l i d i n - 2 - o n e  7  
( < 2 0 % )  w i t h  e x c e l l e n t  m a s s  r e c o v e r y .  P r e s u m a b l y ,  c o m p e t i n g  
f o r m a t i o n  o f  7  a r i s e s  f r o m  p a r t i a l  d e c o m p o s i t i o n  o f  t h e  l i t h i u m  
e n o l a t e  o f  A / - p r o p i o n y l - o x a z o l i d i n - 2 - o n e  1 via a  retro- k e t e n e  
a d d i t i o n  m e c h a n i s m .18 P u r i f i c a t i o n  o f  e a c h  r c T r o - a l d o l  r e a c t i o n  
p r o d u c t  b y  c h r o m a t o g r a p h y  g a v e  c y c l o p r o p a n e  c a r b o x a l d e h y d e s  
( . S \ . S T) - 5 a - e  i n  > 9 5 %  d e  a n d  i n  5 5 - 7 5 %  i s o l a t e d  y i e l d s  ( T a b l e  3 ) .  
T h e  a b s o l u t e  c o n f i g u r a t i o n  o f  c y c l o p r o p a n e  c a r b o x a l d e h y d e s  
( 5 , . S ’) - 5 a  a n d  ( 5 , 5 ) - 5 b  w e r e  c o n f i r m e d  f r o m  t h e i r  p o s i t i v e  s p e c i f i c  
r o t a t i o n s ,19,20 w h i l s t  t h e  e n a n t i o m e r i c  p u r i t y  o f  ( S ^ S O - S b  w a s  
c o n f i r m e d  a s  > 9 5 %  e e  b y  c o n v e r s i o n  t o  i t s  c o r r e s p o n d i n g  
i m i d a z o l i d i n o n e  u s i n g  ( R ,R ) - ( + ) - d i m e t h y l - 1 , 2 - d i p h e n y l - 1 , 2 - e t h a n e -  
d i a m i n e  a s  a  c h i r a l  d e r i v a t i s i n g  a g e n t .21
T r e a t m e n t  o f  . m i - c y c l o p r o p y l - a l d o l s  4 f  a n d  4 g  w i t h  L H M D S  a t  
0  ° C  a l s o  r e s u l t e d  i n  c l e a n  retro- a l d o l  r e a c t i o n s ,  h o w e v e r  a t t e m p t e d  
p u r i f i c a t i o n  o f  a l d e h y d e s  5 f  a n d  5 g  b y  c h r o m a t o g r a p h y  w a s  l e s s  
s u c c e s s f u l  d u e  t o  t h e i r  i n h e r e n t  v o l a t i l i t y  w h i c h  l e d  t o  p o o r  y i e l d s  
o f  a l d e h y d e  b e i n g  i s o l a t e d .  C o n s e q u e n t l y ,  t h e  retro- a l d o l  r e a c t i o n s  
o f  c y c l o p r o p y l - a l d o l s  4 f  a n d  4 g  w e r e  r e p e a t e d  u s i n g  L H M D S  i n  
t o l u e n c - r / x  a t  0 C ,  a n d  e a c h  r e a c t i o n  w o r k e d - u p  via a d d i t i o n  o f  
f i v e  d r o p s  o f  N H 4C l a t l ,  b e f o r e  d r y i n g  o v e r  M g S 0 4 . R e s u l t i n g  
d i s t i l l a t i o n  o f  t h e  r e s p e c t i v e  c r u d e  r e a c t i o n  p r o d u c t s  a f f o r d e d  a  
s o l u t i o n  o f  t h e  d e s i r e d  a l d e h y d e s  5 f  ( > 9 5 %  e e )  a n d  5 g  ( > 9 5 %  d e )  
i n  t o l u e n e - i / g ,22 t h e  y i e l d s  o f  w h i c h  w e r e  d e t e r m i n e d  a s  5 1 %  a n d  
6 5 %  r e s p e c t i v e l y  via ' H  N M R  s p e c t r o s c o p i c  a n a l y s i s  i n  t h e  
p r e s e n c e  o f  a  k n o w n  c o n c e n t r a t i o n  o f  2 , 5 - d i m e t h y l f u r a n  a s  a n
Table 3 Anionic rc/w-aldol reactions afford chiral cyclopropane carboxaldehydes 5a-h in enantiopure form (Step 3)
1
Entry Aldol R 1 R 2  Aldehyde Conditions de (%)" Yield (%)r
1 4a Ph H  5a 1 h  /  0  ° C  > 9 5 24 7 5
2  4b M e ( C H 2)6 H  5b 1 h  /  0  ° C  > 9 5  7 3
3  4c / > - M e O C 6H 4 -  H  5c 3 h  /  5  ° C  > 9 5  6 3
4  4d < > - N 0 2C 6H 4 -  H  5d 5  h  /  1 0  ° C  > 9 5  5 5
5  4e 2 - F u r y l  H  5 e  1 h  /  0  ° C  > 9 5  7 1
6 4 f  M e  M e  5 f  l h / O C  > 9 5 %  e e *  5 1 ( /
7  4g M e  H  5g l h / 0 " C  > 9 5  6 5 ' '
8 4b H  C 5H 1, 5 h  1 h  /  0  ° C  > 9 5 2 S  6 1
" The des o f  cyclopropane carboxaldehydes 5 a - h  were determined from the 111 NM R spectra o f their crude rctro-aldol reaction products. h The 
ee o f  cyclopropane carboxaldehyde 5 f  was determined via derivatisation with (/?,/?)-(+)-dimethyl-l,2-diphenyl-l,2-ethane-diamine . 21 ' *H NM R  
spectroscopic analysis o f  the crude reaction products revealed that all cyclopropane carboxaldehydes had been formed in >70% yield. d Yields 
were determined from ’H  NM R spectroscopic analysis o f the cyclopropane carboxaldehyde in toluene-r/g in the presence o f  a known 
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(Step 3)
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i n t e r n a l  s t a n d a r d  ( T a b l e  3 ).23 F i n a l l y ,  t r e a t m e n t  o f  m - c y c l o p r o p y l -  
a l d o l  ( Z ) - 4 h  w i t h  L H M D S  a t  0  ° C  a l s o  r e s u l t e d  i n  a  c l e a n  
retro-a l d o l  r e a c t i o n  a f f o r d i n g  m - c y c l o p r o p a n e  c a r b o x a l d e h y d e  
( 1  S,2R)-5h  i n  6 1 %  y i e l d ,24 w i t h  n o  e p i m e r i s a t i o n  t o  i t s  m o r e  s t a b l e  
( 1 7 ? , 2 i ? ) - e p i m e r  h a v i n g  o c c u r r e d  u n d e r  t h e  b a s i c  c o n d i t i o n s  u s e d  t o  
f a c i l i t a t e  t h e  retro-aldo1 r e a c t i o n  25
I n  s u m m a r y ,  a  n o v e l  t h r e e - s t e p  a l d o l - c y c l o p r o p a n a t i o n - r c t r o -  
a l d o l  s e q u e n c e  f o r  t h e  d i r e c t  a s y m m e t r i c  s y n t h e s i s  o f  e n a n t i o p u r e  
c y c l o p r o p a n e  c a r b o x a l d e h y d e s  u n d e r  n o n - o x i d a t i v e / n o n - r e d u c t i v e  
c o n d i t i o n s  h a s  b e e n  d e v e l o p e d .  T h i s  p r o t o c o l  d e m o n s t r a t e s  t h e  
p o t e n t i a l  o f  a  n o v e l  s y n t h e t i c  s t r a t e g y  t h a t  e m p l o y s  a  c h i r a l  
a u x i l i a r y  t o  reversibly g e n e r a t e  a  temporary s t e r e o c e n t r e  t h a t  i s  
t h e n  e m p l o y e d  a s  a  s t e r e o d i r e c t i n g  g r o u p  t o  c o n t r o l  f a c i a l  
s e l e c t i v i t y  f o r  a  s u b s t r a t e - d i r e c t a b l e  r e a c t i o n .  W e  a n t i c i p a t e  t h a t  
t h i s  n e w  s t r a t e g y  w i l l  p r o v e  a p p l i c a b l e  t o  t h e  c o m b i n a t i o n  o f  o t h e r  
t y p e s  o f  c h i r a l  a u x i l i a r y  a n d  s u b s t r a t e - d i r e c t a b l e  r e a c t i o n ,  t h u s  
e n a b l i n g  i t s  p o t e n t i a l  f o r  a s y m m e t r i c  s y n t h e s i s  t o  b e  r e a l i s e d  i n  a  
w i d e  r a n g e  o f  d i f f e r e n t  r e a c t i o n  s c e n a r i o s .
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M arine cyanobacteria produce a wide range o f bioac­
tive and structurally complex natural products, a num­
ber o f which have been shown to be derived from 
modified fatty acid fragm ents.1 Gerwick and co-workers 
have recently reported the isolation of a series o f novel 
semiplenamide metabolites from the marine cyanobac­
terium Lynghya semiplena that were shown to be struc­
turally related to anandam ide fatty acid amides.2 All of 
the semiplenamides A -G  la - g  (Fig. 1) displayed 
toxicity toward the brine shrimp model system, semiple­
namides A, B, and G exhibited weak affinity for the rat 
cannabinoid C B 1 receptor, whilst semiplenamide A was 
a m oderate inhibitor of the anandam ide membrane 
transporter.2 Given this range of biological activity, 
we were interested in developing efficient methodology 
for their stereoselective syntheses, and now report here­
in on the development of novel aldol/dehydration meth­




la Semiplenamide A; R = H, R1 = H, R2 = (3 ZO-/J-C17H33- 
II) Semiplenamide B; R = Ac, R1 = H. R2 = (3E)-n-C|7 HVr  
lc Semiplenamide C; R = H, R1 = Me, R2 = rt-C|3 H27 - 
Id Semiplenamide D; R = Ac, R1 = Me, R2 = B-C17H3 5 - 






If Semiplenamide F; R = H, R1 = (S)-Me, R2  = n-C|5 H31- 
lg Semiplenamide G, R = Ac, R1 = Me, R2 = n-CisHii-
Figure 1. S t r u c t u r e s  o f  s e m i p l e n a m i d e s  A - G  la g.
We have recently reported that potassium alkoxides of 
(3-hydroxy-A-acyloxazolidinones 2 undergo stereoselec­
tive elimination to afford trisubstituted (E)-at,P-unsatu­
rated amides 5.3 In these elimination reactions, the 
potassium  alkoxide of 2 first undergoes intramolecular 
attack at its oxazolidin-2-one carbonyl, resulting in 0 - 0  
carbonyl migration, to afford an intermediate 1,3-oxaz- 
inane-2,4-dione alkoxide 3. Subsequent anion equilibra­
Keywords: A - A c y I - o x a z o l i d i n - 2 - o n e ;  j y n - A l d o l ;  E l i m i n a t i o n ;  N a t u r a l  
p r o d u c t .
*  C o r r e s p o n d i n g  a u t h o r .  T e l . :  + 4 4  0 1 2 2 5  8 6 2 6 5 5 ;  f a x :  + 4 4  0 1 2 2 5  
3 8 6 2 3 1 ;  e - m a i l :  s . d . b u l l @ b a t h . a c . u k
tion affords enolate 4 that then undergoes stereoselective 
elimination of carbon dioxide to afford the trisubstituted 
secondary amide (E)-5 (Fig. 2).4
This novel elimination m ethodology appeared ideally 
suited to the synthesis o f the core fatty acid amide 
fragments of the semiplenamides A -E  la - e  that we 
proposed could be easily prepared according to the ret­
ro-synthetic strategy described in Figure 3. Therefore, 
reaction between the enolate o f an L-alanine derived 
A-acyloxazolidin-2-one with an appropriate aldehyde 
would afford a .yj/7-aldol product, whose potassium alk­
oxide would subsequently undergo elimination to afford 
the desired (£)-amide functionality.
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R = n-C|3 H2 7
(45,2'5,3'/?)-9
R = n-C)3 H2 7  
(S)-lc
S c h e m e  1 .  R e a g e n t s  a n d  c o n d i t i o n s :  ( i )  L i A l H 4 ,  E t 20 ;  ( i i )  ( E t O ) 2C O ,  
K O E t ,  T H F ;  ( i i i )  « - B u L i ,  T H F ,  - 7 8  ° C ,  E t C O C l ;  ( i v )  9 - B B N - O T f ,  
' P r 2N E t ,  C H 2C 1 2 ,  0 ° C ,  h - C 13H 27C H O ,  - 7 8  ° C ;  ( v )  K O ' B u ,  T H F ,  
- 7 8  ° C  t o  r t .
Semiplenamide C lc  was chosen as a representative 
synthetic target to develop this methodology, using 
L-alanine methyl ester (S)-6 as an enantiopure starting 
material (Scheme 1). Reduction of (S)-6 with LiAlH4 
in Et20, followed by treatment of the resultant (S)-ami- 
no-alcohol with diethyl carbonate under basic condi­
tions, resulted in the formation of (S)-4-methyl- 
oxazolidin-2-one (S)-7 in a 45% yield over two steps.5 
Subsequent treatment of (S)-l with n-BuLi in THF at 
—78 °C, followed by addition of propionyl chloride 
afforded ./V-propionyl-oxazolidin-2-one (S)-8 in 78% 
yield.
Treatment of (S)-8 with 1.1 equiv of 9-BBN-OTf and 
'Pr2NEt in CH2C12, followed by cooling to —78 °C, 
and addition of 1.1 equiv of tetradecanal,6 resulted in 
syn-aldol 9 in >95% de, and in 81% yield after purifica­
tion by chromatography.7 The .syu-stereochemistry of 
(45',2/5,,3'/?)-aldol 9 was confirmed from the 
coupling constant of 3.0 Hz observed in its 'H NMR 
spectrum.8 The high levels of stereocontrol in this syn- 
aldol reaction are particularly noteworthy considering 
that facial selectivity is controlled by the sterically unde­
manding (45)-methyl group of the oxazolidin-2-one 
fragment.
Generation of the potassium alkoxide of syrc-aldol 9 via 
treatment with 1.1 equiv of KHMDS in toluene at 0 °C 
gave a low 23% yield of semiplenamide C (S)-lc, as well 
as TV-propionyl-oxazolidin-2-one (S)-8, oxazolidin-2-one 
{S)-l, and tetradecanal as unwanted side-products aris­
ing from a competing retro-aldol cleavage pathway.9 
However, it was found that simply changing the base 
employed for deprotonation of syw-aldol 9 to KO'Bu 
in THF at —78 °C resulted in a clean elimination reac­
tion to afford semiplenamide C (S^-lc in 74% yield after 
purification by chromatography.10
In conclusion, we have developed efficient methodology 
for the synthesis of the core (£)-a,(3-unsaturated amide 
fragments of semiplenamides A-E la-e, and have 
applied this methodology to the first synthesis of semi­
plenamide C. Work is currently underway applying this 
approach to the stereoselective synthesis of the remain­
ing semiplenamides, as well as for the synthesis of other 
natural and non-natural anandamide-like products.
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Grenadamide 1, debrom ogrenadadiene 2 and grenad- 
adiene 3 are natural products that were isolated from 
the marine cyanobacterium  Lyngbya nutjuscula, by Sita- 
chitta and Gerwick in 1998 (Fig. I).1 These structurally 
unique cyclopropyl fatty acid derived metabolites were 
shown to dem onstrate cannabinoid receptor binding 
activity, as well as cytotoxicity towards cancer cells. 
Baird and co-workers subsequently confirmed the abso­
lute configuration of the cyclopropane fragment of gren­
adamide 1 as (R ,R ) via total synthesis. Their synthesis 
required 14 steps, with an enzymatic desymmetrisation 
step being employed to introduce the stereogenic centres
o
i
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of the cyclopropane fragm ent.2 We thought that 
this approach appeared a little complicated since this 
structurally simple natural product contains only two 
stereogenic centres. Consequently, we now report an 
alternative asymmetric synthesis o f grenadamide 1 in 
six steps from the chiral auxiliary (/?)-4-benzyl-5,5- 
dimethyl-oxazolidin-2-one 15.
We are interested in developing novel synthetic strate­
gies that employ ‘tem porary’ stereogenic centres as ste- 
reodirecting groups to create remote stereocentres 
using substrate-directable reactions. For example, we 
have recently reported a three-step aldol/directed 
cyclo-propanation/re/ro-aldol protocol for the asym­
metric synthesis of chiral cyclopropane carboxaldehydes 
in good ee (Fig. 2).3 In this approach, a chiral auxiliary 
fragment 4 reacts with an a, P-unsaturated aldehyde 5 to 
afford a sjw-aldol product 6 (Step 1), whose ‘tem porary’ 
P-hydroxyl functionality is then used to control facial 
selectivity in a directed cyclopropanation reaction to 
afford cyclopropane 7 in very high de (Step 2). retro- 
Aldol cleavage o f cyclopropane 7 results in destruction 
o f the ‘tem porary’ P-hydroxyl stereocentre, affording 
the chiral auxiliary fragment 4, and the desired enantio­
pure cyclopropane carboxaldehyde 8 in high de (Step 3).
It was proposed that the excellent diastereoselectivity 
observed for cyclopropanation o f ^/7-aIdol 6 might also 
be exploited to devise a stereoselective synthesis of gren­
adamide 1 using the re/ra-synthetic analysis outlined 
in Figure 3. Therefore, grenadamide 1 would be pre­
pared from conjugate reduction o f a, P-unsaturated
F i g u r e  I .  S t r u c t u r e s  o f  g r e n a d a m i d e  1 ,  d e b r o m o g r e n a d a d i e n e  2  a n d  
g r e n a d a d i e n e  3 .
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amide 14, which could be derived from (3-elimination of 
a-chloro-|3-hydroxy-cyclopropane 13.4 The benzylamide 
functionality of cyclopropane 13 would be introduced 
via direct aminolysis of the oxazolidin-2-one fragment 
of 12 using phenylethylamine as a nucleophile. The 
cyclopropane ring of 12 could be introduced stereoselec- 
tively via a hydroxyl directed cyclopropanation reaction 
on .syTi-aldol 11 that would be prepared from aldol reac­
tion of the (Z)-boron-enolate of Af-chloroacetyl-5,5-di- 
methyl-oxazolidin-2-one 9 with (E)-dec-2-enal 10. This 
synthetic strategy would therefore afford enantiopure 
grenadamide 1 in five steps from TV-chloroacetyl-oxa- 
zolidin-2-one 9 via a relatively straightforward synthetic 
protocol that should be readily amenable to the prepara­
tion of analogues of this natural product as required.
It was thought necessary to employ the (Z)-boron enol­
ate of Af-chloroacetyloxazolidin-2-one 11 in order to 
ensure good levels of stereocontrol in the syn-aldol 
reaction, since boron enolates of N-acetyl-oxazolidin- 
2-ones are known to undergo aldol reactions in poor 
de.5 It should be noted, however, that the presence of 
the a-chloro-substituent is essential for the subsequent 
(3-elimination reaction of amide 13, since it enables 
samarium diiodide to remove the (3-hydroxyl functional­
ity simultaneously, thus affording a, P-unsaturated 
amide 14 in a single step. It was decided to employ
‘SuperQuat’ oxazolidin-2-one 15 as a chiral auxiliary 
for this synthesis because the 5,5-dimethyl substituent 
would discourage nucleophilic attack of phenylethyl­
amine at the endocyclic oxazolidin-2-one carbonyl of 
cyclopropane 12, thus ensuring that this aminolysis 
reaction afforded amide 13 in good yield.6
Our first task was to employ the syrc-aldol/directed 
cyclopropanation methodology described in Figure 2 
for the asymmetric synthesis of cyclopropane 12 in high 
de (Scheme 1). Therefore, (R)-4-benzyl-5,5-dimethyl- 
oxazolidin-2-one 15 was first prepared in 72% yield from 
unnatural D-phenylalanine using a previously reported 
procedure.7 Treatment of (7?)-15 in THF at —78 °C with 
1.1 equiv of n-BuLi, followed by addition of 1.1 equiv of 
chloroacetyl chloride gave a-chloroacetyl-oxazolidin-2- 
one 9 in 78% yield. Treatment of 9 with 1.1 equiv of 
9-BBN-OTf and 'Pr2NEt in CH2C12 at 0 °C, followed 
by cooling to -78 °C and addition of (jE)-dec-2-enal 
10 resulted in .yyn-aldol 11 in 92% de, which was purified 
to >95% de in 74% yield via chromatography.8 The syn- 
stereochemistry of aldol 11 was confirmed from the 
small coupling constant of 3.4 Hz observed in
the ]H NMR spectrum.9 Reaction of syn-aldol 11 with 
5 equiv of Et2Zn and CH2I2 in CH2C12 at —10 °C, 
resulted in a highly stereoselective cyclopropanation 
reaction, to afford syn-cyclopropyl aldol 12 in >95%
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de and in 98% yield.10 Cyclopropanations under this 
type of modified Furukawa conditions are normally 
syn-selective due to minimization of A1,3 strain in the 
transition state, and as a consequence the absolute con­
figuration of 12 was assigned accordingly.11
With the key cyclopropane 1212 in hand it was then nec­
essary to transform it into grenadamide 1 by replacing 
the oxazolidin-2-one fragment with phenylethylamine, 
and substituting both the a-chloro and fl-hydroxy sub­
stituents for hydrogen atoms (Scheme 2). It was found 
that simply dissolving cyclopropane 12 in neat phenyl­
ethylamine resulted in a clean aminolysis reaction to 
afford 5,5-dimethyl-oxazolidin-2-one (/?)-15 and amide 
13,13 which was isolated in 89% yield after chromato­
graphic purification.14 Analysis of the 'H NMR spec­
trum and TLC of the crude product of this aminolysis 
reaction revealed no evidence of any side products aris­
ing from a competing endocyclic cleavage pathway. Pre­
vious work by Concellon et al. had shown that
o  OH
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treatment of a-halo-(3-hydroxy-amides with 3 equiv of 
Sml2 resulted in clean elimination reactions to afford 
(£)-a,P-unsaturated amides in high de.15 Therefore, 
treatment of a-chloro-p-hydroxy-amide 13 with Sml2 in 
THF at room temperature resulted in P-elimination to 
afford (is)-a,P-unsaturated amide 1416 in 85% yield. 
Analysis of the 1H NMR spectrum of the crude reaction 
product revealed no evidence of any of its (Z)-isomer 
having been formed in this reaction. Finally, treatment 
of vinyl-cyclopropane 14 with NaBH4 and 20 mol % of 
CoCl2 in MeOH/THF,17 resulted in conjugate reduction 
of its alkene functionality to afford grenadamide l 18 as 
a white crystalline solid in 88% yield. Comparison of 
the spectroscopic details with that reported previously 
for grenadamide (R,R)-1 ([a]^ —11.0, (c 1.0, CHC13); 
Lit.1 [a]p -11.0 (c 0.1, CHC13)) revealed that the correct 
enantiomer of the natural product had been prepared in 
enantiopure form.
It should be noted that the synthetic strategy described 
for the synthesis of grenadamide 1 represents a powerful 
approach for the asymmetric synthesis of natural prod­
ucts that contain remote stereocentres. The strategy em­
ployed relies on the use of a chiral auxiliary to generate a 
‘temporary’ stereocentre that then acts as a stereodirect- 
ing group to relay stereochemical information via a sub- 
strate-directable reaction. This approach is synthetically 
powerful because it has the potential to afford chiral 
products that contain new stereocentres which are 
remote to the chiral auxiliary fragment, creating chiral 
building blocks that are often difficult to access using 
conventional synthetic approaches. We anticipate that 
this new type of ‘chiral relay’ strategy will prove applic­
able to the combination of other types of chiral auxiliary 
and substrate-directable reactions, thus enabling the 
asymmetric synthesis of other classes of natural product 
that contain remote stereocentres.
In conclusion, we have demonstrated the asymmetric 
synthesis of grenadamide 1 in six steps from 5,5-di- 
methyl-oxazolidin-2-one 15 in an overall 38% yield. 
The use of this methodology is currently under investi­
gation for the synthesis of debromogrenadadiene 2 and
7934 R. Green et al. / Tetrahedron Letters 46 (2005) 7931-7934
grenadadiene 3, since both these natural products 
should be available from the common intermediate 12 .
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